<SEC-DOCUMENT>0000784199-17-000092.txt : 20171011
<SEC-HEADER>0000784199-17-000092.hdr.sgml : 20171011
<ACCEPTANCE-DATETIME>20171010201702
ACCESSION NUMBER:		0000784199-17-000092
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20171010
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20171011
DATE AS OF CHANGE:		20171010

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CRYOLIFE INC
		CENTRAL INDEX KEY:			0000784199
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				592417093
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13165
		FILM NUMBER:		171131655

	BUSINESS ADDRESS:	
		STREET 1:		1655 ROBERTS BOULEVARD N W
		CITY:			KENNESAW
		STATE:			GA
		ZIP:			30144
		BUSINESS PHONE:		7704193355

	MAIL ADDRESS:	
		STREET 1:		1655 ROBERTS BOULEVARD N W
		CITY:			KENNESAW
		STATE:			GA
		ZIP:			30144
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>c199-20171010x8k.htm
<DESCRIPTION>8-K
<TEXT>
<!--HTML document created with Certent Disclosure Management 6.10.0.3-->
<!--Created on: 10/10/2017 8:13:52 PM-->
<html>
	<head>
		<title>
			20171010 8K Jolly SPA
		</title>
	</head>
	<body><div style="margin-left:72pt;margin-right:72pt;">
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:478.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt">
						<a name="_GoBack"></a><font style="display: inline;font-size:1pt;">&#xFEFF;</font><a name="_DV_M0"></a></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:478.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;font-size:11pt;">&#xFEFF;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">UNITED STATES</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<a name="_DV_M1"></a><font style="display: inline;font-weight:bold;font-size:11pt;">SECURITIES AND EXCHANGE COMMISSION</font><br /><font style="display: inline;font-weight:bold;font-size:11pt;"></font><font style="display: inline;font-weight:bold;font-size:11pt;">W</font><font style="display: inline;font-weight:bold;font-size:11pt;">ashington, </font><font style="display: inline;font-weight:bold;font-size:11pt;">D</font><font style="display: inline;font-weight:bold;font-size:11pt;">.</font><font style="display: inline;font-weight:bold;font-size:11pt;">C</font><font style="display: inline;font-weight:bold;font-size:11pt;">. 20549</font><br /><font style="display: inline;font-weight:bold;font-size:11pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<a name="_DV_M2"></a><font style="display: inline;font-weight:bold;font-size:11pt;">FORM 8-K</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">CURRENT REPORT</font><br /><font style="display: inline;font-weight:bold;font-size:11pt;">PURSUANT TO SECTION 13 OR 15(d) OF THE</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<a name="_DV_M3"></a><font style="display: inline;font-weight:bold;font-size:11pt;">SECURITIES EXCHANGE ACT OF 1934</font><br /><font style="display: inline;font-weight:bold;font-size:11pt;"></font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<a name="_DV_M4"></a><font style="display: inline;font-weight:bold;font-size:11pt;">Date of Report (Dat</font><font style="display: inline;font-weight:bold;font-size:11pt;">e of ear</font><font style="display: inline;font-weight:bold;font-size:11pt;">liest event reported): </font><font style="display: inline;font-weight:bold;font-size:11pt;">October </font><font style="display: inline;font-weight:bold;font-size:11pt;">10</font><font style="display: inline;font-weight:bold;font-size:11pt;">, 2017</font><br /><font style="display: inline;font-weight:bold;font-size:11pt;"></font><a name="_DV_M5"></a><font style="display: inline;font-weight:bold;font-size:11pt;">_______________________</font><br /><font style="display: inline;font-weight:bold;font-size:11pt;"></font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<a name="_DV_M6"></a><font style="display: inline;font-weight:bold;font-size:11pt;">CRYOLIFE, INC.</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<a name="_DV_M7"></a><font style="display: inline;font-size:11pt;">(Exact name of registrant as specified in its charter)</font><br /><font style="display: inline;font-weight:bold;font-size:11pt;">_________________________</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;font-size:11pt;">Florida</font></p>
				</td>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;font-size:11pt;">1-13165</font></p>
				</td>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;font-size:11pt;">59-2417093</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">(State or Other Jurisdiction</font><br /><font style="display: inline;font-size:11pt;">of Incorporation)</font></p>
				</td>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">(Commission File Number)</font></p>
				</td>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">(IRS Employer</font></p>
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">Identification No.)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<a name="_DV_M8"></a><font style="display: inline;font-weight:bold;font-size:11pt;">1655 Roberts Boulevard, N.W., Kennesaw, Georgia&nbsp;&nbsp;30144</font><br /><font style="display: inline;font-size:11pt;">(Address of principal executive office) (zip code)</font><br /><font style="display: inline;font-size:11pt;"></font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<a name="_DV_M9"></a><font style="display: inline;font-weight:bold;font-size:11pt;">Registrant's telephone number, including area code: (770) 419-3355</font><br /><font style="display: inline;font-weight:bold;font-size:11pt;"></font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<a name="_DV_M10"></a><font style="display: inline;font-size:10pt;">_____________________________________________________________</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<a name="_DV_M11"></a><font style="display: inline;font-size:10pt;">(Former name or former address, if changed since last report)</font><br /><font style="display: inline;font-size:10pt;"></font><a name="_DV_M12"></a><font style="display: inline;font-weight:bold;font-size:10pt;">_________________________</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<a name="_DV_M13"></a><font style="display: inline;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#x2610;</font><a name="_DV_M14"></a><font style="display: inline;font-size:10pt;font-family:Wingdings;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 18pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<a name="_DV_M15"></a><font style="display: inline;font-size:10pt;">&#x2610;</font><font style="display: inline;font-size:10pt;font-family:Wingdings;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 18pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 6pt 18pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<a name="_DV_M16"></a><font style="display: inline;font-size:10pt;">&#x2610;</font><font style="display: inline;font-size:10pt;font-family:Wingdings;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 18pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#x2610;</font><a name="_DV_M17"></a><font style="display: inline;font-size:10pt;font-family:Wingdings;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 18pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font><a name="_DV_M18"></a>
		</p>
		<p style="margin:12pt 0pt 6pt;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-family:74flzqmmzksgovw;font-size:10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#xA7;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#xA7;240.12b-2 of this chapter). </font>
		</p>
		<p style="margin:12pt 0pt 6pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-family:74flzqmmzksgovw;font-size:10pt;">Emerging growth company </font><font style="display: inline;color:#000000;font-size:10pt;">&#x2610;</font>
		</p>
		<p style="margin:0pt 0pt 6pt;border-top:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-family:74flzqmmzksgovw;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </font><font style="display: inline;color:#000000;font-size:10pt;">&#x2610;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">

		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;font-family:Times New Roman;;font-size: 10pt"><font style="display: inline;color:#000000;font-size:10pt;"></font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:77.40pt;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:401.40pt;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:77.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;font-size:11pt;">Item 1.01</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:401.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;font-size:11pt;">Entry into a Material Definitive Agreement</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-style:italic;font-size:11pt;">Securities Purchase</font><font style="display: inline;font-weight:bold;font-style:italic;font-size:11pt;"> Agreement </font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font><a name="_DV_M19"></a><a name="_DV_M20"></a>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">On </font><font style="display: inline;font-size:11pt;">October </font><font style="display: inline;font-size:11pt;">10</font><font style="display: inline;font-size:11pt;">, 2017</font><font style="display: inline;font-size:11pt;">,</font><font style="display: inline;font-size:11pt;"> CryoLife, Inc.</font><font style="display: inline;font-size:11pt;">, &nbsp;</font><font style="display: inline;font-size:11pt;">(</font><font style="display: inline;font-size:11pt;">&#x201C;CryoLife&#x201D; or </font><font style="display: inline;font-size:11pt;">the </font><font style="display: inline;font-size:11pt;">&#x201C;</font><font style="display: inline;font-size:11pt;">Company</font><font style="display: inline;font-size:11pt;">&#x201D;)</font><font style="display: inline;font-size:11pt;">,</font><font style="display: inline;font-size:11pt;"> entered into an agreement </font><font style="display: inline;font-size:11pt;">to acquire </font><font style="display: inline;font-size:11pt;">shares of JOTEC</font><font style="display: inline;font-size:11pt;"> AG (</font><font style="display: inline;font-size:11pt;">&#x201C;</font><font style="display: inline;font-size:11pt;">JOTEC</font><font style="display: inline;font-size:11pt;">&#x201D;)</font><font style="display: inline;font-size:11pt;">, a </font><font style="display: inline;font-size:11pt;">Swiss</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">public limited corporation</font><font style="display: inline;font-size:11pt;">,</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">pursuant to </font><font style="display: inline;font-size:11pt;">a Securities Purchase Agreement</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">(the &#x201C;Purchase Agreement&#x201D;)</font><font style="display: inline;font-size:11pt;">, by and among CryoLife, </font><font style="display: inline;font-size:11pt;">CryoLife Germany HoldCo GmbH, a German</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">limited company </font><font style="display: inline;font-size:11pt;">and wholly-owned subsidiary of CryoLife</font><font style="display: inline;font-size:11pt;"> (&#x201C;Parent&#x201D;), </font><font style="display: inline;font-size:11pt;">Jolly Buyer </font><font style="display: inline;font-size:11pt;">Acquisition </font><font style="display: inline;font-size:11pt;">GmbH</font><font style="display: inline;font-size:11pt;">, a </font><font style="display: inline;font-size:11pt;">Swiss</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">limited company </font><font style="display: inline;font-size:11pt;">and </font><font style="display: inline;font-size:11pt;">whol</font><font style="display: inline;font-size:11pt;">ly-o</font><font style="display: inline;font-size:11pt;">wned subsidiary of </font><font style="display: inline;font-size:11pt;">Parent </font><font style="display: inline;font-size:11pt;">(&#x201C;</font><font style="display: inline;font-size:11pt;">Buyer</font><font style="display: inline;font-size:11pt;">&#x201D;)</font><font style="display: inline;font-size:11pt;">,</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">the security</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">holders of JOTEC who are party to the Purchase Agreement, </font><font style="display: inline;font-size:11pt;">and </font><font style="display: inline;font-size:11pt;">Lars Sunnanv&#xE4;der</font><font style="display: inline;font-size:11pt;"> in </font><font style="display: inline;font-size:11pt;">his</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">capacity as the </font><font style="display: inline;font-size:11pt;">representative of </font><font style="display: inline;font-size:11pt;">such security</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">holders of JOTEC</font><font style="display: inline;font-size:11pt;">. Pursuant to the </font><font style="display: inline;font-size:11pt;">Purchase Agreement</font><font style="display: inline;font-size:11pt;">, &nbsp;</font><font style="display: inline;font-size:11pt;">the Buyer will acquire at least 94% of the outstanding shares of JOTEC, </font><font style="display: inline;font-size:11pt;">and </font><font style="display: inline;font-size:11pt;">up to all of the shares of JOTEC</font><font style="display: inline;font-size:11pt;">. CryoLife&#x2019;s and </font><font style="display: inline;font-size:11pt;">JOTEC&#x2019;s</font><font style="display: inline;font-size:11pt;"> board</font><font style="display: inline;font-size:11pt;">s</font><font style="display: inline;font-size:11pt;"> of directors each</font><font style="display: inline;font-size:11pt;"> have</font><font style="display: inline;font-size:11pt;"> approved the </font><font style="display: inline;font-size:11pt;">Purchase </font><font style="display: inline;font-size:11pt;">Agreement.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">Und</font><font style="display: inline;font-size:11pt;">er the terms of the Purchase</font><font style="display: inline;font-size:11pt;"> Agreement, CryoLife will pay an aggregate of </font><font style="display: inline;font-size:11pt;">up to </font><font style="display: inline;font-size:11pt;">$</font><font style="display: inline;font-size:11pt;">225</font><font style="display: inline;font-size:11pt;">.0 million in consideration, consisting of </font><font style="display: inline;font-size:11pt;">up to </font><font style="display: inline;font-size:11pt;">$</font><font style="display: inline;font-size:11pt;">168</font><font style="display: inline;font-size:11pt;">.</font><font style="display: inline;font-size:11pt;">75</font><font style="display: inline;font-size:11pt;"> million in cash and </font><font style="display: inline;font-size:11pt;">$</font><font style="display: inline;font-size:11pt;">56.25</font><font style="display: inline;font-size:11pt;"> million </font><font style="display: inline;font-size:11pt;">in shares </font><font style="display: inline;font-size:11pt;">of CryoLife</font><font style="display: inline;font-size:11pt;">&#x2019;s common</font><font style="display: inline;font-size:11pt;"> stock</font><font style="display: inline;font-size:11pt;">, represent</font><font style="display: inline;font-size:11pt;">ed by</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">up to</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">2</font><font style="display: inline;font-size:11pt;">,</font><font style="display: inline;font-size:11pt;">682,403</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">shares</font><font style="display: inline;font-size:11pt;"> of CryoLife</font><font style="display: inline;font-size:11pt;">&#x2019;s common stock</font><font style="display: inline;font-size:11pt;">. &nbsp;</font><font style="display: inline;font-size:11pt;">The </font><font style="display: inline;font-size:11pt;">cash portion of the </font><font style="display: inline;font-size:11pt;">acquisition</font><font style="display: inline;font-size:11pt;"> consideration shall consist of </font><font style="display: inline;font-size:11pt;">a</font><font style="display: inline;font-size:11pt;"> cash amount </font><font style="display: inline;font-size:11pt;">to </font><font style="display: inline;font-size:11pt;">be paid to </font><font style="display: inline;font-size:11pt;">the </font><font style="display: inline;font-size:11pt;">security</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">holders of </font><font style="display: inline;font-size:11pt;">JOTEC who are party to the Purchase Agreement, and cash to be paid to holders of shareholder loans </font><font style="display: inline;font-size:11pt;">extended </font><font style="display: inline;font-size:11pt;">to JOTEC for such shareholder loans</font><font style="display: inline;font-size:11pt;">. &nbsp;</font><font style="display: inline;font-size:11pt;">A portion of the </font><font style="display: inline;font-size:11pt;">acquisition</font><font style="display: inline;font-size:11pt;"> consideration </font><font style="display: inline;font-size:11pt;">may</font><font style="display: inline;font-size:11pt;"> also be used to pay off </font><font style="display: inline;font-size:11pt;">JOTEC&#x2019;s</font><font style="display: inline;font-size:11pt;"> outstanding indebtedness and certain transaction costs </font><font style="display: inline;font-size:11pt;">of </font><font style="display: inline;font-size:11pt;">JOTEC</font><font style="display: inline;font-size:11pt;"> and its security</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">holders in connection with</font><font style="display: inline;font-size:11pt;"> the </font><font style="display: inline;font-size:11pt;">acquisition</font><font style="display: inline;font-size:11pt;">.&nbsp; </font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">The equity</font><font style="display: inline;font-size:11pt;"> portion of the </font><font style="display: inline;font-size:11pt;">acquisition</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">consideration shall </font><font style="display: inline;font-size:11pt;">be issued pursuant to </font><font style="display: inline;font-size:11pt;">a private placement under </font><font style="display: inline;font-size:11pt;">Regulation S</font><font style="display: inline;font-size:11pt;"> promulgated under the Securities Act of 1933, as amended</font><font style="display: inline;font-size:11pt;"> (&#x201C;Regulation S&#x201D;)</font><font style="display: inline;font-size:11pt;">. The </font><font style="display: inline;font-size:11pt;">value of the shares </font><font style="display: inline;font-size:11pt;">of CryoLife&#x2019;s common stock to be issued </font><font style="display: inline;font-size:11pt;">as equity </font><font style="display: inline;font-size:11pt;">acquisition</font><font style="display: inline;font-size:11pt;"> consideration </font><font style="display: inline;font-size:11pt;">is calculated</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">based on a </font><font style="display: inline;font-size:11pt;">60 trading </font><font style="display: inline;font-size:11pt;">day volume-weighted average </font><font style="display: inline;font-size:11pt;">trading </font><font style="display: inline;font-size:11pt;">price of </font><font style="display: inline;font-size:11pt;">CryoLife&#x2019;s</font><font style="display: inline;font-size:11pt;"> common stock </font><font style="display: inline;font-size:11pt;">for </font><font style="display: inline;font-size:11pt;">6</font><font style="display: inline;font-size:11pt;">0 consecutive trading days</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">immediately</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">preceding</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">the </font><font style="display: inline;font-size:11pt;">October </font><font style="display: inline;font-size:11pt;">10</font><font style="display: inline;font-size:11pt;">, 2017</font><font style="display: inline;font-size:11pt;"> signing date of the </font><font style="display: inline;font-size:11pt;">Purchase</font><font style="display: inline;font-size:11pt;"> Agreement</font><font style="display: inline;font-size:11pt;">.</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">Such shares of CryoLife&#x2019;s com</font><font style="display: inline;font-size:11pt;">mon stock will be subject to a six</font><font style="display: inline;font-size:11pt;">-month lockup and transfer restrictions as provided under Regulation S</font><font style="display: inline;font-size:11pt;">.</font><font style="display: inline;font-size:11pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">The aggregate </font><font style="display: inline;font-size:11pt;">acquisition</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">consideration </font><font style="display: inline;font-size:11pt;">payable in the transaction </font><font style="display: inline;font-size:11pt;">is subject to certain adjustments, including amounts based on </font><font style="display: inline;font-size:11pt;">JOTEC&#x2019;s</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">cash</font><font style="display: inline;font-size:11pt;">-</font><font style="display: inline;font-size:11pt;">on</font><font style="display: inline;font-size:11pt;">-</font><font style="display: inline;font-size:11pt;">hand</font><font style="display: inline;font-size:11pt;"> and indebtedness</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">as of the </font><font style="display: inline;font-size:11pt;">closing of the acquisition</font><font style="display: inline;font-size:11pt;">, with an audit of these </font><font style="display: inline;font-size:11pt;">adjustments </font><font style="display: inline;font-size:11pt;">occurring after the closing pursuant to the </font><font style="display: inline;font-size:11pt;">Purchase</font><font style="display: inline;font-size:11pt;"> Agreement</font><font style="display: inline;font-size:11pt;">. &nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">Pursuant to the </font><font style="display: inline;font-size:11pt;">Purchase</font><font style="display: inline;font-size:11pt;"> Agreement, $</font><font style="display: inline;font-size:11pt;">22</font><font style="display: inline;font-size:11pt;">.</font><font style="display: inline;font-size:11pt;">5</font><font style="display: inline;font-size:11pt;"> million </font><font style="display: inline;font-size:11pt;">in cash </font><font style="display: inline;font-size:11pt;">will be held </font><font style="display: inline;font-size:11pt;">in escrow</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">as </font><font style="display: inline;font-size:11pt;">partial </font><font style="display: inline;font-size:11pt;">security for the </font><font style="display: inline;font-size:11pt;">indemnification obligations</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">of </font><font style="display: inline;font-size:11pt;">the</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">JOTEC</font><font style="display: inline;font-size:11pt;"> securit</font><font style="display: inline;font-size:11pt;">y</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">holder</font><font style="display: inline;font-size:11pt;">s</font><font style="display: inline;font-size:11pt;"> who are party to the Purchase Agreement</font><font style="display: inline;font-size:11pt;">. &nbsp;</font><font style="display: inline;font-size:11pt;">T</font><font style="display: inline;font-size:11pt;">he </font><font style="display: inline;font-size:11pt;">funds remaining in the indemnification escrow account</font><font style="display: inline;font-size:11pt;"> will be released </font><font style="display: inline;font-size:11pt;">approximately eighteen months</font><font style="display: inline;font-size:11pt;"> from the date of closing</font><font style="display: inline;font-size:11pt;"> of the </font><font style="display: inline;font-size:11pt;">acquisition</font><font style="display: inline;font-size:11pt;">, less the aggregate amount of any pending </font><font style="display: inline;font-size:11pt;">and unresolved </font><font style="display: inline;font-size:11pt;">claims as of such date</font><font style="display: inline;font-size:11pt;">.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">The </font><font style="display: inline;font-size:11pt;">Purchase</font><font style="display: inline;font-size:11pt;"> Agreement contains</font><font style="display: inline;font-size:11pt;"> customary representations, warranties and covenants </font><font style="display: inline;font-size:11pt;">made </font><font style="display: inline;font-size:11pt;">by the security holders of JOTEC </font><font style="display: inline;font-size:11pt;">who are</font><font style="display: inline;font-size:11pt;"> party to the Purchase Agreement,</font><font style="display: inline;font-size:11pt;"> and CryoLife</font><font style="display: inline;font-size:11pt;">, Parent and Buyer</font><font style="display: inline;font-size:11pt;">. &nbsp;</font><font style="display: inline;font-size:11pt;">JOTEC&#x2019;s</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">security</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">holders</font><font style="display: inline;font-size:11pt;"> who are party to the Pu</font><font style="display: inline;font-size:11pt;">rchase Agreement </font><font style="display: inline;font-size:11pt;">agreed to indemnify </font><font style="display: inline;font-size:11pt;">CryoLife</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">and its affiliates </font><font style="display: inline;font-size:11pt;">for </font><font style="display: inline;font-size:11pt;">certain matters, including breaches of representations, warranties and covenants included in the </font><font style="display: inline;font-size:11pt;">Purchase</font><font style="display: inline;font-size:11pt;"> Agreement, up to the </font><font style="display: inline;font-size:11pt;">$22</font><font style="display: inline;font-size:11pt;">.</font><font style="display: inline;font-size:11pt;">5</font><font style="display: inline;font-size:11pt;"> million escrow fund</font><font style="display: inline;font-size:11pt;">, subject to certain exceptions</font><font style="display: inline;font-size:11pt;"> pursuant to which CryoLife and its affiliates may recover indemnified </font><font style="display: inline;font-size:11pt;">losses from recipients of </font><font style="display: inline;font-size:11pt;">acquisition</font><font style="display: inline;font-size:11pt;"> consideration in amounts in excess of the escrow fund</font><font style="display: inline;font-size:11pt;">.</font><font style="display: inline;font-size:11pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;line-height:10pt;text-align:center;font-family:CG Omega;font-size: 9pt">

			<font style="display: inline;font-family:Times New Roman;font-size:9pt;">-</font><font style="display: inline;font-family:Times New Roman;font-size:9pt;"></font><font style="display: inline;font-family:Times New Roman;font-size:9pt;">2</font><font style="display: inline;font-family:Times New Roman;font-size:9pt;"></font><font style="display: inline;font-family:Times New Roman;font-size:9pt;">-</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 11pt"><font style="display: inline;font-size:11pt;">The closing of the </font><font style="display: inline;font-size:11pt;">acquisition</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">is</font><font style="display: inline;font-size:11pt;"> subject to customary closing conditions for transactions of this type, including, among other things, </font><font style="display: inline;font-size:11pt;">termination </font><font style="display: inline;font-size:11pt;">and/or amendment </font><font style="display: inline;font-size:11pt;">of certain </font><font style="display: inline;font-size:11pt;">agreements</font><font style="display: inline;font-size:11pt;">, &nbsp;</font><font style="display: inline;font-size:11pt;">the accuracy of the representations and warranties</font><font style="display: inline;font-size:11pt;">,</font><font style="display: inline;font-size:11pt;"> and compliance with the covenants set forth in the </font><font style="display: inline;font-size:11pt;">Purchase</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">Agreement.</font><font style="display: inline;font-size:11pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">The foregoing description of the </font><font style="display: inline;font-size:11pt;">Purchase</font><font style="display: inline;font-size:11pt;"> Agreement does not purport to be complete and is qualified in its entirety by reference to the </font><font style="display: inline;font-size:11pt;">Purchase</font><font style="display: inline;font-size:11pt;"> Agreement, which is filed as Exhibit 2.1 to this Current Report on Form 8-K and is incorporated herein by reference.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">The </font><font style="display: inline;font-size:11pt;">Purchase</font><font style="display: inline;font-size:11pt;"> Agreement has been attached to this Current Report on Form 8-K to provide investors with information regarding its terms. The </font><font style="display: inline;font-size:11pt;">Purchase</font><font style="display: inline;font-size:11pt;"> Agreement is not intended to provide any other factual information about </font><font style="display: inline;font-size:11pt;">CryoLife</font><font style="display: inline;font-size:11pt;">, &nbsp;</font><font style="display: inline;font-size:11pt;">JOTEC</font><font style="display: inline;font-size:11pt;"> or any of their respective subsidiaries or affiliates. The representations, warranties and covenants contained in the </font><font style="display: inline;font-size:11pt;">Purchase</font><font style="display: inline;font-size:11pt;"> Agreement were made only for purposes of the </font><font style="display: inline;font-size:11pt;">Purchase</font><font style="display: inline;font-size:11pt;"> Agreement as of the specific dates therein, were solely for the benefit of the parties to the </font><font style="display: inline;font-size:11pt;">Purchase</font><font style="display: inline;font-size:11pt;"> Agreement, may be subject to limitations agreed upon by such contracting parties, including being qualified by confidential disclosures made for the purposes of allocating contractual risk among such parties to the </font><font style="display: inline;font-size:11pt;">Purchase</font><font style="display: inline;font-size:11pt;"> Agreement instead of establishing these matters as facts, and may be subject to standards of materiality applicable to such contracting parties that differ from those applicable to investors. Investors are not third-party beneficiaries under the </font><font style="display: inline;font-size:11pt;">Purchase</font><font style="display: inline;font-size:11pt;"> Agreement and should not rely on the representations, warranties and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of the parties thereto or any of their respective subsidiaries or affiliates. Moreover, information concerning the subject matter of representations and warranties may change after the date of the </font><font style="display: inline;font-size:11pt;">Purchase</font><font style="display: inline;font-size:11pt;"> Agreement, which subsequent information may or may not be fully reflected in </font><font style="display: inline;font-size:11pt;">CryoLife&#x2019;s</font><font style="display: inline;font-size:11pt;"> public disclosures.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:77.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:401.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:77.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;font-size:11pt;">Item 2.02</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:401.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;font-size:11pt;">Results of Operations &amp; Financial Conditions</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;"></font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">On </font><font style="display: inline;font-size:11pt;">October 10, 2017, t</font><font style="display: inline;font-size:11pt;">he Company </font><font style="display: inline;font-size:11pt;">issued a press release announcing </font><font style="display: inline;font-size:11pt;">the execution of the Purchase Agreement, providing an update as to the Company&#x2019;s preliminary results for the third quarter of 2017, and </font><font style="display: inline;font-size:11pt;">providing that an update to </font><font style="display: inline;font-size:11pt;">the Company&#x2019;s guidance for the remainder of 2017</font><font style="display: inline;font-size:11pt;"> with be provided during the Company&#x2019;s third quarter conference call</font><font style="display: inline;font-size:11pt;">. A copy of the Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:77.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:401.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:77.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;font-size:11pt;">Item 3.02</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:401.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;font-size:11pt;">Unregistered Sales of Equity Securities</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">The information set forth in Item 1.01 above with respect to the issuance of shares of </font><font style="display: inline;font-size:11pt;">the Company&#x2019;s</font><font style="display: inline;font-size:11pt;"> common stock as part of the </font><font style="display: inline;font-size:11pt;">acquisition</font><font style="display: inline;font-size:11pt;"> consideration is incorporated into this Item 3.02 by reference. The shares of common stock have not been registered under the Securities Act or any state securities laws. The </font><font style="display: inline;font-size:11pt;">shares will be issued pursuant to a private placement under </font><font style="display: inline;font-size:11pt;">Regulation S</font><font style="display: inline;font-size:11pt;"> promulgated under the Securities Act</font><font style="display: inline;font-size:11pt;">.</font><font style="display: inline;font-size:11pt;"> &nbsp; &nbsp;</font><font style="display: inline;font-size:11pt;">The shares of common stock may not be offered or sold in the United </font><font style="display: inline;font-size:11pt;">States </font><font style="display: inline;font-size:11pt;">absent registration or exemption from registration under the Securities Act and any applicable state securities laws. Neither this Current Report on Form 8-K nor any of the exhibits attached hereto is an offer to sell or the solicitation of an offer to buy shares of common stock or other securities of </font><font style="display: inline;font-size:11pt;">the Company</font><font style="display: inline;font-size:11pt;">.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;line-height:10pt;text-align:center;font-family:CG Omega;font-size: 9pt">

			<font style="display: inline;font-family:Times New Roman;font-size:9pt;">-</font><font style="display: inline;font-family:Times New Roman;font-size:9pt;"></font><font style="display: inline;font-family:Times New Roman;font-size:9pt;">3</font><font style="display: inline;font-family:Times New Roman;font-size:9pt;"></font><font style="display: inline;font-family:Times New Roman;font-size:9pt;">-</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;font-family:Times New Roman;;font-size: 11pt"><font style="display: inline;font-size:11pt;"></font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;background-color:yellow;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:77.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;font-size:11pt;">Item 7.01</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:401.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;font-size:11pt;">Regulation FD Disclosure</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">On </font><font style="display: inline;font-size:11pt;">October </font><font style="display: inline;font-size:11pt;">10</font><font style="display: inline;font-size:11pt;">, 2017</font><font style="display: inline;font-size:11pt;">,</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">the Company</font><font style="display: inline;font-size:11pt;"> issued a press release announcing the execution of the </font><font style="display: inline;font-size:11pt;">Purchase</font><font style="display: inline;font-size:11pt;"> Agreement</font><font style="display: inline;font-size:11pt;">. &nbsp;</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">A</font><font style="display: inline;font-size:11pt;"> copy of </font><font style="display: inline;font-size:11pt;">the press release</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">is </font><font style="display: inline;font-size:11pt;">furnished</font><font style="display: inline;font-size:11pt;"> as Exhibit 99.1 hereto and incorporated herein by reference. </font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">The information in Item</font><font style="display: inline;font-size:11pt;">s 2.02 and</font><font style="display: inline;font-size:11pt;"> 7.01 of this Current Report on Form 8-K</font><font style="display: inline;font-size:11pt;">, including Exhibit 99.1 attached hereto,</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">is being furnished and shall not be deemed &#x201C;filed&#x201D; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#x201C;Exchange Act&#x201D;), or otherwise subject to the liabilities of that section, and it shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or under the Exchange Act, whether made before or after the date hereof, except as expressly set forth by specific reference in such filing to Item </font><font style="display: inline;font-size:11pt;">2.02 or </font><font style="display: inline;font-size:11pt;">7.01 of this Current Report on Form 8-K.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:77.40pt;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:401.40pt;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:77.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;font-size:11pt;">Item 8.01</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:401.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;font-size:11pt;">Other Events</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">Commitment Letter</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">In connection with the Purchase Agreement, the Company entered into a debt commitment letter(the &#x201C;Commitment Letter&#x201D;), dated as of October 10, 2017, with Deutsche Bank AG New York Branch (&#x201C;DBNY&#x201D;) and Deutsche Bank Securities Inc. (together with DBNY, &#x201C;DB&#x201D;), Capital One, National Association (&#x201C;CONA&#x201D;), and Fifth Third Bank (&#x201C;Fifth Third&#x201D; and, together with DB and CONY, collectively, the &#x201C;Commitment Parties&#x201D;), pursuant to which, among other things, the Commitment Parties have committed to provide the Company with a senior secured term loan in an aggregate principal amount of $225,000,000 (the &#x201C;Term Loan Facility&#x201D;) to finance, in part, the acquisition of JOTEC, and a $30,000,000 revolving credit facility (the &#x201C;Revolving Credit Facility&#x201D; and, together with the Term Loan Facility, the &#x201C;Credit Facility&#x201D;).&nbsp;&nbsp;The Company and each of its existing and subsequently acquired or formed domestic subsidiaries (subject to certain exceptions and exclusions) will guarantee the obligations under the Credit Facility (the &#x201C;Guarantors&#x201D;). The Credit Facility will be secured by a security interest in substantially all existing and after-acquired real and personal property (subject to certain exceptions and exclusions) of the Company and the Guarantors. The proceeds from the Term Loan Facility, together with the Company&#x2019;s cash-on-hand, will be sufficient to finance the aggregate cash consideration to JOTEC&#x2019;s security holders who are party to the Purchase Agreement and associated fees and expenses and to repay certain existing Company and JOTEC debt.&nbsp;&nbsp;Pursuant to the Purchase Agreement, JOTEC has agreed to use commercially reasonable efforts to provide cooperation to the Company in connection with the Term Loan Facility.&nbsp;&nbsp;The Commitment Parties&#x2019; commitment to provide the Credit Facility is subject to certain conditions, including: the negotiation and execution of definitive documentation consistent with the Commitment Letter; the consummation of the acquisition of JOTEC substantially concurrently with the initial funding under the Term Loan Facility; delivery of certain unaudited and pro forma financial statements; subject to certain limitations, the absence of a material adverse effect on JOTEC; the accuracy of specified representations and warranties of the security holders who are parties to the Purchase Agreement and specified representations and warranties of the Company to be set forth in the definitive loan documents; and other customary closing conditions. The Financing would replace the Company&#x2019;s existing credit facility.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;line-height:10pt;text-align:center;font-family:CG Omega;font-size: 9pt">

			<font style="display: inline;font-family:Times New Roman;font-size:9pt;">-</font><font style="display: inline;font-family:Times New Roman;font-size:9pt;"></font><font style="display: inline;font-family:Times New Roman;font-size:9pt;">4</font><font style="display: inline;font-family:Times New Roman;font-size:9pt;"></font><font style="display: inline;font-family:Times New Roman;font-size:9pt;">-</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;font-family:Times New Roman;;font-size: 11pt"><font style="display: inline;font-size:11pt;"></font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;background-color:yellow;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:77.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;font-size:11pt;">Item 9.01</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:401.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;font-size:11pt;">Financial Statements and Exhibits</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="display: inline;font-size:11pt;">Exhibits</font><font style="display: inline;font-size:11pt;">.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="middle" style="width:14.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td valign="middle" style="width:86.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td colspan="2" valign="middle" style="width:100.00%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">&#xFEFF;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:14.00%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">&#xFEFF;</font></p>
				</td>
				<td valign="middle" style="width:86.00%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:14.00%;padding:7.2pt 1.8pt 1.8pt 1.8pt;">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;font-size:11pt;text-decoration:underline;">Exhibit No.</font></p>
				</td>
				<td valign="top" style="width:86.00%;padding:7.2pt 1.8pt 1.8pt 1.8pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;font-size:11pt;text-decoration:underline;">Description</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:14.00%;padding:7.2pt 1.8pt 1.8pt 1.8pt;height:44.25pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">&#xFEFF;</font><a href="c199-20171010xex2_1.htm" style="-sec-extract:exhibit"><font style="display: inline;font-size:11pt;">2.1</font></a><font style="display: inline;font-size:11pt;">*</font></p>
				</td>
				<td valign="top" style="width:86.00%;padding:7.2pt 1.8pt 1.8pt 1.8pt;height:44.25pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">Securities Purchase Agreement, dated as of October 10, 2017, by and among CryoLife, Inc., CryoLife Germany HoldCo GmbH, Jolly Buyer Acquisition GmbH, JOTEC AG,&nbsp;&nbsp;each of the security holders identified therein, and Lars Sunnanv&#xE4;der as the representative of such security holders</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:14.00%;padding:7.2pt 1.8pt 1.8pt 1.8pt;">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">&#xFEFF;</font><a href="c199-20171010xex99_1.htm" style="-sec-extract:exhibit"><font style="display: inline;font-size:11pt;">99.1</font></a><font style="display: inline;font-size:11pt;">**</font></p>
				</td>
				<td valign="top" style="width:86.00%;padding:7.2pt 1.8pt 1.8pt 1.8pt;">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">Press Release of CryoLife, Inc., dated October 10, 2017</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="2" valign="top" style="width:100.00%;padding:1.8pt 1.8pt 1.8pt 1.8pt;height:5.25pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 6pt">
						<font style="display: inline;font-size:6pt;">&#xFEFF;</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="2" valign="top" style="width:100.00%;padding:1.8pt 1.8pt 1.8pt 1.8pt;height:34.29pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">* The schedules and exhibits to the Securities Purchase Agreement have been omitted from this filing pursuant to Item 601(b)(2) of Regulation S-K. CryoLife will furnish copies of any such schedules and exhibits to the Securities and Exchange Commission upon request.</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="2" valign="top" style="width:100.00%;padding:1.8pt 1.8pt 1.8pt 1.8pt;height:34.29pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">** Furnished herewith, not filed.</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">&nbsp;</font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;line-height:10pt;text-align:center;font-family:CG Omega;font-size: 9pt">

			<font style="display: inline;font-family:Times New Roman;font-size:9pt;">-</font><font style="display: inline;font-family:Times New Roman;font-size:9pt;"></font><font style="display: inline;font-family:Times New Roman;font-size:9pt;">5</font><font style="display: inline;font-family:Times New Roman;font-size:9pt;"></font><font style="display: inline;font-family:Times New Roman;font-size:9pt;">-</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;;font-size: 11pt"><font style="display: inline;font-weight:bold;font-size:11pt;"></font><font style="display: inline;font-weight:bold;font-size:11pt;">SIGNATURES</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font><a name="_DV_M39"></a>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, CryoLife, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;text-decoration:underline;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:477.90pt;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:45.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:193.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="width:238.50pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">CRYOLIFE, INC.</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:45.00pt;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:193.50pt;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:45.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:193.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">Date:&nbsp; </font><font style="display: inline;font-size:11pt;">October 10, 2017</font></p>
				</td>
				<td valign="top" style="width:45.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">By:</font></p>
				</td>
				<td valign="top" style="width:193.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">/s/ D. Ashley Lee</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:45.00pt;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">Name:</font></p>
				</td>
				<td valign="top" style="width:193.50pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">D. Ashley Lee</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:45.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">Title:</font></p>
				</td>
				<td valign="top" style="width:193.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">Executive Vice President, Chief Operating Officer and Chief Financial Officer</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;line-height:10pt;text-align:center;font-family:CG Omega;font-size: 9pt">

			<font style="display: inline;font-family:Times New Roman;font-size:9pt;">-</font><font style="display: inline;font-family:Times New Roman;font-size:9pt;"></font><font style="display: inline;font-family:Times New Roman;font-size:9pt;">6</font><font style="display: inline;font-family:Times New Roman;font-size:9pt;"></font><font style="display: inline;font-family:Times New Roman;font-size:9pt;">-</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>c199-20171010xex2_1.htm
<DESCRIPTION>EX-2.1
<TEXT>
<!--HTML document created with Certent Disclosure Management 6.10.0.3-->
<!--Created on: 10/10/2017 8:14:21 PM-->
<html>
	<head>
		<title>
			2017.10.10 8K Jolly Exh 2.1
		</title>
	</head>
	<body><div style="margin-left:72pt;margin-right:72pt;"><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:right;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Exhibit 2.1</font>

		</p>

</div>
		<p style="margin:24pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_GoBack"></a><font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:24pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:24pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">SECURITIES PURCHASE AGREEMENT </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">BY AND AMONG</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">CRYOLIFE</font><font style="display: inline;font-weight:bold;">, INC.,</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">CRYOLIFE GERMANY HOLDCO </font><font style="display: inline;font-weight:bold;">GMBH,</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">JOLLY BUYER ACQUISITION</font><font style="display: inline;font-weight:bold;"> GMBH,</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">JOTEC</font><font style="display: inline;font-weight:bold;"> AG,</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">THE SECURITYHOLDERS LISTED ON SCHEDULE 1 HERETO,</font><font style="display: inline;font-weight:bold;"> AND</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">LARS SUNNANV</font><font style="display: inline;font-weight:bold;">&#xC4;</font><font style="display: inline;font-weight:bold;">DER</font><font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;">, as the Securityholder Representative</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">Dated as of </font><font style="display: inline;font-weight:bold;">October 10</font><font style="display: inline;font-weight:bold;">, 2017</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-weight:bold;">TABLE OF CONTENTS</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:495.75pt;margin-left:4.65pt;">
			<tr>
				<td valign="middle" style="width:67.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 12pt">
						<font style="display: inline;">&#xFEFF;</font></p>
				</td>
				<td valign="bottom" style="width:391.95pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="middle" style="width:36.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">&#xFEFF;</font></p>
				</td>
				<td valign="bottom" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;text-decoration:underline;">Page</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">Article&nbsp;I</font><font style="display: inline;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;">DEFINITIONS</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#Definitions"><font style="display: inline;">2</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">1.1</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Definitions</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#Definitions"><font style="display: inline;">2</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">Article&nbsp;II</font><font style="display: inline;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;">PURCHASE AND SALE</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#Salepurchase"><font style="display: inline;">3</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">2.1</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Sale and Purchase of the Shares</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#Salepurchase"><font style="display: inline;">3</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">2.2</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Shareholder Loans, Shares of Minority Shareholders, Shareholder Options and Bonuses</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#Salepurchase"><font style="display: inline;">3</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">2.3</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Closing</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#closing"><font style="display: inline;">4</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">2.4</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Purchase Price</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#closing"><font style="display: inline;">4</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">2.5</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Consideration Schedule</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#considerationschedule"><font style="display: inline;">5</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">2.6</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Exchange Procedures</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#exchangeprocedures"><font style="display: inline;">6</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">Article&nbsp;III</font><font style="display: inline;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;">ACQUISITION CONSIDERATION ADJUSTMENT</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#acquisitionconsideration"><font style="display: inline;">7</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">3.1</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Acquisition Consideration Adjustment</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#acquisitionconsideration"><font style="display: inline;">7</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">Article&nbsp;IV</font><font style="display: inline;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;">REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE SECURITYHOLDERS</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#authority"><font style="display: inline;">9</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">4.1</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Authority; Non-Contravention; Approvals</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#authority"><font style="display: inline;">9</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">4.2</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Title to Sold Shares</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#titletosoldshares"><font style="display: inline;">10</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">4.3</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Litigation</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#litigation"><font style="display: inline;">11</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">4.4</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Interest in Intellectual Property</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#litigation"><font style="display: inline;">11</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">4.5</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Brokers&#x2019; and Finders&#x2019; Fees</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#litigation"><font style="display: inline;">11</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">4.6</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Interested Party Transactions</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#litigation"><font style="display: inline;">11</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">4.7</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Investment Representations, Warranties and Covenants</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#litigation"><font style="display: inline;">11</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">4.8</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Tax Statu</font><font style="display: inline;color:#000000;">s</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#taxstatus"><font style="display: inline;">14</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">4.9</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Lock-Up Period</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#lockupperiod"><font style="display: inline;">15</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">4.10</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Restrictive Legends</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#lockupperiod"><font style="display: inline;">15</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">4.11</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Fair Disclosure</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#fairdisclosure"><font style="display: inline;">16</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">Article&nbsp;V</font><font style="display: inline;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;">REPRESENTATIONS AND WARRANTIES REGARDING THE COMPANY AND THE COMPANY SUBSIDIARIES</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#articlev"><font style="display: inline;">17</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.1</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Organization of the Company</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#articlev"><font style="display: inline;">17</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.2</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Company Capital Structure</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#companycapitalstructure"><font style="display: inline;">18</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.3</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Subsidiaries</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#subsidiaries"><font style="display: inline;">19</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.4</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Authority</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#subsidiaries"><font style="display: inline;">19</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.5</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">No Conflict</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#noconflict"><font style="display: inline;">20</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.6</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Governmental Consents</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#noconflict"><font style="display: inline;">20</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.7</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Company Financial Statements</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#companyfinancialstatements"><font style="display: inline;">21</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.8</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">No Undisclosed Liabilities</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#companyfinancialstatements"><font style="display: inline;">21</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.9</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Internal Controls</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#companyfinancialstatements"><font style="display: inline;">21</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.10</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">No Changes</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#nochanges"><font style="display: inline;">22</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.11</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Tax Matters</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#taxmatters"><font style="display: inline;">25</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.12</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Restrictions on Business Activities</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#restrictionsonbusinessactivities"><font style="display: inline;">29</font></a></p>
				</td>
			</tr></table>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">1</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:495.75pt;margin-left:4.65pt;">
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.13</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Title to Properties; Absence of Liens and Encumbrances</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#titletoproperties"><font style="display: inline;">30</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.14</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Intellectual Property</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#intellectualproperty"><font style="display: inline;">31</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.15</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Agreements, Contracts and Commitments</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#agreementscontracts"><font style="display: inline;">37</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.16</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Related Party Transactions</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#agreementscontracts"><font style="display: inline;">37</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.17</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Health Care Legal Compliance</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#healthcarelegalcompliance"><font style="display: inline;">38</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.18</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Company Authorizations</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#healthcarelegalcompliance"><font style="display: inline;">38</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.19</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Litigation</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#litigation"><font style="display: inline;">39</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.20</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Corporate and Business Records</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#corporateandbusinessrecords"><font style="display: inline;">40</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.21</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Environmental Matters</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#corporateandbusinessrecords"><font style="display: inline;">40</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.22</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Brokers&#x2019; and Finders&#x2019; Fees</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#corporateandbusinessrecords"><font style="display: inline;">40</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.23</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Employee Benefit Plans and Compensation</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#corporateandbusinessrecords"><font style="display: inline;">40</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.24</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Insurance</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#insurance"><font style="display: inline;">43</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.25</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Compliance with Laws</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#compliancewithlaws"><font style="display: inline;">44</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.26</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Export and Import Control Laws</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#compliancewithlaws"><font style="display: inline;">44</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.27</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Bank Accounts, Letters of Credit and Powers of Attorney</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#bankaccounts"><font style="display: inline;">45</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.28</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Customers and Suppliers</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#bankaccounts"><font style="display: inline;">45</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.29</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Warranties to Customers</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#warrantiestocustomers"><font style="display: inline;">46</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.30</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Products</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#warrantiestocustomers"><font style="display: inline;">46</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.31</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Utilization of Assets</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#warrantiestocustomers"><font style="display: inline;">46</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.32</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Disclosure</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#disclosure"><font style="display: inline;">47</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">5.33</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Fair Disclosure</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#disclosure"><font style="display: inline;">47</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">Article&nbsp;VI</font><font style="display: inline;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;">REPRESENTATIONS AND WARRANTIES OF CRYOLIFE, PARENT, AND BUYER</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#articlevi"><font style="display: inline;">48</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">6.1</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Organization, Standing and Power</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#articlevi"><font style="display: inline;">48</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">6.2</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Authority</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#articlevi"><font style="display: inline;">48</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">6.3</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">No Conflict</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#articlevi"><font style="display: inline;">48</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">6.4</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Capitalization</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#capitalization"><font style="display: inline;">49</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">6.5</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Litigation</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#capitalization"><font style="display: inline;">49</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">6.6</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Consents</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#capitalization"><font style="display: inline;">49</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">6.7</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Issuance of CryoLife Common Stock</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#capitalization"><font style="display: inline;">49</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">6.8</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Private Placement</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#privateplacement"><font style="display: inline;">50</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">6.9</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Operations of Parent and Buyer</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#privateplacement"><font style="display: inline;">50</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">6.10</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">SEC Documents</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#privateplacement"><font style="display: inline;">50</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">6.11</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Solvency</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#privateplacement"><font style="display: inline;">50</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">6.12</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Financing</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#financing"><font style="display: inline;">51</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">6.13</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">CryoLife Operational Representations</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#cryolifeoperational"><font style="display: inline;">52</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">6.14</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Disclosure</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#disclosure"><font style="display: inline;">54</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">Article&nbsp;VII</font><font style="display: inline;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;">ADDITIONAL AGREEMENTS</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#articlevii"><font style="display: inline;">54</font></a></p>
				</td>
			</tr></table>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:232pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;"></font><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">2</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:495.75pt;margin-left:4.65pt;">
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">7.1</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Preservation of Business</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#articlevii"><font style="display: inline;">54</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">7.2</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Exclusivity</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#exclusivity"><font style="display: inline;">55</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">7.3</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Confidentiality</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#exclusivity"><font style="display: inline;">55</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">7.4</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Expenses</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#exclusivity"><font style="display: inline;">55</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">7.5</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Transfer Taxes</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#transfertaxes"><font style="display: inline;">56</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">7.6</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">[Intentionally omitted]</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#publicdisclosure"><font style="display: inline;">57</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">7.7</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Public Disclosure</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#publicdisclosure"><font style="display: inline;">57</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">7.8</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Consents</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#publicdisclosure"><font style="display: inline;">57</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">7.9</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Additional Documents and Further Assurances; Reasonable Efforts</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#publicdisclosure"><font style="display: inline;">57</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">7.10</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Section 338(g) Election</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#section338"><font style="display: inline;">59</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">7.11</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Indirect Partial Liquidation</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#section338"><font style="display: inline;">59</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">7.12</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Indemnification of Officers and Directors</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#indemnificationofofficers"><font style="display: inline;">61</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">7.13</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">No Claims against Directors and Officers; Release.</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#indemnificationofofficers"><font style="display: inline;">61</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">7.14</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Securityholder Release</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#securityholderrelease"><font style="display: inline;">62</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">7.15</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Squeeze-Out Merger</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#securityholderrelease"><font style="display: inline;">62</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">7.16</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Restrictions on Other Share Transfers</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#articleviii"><font style="display: inline;">63</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">7.17</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Escrow Agent</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#articleviii"><font style="display: inline;">63</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">Article&nbsp;VIII</font><font style="display: inline;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;">CONDITIONS TO THE ACQUISITION</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#articleviii"><font style="display: inline;">63</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">8.1</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Conditions to Obligations of Each Party to Effect the Acquisition</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#articleviii"><font style="display: inline;">63</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">8.2</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Conditions to the Obligations of Parent and Buyer</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#conditionstoobligationsparent"><font style="display: inline;">64</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">8.3</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Conditions to Obligations of the Company</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">and the Securityholders</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#conditionstoobligationscompany"><font style="display: inline;">65</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">Article&nbsp;IX</font><font style="display: inline;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;">SURVIVAL OF REPRESENTATIONS, WARRANTIES AND COVENANTS</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#articleix"><font style="display: inline;">66</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">9.1</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Survival of Representations, Warranties and Covenants</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#articleix"><font style="display: inline;">66</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">9.2</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Indemnification</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#indemnification"><font style="display: inline;">68</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">9.3</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Escrow Arrangements</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#escrowarrangements"><font style="display: inline;">69</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">9.4</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Indemnification Claims</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#indemnificationclaims"><font style="display: inline;">70</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">9.5</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Securityholder Representative</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#securityholderrepresentative"><font style="display: inline;">74</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">9.6</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Maximum Payments; Remedy</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#maximumpayments"><font style="display: inline;">76</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">9.7</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Purchase Price Adjustments</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#purchasepriceadjustments"><font style="display: inline;">77</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">9.8</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Sole Remedy</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#purchasepriceadjustments"><font style="display: inline;">77</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">9.9</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Termination</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#purchasepriceadjustments"><font style="display: inline;">77</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">Article&nbsp;X</font><font style="display: inline;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;">AMENDMENT AND WAIVER</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#articlex"><font style="display: inline;">78</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">10.1</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Amendment</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#articlex"><font style="display: inline;">78</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">10.2</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Extension; Waiver</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#articlex"><font style="display: inline;">78</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">Article&nbsp;XI</font><font style="display: inline;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;">GENERAL PROVISIONS</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#articlexi"><font style="display: inline;">79</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">11.1</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Notices</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#articlexi"><font style="display: inline;">79</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">11.2</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Interpretation</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#interpretation"><font style="display: inline;">81</font></a></p>
				</td>
			</tr></table>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:232pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;"></font><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">3</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:495.75pt;margin-left:4.65pt;">
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">11.3</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Counterparts</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#interpretation"><font style="display: inline;">81</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">11.4</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Entire Agreement; Assignment</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#interpretation"><font style="display: inline;">81</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">11.5</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Severability</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#interpretation"><font style="display: inline;">81</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">11.6</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Other Remedies; Specific Performance</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#interpretation"><font style="display: inline;">81</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">11.7</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Governing Law; Venue</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#governinglaw"><font style="display: inline;">82</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">11.8</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Rules of Construction</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#governinglaw"><font style="display: inline;">82</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">11.9</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Successors and Assigns</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#successorsandassigns"><font style="display: inline;">83</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">11.10</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Taking of Necessary Action</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#successorsandassigns"><font style="display: inline;">83</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">11.11</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Third Party Beneficiaries</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#successorsandassigns"><font style="display: inline;">83</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">11.12</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">No Recourse; Certain Limitations on Remedies</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#norecourse"><font style="display: inline;">84</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:67.80pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#010000;">11.13</font></p>
				</td>
				<td valign="middle" style="width:391.95pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Waiver of Jury Trial</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;height:15.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<a href="#norecourse"><font style="display: inline;">84</font></a></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:81.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:396.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:81.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;text-decoration:underline;">Schedules</font><font style="display: inline;">:</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:396.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:81.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#xFEFF;</font><a href="#schedule1"><font style="display: inline;">Schedule 1</font></a></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:396.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Securityholders</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:81.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#xFEFF;</font><a href="#schedule2"><font style="display: inline;">Schedule 2</font></a></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:396.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Company Subsidiaries</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:81.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#xFEFF;</font><a href="#schedule3"><font style="display: inline;">Schedule 3</font></a></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:396.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Company Products</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:81.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#xFEFF;</font><a href="#schedule4"><font style="display: inline;">Schedule 4</font></a></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:396.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Consideration Schedule</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:81.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#xFEFF;</font><a href="#schedule5"><font style="display: inline;">Schedule 5</font></a></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:396.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Defined Terms</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:81.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#xFEFF;</font><a href="#schedule6"><font style="display: inline;">Schedule 6</font></a></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:396.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Excluded Contracts</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:81.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#xFEFF;</font><a href="#schedule7"><font style="display: inline;">Schedule 7</font></a></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:396.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Third Party Consents and Notices</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:81.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#xFEFF;</font><a href="#schedule8"><font style="display: inline;">Schedule 8</font></a></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:396.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Liens to be Released</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:81.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#xFEFF;</font><a href="#schedule9"><font style="display: inline;">Schedule 9</font></a></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:396.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Contracts to be Terminated</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:81.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#xFEFF;</font><a href="#schedule10"><font style="display: inline;">Schedule 10</font></a></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:396.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Contracts to be Amended</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:81.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#xFEFF;</font><a href="#schedule11"><font style="display: inline;">Schedule 11</font></a></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:396.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Special Indemnification Matters</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:81.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#xFEFF;</font><a href="#schedule12"><font style="display: inline;">Schedule 12</font></a></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:396.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Already Considered Purchase Price Reductions</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:81.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;text-decoration:underline;">Exhibits</font><font style="display: inline;">:</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:396.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:81.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#xFEFF;</font><a href="#exhibita"><font style="display: inline;">Exhibit A</font></a></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:396.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Escrow Agreement </font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:81.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#xFEFF;</font><a href="#exhibitb"><font style="display: inline;">Exhibit B</font></a></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:396.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Securityholder Agreement </font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="Preamble"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:232pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;"></font><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">4</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-weight:bold;">SECURITIES PURCHASE AGREEMENT</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">This SECURITIES PURCHASE AGREEMENT (the &#x201C;</font><font style="display: inline;font-weight:bold;">Agreement</font><font style="display: inline;">&#x201D;) is made and entered into as of</font><font style="display: inline;"> October</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">10</font><font style="display: inline;">, 2017 by and among </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Inc., a Florida corporation (&#x201C;</font><font style="display: inline;font-weight:bold;">CryoLife</font><font style="display: inline;">&#x201D;), CryoLife Germany HoldCo GmbH</font><font style="display: inline;">, a German GmbH (&#x201C;</font><font style="display: inline;font-weight:bold;">Parent</font><font style="display: inline;">&#x201D;), </font><font style="display: inline;">Jolly Buyer Acquisition GmbH</font><font style="display: inline;">, a Swiss GmbH (&#x201C;</font><font style="display: inline;font-weight:bold;">Buyer</font><font style="display: inline;">&#x201D;), </font><font style="display: inline;">JOTEC</font><font style="display: inline;"> AG, a Swiss AG (the &#x201C;</font><font style="display: inline;font-weight:bold;">Company</font><font style="display: inline;">&#x201D;), the securityholders of the Company listed on </font><font style="display: inline;font-weight:bold;">Schedule 1</font><font style="display: inline;"> hereto (the &#x201C;</font><font style="display: inline;font-weight:bold;">Securityholders</font><font style="display: inline;">&#x201D;)</font><font style="display: inline;"> who have signed this Agreement below</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">and Lars Sunnanv</font><font style="display: inline;">&#xE4;</font><font style="display: inline;">der</font><font style="display: inline;"> (the &#x201C;</font><font style="display: inline;font-weight:bold;">Securityholder Representative</font><font style="display: inline;">&#x201D;)</font><font style="display: inline;">.</font><font style="display: inline;"> Each person or entity noted above is referred to as a &#x201C;</font><font style="display: inline;font-weight:bold;">Party</font><font style="display: inline;">&#x201D; and collectively as the &#x201C;</font><font style="display: inline;font-weight:bold;">Parties</font><font style="display: inline;">&#x201D;, and references to Schedules and Exhibits refer to the Schedules and Exhibits attached to this Agreement, unless otherwise noted.&nbsp; </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">RECITALS</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">A.</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 28.8pt 0pt 0pt;"></font><font style="display: inline;"></font><a name="RecitalB"></a><font style="display: inline;">The Company and each of the subsidiaries of the Company listed in </font><font style="display: inline;font-weight:bold;">Schedule 2</font><font style="display: inline;"> (each, a &#x201C;</font><font style="display: inline;font-weight:bold;">Company Subsidiary</font><font style="display: inline;">&#x201D; and, </font><font style="display: inline;">collectively</font><font style="display: inline;">, the &#x201C;</font><font style="display: inline;font-weight:bold;">Company Subsidiaries</font><font style="display: inline;">&#x201D;) design, develop, market and sell aortic and vascular surgical and endovascular medical devices and accessories</font><font style="display: inline;"> (including but not limited to thoracic medical devices and accessories)</font><font style="display: inline;"> (the &#x201C;</font><font style="display: inline;font-weight:bold;">Business</font><font style="display: inline;">&#x201D;), including the Company Products (as defined in this Agreement), all of which are listed and described in </font><font style="display: inline;font-weight:bold;">Schedule 3</font><font style="display: inline;">.&nbsp; </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">B.</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 28.8pt 0pt 0pt;"></font><font style="display: inline;">The Securityholders are </font><font style="display: inline;">currently</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">the holders of </font><font style="display: inline;">101,923 of all issued and </font><font style="display: inline;">outstanding </font><font style="display: inline;">Shares </font><font style="display: inline;">(as defined in this Agreement)</font><font style="display: inline;">, representing approximately </font><font style="display: inline;">94.4</font><font style="display: inline;">% of the Shares</font><font style="display: inline;">.</font><a name="RecitalC"></a><font style="display: inline;"> &nbsp;U</font><font style="display: inline;">pon the terms and subject to the conditions set forth in this Agreement</font><font style="display: inline;">, at the Closing, t</font><font style="display: inline;">he</font><font style="display: inline;"> &nbsp;S</font><font style="display: inline;">ecurityholders desire to sell to Buyer and Buyer desires to purchase from the Securityholders, </font><font style="display: inline;">all of the Shares held by the Securityholders immediately prior to Closing </font><font style="display: inline;">(</font><font style="display: inline;">the </font><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Acquisition</font><font style="display: inline;">&#x201D;)</font><font style="display: inline;">.&nbsp; </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">C.</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 28.8pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;">Upon the terms and subject to the conditions set forth in this Agreement, the $22</font><font style="display: inline;">5</font><font style="display: inline;">,000,000 in consideration payable by Buyer</font><font style="display: inline;"> for 100% of the Shares</font><font style="display: inline;">, subject to adjustments set forth in this Agreement and the escrow amount described below, will be paid partially in </font><font style="display: inline;">U.S. Dollars</font><font style="display: inline;"> and partially in shares of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock, to be allocated among the Securityholders as described in </font><font style="display: inline;font-weight:bold;">Schedule 4 </font><font style="display: inline;">which schedule shall be updated prior to C</font><font style="display: inline;">losing</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">(the &#x201C;</font><font style="display: inline;font-weight:bold;">Consideration Schedule</font><font style="display: inline;">&#x201D;).</font><font style="display: inline;"> &nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">D</font><font style="display: inline;">.</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 29.4pt 0pt 0pt;"></font><font style="display: inline;"></font><a name="RecitalD"></a><font style="display: inline;">In connection with the Acquisition, (i) at the Closing, the holders of the Shareholder Loans (as defined in this Agreement) </font><font style="display: inline;">desire to sell and transfer the Shareholder Loans to Buyer for the amount of principal and interest then outstanding under the Shareholder Loans (the &#x201C;</font><font style="display: inline;font-weight:bold;">Consideration for the Shareholder Loans</font><font style="display: inline;">&#x201D;) and Buyer desires to purchase</font><font style="display: inline;"> the Shareholder Loans to be allocated among the holders of the Shareholder Loans as described in the Consideration Schedule,</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">(ii) prior to the Closing, the Securityholders desire to purchase the Shares they do not own from the other shareholders of the Company (each a &#x201C;</font><font style="display: inline;font-weight:bold;">Minority Shareholder</font><font style="display: inline;">&#x201D; and collectively the &#x201C;</font><font style="display: inline;font-weight:bold;">Minority Shareholders</font><font style="display: inline;">&#x201D;); (iii) prior to the Closing, the Securityholders who granted </font><font style="display: inline;">the </font><font style="display: inline;">Shareholder Options (each an &#x201C;</font><font style="display: inline;font-weight:bold;">Option Grantor</font><font style="display: inline;">&#x201D; and </font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">1</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">collectively the &#x201C;</font><font style="display: inline;font-weight:bold;">Option Grantors</font><font style="display: inline;">&#x201D;) desire to redeem the Shareholder Options (as defined in this Agreement) from the holders of such Shareholder Options; and (iv) following Closing, subject to Closing occurring, certain Securityholders shall pay the </font><font style="display: inline;">bonus or change of control payments (subject to the terms of the respective Contracts</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">between the recipients of such bonuses and such Securityholders) to Employees of the Company or any Company Subsidiaries in connection with the Acquisition</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">E.</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 28.8pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;">Contemporaneously with the execution and delivery of this Agreement</font><font style="display: inline;">, Buyer and the Securityholder Representative are </font><font style="display: inline;">enter</font><font style="display: inline;">ing </font><font style="display: inline;">into </font><font style="display: inline;">the escrow agreement attached as </font><font style="display: inline;font-weight:bold;">Exhibit A</font><font style="display: inline;"> (the &#x201C;</font><font style="display: inline;font-weight:bold;">Escrow</font><font style="display: inline;font-weight:bold;"> Agreement</font><font style="display: inline;">&#x201D;), to be effective as of the Closing Date</font><font style="display: inline;"> subject to Closing occurring, and a</font><font style="display: inline;"> portion of the cash consideration otherwise payable in connection with the Acquisition shall be placed in </font><font style="display: inline;">an </font><font style="display: inline;">escrow</font><font style="display: inline;"> account</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">with U.S. Bank, N.A., in its capacity as escrow agent (the &#x201C;</font><font style="display: inline;font-weight:bold;">Escrow </font><font style="display: inline;font-weight:bold;">Agent</font><font style="display: inline;">&#x201D;), pursuant to the Escrow Agreement </font><font style="display: inline;">as partial security for any amounts payable for indemnification claims and other payment obligations</font><font style="display: inline;">, as</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">described</font><font style="display: inline;"> in this Agreement.</font><font style="display: inline;"> &nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">F</font><font style="display: inline;">.</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 29.4pt 0pt 0pt;"></font><font style="display: inline;"></font><a name="RecitalF"></a><font style="display: inline;">Contemporaneously </font><font style="display: inline;">with</font><font style="display: inline;"> the execution and delivery of this Agreement by the Parties, </font><font style="display: inline;">the </font><font style="display: inline;">Key Employee</font><font style="display: inline;"> (as defined in this Agreement) is </font><font style="display: inline;">executing one or more documents with </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> or one of its subsidiaries (each a &#x201C;</font><font style="display: inline;font-weight:bold;">Key</font><font style="display: inline;font-weight:bold;"> Employee Document</font><font style="display: inline;">&#x201D; and collectively, the &#x201C;</font><font style="display: inline;font-weight:bold;">Key</font><font style="display: inline;font-weight:bold;"> Employee Documents</font><font style="display: inline;">&#x201D;), each to be effective as of the Closing Date</font><font style="display: inline;"> subject to Closing occurring</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">G</font><font style="display: inline;">.</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 29.4pt 0pt 0pt;"></font><font style="display: inline;"></font><a name="RecitalG"></a><font style="display: inline;">Contemporaneously with the execution and delivery of this Agreement, as a material inducement to </font><font style="display: inline;">Candy, Parent and </font><font style="display: inline;">Buyer to enter into this Agreement, each of the Securityholders is entering into a Contract not to compete with the Business or solicit employees or customers of the Business following the Acquisition, in substantially the form of </font><font style="display: inline;font-weight:bold;">Exhibit </font><font style="display: inline;font-weight:bold;">B</font><font style="display: inline;"> (the &#x201C;</font><font style="display: inline;font-weight:bold;">Securityholder Agreement</font><font style="display: inline;">&#x201D;), each to be effective as of the Closing Date</font><font style="display: inline;"> subject to Closing occurring</font><font style="display: inline;">. &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">NOW, THEREFORE, in consideration of the mutual agreements, covenants and other promises set forth herein, the mutual </font><font style="display: inline;">benefits</font><font style="display: inline;"> to be gained by the performance thereof, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged and accepted, the Parties hereby agree as follows:</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc487751012"></a><a name="_Toc487788467"></a><a name="_Toc487788659"></a><a name="_Toc487788792"></a><a name="_Toc491721268"></a><a name="_Toc493797716"></a><a name="_Toc493797839"></a><a name="_Toc493844624"></a><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#010000;">Article&nbsp;I</font><br /><font style="display: inline;font-weight:bold;text-transform:uppercase;"></font><br /><font style="display: inline;font-weight:bold;text-transform:uppercase;"></font><a name="_Toc493869118"></a><a name="_Toc493869362"></a><a name="_Toc495394213"></a><font style="display: inline;font-weight:bold;text-transform:uppercase;">DEFINITIONS</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="Definitions"></a><a name="_Toc370996716"></a><a name="_Toc373830361"></a><a name="_Ref451977311"></a><a name="_Toc487751013"></a><a name="_Toc487788468"></a><a name="_Toc487788660"></a><a name="_Toc487788793"></a><a name="_Toc491721269"></a><a name="_Toc493797717"></a><a name="_Toc493797840"></a><a name="_Toc493844625"></a><a name="_Toc493869119"></a><a name="_Toc493869363"></a><a name="_Toc495394214"></a><a name="_Ref151403883"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">1.1</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Definitions</font><font style="display: inline;">.&nbsp;&nbsp;For all purposes of this Agreement, the defined terms set forth on </font><font style="display: inline;font-weight:bold;">Schedule 5</font><font style="display: inline;"> are hereby incorporated in this Agreement.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc379314106"></a><a name="_Toc379314483"></a><a name="_Toc379315097"></a><a name="_Ref376996370"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">2</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#010000;">Article&nbsp;II</font><br /><font style="display: inline;font-weight:bold;text-transform:uppercase;"></font><br /><font style="display: inline;font-weight:bold;text-transform:uppercase;"></font><a name="_Ref377060869"></a><a name="_Toc487751014"></a><a name="_Toc487788469"></a><a name="_Toc487788661"></a><a name="_Toc487788794"></a><a name="_Toc491721270"></a><a name="_Toc493797718"></a><a name="_Toc493797841"></a><a name="_Toc493844626"></a><a name="_Toc493869120"></a><a name="_Toc493869364"></a><a name="_Toc495394215"></a><font style="display: inline;font-weight:bold;text-transform:uppercase;">PURCHASE AND SALE</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="Salepurchase"></a><a name="_Ref444774221"></a><a name="_Ref444775667"></a><a name="_Ref444977475"></a><a name="_Toc487751015"></a><a name="_Toc487788470"></a><a name="_Toc487788662"></a><a name="_Toc487788795"></a><a name="_Toc491721271"></a><a name="_Toc493797719"></a><a name="_Toc493797842"></a><a name="_Ref493799144"></a><a name="_Toc493844627"></a><a name="_Toc493869121"></a><a name="_Toc493869365"></a><a name="_Toc495394216"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">2.1</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Sale and Purchase of the </font><font style="display: inline;font-weight:bold;font-style:italic;">Share</font><font style="display: inline;font-weight:bold;font-style:italic;">s</font><font style="display: inline;font-style:italic;">.</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">&nbsp;</font><a name="_Ref444358875"></a><font style="display: inline;">On the terms and subject to the conditions of this Agreement, at the Closing, </font><font style="display: inline;">(a)</font><font style="display: inline;"> the Securityholders shall sell, transfer, assign, convey and deliver to Buyer all of the Shares </font><font style="display: inline;">owned by the Securityholders as of the Closing Date immediately prior to Closing (the &#x201C;</font><font style="display: inline;font-weight:bold;">Sold Shares</font><font style="display: inline;">&#x201D;; each a &#x201C;</font><font style="display: inline;font-weight:bold;">Sold Share</font><font style="display: inline;">&#x201D;) </font><font style="display: inline;">free and clear of any Liens, and </font><font style="display: inline;">(b)</font><font style="display: inline;"> Buyer shall purchase and acquire all </font><font style="display: inline;">Sold </font><font style="display: inline;">Shares</font><font style="display: inline;">,</font><font style="display: inline;"> free and clear of any Liens</font><font style="display: inline;">, for the </font><font style="display: inline;">consideration described in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">2.4</font><font style="display: inline;">.</font><font style="display: inline;"> &nbsp; &nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc487751016"></a><a name="_Toc487788471"></a><a name="_Toc487788663"></a><a name="_Toc487788796"></a><a name="_Ref491504009"></a><a name="_Ref491549505"></a><a name="_Ref491676674"></a><a name="_Ref491679533"></a><a name="_Ref491683996"></a><a name="_Ref491701685"></a><a name="_Toc491721272"></a><a name="_Toc493797720"></a><a name="_Toc493797843"></a><a name="_Toc493869122"></a><a name="_Toc493869366"></a><a name="_Toc495394217"></a><a name="_Toc493844628"></a><a name="_Ref445046695"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">2.2</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Shareholder Loans</font><font style="display: inline;font-weight:bold;font-style:italic;">, Shares of Min</font><font style="display: inline;font-weight:bold;font-style:italic;">ority Shareholders, Shareholder</font><font style="display: inline;font-weight:bold;font-style:italic;"> Options and Bonuses</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#010000;">(a)</font><font style="display: inline;color:#010000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 61.2pt 0pt 0pt;"></font><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Shareholder Loans</font><font style="display: inline;">: &nbsp;</font><font style="display: inline;">On the terms and subject to the conditions of this Agreement, at the Closing, the holders of the </font><font style="display: inline;">Shareholder Loans shall sell and transfer to Buyer and </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> shall or shall cause Buyer to acquire the</font><font style="display: inline;"> Shareholder Loans from the holders thereof, for the </font><font style="display: inline;">consideration described in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">2.4</font><font style="display: inline;">. &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#010000;">(b)</font><font style="display: inline;color:#010000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 61.2pt 0pt 0pt;"></font><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Shares of Minority Shareholders</font><font style="display: inline;font-weight:bold;">.</font><font style="display: inline;"> Between the date of this Agreement and the Closing </font><font style="display: inline;">and at such time as the</font><font style="display: inline;"> Securityholders</font><font style="display: inline;"> reasonably believe will enable </font><font style="display: inline;">as many </font><font style="display: inline;">Shares </font><font style="display: inline;">as possible not owned by the Securityholders, yet, </font><font style="display: inline;">to be </font><font style="display: inline;">acquired from </font><font style="display: inline;">the </font><font style="display: inline;">Minority Shareholders prior to the Closing Date subject to Closing occurring</font><font style="display: inline;">, the </font><font style="display: inline;">Securityholders </font><font style="display: inline;">shall </font><font style="display: inline;"> acquire as many </font><font style="display: inline;">Shares </font><font style="display: inline;">as possible not owned by the Securityholders as of the date hereof from the Minority Shareholders subject to Closing occurring</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref493715494"></a><font style="display: inline;color:#010000;">(c)</font><font style="display: inline;color:#010000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 61.2pt 0pt 0pt;"></font><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Shareholder Options</font><font style="display: inline;font-weight:bold;">. &nbsp;</font><font style="display: inline;">On the terms and subject to the c</font><font style="display: inline;">onditions of this Agreement, </font><font style="display: inline;">prior to </font><font style="display: inline;">the Closing, the Option Grantors shall redeem the Shareholder Options subject to the Closing occurring</font><font style="display: inline;"> and </font><font style="display: inline;">shall terminate prior to the Closing subject to Closing occurring all rights under</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">or related to the Shareholder Options.</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#010000;">(d)</font><font style="display: inline;color:#010000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 61.2pt 0pt 0pt;"></font><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Shareholder Bonuses</font><font style="display: inline;font-weight:bold;">.</font><font style="display: inline;"> On the terms and subject to the conditions of this Agreement, any Securityholders who committed to pay or otherwise pay a bonus or change of control payment to Employees of the Company or any Company Subsidiaries (each a &#x201C;</font><font style="display: inline;font-weight:bold;">Bonus Payor</font><font style="display: inline;">&#x201D; and collectively the &#x201C;</font><font style="display: inline;font-weight:bold;">Bonus Payors</font><font style="display: inline;">&#x201D;) in connection with the Acquisition shall pay subject to Closing occurring such bonuses or change of control payments at the latest one (1) Business Day following the Closing. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#010000;">(e)</font><font style="display: inline;color:#010000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 61.2pt 0pt 0pt;"></font><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Documentation</font><font style="display: inline;font-weight:bold;">.</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">The Securityholders</font><font style="display: inline;">, including</font><font style="display: inline;"> each of the holders of the </font><font style="display: inline;">Shareholder Loans, the Option Grantors and Bonus Payors, </font><font style="display: inline;">shall </font><font style="display: inline;">execute and shall apply commercially reasonable efforts to have the recipients of the Shareholder Options and the bonus or change of control payments </font><font style="display: inline;">execute all such documents and take all such other actions as may be necessary to </font><font style="display: inline;">confirm the foregoing actions to occur at or prior to the Closing, as applicable</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#010000;">(f)</font><font style="display: inline;color:#010000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 61.2pt 0pt 0pt;"></font><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Required Withholding Tax</font><font style="display: inline;font-weight:bold;">.</font><font style="display: inline;"> Half of the amount payable to holders of Shareholder Options pursuant to this </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">2.2</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">will be withheld by the Option Grantors on </font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">3</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">behalf of the holders of Shareholder Options who are employees of any of the Company Subsidiaries and paid by the Option Grantors on behalf of the holder of the Shareholders Option to the relevant Company Subsidiary at the latest one (1) Business Day following the Closing to satisfy the employee and employer portion of any associated Taxes, social security or similar obligations </font><font style="display: inline;">required to be deducted or withh</font><font style="display: inline;">e</font><font style="display: inline;">ld therefrom under any provision of applicable Law</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">(a &#x201C;</font><font style="display: inline;font-weight:bold;">Required Withholding Tax</font><font style="display: inline;">&#x201D;)</font><font style="display: inline;"> and the Bonus Payors shall withhold half of the bonus or change of control amount payable to each of the Employees any of the Company Subsidiaries pursuant to this </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">2.2</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">and pay such withheld amounts on behalf of the Employees receiving such bonuses or change of control payments to the relevant Company Subsidiary at the latest one (1) Business Day following the Closing to satisfy any associated Required Withholding Tax. In the event that the amount so withheld and paid falls short of the amount required to be paid to the applicable Governmental Authority with respect to (A) a Shareholder Option or (B) a bonus or change of control amounts payable by the Bonus Payors, the shortfall of such Required Withholding Tax shall be paid upon demand of the Buyer at the option of the Buyer either to the Company or applicable Company Subsidiary directly by the former holder of a Shareholder Option or the applicable Employee to the applicable Governmental Authority. The Company will cause the relevant Company Subsidiary to release any excess amount not used to pay the Required Withholding Tax (the &#x201C;</font><font style="display: inline;font-weight:bold;">Excess Withholding Amount</font><font style="display: inline;">&#x201D;) to the applicable Employee or former holder of a Shareholder Option upon the relevant Company Subsidiary&#x2019;s receipt of reasonable satisfactory evidence as to the existence and calculation of an Excess Withholding Amount.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc487751017"></a><a name="_Ref487784292"></a><a name="_Ref487784359"></a><a name="_Toc487788472"></a><a name="_Toc487788664"></a><a name="_Toc487788797"></a><a name="_Toc491721273"></a><a name="_Toc493797721"></a><a name="_Toc493797844"></a><a name="_Toc493844629"></a><a name="_Toc493869123"></a><a name="_Toc493869367"></a><a name="_Toc495394218"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">2.3</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="closing"></a><font style="display: inline;font-weight:bold;font-style:italic;">Closing</font><font style="display: inline;">.&nbsp; </font><font style="display: inline;">Unless the Securityholders holding a majority of the Shares Representative and Buyer mutually agree in writing to a different date and time, t</font><font style="display: inline;">he Acquisition will take place at 12:01 a.m. Eastern Time on the fifth (5</font><font style="display: inline;font-size:6pt;vertical-align:super;line-height:100%">th</font><font style="display: inline;">) Business Day following the date on which the satisfaction or written waiver </font><font style="display: inline;">(to the extent legally permissible) </font><font style="display: inline;">of the conditions precedent set forth in </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;VIII</font><font style="display: inline;"> occurs and continues</font><font style="display: inline;">. The Acquisition shall take place remotely by facsimile, e-mail or other electronic communication, unless another method is mutually agreed upon in writing by Buyer and the</font><font style="display: inline;"> Securityholder Representative</font><font style="display: inline;">. The consummation of the Acquisition is referred to as the &#x201C;</font><font style="display: inline;font-weight:bold;">Closing</font><font style="display: inline;">.&#x201D; The date and time upon which the Closing is effective shall be referred to herein as the &#x201C;</font><font style="display: inline;font-weight:bold;">Closing Date</font><font style="display: inline;">.&#x201D;</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc370996719"></a><a name="_Toc373830364"></a><a name="_Ref373830587"></a><a name="_Ref373832710"></a><a name="_Ref376996570"></a><a name="_Ref376999592"></a><a name="_Ref444843176"></a><a name="_Ref445046684"></a><a name="_Ref487622836"></a><a name="_Toc487751018"></a><a name="_Toc487788473"></a><a name="_Toc487788665"></a><a name="_Toc487788798"></a><a name="_Toc491721274"></a><a name="_Ref493708537"></a><a name="_Toc493797722"></a><a name="_Toc493797845"></a><a name="_Toc493844630"></a><a name="_Ref332965021"></a><a name="_Ref334692581"></a><a name="_Toc493869124"></a><a name="_Toc493869368"></a><a name="_Toc495394219"></a><a name="_Ref533246062"></a><a name="_Toc374597658"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">2.4</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Purchase Price</font><a name="_Ref366449126"></a><a name="_Ref373830526"></a><a name="_Ref332964236"></a><a name="_Ref536425148"></a><a name="_Ref536453386"></a><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444798285"></a><a name="_Ref374398276"></a><a name="_Ref376996432"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Payments of Closing Consideration and Consideration for Shareholder Loans</font><font style="display: inline;">.</font><a name="_Ref487619949"></a><a name="_Ref444842508"></a><font style="display: inline;"> &nbsp;On the terms and subject to the conditions of this Agreement, including </font><font style="display: inline;">the provisions of </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">2.2</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">and </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">2.4(b)</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">and</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">the adjustment set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">3.1</font><font style="display: inline;">, in full consideration for the transfer of all of the </font><font style="display: inline;">Sold </font><font style="display: inline;">Shares to Buyer and the </font><font style="display: inline;">purchase </font><font style="display: inline;">of the Shareholders Loans by Buyer</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">at </font><font style="display: inline;">the Closing, </font><font style="display: inline;">CryoLife shall pay or cause </font><font style="display: inline;">Buyer </font><font style="display: inline;">to </font><font style="display: inline;">pay to the Paying Agent for further distribution by the Paying Agent to each of the Securityholders the</font><font style="display: inline;">ir respective portion </font><font style="display: inline;">of </font><font style="display: inline;">(i) </font><font style="display: inline;">the Closing Consideration</font><font style="display: inline;"> and (ii) the Consideration for Shareholder Loans as set forth on the Consideration Schedule a</font><font style="display: inline;">nd</font><font style="display: inline;">,</font><font style="display: inline;"> in the case of the </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock comprising a portion of the Closing Consideration, </font><font style="display: inline;">CryoLife shall</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">irrevocably </font><font style="display: inline;">instruct American Stock Transfer &amp; Trust Company, LLC (the &#x201C;</font><font style="display: inline;font-weight:bold;">Transfer Agent</font><font style="display: inline;">&#x201D;)</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">to reflect in book entry form the issuance of shares of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock to such Securityholders, as set fo</font><font style="display: inline;">rth on the Consideration Schedule.</font><font style="display: inline;"> &nbsp; &nbsp;</font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">4</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">The Paying Agent shall distribute the </font><font style="display: inline;">cash portion of the </font><font style="display: inline;">Closing Consideration</font><font style="display: inline;"> and the Consideration for Shareholder Loans</font><font style="display: inline;"> by </font><font style="display: inline;">an irrevocable </font><font style="display: inline;">bank wire transfer of immediately available funds to accounts designated in writing by the Securityholders, as set forth on the Consideration Schedule.</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">For the avoidance of doubt, when the parties determined the Closing Consideration, they agreed that the items mentioned in Schedule </font><font style="display: inline;">12</font><font style="display: inline;"> are already reflected in the Closing Consideration and shall thus not be further considered whatsoever, neither for purposes of the net debt Acquisition Consideration adjustment, nor for any breach of representation or warranty, nor for </font><font style="display: inline;">any indemnification or otherwise.</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref445016884"></a><a name="_Ref374643834"></a><a name="_Ref379721254"></a><a name="_Ref379800583"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Escrow</font><font style="display: inline;">.&nbsp; </font><font style="display: inline;">On the Closing Date and s</font><font style="display: inline;">ubject to the terms and conditions of this Agreement,</font><font style="display: inline;"> including the </font><font style="display: inline;">provisions of </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.3</font><font style="display: inline;">,</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">CryoLife shall or shall cause </font><font style="display: inline;">Buyer </font><font style="display: inline;">to </font><font style="display: inline;">deposit with the Escrow Agent an amount in cash equal to the </font><font style="display: inline;">Escrow Amount</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">The Securityholders&#x2019; respective Pro Rata Portions of the </font><font style="display: inline;">Escrow Amount</font><font style="display: inline;"> shall equal</font><font style="display: inline;"> in the aggregate</font><font style="display: inline;"> the </font><font style="display: inline;">Escrow Amount</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(c)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Withholding Taxes</font><font style="display: inline;">. Notwithstanding any other provision in this Agreement, Buyer, the Company, the Paying Agent and the Escrow Agent shall have the right to deduct and withhold from any payments to be made hereunder such amounts as are required to be deducted or withheld therefrom under any provision of applicable Law, and to reasonably request any necessary Tax forms, as applicable, and any similar information. To the extent that any such amounts are so withheld and paid over to the appropriate Governmental Authority, such withheld and paid amounts shall be treated for all purposes of this Agreement as having been paid to the Person in respect of which such deduction and withholding was made. To the extent that any payment pursuant to this Agreement is not reduced by such required deductions or withholdings, such Person shall indemnify Buyer, the Company and the Escrow Agent for any liability to any Governmental Authority for such required deductions or withholdings together with all related Losses. None of the Company or any other Party shall be liable to a holder of the Shareholder Loans or the Shareholder Options or any bonuses or change of control payments for any amount properly paid to </font><font style="display: inline;">a Governmental Authority pursuant to any applicable abandoned property, escheat or similar Law. Notwithstanding anything to the contrary in this Section 2.4(c), </font><font style="display: inline;">the Buyer shall be responsible for any deductions or withholdings from payments to be made to Securityholders pursuant to this Agreement that are imposed by </font><font style="display: inline;">a jurisdiction other than Switzerland or Germany (or, in each case, any political subdivision thereof) solely as a result of the Buyer acquiring, or being deemed to have acquired, the Company through an entity organized under the laws of </font><font style="display: inline;">the jurisdiction imposing such deduction or withholding and, for the avoidance of doubt, not as the sole result of the status of any Securityholder as a citizen or Tax resident of the jurisdiction imposing such deduction or withholding, and in such case the amount of the payment due shall be increased to an amount which (after making any Tax deductions) leaves an amount equal to the payment which would have been due if the Tax deductions made had not been required</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc374597662"></a><a name="_Ref379814178"></a><a name="_Ref444769948"></a><a name="_Ref444876030"></a><a name="_Toc487751019"></a><a name="_Toc487788474"></a><a name="_Toc487788666"></a><a name="_Toc487788799"></a><a name="_Ref488736270"></a><a name="_Toc491721275"></a><a name="_Ref492293162"></a><a name="_Toc493797723"></a><a name="_Toc493797846"></a><a name="_Toc493844631"></a><a name="_Toc493869125"></a><a name="_Toc493869369"></a><a name="_Toc495394220"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">2.5</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="considerationschedule"></a><font style="display: inline;font-weight:bold;font-style:italic;">Consideration Schedule</font><font style="display: inline;">. &nbsp;</font><font style="display: inline;">No later than three (3) Business Days </font><font style="display: inline;">before the Closing, the Company shall deliver to Buyer and Paying Agent the </font><font style="display: inline;">updated Consideration Schedule (to reflect the purchase by one or several of the Securityholders of Shares from the Minority Shareholders) </font><font style="display: inline;">setting forth </font><font style="display: inline;">(i)</font><font style="display: inline;"> the name and mailing address of each Securityholder; </font><font style="display: inline;">(ii)</font><font style="display: inline;">&nbsp;</font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">5</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">the </font><font style="display: inline;">Sold Shares and the sold Shareholder Loans </font><font style="display: inline;">held by each Securityholder, in each case as of immediately prior to the Closing; </font><font style="display: inline;">(iii)</font><font style="display: inline;"> each Securityholder&#x2019;s Pro Rata Portion of the Escrow Amount; </font><font style="display: inline;">(iv)</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">the Estimated Net Debt and </font><font style="display: inline;">each Securityholder&#x2019;s Pro Rata Portion of </font><font style="display: inline;">Estimated Net Debt; (v) </font><font style="display: inline;">e</font><font style="display: inline;">ach Securityholder&#x2019;s </font><font style="display: inline;">Pro-Rata Portion </font><font style="display: inline;">of the Closing Consideration (including the amount of cash and number of shares of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock to which such Securityholder is entitled), payable to each such Securityholder with respect to their respective</font><font style="display: inline;"> Sold Shares</font><font style="display: inline;">; &nbsp;</font><font style="display: inline;">(vi) each Securityholders&#x2019; share of the Consideration for the Shareholder Loans </font><font style="display: inline;">and </font><font style="display: inline;">(vii)</font><font style="display: inline;"> as applicable, with respect to any Shares issued on or after January 1, 2011 or any other Shares, in each case constituting a &#x201C;covered security&#x201D; under Treasury Regulation &#xA7; 1.6045-1(a)(15), the cost basis and date of issuance of such Shares or Shares. The Paying Agent shall be responsible for the distribution of such amounts delivered to the Paying Agent. </font><font style="display: inline;">Upon </font><font style="display: inline;">(i) </font><font style="display: inline;">paying the Escrow Amount to the Escrow Agent, </font><font style="display: inline;">(ii) </font><font style="display: inline;">pay</font><font style="display: inline;">ment of the Consideration for the Shareholder Loans and </font><font style="display: inline;">the cash portion of the Closing Conside</font><font style="display: inline;">ration to the Paying Agent, and (iii) </font><font style="display: inline;">instructing the Transfer Agent to reflect in book entry form the issuance of the </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock issuable as Closing Consideration to the Securityholders as set forth in the Consideration Schedule, </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent and Buyer shall have fulfilled their respective obligations with respect to the</font><font style="display: inline;"> Closing, subject to the Acquisition Consideration adjustment set forth in </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;III</font><font style="display: inline;">.</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref487622883"></a><a name="_Toc487751020"></a><a name="_Toc487788475"></a><a name="_Toc487788667"></a><a name="_Toc487788800"></a><a name="_Toc491721276"></a><a name="_Toc493797724"></a><a name="_Toc493797847"></a><a name="_Toc493844632"></a><a name="_Toc493869126"></a><a name="_Toc493869370"></a><a name="_Toc495394221"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">2.6</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="exchangeprocedures"></a><font style="display: inline;font-weight:bold;font-style:italic;">Exchange Procedures</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref379806897"></a><a name="_Ref288597545"></a><a name="_Ref487465962"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Shares</font><font style="display: inline;font-style:italic;">.&nbsp; </font><font style="display: inline;">At Closing, the Company and each of the Securityholders shall take such steps that are required for Buyer to be registered as the owner of all of the </font><font style="display: inline;">Sold </font><font style="display: inline;">Shares in the share register of the Company and deliver to Buyer such other notices and documentation, duly executed on behalf of the Company if necessary, confirming that Buyer is entered in the register as sole owner of the </font><font style="display: inline;">Sold </font><font style="display: inline;">Shares, accompanied by a copy of such register duly signed by the Company&#x2019;s board of directors (the &#x201C;</font><font style="display: inline;font-weight:bold;">Board of Directors</font><font style="display: inline;">&#x201D;) or such other evidence as is necessary, customary and appropriate that Buyer has been registered as the sole owner of all </font><font style="display: inline;">Sold </font><font style="display: inline;">Shares, free and clear of any Liens.&nbsp; </font><font style="display: inline;">In particular, the Securityholders shall deliver or cause to be delivered to the Buyer at Closing: (i) the original share certificates representing the Sold Shares, each duly endorsed in blank by the respective Securityholder; (ii) the original minutes of the meeting of the Board of Directors approving the acquisition of the Sold Shares by the Buyer and the entry of the Buyer as owner of the Sold Shares with full voting rights in the share register of the Company; and (iii) the original share register of the Company</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">as of the Closing Date, duly signed by the Board of Directors, in which the Buyer is registered as the owner of the Sold Shares</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">with full voting rights, free and clear of any Liens.&nbsp;&nbsp;Upon Closing, </font><font style="display: inline;">the Buyer </font><font style="display: inline;">shall </font><font style="display: inline;">be recorded as the sole owner of all </font><font style="display: inline;">Sold </font><font style="display: inline;">Shares in the Company&#x2019;s share register, </font><font style="display: inline;">and </font><font style="display: inline;">in accordance with the terms and subject to the conditions set forth </font><font style="display: inline;">in this Agreement</font><font style="display: inline;">,</font><font style="display: inline;"> each </font><font style="display: inline;">Securityholder shall receive from Buyer in exchange therefor </font><font style="display: inline;">the Pro Rata Portion of </font><font style="display: inline;">the </font><font style="display: inline;">Closing </font><font style="display: inline;">Consideration to which each such Securityholder is entitled pursuant to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">2.5</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">as set forth on the Consideration Schedule, </font><font style="display: inline;">which </font><font style="display: inline;">for purposes of clarification </font><font style="display: inline;">shall be subject to adjustment as provided in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">3.1</font><font style="display: inline;">.</font><font style="display: inline;"> &nbsp; &nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Resignation of Officers and Directors</font><font style="display: inline;">.&nbsp; </font><font style="display: inline;">At the Closing, the Securityholders shall deliver to </font><font style="display: inline;">Buyer a written resignation from each of the officers and </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">6</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">directors of each of the Company and the Company Subsidiaries</font><font style="display: inline;"> in form and substance that will allow Buyer to cause such resignations to be effective as of or promptly following the Closing</font><font style="display: inline;">.</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(c)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Declaration of Beneficial Owner</font><font style="display: inline;">.&nbsp;&nbsp;At the Closing, the Buyer shall </font><font style="display: inline;">deliver </font><font style="display: inline;">to the Company </font><font style="display: inline;">a notification of beneficial ownership regarding the </font><font style="display: inline;">Sold </font><font style="display: inline;">Shares in accordance with article 697j </font><font style="display: inline;">of the Swiss Code of Obligations.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref448588636"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(d)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Joint Closing Actions / Deemed Occurrence of the Closing Act</font><font style="display: inline;font-weight:bold;">ions</font><font style="display: inline;">.</font><font style="display: inline;"> &nbsp; &nbsp;</font><font style="display: inline;">All actions to be taken and documents to be delivered by the Parties at Closing as set forth in </font><font style="display: inline;">this Agreement </font><font style="display: inline;">are deemed to have </font><font style="display: inline;">(i)</font><font style="display: inline;"> been taken, executed and delivered simultaneously and </font><font style="display: inline;">(ii)</font><font style="display: inline;"> occurred only if and when all such actions and documents have been taken, executed and delivered. In case Closing </font><font style="display: inline;">does not</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">occur</font><font style="display: inline;">, the Parties undertake to use their commercially reasonable best efforts to unwind all Clo</font><font style="display: inline;">sing actions initiated or taken</font><font style="display: inline;">.&nbsp; </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;text-transform:uppercase;color:#010000;">Article&nbsp;III</font><br /><font style="display: inline;font-weight:bold;text-transform:uppercase;"></font><br /><font style="display: inline;font-weight:bold;text-transform:uppercase;"></font><a name="_Toc374597667"></a><a name="_Ref445044841"></a><a name="_Toc487751021"></a><a name="_Toc487788476"></a><a name="_Toc487788668"></a><a name="_Toc487788801"></a><a name="_Toc491721277"></a><a name="_Ref492292708"></a><a name="_Ref492388819"></a><a name="_Ref492402899"></a><a name="_Ref492406987"></a><a name="_Toc493797725"></a><a name="_Toc493797848"></a><a name="_Toc493844633"></a><a name="_Toc493869127"></a><a name="_Toc493869371"></a><a name="_Ref494310468"></a><a name="_Toc495394222"></a><font style="display: inline;font-weight:bold;text-transform:uppercase;">ACQUISITION CONSIDERATION ADJUSTMENT</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref374398784"></a><a name="_Toc374597668"></a><a name="_Toc487751022"></a><a name="_Toc487788477"></a><a name="_Toc487788669"></a><a name="_Toc487788802"></a><a name="_Toc491721278"></a><a name="_Toc493797726"></a><a name="_Toc493797849"></a><a name="_Toc493844634"></a><a name="_Toc493869128"></a><a name="_Toc493869372"></a><a name="_Toc495394223"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">3.1</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="acquisitionconsideration"></a><font style="display: inline;font-weight:bold;font-style:italic;">Acquisition Consideration Adjustment</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref492293640"></a><a name="_Ref445042102"></a><a name="_Ref332963932"></a><a name="_Ref374328448"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">No later than </font><font style="display: inline;">three (3) </font><font style="display: inline;">Business Days prior to Closing, the </font><font style="display: inline;">Company </font><font style="display: inline;">shall deliver to Buyer a written statement of its reasonable good faith estimate of the Net </font><font style="display: inline;">Company </font><font style="display: inline;">Debt as at the Closing Date (the </font><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Estimated Net Debt</font><font style="display: inline;">&#x201D;</font><font style="display: inline;">), together with a reasonably detailed explanation of the calculation thereof</font><font style="display: inline;">. The amount of the Estimated </font><font style="display: inline;">Net Debt </font><font style="display: inline;">shall be reflected in the calculation of the Closing Consideration to be paid by Buyer at Closing pursuant to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">2.4</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref493830678"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Within </font><font style="display: inline;">sixty </font><font style="display: inline;">(</font><font style="display: inline;">6</font><font style="display: inline;">0) days after the Closing Date, </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> shall cause to be prepared and delivered to the </font><font style="display: inline;">Securityholder Representative a statement</font><font style="display: inline;"> setting forth the calculation of the Net Company Debt</font><font style="display: inline;"> as of the Closing Date, </font><font style="display: inline;">together with a reasonably detailed explanation of the calculation thereof</font><font style="display: inline;"> (the &#x201C;</font><font style="display: inline;font-weight:bold;">Company </font><font style="display: inline;font-weight:bold;">Net </font><font style="display: inline;font-weight:bold;">Debt </font><font style="display: inline;font-weight:bold;">Statement</font><font style="display: inline;">&#x201D;)</font><font style="display: inline;"> and a statement setting forth the calculation of the adjustment amount to the Acquisition Consideration (if any) based on the difference between the Estimated Net Debt and the Company Net Debt determined pursuant to the Company Net Debt Statement </font><font style="display: inline;">(</font><font style="display: inline;">this statement, </font><font style="display: inline;">collectively wit</font><font style="display: inline;">h the </font><font style="display: inline;">Company </font><font style="display: inline;">Net </font><font style="display: inline;">Debt </font><font style="display: inline;">Statement,</font><font style="display: inline;"> the &#x201C;</font><font style="display: inline;font-weight:bold;">Closing Adjustment </font><font style="display: inline;font-weight:bold;">Statement</font><font style="display: inline;">&#x201D;).</font><font style="display: inline;"> &nbsp; &nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref374328449"></a><a name="_Ref332964683"></a><a name="_Ref339985680"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(c)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Within sixty (60) days following receipt by the Securityholder Representative of the </font><font style="display: inline;">Closing Adjustment </font><font style="display: inline;">Statement, the Securityholder Representative shall deliver written notice to </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> of any dispute it has with respect to the preparation or content of the </font><font style="display: inline;">Closing Adjustment Statement</font><font style="display: inline;">.&nbsp;&nbsp;If the Securityholder Representative does not notify </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> in writing of a dispute with respect to the </font><font style="display: inline;">Closing Adjustment Statement</font><font style="display: inline;"> within such sixty (60)-day period, </font><font style="display: inline;">pursuant to a written notice</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">describing in reasonable detail </font><font style="display: inline;">the specific calculations that are disputed and the basis for such dispute, such </font><font style="display: inline;">Closing Adjustment Statement</font><font style="display: inline;"> will be final, conclusive and binding on the Parties. I</font><font style="display: inline;">f</font><font style="display: inline;"> the </font><font style="display: inline;">Securityholder Representative notifies CryoLife in writing of a dispute with respect to the Closing Adjustment Statement within such sixty (60)-day period, pursuant to a written statement describing in reasonable detail the specific </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">7</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">calculations that are disputed and the basis for such dispute, CryoLife</font><font style="display: inline;"> and the Securityholder Representative shall negotiate in good faith to resolve such dispute.&nbsp;&nbsp;If </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> and the Securityholder Representative, notwithstanding such good faith effort, fail to resolve such dispute within thirty (30) days after the Securityholder Representative advises </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> of its objections, then </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> and the Securityholder Representative jointly shall be entitled to engage the Arbitration Firm to resolve such dispute. As promptly as practicable thereafter (and, in any event, within fifteen (15) days after the Arbitration Firm&#x2019;s engagement), the Securityholder Representative shall submit any unresolved elements of its objection to the Arbitration Firm in writing (with a copy to </font><font style="display: inline;">CryoLife</font><font style="display: inline;">), supported by any documents and arguments upon which it relies. As promptly as practicable thereafter (and, in any event, within fifteen (15) days following the Securityholder Representative&#x2019;s submission of such unresolved elements), </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> shall submit its response to the Arbitration Firm (with a copy to the Securityholder Representative) supported by any documents and arguments upon which it relies.&nbsp; </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> and the Securityholder Representative shall request that the Arbitration Firm render its determination within fifteen (15) days following its receipt of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">&#x2019;s response. The scope of the disputes to be resolved by the Arbitration Firm shall be limited to the unresolved items to which the Securityholder Representative objected.&nbsp;&nbsp;In resolving any disputed item, the Arbitration Firm may not assign a value to any item greater than the greatest value claimed for such item by either Party or less than the smallest value claimed for such item by either Party.&nbsp;&nbsp;All determinations made by the Arbitration Firm will be final, conclusive and binding on the Parties.&nbsp;&nbsp;The Arbitration Firm shall have the authority to allocate all fees and costs of the Arbitration Firm in resolving any disputed item to the non-prevailing party, as determined by the Arbitration Firm.</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref445042558"></a><a name="_Ref493807533"></a><a name="_Ref332964790"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(d)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">If Net Company Debt (as finally determined </font><font style="display: inline;">after the Closing </font><font style="display: inline;">pursuant to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">3.1(c</font><font style="display: inline;">)</font><font style="display: inline;">) exceeds the </font><font style="display: inline;">Estimated </font><font style="display: inline;">Net Debt delivered </font><font style="display: inline;">prior to the Closing </font><font style="display: inline;">by the Company to Buyer pursuant to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">3.1(a)</font><font style="display: inline;">, then </font><font style="display: inline;">the Acquisition Consideration</font><font style="display: inline;"> will be adjusted downward by such excess </font><font style="display: inline;">amount</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">and the </font><font style="display: inline;">Securityholders shall</font><font style="display: inline;">,</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">within (10) Business Days, pay Buyer </font><font style="display: inline;">an amount of cash </font><font style="display: inline;">by wire transfer of immediately available funds an amount equal </font><font style="display: inline;">to </font><font style="display: inline;">(i)</font><font style="display: inline;"> the Net Company Debt (as finally determined </font><font style="display: inline;">after the Closing </font><font style="display: inline;">pursuant to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">3.1(c</font><font style="display: inline;">)</font><font style="display: inline;">) &nbsp;</font><font style="display: inline;text-decoration:underline;">minus</font><font style="display: inline;"> (ii) </font><font style="display: inline;">the </font><font style="display: inline;">Estimated </font><font style="display: inline;">Net Debt (such amount described in clauses </font><font style="display: inline;">&#x200E;</font><font style="display: inline;">(i)</font><font style="display: inline;"> and </font><font style="display: inline;">&#x200E;</font><font style="display: inline;">(ii)</font><font style="display: inline;"> collectively, the &#x201C;</font><font style="display: inline;font-weight:bold;">Downward </font><font style="display: inline;font-weight:bold;">Adjustment Amount</font><font style="display: inline;">&#x201D;) in accordance with their respective Pro Rata Portion of </font><font style="display: inline;">the Downward Adjustment Amount or, at Buyer&#x2019;s request, </font><font style="display: inline;">the Securityholder Representative and </font><font style="display: inline;">Buyer </font><font style="display: inline;">shall deliver a joint written authorization to the Escrow Agent within two (2) Business Days from the date on which Net Company Debt</font><font style="display: inline;"> is</font><font style="display: inline;"> finally determined pursuant to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">3.1(c</font><font style="display: inline;">)</font><font style="display: inline;"> authorizing the Escrow Agent to release to </font><font style="display: inline;">Buyer </font><font style="display: inline;">from the </font><font style="display: inline;">Indemnity Escrow Fund</font><font style="display: inline;">, within three (3) Business Days from the date </font><font style="display: inline;">of such authorization an amount equal to the Downward Adjustment Amount</font><font style="display: inline;">. &nbsp;</font><font style="display: inline;">Any fees and costs of the Arbitration Firm to be borne by the Securityholders pursuant to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">3.1(c</font><font style="display: inline;">) shall be paid directly by the Securityholders in accordance with their respective Pro Rata Portion</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref494193683"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(e)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">If Net Company Debt (as finally determined </font><font style="display: inline;">after the Closing </font><font style="display: inline;">pursuant to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">3.1(c</font><font style="display: inline;">)</font><font style="display: inline;">) &nbsp;</font><font style="display: inline;">is below </font><font style="display: inline;">the </font><font style="display: inline;">Estimated </font><font style="display: inline;">Net Debt delivered </font><font style="display: inline;">prior to the Closing </font><font style="display: inline;">by the Company to Buyer pursuant to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">3.1(a)</font><font style="display: inline;">, then </font><font style="display: inline;">the Acquisition Consideration</font><font style="display: inline;"> will be adjusted </font><font style="display: inline;">up</font><font style="display: inline;">ward by such excess </font><font style="display: inline;">amount and CryoLife </font><font style="display: inline;">shall</font><font style="display: inline;"> or shall cause Buyer to,</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">within ten (10) Business </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">8</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">Days,</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">pay</font><font style="display: inline;"> the Paying Agent for further distribution to each of the Securityholders,</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">as if such amount had been distributed at Closing, </font><font style="display: inline;">by</font><font style="display: inline;"> wire transfer of immediately available funds an amount equal to </font><font style="display: inline;">(i)</font><font style="display: inline;"> the </font><font style="display: inline;">Estimated Net Debt </font><font style="display: inline;">Net </font><font style="display: inline;text-decoration:underline;">minus</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">(ii)</font><font style="display: inline;"> Net Company Debt (as finally determined </font><font style="display: inline;">after the Closing </font><font style="display: inline;">pursuant to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">3.1(c</font><font style="display: inline;">)</font><font style="display: inline;">)</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">(such amount described in clauses </font><font style="display: inline;">&#x200E;</font><font style="display: inline;">(i)</font><font style="display: inline;"> and </font><font style="display: inline;">&#x200E;</font><font style="display: inline;">(ii)</font><font style="display: inline;"> collectively, the &#x201C;</font><font style="display: inline;font-weight:bold;">Upward </font><font style="display: inline;font-weight:bold;">Adjustment Amount</font><font style="display: inline;">&#x201D;)</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">in accordance with their respective Pro Rata Portion</font><font style="display: inline;">s</font><font style="display: inline;"> of </font><font style="display: inline;">the Upward Adjustment Amount, or at Buyer&#x2019;s request</font><font style="display: inline;"> (ii) the Securityholder Representative and </font><font style="display: inline;">Buyer </font><font style="display: inline;">shall deliver a joint written authorization to the Escrow Agent within two (2) Business Days from the date on which Net Company Debt</font><font style="display: inline;"> is</font><font style="display: inline;"> finally determined pursuant to </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">3.1(c)</font><font style="display: inline;"> authorizing the Escrow Agent to release from the </font><font style="display: inline;">Indemnity Escrow Fund</font><font style="display: inline;">, within three (3) Business Days from </font><font style="display: inline;">the date of such authorization </font><font style="display: inline;">to the Paying Agent, for further distribution to each of the Securityholders in proportion to their respective Pro Rata Portions, </font><font style="display: inline;">an amount of cash equal to the Upward Adjustment Amount</font><font style="display: inline;">. &nbsp;</font><font style="display: inline;">Any fees and costs of the Arbitration Firm to be borne by the Securityholders pursuant to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">3.1(c</font><font style="display: inline;">) shall be paid directly by the Securityholders in accordance with their respective Pro Rata Portion</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:25pt;"><font style="display: inline;color:#010000;">(f)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">The </font><font style="display: inline;">adjusted </font><font style="display: inline;">payment</font><font style="display: inline;"> obligations</font><font style="display: inline;"> contemplated in this </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">3.1</font><font style="display: inline;"> shall be treated </font><font style="display: inline;">for all purposes </font><font style="display: inline;">as adjustments to the Acquisition Consideration, except as otherwise required by applicable Law.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;text-transform:uppercase;color:#010000;">Article&nbsp;IV</font><br /><font style="display: inline;font-weight:bold;text-transform:uppercase;"></font><br /><font style="display: inline;font-weight:bold;text-transform:uppercase;"></font><a name="_Ref151206465"></a><a name="_Ref187073677"></a><a name="_Ref366710533"></a><a name="_Toc370996725"></a><a name="_Toc373830370"></a><a name="_Ref444865958"></a><a name="_Toc487751023"></a><a name="_Toc487788478"></a><a name="_Toc487788670"></a><a name="_Toc487788803"></a><a name="_Toc491721279"></a><a name="_Toc493797727"></a><a name="_Toc493797850"></a><a name="_Toc493844635"></a><a name="_Toc493869129"></a><a name="_Toc493869373"></a><a name="_Toc495394224"></a><font style="display: inline;font-weight:bold;text-transform:uppercase;">REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE </font><font style="display: inline;font-weight:bold;text-transform:uppercase;">SECURITYHOLDERS</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Each of the Securityholders severally </font><font style="display: inline;">(and not jointly) hereby </font><font style="display: inline;">represents and warrants to </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, and Buyer, subject to such exceptions as ar</font><font style="display: inline;">e disclosed in the </font><font style="display: inline;">Company Disclosure Schedule (</font><font style="display: inline;">as </font><font style="display: inline;">defined below)</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">(</font><font style="display: inline;">specifically </font><font style="display: inline;">referencing the appropriate section</font><font style="display: inline;"> (e.g. 4.7), subsection (e.g. 4.7(b))</font><font style="display: inline;"> and paragraph </font><font style="display: inline;">(e.g. 4.7(b)(i), as applicable</font><font style="display: inline;">)</font><font style="display: inline;"> &nbsp;(</font><font style="display: inline;">it being understood and hereby agreed that</font><font style="display: inline;"> (i) a matter is deemed to be disclosed in the Company Disclosure Schedule for the purposes of this</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;IV</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">if such matter is included in the Company Disclosure Schedule in sufficient detail to enable Buyer, Parent and CryoLife, upon a diligent review of the Company Disclosure Schedule (together with documents and information included therein, which have been made available to Buyer), to reasonably understand the appropriate sections, subsections and paragraphs, as applicable, of the Company Disclosure Schedule to which such disclosure applies and to reasonably assess the nature, scope, importance and relevance of the disclosed matter and the impact of such disclosure on the Company, the Company Subsidiaries, CryoLife, Parent and Buyer and (ii) except with respect to Fundamental Representations, the fair disclosure statement in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">4.11 </font><font style="display: inline;">shall apply </font><font style="display: inline;">for the purposes of this</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;IV</font><font style="display: inline;">)</font><font style="display: inline;">, on the date hereof and as of the Closing Date</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">(other than the representations and warranties which are made as of a specified date, which speak only as of such date)</font><font style="display: inline;">, and covenants and agrees, as follows:</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref366544075"></a><a name="_Toc370996726"></a><a name="_Toc373830371"></a><a name="_Toc487751024"></a><a name="_Toc487788479"></a><a name="_Toc487788671"></a><a name="_Toc487788804"></a><a name="_Toc491721280"></a><a name="_Toc493797728"></a><a name="_Toc493797851"></a><a name="_Toc493844636"></a><a name="_Toc493869130"></a><a name="_Toc493869374"></a><a name="_Toc495394225"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">4.1</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="authority"></a><font style="display: inline;font-weight:bold;font-style:italic;">Authority</font><font style="display: inline;font-weight:bold;font-style:italic;">; &nbsp;</font><font style="display: inline;font-weight:bold;font-style:italic;">Non-Contravention; Approvals</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref379808522"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Such Securityholder has all requisite power and authority to execute and deliver this Agreement and the Related Agreements to which such Securityholder is a party, and </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">9</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">to perform the transactions contemplated in this Agreement and the Related Agreements to which such Securityholder is a party.&nbsp;&nbsp;This Agreement has been, and upon the execution of the Related Agreements to which such Securityholder is a party, the Related Agreements will be, duly executed and delivered by such Securityholder and, assuming the due authorization, execution and delivery of this Agreement by </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, and Buyer, constitutes and upon </font><font style="display: inline;">CryoLife</font><font style="display: inline;">&#x2019;s, Parent&#x2019;s and Buyer&#x2019;s execution of the applicable Related Agreements will constitute, valid and binding obligations of such Securityholder</font><font style="display: inline;">,</font><font style="display: inline;"> enforceable against such Securityholder in accordance with their respective terms.</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">The execution and delivery by such Securityholder of this Agreement and the Related Agreements to which he, she or it is a party and the performance of the transactions contemplated in this Agreement and the Related Agreements to which he, she or it is a party do not and will not (i) result in a material violation or breach of or constitute a default (or an event which, with or without notice or lapse of time or both, would constitute a default) under, or result in the termination of, or the loss of a benefit under or accelerate the performance required by, or result in a right of termination, modification, cancellation or acceleration under, the terms, conditions or provisions of any Contract or other instrument of any kind to which such Securityholder </font><font style="display: inline;">or such Securityholder&#x2019;s Affiliates </font><font style="display: inline;">is now a party or by which such Securityholder or any of its assets may be bound or affected; or (ii) result in a material violation of any order, writ, injunction, decree, statute, treaty, rule or regulation applicable to such Securityholder.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(c)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">N</font><font style="display: inline;">o declaration, filing or registration with, or notice to, or authorization, consent, order or approval of, any Governmental Authority is required to be obtained </font><font style="display: inline;">by </font><font style="display: inline;">or made </font><font style="display: inline;">such Securityholder </font><font style="display: inline;">in connection with or as a result of the execution and delivery of this Agreement and the Related Agreements to which such Securityholder is a party or the performance by such Securityholder of the transactions contemplated in this Agreement and the Related Agreements to which such Securityholder is a party.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref378955520"></a><a name="_Toc487751025"></a><a name="_Toc487788480"></a><a name="_Toc487788672"></a><a name="_Toc487788805"></a><a name="_Toc491721281"></a><a name="_Toc493797729"></a><a name="_Toc493797852"></a><a name="_Toc493844637"></a><a name="_Toc493869131"></a><a name="_Toc493869375"></a><a name="_Toc495394226"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">4.2</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="titletosoldshares"></a><font style="display: inline;font-weight:bold;font-style:italic;">Title to </font><font style="display: inline;font-weight:bold;font-style:italic;">Sold Shares</font><font style="display: inline;">.&nbsp;&nbsp;Such Securityholder has, and will deliver to Buyer at Closing, good and marketable title</font><font style="display: inline;">, free and clear of all Liens,</font><font style="display: inline;"> to the </font><font style="display: inline;">Sold </font><font style="display: inline;">Shares </font><font style="display: inline;">that the Consideration Schedule indicates are owned by such Securityholder</font><font style="display: inline;">.&nbsp; </font><font style="display: inline;">If such Securityholder holds a Shareholder Loan, the principal and interest due under such Shareholder Loan is accurately reflected in the Consideration Schedule.</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Other than </font><font style="display: inline;">as provided for in this Agreement and </font><font style="display: inline;">that certain </font><font style="display: inline;">s</font><font style="display: inline;">hareholders </font><font style="display: inline;">a</font><font style="display: inline;">greement dated May 1, 2005, by and among the Company and the</font><font style="display: inline;"> other</font><font style="display: inline;"> parties thereto (the &#x201C;</font><font style="display: inline;font-weight:bold;">Shareholders Agreement</font><font style="display: inline;">&#x201D;), such Securityholder is not a party to any voting trust, proxy, or other Contract or understanding with respect to any of the Shares or other Company Securities held by such Securityholder.&nbsp; </font><font style="display: inline;">S</font><font style="display: inline;">uch Securityholder is </font><font style="display: inline;">party to the Shareholders Agreement</font><font style="display: inline;">,</font><font style="display: inline;"> and prior to the Closing</font><font style="display: inline;">,</font><font style="display: inline;"> shall comply </font><font style="display: inline;">or shall have complied </font><font style="display: inline;">with their obligations under the Shareholders Agreement with respect to the transactions contemplated hereby.</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">As of the date hereof, t</font><font style="display: inline;">he </font><font style="display: inline;">Sold </font><font style="display: inline;">Shares set forth on </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.2(a)</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">of the Company Disclosure Schedule opposite such Securityholder&#x2019;s name represent such Securityholder&#x2019;s entire right, title and interest in and to the shares of the share capital of the Company</font><font style="display: inline;"> as of the date hereof</font><font style="display: inline;">. &nbsp;</font><font style="display: inline;">As of the Closing Date, t</font><font style="display: inline;">he </font><font style="display: inline;">Sold Shares set forth in the Consideration </font><font style="display: inline;">Schedule opposite such Securityholder&#x2019;s name represent such Securityholder&#x2019;s entire right, title and interest in and </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">10</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">to the shares of the share capital of the Company</font><font style="display: inline;"> as of the Closing Date</font><font style="display: inline;">. Such Securityholder has not breached or violated any provision of the Shareholders Agreement.</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc370996730"></a><a name="_Toc373830375"></a><a name="_Ref378955531"></a><a name="_Toc487751026"></a><a name="_Toc487788481"></a><a name="_Toc487788673"></a><a name="_Toc487788806"></a><a name="_Toc491721282"></a><a name="_Toc493797730"></a><a name="_Toc493797853"></a><a name="_Toc493844638"></a><a name="_Toc493869132"></a><a name="_Toc493869376"></a><a name="_Toc495394227"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">4.3</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Litigation</font><font style="display: inline;">.&nbsp;&nbsp;There is no proceeding pending that relates to this Agreement or the transactions contemplated in this Agreement or, to the knowledge of such Securityholder, threatened, against or affecting such Securityholder that challenges the validity or enforceability of this Agreement with respect to such Securityholder or seeks to enjoin or prohibit consummation of, or seek other material equitable relief with respect to, the transactions contemplated in this Agreement with respect to such Securityholder or that could reasonably be expected to impair or delay such Securityholder&#x2019;s ability to consummate the transactions contemplated in this Agreement.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc487751027"></a><a name="_Toc487788482"></a><a name="_Toc487788674"></a><a name="_Toc487788807"></a><a name="_Toc491721283"></a><a name="_Toc493797731"></a><a name="_Toc493797854"></a><a name="_Toc493844639"></a><a name="_Toc493869133"></a><a name="_Toc493869377"></a><a name="_Toc495394228"></a><a name="_Ref487636805"></a><a name="_Ref444875472"></a><a name="_Ref444875495"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">4.4</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Interest in Intellectual Property</font><font style="display: inline;">.&nbsp; </font><font style="display: inline;">Neither s</font><font style="display: inline;font-size:11pt;">uch Securityholder </font><font style="display: inline;font-size:11pt;">nor any of its Affiliates has</font><font style="display: inline;font-size:11pt;"> any rights, title or interest in, or right or permission to use, any Intellectual Property of the Company or any of its Subsidiaries or Intellectual Property used by the Company or any Company Subsidiary</font><font style="display: inline;font-size:11pt;"> or necessary </font><font style="display: inline;font-size:11pt;">for the operation of the Business as currently conducted.</font><font style="display: inline;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref487636807"></a><a name="_Toc487751028"></a><a name="_Toc487788483"></a><a name="_Toc487788675"></a><a name="_Toc487788808"></a><a name="_Toc491721284"></a><a name="_Toc493797732"></a><a name="_Toc493797855"></a><a name="_Toc493844640"></a><a name="_Toc493869134"></a><a name="_Toc493869378"></a><a name="_Toc495394229"></a><a name="_Ref487624553"></a><a name="_Ref487624665"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">4.5</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Brokers&#x2019; and Finders&#x2019; Fees</font><font style="display: inline;">.&nbsp; </font><font style="display: inline;">Such Securi</font><font style="display: inline;">tyholder has not,</font><font style="display: inline;"> directly or indirectly, </font><font style="display: inline;">entered into any Contract that will cause the Company, any Company Subsidiary or Buyer to incur, </font><font style="display: inline;">any liability for brokerage or finders&#x2019; fees or agents&#x2019; commissions, fees related to investment banking or similar advisory services or any similar charges in connection with this Agreement or any transaction contemplated in this Agreement.</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Such Securityholder is not, nor has such Securityholder engaged any intermediary that is, a registered Swiss securities dealer for the purposes of Swiss securities transfer tax.</font><font style="display: inline;">&nbsp;</font></font>
		</p><a name="_Toc491721285"></a><a name="_Toc493797733"></a><a name="_Toc493797856"></a><a name="_Toc493844641"></a><a name="_Toc493869135"></a><a name="_Toc493869379"></a><a name="_Toc495394230"></a><font style="display: inline;color:#010000;">4.6</font><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Interested Party Transactions</font><font style="display: inline;">.&nbsp; </font>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Except as set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.16</font><font style="display: inline;"> of the Company Disclosure Schedule and other than </font><font style="display: inline;">(i)</font><font style="display: inline;"> standard benefits generally made available to all Employees, </font><font style="display: inline;">(ii)</font><font style="display: inline;"> standard director, manager and/or officer indemnification Contracts approved by the Company or the relevant Company Subsidiary, and </font><font style="display: inline;">(iii)</font><font style="display: inline;"> the purchase of Shares and the issuance of Company Options, in each case pursuant to Contracts that have been made available to Buyer or its counsel, there are no Contracts, </font><font style="display: inline;">or </font><font style="display: inline;">understandings between such Securityholder or any Affiliate or family member thereof, on the one hand, and the Company or any Company Subsidiary, on the other.&nbsp;&nbsp;Other than pursuant to the </font><font style="display: inline;">Shareholder Loans</font><font style="display: inline;">, neither the Company nor any Company Subsidiary </font><font style="display: inline;">has any obligation for indebtedness for borrowed money to </font><font style="display: inline;">such Securityholder or any Affiliate or family member thereof. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc487788484"></a><a name="_Toc487788676"></a><a name="_Toc487788809"></a><a name="_Ref491555263"></a><a name="_Toc491721286"></a><a name="_Toc493797734"></a><a name="_Toc493797857"></a><a name="_Ref493799497"></a><a name="_Ref493800917"></a><a name="_Toc493844642"></a><a name="_Toc493869136"></a><a name="_Toc493869380"></a><a name="_Toc495394231"></a><a name="_Ref487731369"></a><a name="_Ref487731370"></a><a name="_Ref487731430"></a><a name="_Toc487751029"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">4.7</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Investment Representations, Warranties and Covenants</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">This Agreement is made by Parent, </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Buyer, the Company and each of the Company Subsidiaries with such Securityholder in reliance upon </font><font style="display: inline;">such</font><font style="display: inline;"> Securityholder&#x2019;s representations, warranties and covenants made in this </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">4.7</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">11</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Such Securityholder </font><font style="display: inline;">has</font><font style="display: inline;"> been advised and acknowledge</font><font style="display: inline;">s</font><font style="display: inline;"> that:</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;color:#010000;">(i)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">the shares of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock issuable pursuant to this Agreement have not been, and when issued, will not be registered under the Securities A</font><font style="display: inline;">ct, the securities laws of any S</font><font style="display: inline;">tate of the United States or the securities laws of any other country;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:24pt;"><font style="display: inline;color:#010000;">(ii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">in issuing and selling the shares of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock issuable pursuant to this Agreement to such Securityholder pursuant hereto, </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> is relying upon the &#x201C;safe harbor&#x201D; provided by Regulation S and/or on Section 4(a)(2) under the Securities Act;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;color:#010000;">(iii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">it is a condition to the availability of the Regulation S &#x201C;safe harbor&#x201D; that the shares of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock issuable pursuant to this Agreement not be offered or sold in the United States or to a U.S. person until the expiration of a six-month &#x201C;distribution compliance period,&#x201D; if </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> is a &#x201C;reporting issuer,&#x201D; as defined in Regulation S (or a one-year &#x201C;distribution compliance period&#x201D; if </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> is not a &#x201C;reporting issuer&#x201D; as defined in Regulation S) following the Closing Date; and</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444775644"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;color:#010000;">(iv)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">notwithstanding the foregoing, prior to the expiration of the six-month &#x201C;distribution compliance period,&#x201D; if </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> is a &#x201C;reporting issuer,&#x201D; as defined in Regulation S (or the one-year &#x201C;distribution compliance period,&#x201D; if </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> is </font><font style="display: inline;">not </font><font style="display: inline;">a &#x201C;reporting issuer,&#x201D; as defined in Regulation S)</font><font style="display: inline;">,</font><font style="display: inline;"> after the Closing (the &#x201C;</font><font style="display: inline;font-weight:bold;">Restricted Period</font><font style="display: inline;">&#x201D;), the shares of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock issuable pursuant to this Agreement may be offered and sold by the holder thereof only if such offer and sale is made in compliance with the terms of this Agreement, and either: </font><font style="display: inline;">(A)</font><font style="display: inline;"> if the offer or sale is within the United States or to or for the account of a U.S. person (as such terms are defined in Regulation S), the securities are offered and sold pursuant to an effective registration statement or pursuant to Rule 144 under the Securities Act or pursuant to an exemption from the registration requirements of the Securities Act; or </font><font style="display: inline;">(B)</font><font style="display: inline;"> the offer and sale is outside the United States and to a person other than a U.S. person.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444775290"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(c)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">As used herein, the term &#x201C;</font><font style="display: inline;font-weight:bold;">United States</font><font style="display: inline;">&#x201D; means the United States of America, its territories and possessions, any State of the United States, and the District of Columbia, and the term &#x201C;</font><font style="display: inline;font-weight:bold;">U.S. person</font><font style="display: inline;">&#x201D; (as defined in Regulation S) means:</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444776247"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;color:#010000;">(i)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">a natural person resident in the United States;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:24pt;"><font style="display: inline;color:#010000;">(ii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">any partnership or corporation organized or incorporated under the laws of the United States;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;color:#010000;">(iii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">any estate of which any executor or administrator is a U.S. person;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;color:#010000;">(iv)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">any trust of which any trustee is a U.S. person;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(v)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">any agency or branch of a foreign entity located in the United States;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">12</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;color:#010000;">(vi)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">any nondiscretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:20pt;"><font style="display: inline;color:#010000;">(vii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated and (if an individual) resident in the United States; and</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444776261"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:18pt;"><font style="display: inline;color:#010000;">(viii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">a corporation or partnership organized under the laws of any foreign jurisdiction and formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a) under the Securities Act) who are not natural persons, estates or trusts.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref493851417"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(d)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">As used herein, the term &#x201C;</font><font style="display: inline;font-weight:bold;">Non-U.S. person</font><font style="display: inline;">&#x201D; means any person who is not a U.S. person or is deemed not to be a U.S. person under Rule 902(k)(2) of the Securities Act.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(e)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Such Securityholder agrees that with respect to the shares of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock issuable pursuant to this Agreement, until the expiration of the Restricted Period:</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;color:#010000;">(i)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">such Securityholder, its agents or its representatives have not and will not solicit offers to buy, offer for sale or sell any of the shares of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock issuable pursuant to this Agreement, or any beneficial interest therein in the United States or to or for the account of a U.S. person; and</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:24pt;"><font style="display: inline;color:#010000;">(ii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">notwithstanding the foregoing, the shares of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock issuable pursuant to this Agreement may be offered and sold by the holder thereof only if such offer and sale is made in compliance with the terms of this Agreement and either: </font><font style="display: inline;">(A)</font><font style="display: inline;"> if the offer or sale is within the United States or to or for the account of a U.S. person (as such terms are defined in Regulation S), the securities are offered and sold pursuant to an effective registration statement or pursuant to Rule 144 under the Securities Act or pursuant to an exemption from the registration requirements of the Securities Act; or </font><font style="display: inline;">(B)</font><font style="display: inline;"> the offer and sale is outside the United States and to other than a U.S. person; and</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;color:#010000;">(iii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">such Securityholder shall not engage in hedging transactions with regard to the shares of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock issuable pursuant to this Agreement unless in compliance with the Securities Act.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">The foregoing restrictions are binding upon subsequent transferees of the shares of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock issuable pursuant to this Agreement, except for transferees pursuant to an effective registration statement or valid exemption from registration. Such Securityholder agrees that after the Restricted Period, the shares of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock issuable pursuant to this Agreement may be offered or sold within the United States or to or for the account of a U.S. person only pursuant to applicable securities laws.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:25pt;"><font style="display: inline;color:#010000;">(f)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Such Securityholder has not engaged nor is he, she or it aware that any party has engaged, or that any Non-U.S. person will engage or cause any third party to engage, in </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">13</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">any directed selling efforts (as such term is defined in Regulation S) in the United States with respect to the shares of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock issuable pursuant to this Agreement.</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(g)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Such Securityholder: </font><font style="display: inline;">(i)</font><font style="display: inline;"> is domiciled and</font><font style="display: inline;">, if applicable,</font><font style="display: inline;"> has its principal place of business outside the United States; </font><font style="display: inline;">(ii)</font><font style="display: inline;"> certifies it is not a U.S. person and is not acquiring the shares of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock issuable pursuant to this Agreement for the account or benefit of any U.S. person; and </font><font style="display: inline;">(iii)</font><font style="display: inline;"> at the time of the Closing Date, such Securityholder or persons acting on such Securityholder&#x2019;s behalf in connection </font><font style="display: inline;">with the transactions contemplated by this Agreement</font><font style="display: inline;"> will be located outside the United States.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(h)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">At the time of offering to such Securityholder and communication of such Securityholder&#x2019;s order to purchase the shares of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock issuable pursuant to this Agreement and at the time of such Securityholder&#x2019;s execution of this Agreement, such Securityholder or persons acting on such Securityholder&#x2019;s behalf in connection therewith were located outside the United States.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;color:#010000;">(i)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Such Securityholder person is not a &#x201C;distributor&#x201D; (as defined in Regulation S) or a &#x201C;dealer&#x201D; (as defined in the Securities Act).</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:25pt;"><font style="display: inline;color:#010000;">(j)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Such Securityholder acknowledges that </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> shall make a notation in its stock books regarding the restrictions on transfer set forth in this </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">4.7 </font><font style="display: inline;">and shall transfer such shares on the books of Parent only to the extent consistent therewith.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">In particular, such Securityholder acknowledges that </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> shall refuse to register any transfer of the shares of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock issuable pursuant to this Agreement not made in accordance with the provisions of Regulation S, pursuant to registration under the Securities Act or pursuant to an available exemption from registration.</font><a name="_Ref444875682"></a><a name="_Ref444875691"></a>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc492967701"></a><a name="_Toc492967827"></a><a name="_Toc492967994"></a><a name="_Toc492968117"></a><a name="_Toc492968240"></a><a name="_Toc492968362"></a><a name="_Toc492968559"></a><a name="_Toc493011576"></a><a name="_Toc493797735"></a><a name="_Toc493797858"></a><a name="_Toc493844643"></a><a name="_Toc493869137"></a><a name="_Toc493869381"></a><a name="_Toc495394232"></a><a name="_Ref451529489"></a><a name="_Toc487751030"></a><a name="_Toc487788485"></a><a name="_Toc487788677"></a><a name="_Toc487788810"></a><a name="_Toc491721287"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">4.8</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="taxstatus"></a><font style="display: inline;font-weight:bold;font-style:italic;">Tax Statu</font><font style="display: inline;">s</font><font style="display: inline;">.</font><font style="display: inline;font-size:8pt;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref492964331"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Such Securityholder certifies that it is not a U.S. Tax Person.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref493010772"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">As used herein, </font><font style="display: inline;">the term </font><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">U.S. </font><font style="display: inline;font-weight:bold;">T</font><font style="display: inline;font-weight:bold;">ax </font><font style="display: inline;font-weight:bold;">P</font><font style="display: inline;font-weight:bold;">erson</font><font style="display: inline;">&#x201D;</font><font style="display: inline;"> means:</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;color:#010000;">(i)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">an individual who is a citizen of the United States;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:24pt;"><font style="display: inline;color:#010000;">(ii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">a</font><font style="display: inline;">n individual who is a resident of the United States for U.S. federal income tax purposes</font><font style="display: inline;">;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;color:#010000;">(iii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any state thereof or the District of Columbia;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;color:#010000;">(iv)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">a partnership</font><font style="display: inline;"> (or other entity treated as a </font><font style="display: inline;">partnership</font><font style="display: inline;"> for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any state thereof or the District of Columbia;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">14</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(v)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">an estate the income of which is subject to U.S. federal income tax regardless of its source; or</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;color:#010000;">(vi)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">a trust </font><font style="display: inline;">(i) </font><font style="display: inline;">the administration of which is subject to the primary supervision of a U.S. court and which has one or more United States persons who have the authority to control all substantial decisions of the trust or </font><font style="display: inline;">(ii) </font><font style="display: inline;">which has made a valid election under applicable U.S. Treasury regulations to be treated as a United States person.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref493788663"></a><a name="_Toc493797736"></a><a name="_Toc493797859"></a><a name="_Toc493844644"></a><a name="_Toc493869138"></a><a name="_Toc493869382"></a><a name="_Toc495394233"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">4.9</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="lockupperiod"></a><font style="display: inline;font-weight:bold;font-style:italic;">Lock-Up Period</font><font style="display: inline;">.&nbsp;&nbsp;Such Securityholder hereby agrees that such Securityholder shall not offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any securities of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> or enter into any swap, hedging or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any securities of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> held by such Securityholder from the Closing Date </font><font style="display: inline;">through the date that is six (6) months following the Closing Date</font><font style="display: inline;">.&nbsp;&nbsp;Parent may impose stop-transfer instructions with respect to securities subject to the foregoing restriction until the end of such period. Such Securityholder agrees that during such time when this </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">4.9 </font><font style="display: inline;">is applicable to any </font><font style="display: inline;">of </font><font style="display: inline;">Securityholder&#x2019;s shares of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock, any transferee of such Securityholder&#x2019;s shares of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock or other securities of Parent shall be bound by this </font><font style="display: inline;font-weight:bold;">Section</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">4.9</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444775754"></a><a name="_Toc487751031"></a><a name="_Toc487788486"></a><a name="_Toc487788678"></a><a name="_Toc487788811"></a><a name="_Toc491721288"></a><a name="_Toc493797737"></a><a name="_Toc493797860"></a><a name="_Toc493844645"></a><a name="_Toc493869139"></a><a name="_Toc493869383"></a><a name="_Toc495394234"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">4.10</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Restrictive Legends</font><font style="display: inline;">.&nbsp;&nbsp;Such Securityholder understands and agrees that each book entry or certificate held by such Securityholder representing the shares of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock issuable pursuant to this Agreement, or any other securities issued in respect of the shares of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock issuable pursuant to this Agreement upon any stock split, stock dividend, recapitalization, merger, consolidation or similar event, shall bear the following legends (in addition to any legend required by this Agreement or under applicable state securities laws):</font></font>
		</p>
		<p style="margin:0pt 54pt 12pt 72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#x201C;SECURITIES ACT&#x201D;), AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S PROMULGATED UNDER THE SECURITIES ACT, PURSUANT TO REGISTRATION UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION. HEDGING TRANSACTIONS INVOLVING THE SHARES REPRESENTED HEREBY MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT. THIS CERTIFICATE MUST BE SURRENDERED TO THE ISSUER OR ITS TRANSFER AGENT AS A CONDITION PRECEDENT TO THE SALE, PLEDGE, HYPOTHECATION OR ANY OTHER TRANSFER OF ANY INTEREST IN ANY OF THE SHARES REPRESENTED BY THIS CERTIFICATE.</font>
		</p>
		<p style="margin:0pt 54pt 12pt 72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">15</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 54pt 12pt 72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;">THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON TRANSFER FOR A PERIOD OF TIME SET FORTH IN AN AGREEMENT BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THESE SHARES AND MAY NOT BE SOLD OR OTHERWISE DISPOSED OF BY THE HOLDER PRIOR TO THE EXPIRATION OF SUCH PERIOD WITHOUT THE CONSENT OF THE ISSUER.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Any transferee of a holder of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock acquired hereby shall take such </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock subject to the restrictions set forth in this </font><font style="display: inline;font-weight:bold;">Section</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">4.10</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref493828527"></a><a name="_Ref493828543"></a><a name="_Toc493844646"></a><a name="_Toc493869140"></a><a name="_Toc493869384"></a><a name="_Toc495394235"></a><a name="_Toc493797738"></a><a name="_Toc493797861"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">4.11</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="fairdisclosure"></a><font style="display: inline;font-weight:bold;font-style:italic;">Fair Disclosure</font><font style="display: inline;font-weight:bold;font-style:italic;">.</font><font style="display: inline;font-weight:bold;font-style:italic;"> &nbsp; &nbsp;</font><font style="display: inline;">Solely with respect to the Securityholders&#x2019; representations and warranties in this </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;IV</font><font style="display: inline;"> that are not Fundamental Representations (it being understood and agreed that this </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">4.11</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">shall not apply to the Fundamental Representations)</font><font style="display: inline;">:</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref493010801"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Such representations and warranties that are not Fundamental Representations are subject to the matters that are fairly disclosed in the Company Disclosure Schedule or the materials made available to Buyer in the electronic data room maintained by the Company at the folder titled &#x201C;</font><font style="display: inline;">Project Jelly</font><font style="display: inline;">&#x201D;, located at </font><font style="display: inline;color:#0000FF;text-decoration:underline;">https://eu1.merrillcorp.com/bidder/index_frame.do?projectId=224838</font><font style="display: inline;"> (the &#x201C;</font><font style="display: inline;font-weight:bold;">VDR</font><font style="display: inline;">&#x201D;)</font><font style="display: inline;">; &nbsp;</font><font style="display: inline;font-style:italic;">provided, however</font><font style="display: inline;">, that, in so far </font><font style="display: inline;">as </font><font style="display: inline;">the VDR is concerned, only matters that were fairly disclosed in the VDR as of 11:59 p.m. Eastern </font><font style="display: inline;">Time</font><font style="display: inline;"> on August 31, 2017 shall receive the benefit of the fair disclosure trea</font><font style="display: inline;">tment set forth in this </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">4.11</font><font style="display: inline;">, and materials subsequently added to the VDR shall not qualify such representations or warranties;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">A</font><font style="display: inline;">ny </font><font style="display: inline;">document</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">to the extent included</font><font style="display: inline;"> in the VDR </font><font style="display: inline;">(</font><font style="display: inline;">as of 11:59 p.m. Eastern </font><font style="display: inline;">Time</font><font style="display: inline;"> on August 31, 2017</font><font style="display: inline;">) &nbsp;</font><font style="display: inline;">is deemed to be disclosed generally</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">for the purposes of this </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;IV </font><font style="display: inline;">and will be deemed an exception for the applicable representations and warranties contained in this </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;IV </font><font style="display: inline;">that are not Fundamental Representations</font><font style="display: inline;">,</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">solely </font><font style="display: inline;">with respect to</font><font style="display: inline;"> the portion of the document included in the VDR;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(c)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Except with respect to Fundamental Representations, as to which this </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">4.11</font><font style="display: inline;"> shall not apply, a</font><font style="display: inline;"> matter is deemed to be fairly disclosed for the purposes of this </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;IV</font><font style="display: inline;"> if such matter is </font><font style="display: inline;">included</font><font style="display: inline;"> in the VDR </font><font style="display: inline;">(</font><font style="display: inline;">as of 11:59 p.m. Eastern </font><font style="display: inline;">Time</font><font style="display: inline;"> on August 31, 2017</font><font style="display: inline;">) &nbsp;</font><font style="display: inline;">or</font><font style="display: inline;"> in</font><font style="display: inline;"> the </font><font style="display: inline;">Company</font><font style="display: inline;"> Disclosure Schedule in sufficient detail to enable Buyer, Parent and </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, upon a diligent review of the </font><font style="display: inline;">documents included in the </font><font style="display: inline;">VDR </font><font style="display: inline;">or included in</font><font style="display: inline;"> the </font><font style="display: inline;">Company</font><font style="display: inline;"> Disclosure Schedule (together with documents and </font><font style="display: inline;">information</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">included </font><font style="display: inline;">therein</font><font style="display: inline;"> that have been made available to Buyer</font><font style="display: inline;">), to reasonably assess the</font><font style="display: inline;"> nature, scope, importance and relevance of the disclosed matter and the</font><font style="display: inline;"> impact of such disclosure on the </font><font style="display: inline;">Company, the Company Subsidiaries, CryoLife, Parent and Buyer; and </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(d)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">In the event that the Company Disclosure Schedule omits disclosure with respect to the applicable representations and warranties provided in this </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;IV</font><font style="display: inline;">, but fair disclosure is provided in the VDR (</font><font style="display: inline;">as of 11:59 p.m. Eastern </font><font style="display: inline;">Time on</font><font style="display: inline;"> August 31, 2017</font><font style="display: inline;">), the materials in the VDR will take precedence.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="articlev"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">16</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;color:#010000;">Article&nbsp;V</font><br /><font style="display: inline;font-weight:bold;text-transform:uppercase;"></font><br /><font style="display: inline;font-weight:bold;text-transform:uppercase;"></font><a name="_Ref288596153"></a><a name="_Ref288596283"></a><a name="_Ref288596297"></a><a name="_Toc374597669"></a><a name="_Ref379808603"></a><a name="_Ref444864796"></a><a name="_Ref446780143"></a><a name="_Ref446780498"></a><a name="_Ref451964004"></a><a name="_Toc487751032"></a><a name="_Toc487788487"></a><a name="_Toc487788679"></a><a name="_Toc487788812"></a><a name="_Ref491673399"></a><a name="_Toc491721289"></a><a name="_Toc493797739"></a><a name="_Toc493797862"></a><a name="_Ref493801823"></a><a name="_Toc493844647"></a><a name="_Toc493869141"></a><a name="_Toc493869385"></a><a name="_Toc495394236"></a><font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;">REPRESENTATIONS AND WARRANTIES REGARDING THE COMPANY</font><font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;"> AND THE COMPANY SUBSIDIARIES</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Each of the Securityholders severally (and not jointly) </font><font style="display: inline;">hereby represents and warrants to </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent and Buyer on the date hereof and as of the Closing Date (other than the representations and warrant</font><font style="display: inline;">ie</font><font style="display: inline;">s which are made as of a specified date, which speak only as of such date), </font><font style="display: inline;">subject</font><font style="display: inline;"> to</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">such exceptions as are disclosed in the disclosure schedule (</font><font style="display: inline;">specifically </font><font style="display: inline;">referencing the appropriate section</font><font style="display: inline;"> (e.g. 5.11), subsection (e.g. 5.11(b))</font><font style="display: inline;"> and paragraph </font><font style="display: inline;">(e.g. 5.11(b)(iii), as applicable</font><font style="display: inline;">) supplied by the Company to </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent and Buyer on the date hereof (the &#x201C;</font><font style="display: inline;font-weight:bold;">Company Disclosure Schedule</font><font style="display: inline;">&#x201D;) (it being understood and hereby agreed that</font><font style="display: inline;"> (i) a matter is deemed to be disclosed in the Company Disclosure Schedule for the purposes of this </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;V</font><font style="display: inline;"> if such matter is included in the Company Disclosure Schedule in sufficient detail to enable Buyer, Parent and CryoLife, upon a diligent review of the Company Disclosure Schedule (together with documents and information included therein, which have been made available to Buyer), to reasonably understand the appropriate sections, subsections and paragraphs, as applicable, of the Company Disclosure Schedule to which such disclosure applies and to reasonably assess the nature, scope, importance and relevance of the disclosed matter and the impact of such disclosure on the Company, the Company Subsidiaries, CryoLife, Parent and Buyer and (ii) except with respect to Fundamental Representations, the fair disclosure statement in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.33</font><font style="display: inline;"> shall also apply</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">for the purposes of this </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;V</font><font style="display: inline;">)</font><font style="display: inline;">, as follows:&nbsp; </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288597665"></a><a name="_Ref288597678"></a><a name="_Toc374597670"></a><a name="_Toc487751033"></a><a name="_Toc487788488"></a><a name="_Toc487788680"></a><a name="_Toc487788813"></a><a name="_Toc491721290"></a><a name="_Toc493797740"></a><a name="_Toc493797863"></a><a name="_Toc493844648"></a><a name="_Toc493869142"></a><a name="_Toc493869386"></a><a name="_Toc495394237"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.1</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="organizationofthecompany"></a><font style="display: inline;font-weight:bold;font-style:italic;">Organization of the Company</font><font style="display: inline;">.&nbsp;&nbsp;The Company is a Swiss AG duly organized and validly existing under the Laws of Switzerland.&nbsp;&nbsp;Each of the Company Subsidiaries is duly organized, validly existing and in (to the extent such phrase is recognized in the applicable jurisdiction) good standing under the Laws of the applicable jurisdiction noted for such entity in </font><font style="display: inline;font-weight:bold;">Schedule 2</font><font style="display: inline;">. The Company and each of the Company Subsidiaries</font><font style="display: inline;"> have</font><font style="display: inline;"> the corporate power to own its properties and to carry on its business as currently conducted.&nbsp;&nbsp;The Company and each of the Company Subsidiaries is duly qualified or licensed to do business and (to the extent such phrase is recognized in the applicable jurisdiction) in good standing as a foreign corporation in each jurisdiction in which such qualification or licensure is required by Law, except for those jurisdictions where the failure to be so qualified or licensed and in good standing would not reasonably be expected to have, individually, or in the aggregate, a Company Material Adverse Effect. The Company and each of the Company Subsidiaries has made available a true and correct copy of its certificate of incorporation and bylaws or comparable governing documents, each as amended to date and in full force and effect on the date hereof (collectively, the &#x201C;</font><font style="display: inline;font-weight:bold;">Charter Documents</font><font style="display: inline;">&#x201D;), to Buyer.&nbsp; </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.1</font><font style="display: inline;"> of the Company Disclosure Schedule lists the directors, officers, and managers of the Company and each of the Company Subsidiaries as of the date hereof.&nbsp;&nbsp;The Business and the operations now being conducted by the Company and the Company Subsidiaries are not now and have never been conducted by the Company or any of the Company Subsidiaries under any other name. </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.1 </font><font style="display: inline;">of the Company Disclosure Schedule lists (a)&nbsp;each jurisdiction in which the Company is qualified or licensed to do business, </font><font style="display: inline;">to the extent required by Law </font><font style="display: inline;">(b)&nbsp;each jurisdiction in which each of the Company Subsidiaries is qualified or licensed to do business, </font><font style="display: inline;">to the extent required by Law </font><font style="display: inline;">and </font>
		</font></p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">17</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">(c) &nbsp;every state or foreign jurisdiction in which the Company or any of the Company Subsidiaries has employees or facilities. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288601122"></a><a name="_Ref288601682"></a><a name="_Ref288601732"></a><a name="_Ref288602290"></a><a name="_Toc374597671"></a><a name="_Toc487751034"></a><a name="_Toc487788489"></a><a name="_Toc487788681"></a><a name="_Toc487788814"></a><a name="_Toc491721291"></a><a name="_Toc493797741"></a><a name="_Toc493797864"></a><a name="_Toc493844649"></a><a name="_Toc493869143"></a><a name="_Toc493869387"></a><a name="_Toc495394238"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.2</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="companycapitalstructure"></a><font style="display: inline;font-weight:bold;font-style:italic;">Company Capital Structure</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288597697"></a><a name="_Ref444770111"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">T</font><font style="display: inline;">he Shares set forth on </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.2(a)(i)</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">of the Company Disclosure Schedule are the only shares of the share capital of the Company </font><font style="display: inline;">issued and </font><font style="display: inline;">outstanding, and</font><font style="display: inline;">,</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">as of the Closing Date, </font><font style="display: inline;">the Company has no shares of the share capital of the Company, other than </font><font style="display: inline;">such</font><font style="display: inline;"> Shares, authorized, issued or outstanding.&nbsp; </font><font style="display: inline;">As of the date hereof, t</font><font style="display: inline;">he Company Securities are held by the Persons with the registered addresses and in the numbers as set forth on </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.2(a)(ii)</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">of the Company Disclosure Schedule. All </font><font style="display: inline;">issued and </font><font style="display: inline;">outstanding Shares are duly authorized, validly issued, fully paid and non-assessable and are not subject to preemptive rights created by statute, the Charter Documents of the Company, or any Contract to which the Company is a party or by which it is bound</font><font style="display: inline;"> (save for the Shareholders Agreement which will be terminated with regard to the Securityholders on the Closing Date subject to Closing occurring)</font><font style="display: inline;">, and have been issued in compliance with all applicable Laws. </font><font style="display: inline;">All certificates representing Shares have been correctly and validly issued and not been cancelled. Neither</font><font style="display: inline;"> the Company nor any of the Company Subsidiaries has or will have suffered or incurred any Liability, arising out of the issuance</font><font style="display: inline;">, redemption, </font><font style="display: inline;">or repurchase of any </font><font style="display: inline;">Company Securities </font><font style="display: inline;">or the repayment, conversion or purported conversion of the Company Promissory Notes, or out of any Contracts or arrangements relating to any of the Company Securities (including any amendment of the terms of any such Contract or arrangement).&nbsp;&nbsp;Except as contemplated in this Agreement, there are no declared or accrued but unpaid dividends with respect to any of the Shares.&nbsp;&nbsp;A complete and detailed description of the capitalization of each of the Company Subsidiaries, including the names and amounts held by the holders of interests in each of the Company Subsidiaries</font><font style="display: inline;"> as of the date hereof</font><font style="display: inline;">, is set forth on </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.2(a)(iv)</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">of the Company Disclosure Schedule.</font><font style="display: inline;"> &nbsp; &nbsp;</font><font style="display: inline;">All </font><font style="display: inline;">issued and </font><font style="display: inline;">outstanding shares or equity interests in the Company Subsidiaries are duly authorized, validly issued, fully paid and non-assessable and are not subject to preemptive rights created by statute, the organizational documents of the Company Subsidiaries, or any Contract to which a Company Subsidiary is a party or by which it is bound, and have been issued in compliance with all applicable Laws. </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288596956"></a><a name="_Ref444730410"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.2(b)</font><font style="display: inline;"> of the Company Disclosure Schedule lists each stock option plan and each other plan for equity compensation maintained or sponsored by the Company or any of the Company Subsidiaries.&nbsp; </font><font style="display: inline;">Other than the Shareholder Options to be redeemed as provided in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">2.2(c)</font><font style="display: inline;">, there are no options, warrants, calls, rights, Convertible Securities, commitments or Contracts of any character, written or oral, to which the Company or any Company Subsidiary is a party or by which the Company or any Company Subsidiary is bound obligating the Company or any Company Subsidiary to issue, deliver, sell, repurchase or redeem, or cause to be issued, delivered, sold, repurchased or redeemed, any shares of the share capital of the Company or any of the Company Subsidiaries.&nbsp; </font><font style="display: inline;">Other than the Shareholder Options to be redeemed as provided in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">2.2(c)</font><font style="display: inline;">, t</font><font style="display: inline;">here are no outstanding or authorized stock appreciation, phantom stock, profit participation, or other rights, rights of any type, the value of which is determined by reference in whole or in part to the value of the share capital of the Company or any of the Company Securities (whether payable in cash, property or otherwise).&nbsp; </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">18</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">Except as provided in</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.2(b) </font><font style="display: inline;">of the Company Disclosure Schedule</font><font style="display: inline;">, each of the Shareholder Options was granted to and is held by Employees of JOTEC GmbH who currently reside in Germany.</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Other than the Shareholder Loans provided on the Consideration Schedule, there are no Company Promissory Notes. </font><font style="display: inline;">Except </font><font style="display: inline;">as set forth </font><font style="display: inline;">in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.2(b)</font><font style="display: inline;"> of the Company Disclosure Schedule (such schedule to contain </font><font style="display: inline;">the </font><font style="display: inline;">Shareholders Agreement</font><font style="display: inline;">)</font><font style="display: inline;">, there are no voting trusts, proxies, or other Contracts or understandings with respect to the voting securities of the Company or any of the Company Subsidiaries.&nbsp;&nbsp;Except </font><font style="display: inline;">as set forth </font><font style="display: inline;">in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.2(b)</font><font style="display: inline;"> of the Company Disclosure Schedule (such schedule to contain </font><font style="display: inline;">the </font><font style="display: inline;">Shareholders Agreement</font><font style="display: inline;">)</font><font style="display: inline;">, there are no Contracts to which the Company or any of the Company Subsidiaries is a party relating to the registration, sale or transfer (including Contracts relating to rights of first refusal, co-sale rights or &#x201C;drag-along&#x201D; rights) of any Company Securities or any securities of any of the Company Subsidiaries</font><font style="display: inline;">.&nbsp; </font><font style="display: inline;">The Consideration Schedule is complete and correct. At the Closing, the allocation of Acquisition Consideration set forth in the Consideration Schedule will comply with the Charter Documents of the Company and applicable Law and will not result in any violation of any Contract between the Company on the one hand and any of the Securityholders, on the other hand.&nbsp;&nbsp;All Securityholders that hold a share of the share capital of the Company are parties to the Shareholders Agreement. </font><font style="display: inline;"> To the Knowledge of the Company, n</font><font style="display: inline;">one of the Securityholders has breached or violated any provision of the Shareholders Agreement.&nbsp;&nbsp;As a result of the Acquisition, and assuming the satisfaction of the payment obligations of </font><font style="display: inline;">CryoLife, </font><font style="display: inline;">Parent and Buyer herein, Buyer will be the sole record and beneficial holder of all</font><font style="display: inline;"> Sold Shares of the Securityholders, </font><font style="display: inline;">which will represent at least ninety-f</font><font style="display: inline;">our </font><font style="display: inline;">percent (9</font><font style="display: inline;">4</font><font style="display: inline;">%) of the issued and outstanding shares of the Company&#x2019;s share capital</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444867771"></a><a name="_Toc487751035"></a><a name="_Toc487788490"></a><a name="_Toc487788682"></a><a name="_Toc487788815"></a><a name="_Toc491721292"></a><a name="_Toc493797742"></a><a name="_Toc493797865"></a><a name="_Toc493844650"></a><a name="_Toc493869144"></a><a name="_Toc493869388"></a><a name="_Toc495394239"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.3</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="subsidiaries"></a><font style="display: inline;font-weight:bold;font-style:italic;">Subsidiaries</font><font style="display: inline;">.&nbsp;&nbsp;The Company has never had</font><font style="display: inline;">, at any time during the ten (10) year period immediately preceding the date hereof,</font><font style="display: inline;"> any subsidiaries other than the Company Subsidiaries and those that are listed in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.3</font><font style="display: inline;"> of the Company Disclosure Schedule.&nbsp; </font><font style="display: inline;">Neither the Company nor any Company Subsidiary has agreed, is obligated to make, or is bound by any Contract under which it may become obligated to make, or is bound by any Contract under which it may become obligated to make any future investment in, or capital contribution to, any other Person.</font><font style="display: inline;"> &nbsp;Except as set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.3</font><font style="display: inline;"> of the Company Disclosure Schedule, neither the Company nor any of the Company Subsidiaries directly or indirectly owns any equity or similar interest in</font><font style="display: inline;">,</font><font style="display: inline;"> or any interest convertible, </font><font style="display: inline;">exchangeable or exercisable for</font><font style="display: inline;"> any equity or similar interest in, any Person.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288597836"></a><a name="_Toc374597673"></a><a name="_Toc487751036"></a><a name="_Toc487788491"></a><a name="_Toc487788683"></a><a name="_Toc487788816"></a><a name="_Toc491721293"></a><a name="_Toc493797743"></a><a name="_Toc493797866"></a><a name="_Toc493844651"></a><a name="_Toc493869145"></a><a name="_Toc493869389"></a><a name="_Toc495394240"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.4</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Authority</font><font style="display: inline;">.&nbsp;&nbsp;The Company has all requisite power and authority to enter into this Agreement and any Related Agreements to which it is a party and to consummate the transactions contemplated in this Agreement and such Related Agreements. The execution and delivery of this Agreement and any Related Agreements to which the Company is a party and the consummation of the transactions contemplated in this Agreement and the Related Agreements have been duly authorized by all necessary corporate action on the part of the Company</font><font style="display: inline;">,</font><font style="display: inline;"> and no further action is required on the part of the Company to authorize, execute and deliver the Agreement and any Related Agreements to which it is a party or the transactions contemplated in this Agreement or such Related Agreements. This Agreement </font><font style="display: inline;">has</font><font style="display: inline;"> been approved by </font><font style="display: inline;">the </font><font style="display: inline;">Board of Directors.&nbsp;&nbsp;This Agreement and each of the Related Agreements to which the Company is a party have been duly executed and delivered by the Company and, assuming the due authorization, </font>
		</font></p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">19</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">execution and delivery by the other parties hereto and thereto, shall constitute the valid and binding obligations of the Company enforceable against it in accordance with their respective terms, except as such enforceability may be subject to the Laws of general application relating to bankruptcy, insolvency, and the relief of debtors and rules of Law governing specific performance, injunctive relief, or other equitable remedies.&nbsp; </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref356295044"></a><a name="_Toc374597674"></a><a name="_Toc487751037"></a><a name="_Toc487788492"></a><a name="_Toc487788684"></a><a name="_Toc487788817"></a><a name="_Toc491721294"></a><a name="_Toc493797744"></a><a name="_Toc493797867"></a><a name="_Toc493844652"></a><a name="_Toc493869146"></a><a name="_Toc493869390"></a><a name="_Toc495394241"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.5</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="noconflict"></a><font style="display: inline;font-weight:bold;font-style:italic;">No Conflict</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288597851"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Except as set forth on </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.5(a</font><font style="display: inline;">)</font><font style="display: inline;"> of the Company Disclosure Schedule, the execution and delivery by the Company of this Agreement and any Related Agreement to which the Company is a party, and the consummation of the transactions contemplated in this Agreement and such Related Agreements, will not conflict with or result in any violation of or default under (with or without notice or lapse of time, or both) or give rise to a right of termination, cancellation, modification or acceleration of any obligation or loss of any benefit under (any such event, a &#x201C;</font><font style="display: inline;font-weight:bold;">Conflict</font><font style="display: inline;">&#x201D;) </font><font style="display: inline;">(i)</font><font style="display: inline;">&nbsp;any provision of the Charter Documents, </font><font style="display: inline;">(ii)</font><font style="display: inline;">&nbsp;any Material Contract, or </font><font style="display: inline;">(iii)</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">any </font><font style="display: inline;">Law applicable to the Company, any of the Company Subsidiaries or any of their respective properties (whether tangible or intangible) or assets</font><font style="display: inline;">, except in the case of </font><font style="display: inline;">&#x200E;</font><font style="display: inline;">(iii) for immaterial violations of a Law</font><font style="display: inline;">.&nbsp; </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288597887"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.5(b</font><font style="display: inline;">)</font><font style="display: inline;"> of the Company Disclosure Schedule identifies all consents, waivers and approvals of, and notices to parties to any Material Contract as are required thereunder in connection with the execution and delivery of this Agreement and any Related Agreement to which the Company or any such Company Subsidiary, is a party or the consummation of the transactions by the Company or any such Company Subsidiary, contemplated in this Agreement or the Related Agreements.&nbsp;&nbsp;Following the Closing, the Company and each Company Subsidiary will be permitted to exercise all of their respective rights under such Material Contracts without the payment of any additional amounts or consideration other than ongoing fees, royalties or payments which the Company or such Company Subsidiary would otherwise be required to pay pursuant to the terms of such Material Contracts had the transactions contemplated in this Agreement not occurred.&nbsp; </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288664708"></a><a name="_Ref288664716"></a><a name="_Toc374597675"></a><a name="_Toc487751038"></a><a name="_Toc487788493"></a><a name="_Toc487788685"></a><a name="_Toc487788818"></a><a name="_Toc491721295"></a><a name="_Toc493797745"></a><a name="_Toc493797868"></a><a name="_Toc493844653"></a><a name="_Toc493869147"></a><a name="_Toc493869391"></a><a name="_Toc495394242"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.6</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Governmental Consent</font><font style="display: inline;font-weight:bold;font-style:italic;">s.</font><font style="display: inline;"> &nbsp;No consent, notice, waiver, approval, order or authorization of, or registration, declaration or filing with any court, tribunal, judicial, legislative or administrative agency, body or commission or other federal, state, county, local or foreign, governmental or regulatory authority, instrumentality, agency, department, ministry, administrative body, or commission or other public or quasi-public legal authority (each, a &#x201C;</font><font style="display: inline;font-weight:bold;">Governmental Authority</font><font style="display: inline;">&#x201D;), is </font><font style="display: inline;">required b</font><font style="display: inline;">y, or with respect to,</font><font style="display: inline;"> the Company or any of the Company Subsidiaries, in connection with the execution and delivery of this Agreement and any Related Agreement to which the Company or any such Company Subsidiary is a party or the consummation of the transactions by the Company or any such Company Subsidiary, contemplated in this Agreement or the Related Agreements</font><font style="display: inline;">, except for immaterial consents, notices, waivers, approvals, orders or authorizations; provided, however, that this representation and warranty does not apply to the extent CryoLife, Parent or Buyer would be solely responsible for any filings with any Governmental Authority</font><font style="display: inline;">.</font></font><a name="_Ref288597929"></a><a name="_Toc374597676"></a><a name="_Toc493869148"></a><a name="_Toc493869392"></a><a name="_Toc495394243"></a><a name="_Toc487751039"></a><a name="_Toc487788494"></a><a name="_Toc487788686"></a><a name="_Toc487788819"></a><a name="_Toc491721296"></a><a name="_Toc493797746"></a><a name="_Toc493797869"></a><a name="_Toc493844654"></a>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">20</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">&nbsp;</font><font style="display: inline;color:#010000;">5.7</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="companyfinancialstatements"></a><font style="display: inline;font-weight:bold;font-style:italic;">Company Financial Statements</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref289174159"></a><font style="display: inline;color:#010000;">(a)</font><font style="display: inline;color:#010000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 61.2pt 0pt 0pt;"></font><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">5.7(a</font><font style="display: inline;">)</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">of the Company Disclosure Schedule sets forth the Company&#x2019;s </font><font style="display: inline;">(i)</font><font style="display: inline;">&nbsp;audited, consolidated balance sheets as of December 31, 2015 and December 31, 2016, and the audited, consolidated statements of income, cash flow and stockholders&#x2019; equity for the twelve (12) month periods ended December 31, 2015 and December 31, 2016 (the &#x201C;</font><font style="display: inline;font-weight:bold;">Year-End Financials</font><font style="display: inline;">&#x201D;), and </font><font style="display: inline;">(ii)</font><font style="display: inline;">&nbsp;unaudited, consolidated balance sheet at June 30, 2017 (the &#x201C;</font><font style="display: inline;font-weight:bold;">Balance Sheet Date</font><font style="display: inline;">&#x201D;), and the related unaudited, consolidated statements of income and cash flow for the six (6) month period ended June 30, 2017 (the &#x201C;</font><font style="display: inline;font-weight:bold;">Interim Financials</font><font style="display: inline;">&#x201D;). The Year-End Financials and the Interim Financials (collectively referred to as the &#x201C;</font><font style="display: inline;font-weight:bold;">Financials</font><font style="display: inline;">&#x201D;) have been prepared on a consistent basis throughout the periods indicated and consistent with each other.&nbsp; </font><font style="display: inline;">The Financials</font><font style="display: inline;">, prepared in accordance with GAAP,</font><font style="display: inline;"> present in all material respects</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">the Company&#x2019;s financial condition, operating results and cash flows as of the dates and during the </font><font style="display: inline;">periods indicated therein</font><font style="display: inline;">. &nbsp;</font><font style="display: inline;"> The Financials have been prepared in accordance with GAAP,</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">provided that the Interim Financials are subject to ordinary year-end adjustments that are not expected to be material in the aggregat</font><font style="display: inline;">e</font><font style="display: inline;">.&nbsp; </font><font style="display: inline;">The Com</font><font style="display: inline;">pany&#x2019;s unaudited, consolidated balance sheet as of the Balance Sheet Date is referred to hereinafter as the &#x201C;</font><font style="display: inline;font-weight:bold;">Current Balance Sheet</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref289174195"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">The Accounts Receivable of the Company and each of the Company Subsidiaries have or will have arisen from bona fide arm&#x2019;s length transactions in the ordinary course of business of the Company or such Company Subsidiaries, consistent with their respective past practices.&nbsp;&nbsp;There has not been any material adverse change in the collectability of such Accounts Receivable during the twelve (12) month period ending on the Balance Sheet Date.&nbsp; </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.7(b</font><font style="display: inline;">)</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">of the Company Disclosure Schedule sets forth a list of all such Accounts Receivable that are more than ninety (90) days past due as of the Balance Sheet Date, and of all such Accounts Receivable classified as doubtful accounts on the Current Balance Sheet.&nbsp;&nbsp;All Accounts Payable of the Company have or will have arisen from bona fide arm&#x2019;s length transactions in the ordinary course of business of the Company and the Company Subsidiaries, consistent with their respective past practices.&nbsp;&nbsp;Since </font><font style="display: inline;">December 31</font><font style="display: inline;">, 201</font><font style="display: inline;">6</font><font style="display: inline;">, the Company and each of the Company Subsidiaries has paid its Accounts Payable in the ordinary course of business of the Company and the Company Subsidiaries consistent with their respective past practices.&nbsp; </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(c)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Except for usual consignment stocks consistent with past practice, t</font><font style="display: inline;">he Company has no Company Products placed with its customers under an understanding permitting their return to the Company other than pursuant to a breach of warranty.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288672621"></a><a name="_Toc374597677"></a><a name="_Toc487751040"></a><a name="_Toc487788495"></a><a name="_Toc487788687"></a><a name="_Toc487788820"></a><a name="_Toc491721297"></a><a name="_Toc493797747"></a><a name="_Toc493797870"></a><a name="_Toc493844655"></a><a name="_Toc493869149"></a><a name="_Toc493869393"></a><a name="_Toc495394244"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.8</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">No Undisclosed Liabilities</font><font style="display: inline;">.&nbsp; </font><font style="display: inline;">N</font><font style="display: inline;">either the Company nor any of the Company Subsidiaries has any Liabilities</font><font style="display: inline;"> that</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">(a)</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">as of the end of December 31, 2016, </font><font style="display: inline;">have not been reflected in the </font><font style="display: inline;">Year-End Financials if required by GAAP to be so reflected</font><font style="display: inline;">, or </font><font style="display: inline;">(b)</font><font style="display: inline;">&nbsp;have not arisen in the ordinary course of business of the Company or such Company Subsidiary, consistent with their respective past practices</font><font style="display: inline;">, since December 31, 2016 in an amount that exceeds &#x20AC;</font><font style="display: inline;">100,000 in any one case or &#x20AC;250,000 in</font><font style="display: inline;"> the aggregate.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc493797748"></a><a name="_Toc493797871"></a><a name="_Toc493844656"></a><a name="_Toc493869394"></a><a name="_Toc495394245"></a><a name="_Toc493869150"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.9</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Internal Controls</font><font style="display: inline;font-weight:bold;font-style:italic;">.&nbsp; </font><font style="display: inline;">The Company</font><font style="display: inline;"> maintains</font><font style="display: inline;"> books and records reflecting the assets and Liabilities of the Company and the Company Subsidiaries</font><font style="display: inline;"> that are in accordance with applicable Law and are </font><font style="display: inline;">in all material respects </font><font style="display: inline;">accurate</font><font style="display: inline;">.&nbsp;&nbsp;The Company</font><font style="display: inline;"> maintains </font><font style="display: inline;">a system </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">21</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">of internal accounting controls designed to provide reasonable assurances </font><font style="display: inline;">(in light of the Company&#x2019;s consolidated size and privately held status) that </font><font style="display: inline;">(a)</font><font style="display: inline;"> transactions are executed with management&#x2019;s authorization; </font><font style="display: inline;">(b)</font><font style="display: inline;"> transactions are recorded a</font><font style="display: inline;">s necessary to permit preparation of the consolidated financial statements of the Company in accordance with GAAP and to maintain accountability for the Company&#x2019;s consolidated assets; and </font><font style="display: inline;">(c)</font><font style="display: inline;"> account receivables are recorded accurately and adequate procedures are implemented to effect the collection thereof on a timely basis</font><font style="display: inline;">,</font><font style="display: inline;font-style:italic;">&nbsp;</font><font style="display: inline;font-style:italic;">provided, however</font><font style="display: inline;">, that the Parties agree that U.S. financial reporting and disclosure Laws are not applicable when evaluating the accuracy of this sentence.&nbsp;&nbsp;There are no significant deficiencies in the design or operation of the Company&#x2019;s internal controls over financial reporting that could be reasonably expected to adversely affect in any material respect the Company&#x2019;s ability to record, process, summarize and report consolidated financial data, </font><font style="display: inline;font-style:italic;">provided, however</font><font style="display: inline;">, that the Parties agree that U.S. financial reporting and disclosure Laws are not applicable when evaluating the accuracy of this sentence</font><font style="display: inline;">.&nbsp; </font><font style="display: inline;">T</font><font style="display: inline;">o the Knowledge of the Company, there has been no fraud, whether or n</font><font style="display: inline;">ot material, that involved management or other Employees who have a significant role in the Company&#x2019;s internal control over financial reporting.</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref494313412"></a><a name="_Toc495394246"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.10</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="nochanges"></a><font style="display: inline;font-weight:bold;font-style:italic;">No Changes</font><font style="display: inline;font-weight:bold;font-style:italic;">.&nbsp; </font><font style="display: inline;">Except for immaterial changes or developments or actions in the ordinary course of business of the Company and the applicable Company Subsidiary consistent with their respective past practices, s</font><font style="display: inline;">ince December 31, 2016, there has not been, occurred or arisen any:</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288602999"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">other than as contemplated in this Agreement, transaction by the Company or any Company Subsidiary, except in the ordinary course of business of the Company and such Company Subsidiary, consistent with their respective past practices, as conducted on that date and consistent with past practices;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">amendments or changes to the Charter Documents, other than as contemplated in this Agreement;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(c)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">capital expenditure or commitment by the Company or any Company Subsidiary exceeding </font><font style="display: inline;">&#x20AC;100,000 individually or &#x20AC;250</font><font style="display: inline;">,000</font><font style="display: inline;"> in</font><font style="display: inline;"> the aggregate</font><font style="display: inline;"> (inclusive of all ordinary course capital expenditures and commitments)</font><font style="display: inline;">;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(d)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">payment, discharge or satisfaction of any claim or Liability, other than payments, discharges or satisfactions in the ordinary course of business of the Company and the Company Subsidiaries, consistent with their respective past practices, of Liabilities reflected or reserved against in the </font><font style="display: inline;">Year-End Financials </font><font style="display: inline;">or arising in the ordinary course of business of the Company and the Company Subsidiaries, consistent with their respective past practices,</font><font style="display: inline;"> since</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">December 31, 2016</font><font style="display: inline;">;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(e)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">destruction of, damage to, or loss of any material assets (whether tangible or intangible), material business or Customer of the Company or any of the Company Subsidiaries (whether or not covered by insurance)</font><font style="display: inline;">, in each case to the Knowledge of the Company</font><font style="display: inline;">;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">22</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="text-indent:0pt;margin-left:0pt; padding-right:25pt;"><font style="display: inline;color:#010000;">(f)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">change in accounting methods or practices (including any change in depreciation or amortization policies or rates) by the Company or any of the Company Subsidiaries, other than as required by applicable Law;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(g)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">revaluation by the Company or any of the Company Subsidiaries of any of their respective assets (whether tangible or intangible), including writing down the value of inventory or writing off notes or Accounts Receivable or change in pricing of any of the Company Products or services;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(h)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">declaration, setting aside or payment of a dividend or other distribution (whether in cash, stock or property) in respect of any Company Securities, or any split, combination or reclassification in respect of any Company Securities, or any issuance or authorization of any issuance of any other securities in respect of, in lieu of or in substitution for Company Securities (other than shares of the share capital of the Company issued upon the exercise or conversion of the Convertible Securities), or any direct or indirect repurchase, redemption, or other acquisition by the Company of any Company Securities (or options, warrants or other rights convertible into, exercisable or exchangeable therefor); </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;color:#010000;">(i)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">hiring or termination of any Employee</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">promotion, demotion or other change to the employment status or title of any officer of the Company or any of the Company Subsidiaries, or resignation or removal of any director or manager of the Company or any of the Company Subsidiaries, </font><font style="display: inline;">except in the ordinary course of business of the Company or any of the Company Subsidiaries consistent with their respective past practices</font><font style="display: inline;">;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:25pt;"><font style="display: inline;color:#010000;">(j)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">increase in or other change to the salary, employment status, title or other compensation (including equity based compensation whether payable in cash, securities or otherwise) payable or to become payable by the Company or any of the Company Subsidiaries to any of the Employees</font><font style="display: inline;">,</font><font style="display: inline;"> or the declaration, adoption, Contract, payment or commitment or obligation of any kind for the payment (whether in cash or equity) by the Company or any of the Company Subsidiaries of a severance payment, termination payment, bonus or other additional salary or compensation to any such Person (except amendments required to comply with applicable Law), </font><font style="display: inline;">in each case except in the ordinary course of business of the Company or any of the Company Subsidiaries consistent with their respective past practices</font><font style="display: inline;">;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(k)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">other than as contemplated in this Agreement, Contract, covenant, instrument, lease, license or commitment to which the Company or any of the Company Subsidiaries is a party or by which the Company or any of the Company Subsidiaries or any of their respective material assets (whether tangible or intangible) are bound or any termination, extension, amendment or modification of the terms of any Contract, covenant, instrument, lease, license or commitment to which the Company or any of the Company Subsidiaries is a party or by which the Company or any of the Company Subsidiaries or any of their respective material assets are bound, other than Contracts, covenants, instruments, leases, licenses or commitments entered into in the ordinary course of business of the Company or such Company Subsidiary, consistent with their respective past practices;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">23</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;color:#010000;">(l)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">other than as contemplated in this Agreement, sale, lease, license or other disposition of any of the material assets (whether tangible or intangible) or properties of the Company or any of the Company Subsidiaries outside of the ordinary course of business of the Company or such Company Subsidiary, consistent with their respective past practices, including the sale of any Accounts Receivable, or any creation of any security interest in such assets or properties;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:21pt;"><font style="display: inline;color:#010000;">(m)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">loan by the Company or any of the Company Subsidiaries to any Person, or purchase by the Company or any of the Company Subsidiaries of any debt securities of any Person, except for advances to employees for travel and business expenses in the ordinary course of business of the Company or the Company Subsidiaries, consistent with their respective past practices;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(n)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">incurrence by the Company or any of the Company Subsidiaries of any Indebtedness, amendment of the terms of any outstanding loan Contract, guaranteeing by the Company or any of the Company Subsidiaries of any Indebtedness, issuance or sale of any debt securities of the Company or any of the Company Subsidiaries or guaranteeing of any debt securities of others, except for advances to employees for travel and business expenses in the ordinary course of business of the Company or such Company Subsidiary, consistent with their respective past practices;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(o)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">waiver or release of any right or claim of the Company or any of the Company Subsidiaries, including any write-off or other compromise of any Accounts Receivable, or change in practices or procedures with respect to the collection of Accounts Receivable or extension of any other incentive with respect thereto, in each case outside the ordinary course of business of the Company or any Company Subsidiary, consistent with their respective past practices;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref492390810"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(p)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">other than as contemplated in this Agreement, </font><font style="display: inline;">(i)</font><font style="display: inline;"> sale, lease, license, assignment, or transfer by the Company or any of the Company Subsidiaries to any Person of any Company Intellectual Property or execution, modification, termination, or amendment of any Contract to which the Company or any of the Company Subsidiaries is a party with respect to the Company Intellectual Property with any Person or with respect to the Intellectual Property Rights of any Person, in each case, excluding standard end user licenses and Contracts and similar Contracts entered into in the ordinary course of business of the Company or such Company Subsidiary, in each case consistent with their respective past practices, </font><font style="display: inline;">(ii)</font><font style="display: inline;"> purchase, assignment, or license of any Intellectual Property Rights or execution, modification, termination, or amendment of any Contract to which the Company or any of the Company Subsidiaries is a party with respect to the Intellectual Property Rights of any Person, </font><font style="display: inline;">(iii)</font><font style="display: inline;"> Contract, termination, modification, or amendment of an existing Contract to which the Company or any of the Company Subsidiaries is a party with respect to the development of any Technology or Intellectual Property Rights with a third party, or </font><font style="display: inline;">(iv)</font><font style="display: inline;"> change in pricing or royalties set or charged by the Company or any of the Company Subsidiaries to their customers or licensees or in pricing or royalties set or charged by Persons who have licensed Technology or Intellectual Property Rights to the Company or any of the Company Subsidiaries, other than </font>
		</font></p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">24</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">pursuant to the terms of such Contracts or in the ordinary course of business of the Company or such Company Subsidiary, consistent with their respective past practices;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(q)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">entering into a Contract or material modification to any Contract pursuant to which any other party was granted marketing, distribution, development, manufacturing or similar rights of any type or scope with respect to any Company Product, except in the ordinary course of business of the Company and the Company Subsidiaries, consistent with their respective past practices;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:25pt;"><font style="display: inline;color:#010000;">(r)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">lease, license, sublease, or other occupa</font><font style="display: inline;">ncy of any Leased Real Property</font><font style="display: inline;"> by the Company or any Company Subsidiary</font><font style="display: inline;">;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:24pt;"><font style="display: inline;color:#010000;">(s)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Contract by the Company or any of the Company Subsidiaries, or any Employee on behalf of the Company or any of the Company Subsidiaries, to do any of the things described in the preceding clauses </font><font style="display: inline;">&#x200E;</font><font style="display: inline;">(a)</font><font style="display: inline;"> through </font><font style="display: inline;">&#x200E;</font><font style="display: inline;">(p) </font><font style="display: inline;">of this </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.10</font><font style="display: inline;"> (other than negotiations with </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> and its representatives regarding the transactions contemplated in this Agreement and the Related Agreements)</font><font style="display: inline;">; or</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:25pt;"><font style="display: inline;color:#010000;">(t)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Company Material Adverse Effect</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288597257"></a><a name="_Ref288597944"></a><a name="_Toc374597680"></a><a name="_Toc487788498"></a><a name="_Toc487788690"></a><a name="_Toc487788823"></a><a name="_Toc491721300"></a><a name="_Ref493784924"></a><a name="_Toc493797750"></a><a name="_Toc493797873"></a><a name="_Toc493844658"></a><a name="_Toc493869152"></a><a name="_Toc493869396"></a><a name="_Toc495394247"></a><a name="_Ref487635509"></a><a name="_Toc487751043"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.11</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="taxmatters"></a><font style="display: inline;font-weight:bold;font-style:italic;">Tax Matter</font><font style="display: inline;font-weight:bold;font-style:italic;">s</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288598061"></a><a name="_Ref451546124"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Defined Terms</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref493801142"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;color:#010000;">(i)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;text-decoration:underline;">Taxes</font><font style="display: inline;">.&nbsp;&nbsp;For purposes of this Agreement, the term &#x201C;</font><font style="display: inline;font-weight:bold;">Tax</font><font style="display: inline;">&#x201D; or, collectively, &#x201C;</font><font style="display: inline;font-weight:bold;">Taxes</font><font style="display: inline;">&#x201D; shall mean </font><font style="display: inline;">(A)</font><font style="display: inline;">&nbsp;any and all federal, state, local and foreign taxes, assessments and other Governmental Authority charges, duties, impositions and liabilities, including taxes based upon or measured by income, profits, gross receipts, net proceeds, alternative or add on minimum, ad valorem, value added, turnover, sales, use, property, personal property (tangible and intangible), environmental, stamp, leasing, lease, user, excise, duty, franchise, capital stock, transfer, registration, license, withholding, public imposts or fees, social security (or similar charges including health, unemployment and pension insurance), unemployment, disability, payroll, recapture, escheat, employment, social contributions, national insurance contributions, fuel, excess profits, occupational, premium, windfall profit, severance, estimated, or other charge of any kind whatsoever, including any interest, penalty, or addition thereto (including any penalty or addition for failure to file any Tax Return), whether disputed or not, </font><font style="display: inline;">(B)</font><font style="display: inline;">&nbsp;any liability for the payment of any amounts of the type described in clause </font><font style="display: inline;">&#x200E;</font><font style="display: inline;">(A)</font><font style="display: inline;"> of this </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.11(a)(i)</font><font style="display: inline;"> as a result of being or having been a member of an affiliated, consolidated, combined, unitary or similar group for any period (including any arrangement for group or consortium relief or similar arrangement), and </font><font style="display: inline;">(C)</font><font style="display: inline;">&nbsp;any liability for the payment of any amounts of the type described in clauses </font><font style="display: inline;">&#x200E;</font><font style="display: inline;">(A)</font><font style="display: inline;"> or </font><font style="display: inline;">&#x200E;</font><font style="display: inline;">(B)</font><font style="display: inline;"> of this </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.11(a)(i)</font><font style="display: inline;"> as a result of any obligation to indemnify any other Person or as a result of any obligation under any Contract or arrangement with any other Person with respect to such amounts and including any liability for taxes of a predecessor or transferor or otherwise by operation of law.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">25</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="text-indent:0pt;margin-left:0pt; padding-right:24pt;"><font style="display: inline;color:#010000;">(ii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;text-decoration:underline;">Applicable Tax Law</font><font style="display: inline;">.&nbsp;&nbsp;For purposes of this Agreement, the term &#x201C;</font><font style="display: inline;font-weight:bold;">Applicable Tax Law</font><font style="display: inline;">&#x201D; shall mean, with respect to the Company or a Company Subsidiary, as the case may be, any Law relating to Taxes (including regulations, judicial doctrines, and other official pronouncements of any Governmental Entity charged with interpreting such applicable Law) applicable to </font><font style="display: inline;">(A)</font><font style="display: inline;"> such entity </font><font style="display: inline;">(B)</font><font style="display: inline;"> such entity&#x2019;s properties or income, or </font><font style="display: inline;">(C)</font><font style="display: inline;"> such entity&#x2019;s direct or indirect shareholders with respect to such entity&#x2019;s income.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref487620782"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Tax Representations</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref379810933"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;color:#010000;">(i)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Neither the Company nor any of the Company Subsidiaries </font><font style="display: inline;">(i) </font><font style="display: inline;">was created or organized under the laws of the United States, any state thereof, or the District of Columbia or </font><font style="display: inline;">(ii) </font><font style="display: inline;">treated as a United States corporation pursuant t</font><font style="display: inline;">o Section 7874(b) of the Code.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref493831823"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:24pt;"><font style="display: inline;color:#010000;">(ii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">The Company and the Company Subsidiaries have prepared and timely filed all federal, state, local and foreign returns, declarations, reports, claims for refund, estimates, information statements and reports, that are due, including any attachments or schedules thereto and any amendments thereof relating to all Taxes (&#x201C;</font><font style="display: inline;font-weight:bold;">Tax Returns</font><font style="display: inline;">&#x201D;) concerning or attributable to the Business, the Company, the Company Subsidiaries or the operations or assets of the Company or any of the Company Subsidiaries and such Tax Returns are true and correct in all material respects and have been completed in compliance with applicable Law, except for an immaterial violation of Law.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref492398425"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;color:#010000;">(iii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">All Taxes due and required to be paid up to the Closing Date have been timely paid.&nbsp;&nbsp;Neither the Company nor any of the Company Subsidiaries is liable to pay any penalty, fine, surcharge, interest or similar amount in relation to Taxes.</font><font style="display: inline;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;color:#010000;">(iv)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">To the Knowledge of the Company, no Minority Shareholder is a U.S. Tax Person.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(v)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">There</font><font style="display: inline;"> is no claim against the Company, any of the Company Subsidiaries or any of the assets of the Company or the Company Subsidiaries for any Taxes, and no assessment, deficiency, or adjustment has been asserted, proposed, or threatened with respect to any Taxes or Tax Returns of or with respect to the Company, any of the Company Subsidiaries or any of the assets of the Company or the Company Subsidiaries.&nbsp;&nbsp;To the Knowledge of the Company, no Tax audits or administrative or judicial proceedings are being conducted, pending or threatened with respect to the Company, any of the Company Subsidiaries or any of the assets of the Company or the Company Subsidiaries.&nbsp; </font><font style="display: inline;">The Company and the Company Subsidiaries have not received notice of any </font><font style="display: inline;">claim made by an authority in a jurisdiction where the Company, or any of the Company Subsidiaries, does not file Tax Returns that it is or may be subject to taxation in that jurisdiction. </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref493845275"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;color:#010000;">(vi)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Except as provided in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.11(b)(vi)</font><font style="display: inline;"> of the Company Disclosure Schedule, </font><font style="display: inline;">there is not in force any extension of time</font><font style="display: inline;"> with respect to the due date for the filing of any Tax Return of or with respect to the Company or any of the Company Subsidiaries or any waiver or Contract for any extension of time</font><font style="display: inline;"> for the </font><font style="display: inline;">assessment or </font><font style="display: inline;">payment of any Tax of or with respect to the Company or any of the Company Subsidiaries. </font><font style="display: inline;">Except for </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">26</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">changes that are immaterial in amount, individually and collectively, or developments or actions in the ordinary course of business of the Company and the applicable Company Subsidiary consistent with their respective past practices, since December 31, 2016, there has not been (i) any adoption of any change to any material Tax election or Tax accounting method, (ii) the execution of or agreement to any closing Contract with respect to Taxes, (iii) an assertion of any Tax claim or assessment (other than for Taxes that arise and become due and payable in the ordinary course of business of the Company and the Company Subsidiaries, consistent with their respective past practices), or (iv) any settlement or compromise of any Tax claim or assessment</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref493845309"></a><a name="_Ref487563149"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:20pt;"><font style="display: inline;color:#010000;">(vii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">To the Knowledge of the Company, except as provided in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.11(b)(vii) </font><font style="display: inline;">of the Company Disclosure Schedule</font><font style="display: inline;">, n</font><font style="display: inline;">o power of attorney that is currently in force has been granted with respect to any matter relating to Taxes that could affect the Company or any Company Subsidiary.</font><font style="display: inline;font-weight:bold;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:18pt;"><font style="display: inline;color:#010000;">(viii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">The Company has made available to Buyer copies of all Tax Returns for the Company and the Company Subsidiaries filed for all periods for which the applicable statute of limitations period has not expired.&nbsp; </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;color:#010000;">(ix)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">To the Knowledge of the Company, the Company and the Company Subsidiaries have timely paid or withheld with respect to their Employees and other third parties, all Taxes required to be withheld, and have timely paid over any such withheld Taxes to the appropriate authorities.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(x)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">To the Knowledge of the Company, a</font><font style="display: inline;">s of </font><font style="display: inline;">the end of</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">December 31, 2016</font><font style="display: inline;">, neither the Company nor any of the Company Subsidiaries had liabilities for unpaid Taxes that had not been accrued or reserved on the </font><font style="display: inline;">Year-End Financials</font><font style="display: inline;"> (excluding any reserves for deferred Taxes), whether asserted or unasserted, contingent or otherwise.&nbsp;&nbsp; </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;color:#010000;">(xi)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">None of the property of the Company or any of the Company Subsidiaries is subject to any tax partnership Contract or is otherwise treated, or required to be treated, as held in an arrangement requiring a partnership income Tax Return to be filed under Applicable Tax Law. </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:20pt;"><font style="display: inline;color:#010000;">(xii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">No asset or liability of the Company or any of the Company Subsidiaries is a debt obligation that, to the Knowledge of the Company and pursuant to any Applicable Tax Law, results in (a) the denial or deferral of interest deductions to the issuer or (b) the receipt of interest income by the holder in excess of such obligation&#x2019;s stated interest. </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:18pt;"><font style="display: inline;color:#010000;">(xiii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">There are (and immediately following the Closing there will be) no Liens on any assets of the Company or any assets of the Company Subsidiaries currently existing, pending or threatened attributable to Taxes, other than statutory Liens for Taxes not yet due and payable.&nbsp; </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref447044161"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:17pt;"><font style="display: inline;color:#010000;">(xiv)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Neither the Company nor any of the Company Subsidiaries has </font><font style="display: inline;">(a) </font><font style="display: inline;">&nbsp;ever been a member of a group of entities (1) filing a single Tax Return on behalf of all such entities with respect to any Tax or (2) where the income, gain, deductions, losses, or other items </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">27</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">or attributes of the members of such group is consolidated or otherwise aggregated with that of other members of the group for the purposes of determining the Tax liability of the group (any such group, a &#x201C;</font><font style="display: inline;font-weight:bold;">Tax Group</font><font style="display: inline;">&#x201D;), </font><font style="display: inline;">(b)</font><font style="display: inline;">&nbsp;ever been a party to any Tax sharing, indemnification, allocation or similar Contract or arrangement nor does the Company or any of the Company Subsidiaries owe any amount under such a Contract or arrangement (excluding, for purposes of this </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.11(b)(xiv)</font><font style="display: inline;">, commercial Contracts entered into in the ordinary course of business of the Company or any of the Company Subsidiaries the primary purpose of which does not relate to Taxes), </font><font style="display: inline;">(c)</font><font style="display: inline;">&nbsp;any liability for the Taxes of any Person under any arrangement for group or consortium relief or similar arrangement)), as a transferee or successor, or by operation of Law, by Contract or otherwise, and </font><font style="display: inline;">(d)</font><font style="display: inline;">&nbsp;ever been a party to any joint venture, partnership or other arrangement that could be treated as a partnership for Tax purposes.</font><font style="display: inline;">&nbsp;</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:19pt;"><font style="display: inline;color:#010000;">(xv)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Neither the Company nor any Company Subsidiary owns, or has owned in a five-year period ending on the Closing Date, an interest in real property (including an interest in a mine, well, or other natural deposit) located in the United States or the Virgin Islands.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:17pt;"><font style="display: inline;color:#010000;">(xvi)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Neither the Company nor any Company Subsidiary has been a party to any transaction or series of transactions that could reasonably be considered fraudulent or criminal under any applicable Law relating to the avoidance of Tax.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"><font style="display: inline;color:#010000;">(xvii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">The Company and the Company Subsidiaries use the accrual method of accounting for tax purposes.&nbsp; </font><font style="display: inline;">To the Knowledge of the Company, neither</font><font style="display: inline;"> the Company </font><font style="display: inline;">n</font><font style="display: inline;">or any Company Subsidiary will be required to include any item of income in, or exclude any item of deduction from, taxable income for any taxable period (or portion thereof) beginning after the Closing Date as a result of:&nbsp; </font><font style="display: inline;">(a)</font><font style="display: inline;"> a change in its method of accounting; </font><font style="display: inline;">(b)</font><font style="display: inline;"> any transfer pricing allocation required pursuant to any Applicable Tax Law; </font><font style="display: inline;">(c) </font><font style="display: inline;">any closing agreement or other agreement entered into with a Governmental Authority related to Taxes; </font><font style="display: inline;">(d)</font><font style="display: inline;"> any transaction between the Company, or a Company Subsidiary, and another member of such entity&#x2019;s Tax Group; </font><font style="display: inline;">(e)</font><font style="display: inline;"> an installment sale or open transaction disposition made on or prior to the Closing Date; </font><font style="display: inline;">(f)</font><font style="display: inline;"> the cash method of accounting or long-term contract method of accounting utilized prior to the Closing Date; or </font><font style="display: inline;">(g)</font><font style="display: inline;"> a prepaid amount received on or prior to the Closing Date.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:14pt;"><font style="display: inline;color:#010000;">(xviii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Neither the Company nor any Company Subsidiary has entered into any Contract or arrangement (including &#x201C;rulings&#x201D;) with any Tax authority or is subject to a special regime with regard to the payment of Taxes.&nbsp;&nbsp;Neither the Company nor any Company Subsidiary is a party to any Contract with any Tax authority that would be terminated or adversely affected as a result of the transactions contemplated in this Agreement. </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref379810990"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:17pt;"><font style="display: inline;color:#010000;">(xix)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">To the Knowledge of the Company, the Company and the Company Subsidiaries are in compliance in all material respects with all terms and conditions of any Tax exemption, Tax holiday, Tax subsidy or other Tax reduction Contract or order (&#x201C;</font><font style="display: inline;font-weight:bold;">Tax Incentive</font><font style="display: inline;">&#x201D;), and the consummation of the transactions contemplated in this Agreement will not have any adverse effect on the continued validity and effectiveness of any such Tax Incentive.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">28</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="text-indent:0pt;margin-left:0pt; padding-right:19pt;"><font style="display: inline;color:#010000;">(xx)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">To the Knowledge of the Company, all of the Company&#x2019;s property and the Company Subsidiaries&#x2019; property that is subject to property Tax has been properly listed and described on the property tax rolls of the appropriate taxing jurisdiction for all periods prior to Closing and no portion of the Company&#x2019;s property or the Company Subsidiaries&#x2019; property constitutes omitted property for property tax purposes.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:17pt;"><font style="display: inline;color:#010000;">(xxi)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">No Form 8832 (Entity Classification Election) has been filed with the Internal Revenue Service with respect to the Company or any Company Subsidiary. Neither the Company&#x2019;s nor any Company Subsidiary&#x2019;s classification for tax purposes has changed under any applicable Law since January 1, 2016. Neither the Company&#x2019;s nor any Company Subsidiary&#x2019;s jurisdiction of organization has changed since January 1, 2016.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"><font style="display: inline;color:#010000;">(xxii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Neither the Company nor any Company Subsidiary is or has been engaged in a trade or business within the United States for U.S. federal income tax purposes (including through a United States branch, office, or other fixed place of business, through an employee or other agent located in the United States, or otherwise).</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:14pt;"><font style="display: inline;color:#010000;">(xxiii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">To the Knowledge of the Company, neither the Company nor any Company Subsidiary is subject to Tax in any jurisdiction, other than the country in which it is organized, by virtue of </font><font style="display: inline;">(a)</font><font style="display: inline;"> having, or being deemed to have, a permanent establishment, fixed place of business, or similar presence in such other country or </font><font style="display: inline;">(b)</font><font style="display: inline;"> being a Tax resident in such other country.&nbsp; </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:13pt;"><font style="display: inline;color:#010000;">(xxiv)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">To the Knowledge of the Company, all payments by, to or among the Company and the Company Subsidiaries comply with all applicable transfer pricing requirements imposed by any Governmental Authority.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref491555035"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:15pt;"><font style="display: inline;color:#010000;">(xxv)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Neither the Company nor any Company Subsidiary is a party to any contract or arrangement with a Governmental Authority pursuant to which tax on gain realized upon the transfer of assets to the Company or any Company Subsidiary was deferred (any such agreement, a &#x201C;</font><font style="display: inline;font-weight:bold;">Gain Recognition Agreement</font><font style="display: inline;">&#x201D;). Any gain deferred pursuant to a Gain Recognition Agreement to which a Company or Company Subsidiary is a party will not be realized as a result of&nbsp;&nbsp;the consummation of the transactions contemplated under this Agreement.</font><font style="display: inline;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288598133"></a><a name="_Toc374597681"></a><a name="_Toc487751044"></a><a name="_Toc487788499"></a><a name="_Toc487788691"></a><a name="_Toc487788824"></a><a name="_Toc491721301"></a><a name="_Toc493797751"></a><a name="_Toc493797874"></a><a name="_Toc493844659"></a><a name="_Toc493869153"></a><a name="_Toc493869397"></a><a name="_Toc495394248"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.12</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="restrictionsonbusinessactivities"></a><font style="display: inline;font-weight:bold;font-style:italic;">Restrictions on Business Activities</font><a name="_Ref288597998"></a><a name="_Toc374597682"></a><font style="display: inline;">.&nbsp;&nbsp;There is no Contract (non-competition or otherwise), commitment, judgment, injunction, order or decree to which the Company or any of the Company Subsidiaries is a party or otherwise binding upon the Company or any of the Company Subsidiaries which has the effect of prohibiting or materially impairing any business practice of the Company or any of the Company Subsidiaries, any acquisition of property (tangible or intangible) by the Company or any of the Company Subsidiaries, the conduct of business by the Company or any of the Company Subsidiaries</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">or otherwise limiting the freedom of the Company or any of the Company Subsidiaries to engage in any line of business or to compete with any Person</font><font style="display: inline;">. Without limiting the generality of the foregoing, neither the Company nor any of the Company Subsidiaries have entered into any Contract under which the Company or such Company Subsidiary is </font><font style="display: inline;">prohibited or materially </font><font style="display: inline;">restricted from selling, licensing, manufacturing or otherwise distributing or providing any Company Products to </font>
		</font></p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">29</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">customers or potential customers or any class of customers, in any geographic area, during any period of time, or in any segment of the market, or from hiring or soliciting potential employees, consultants or independent contractors.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc487788500"></a><a name="_Toc487788692"></a><a name="_Toc487788825"></a><a name="_Toc491721302"></a><a name="_Ref493785034"></a><a name="_Toc493797752"></a><a name="_Toc493797875"></a><a name="_Toc493844660"></a><a name="_Toc493869154"></a><a name="_Toc493869398"></a><a name="_Toc495394249"></a><a name="_Ref487733155"></a><a name="_Toc487751045"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.13</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="titletoproperties"></a><font style="display: inline;font-weight:bold;font-style:italic;">Title to Properties</font><font style="display: inline;font-weight:bold;font-style:italic;">; Absence of Liens and Encumbrances</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288598158"></a><a name="_Ref379811049"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Neither the Company nor any of the Company Subsidiaries owns any real property, nor has the Company or any of the Company Subsidiaries ever owned any real property.&nbsp; </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.13(a</font><font style="display: inline;">)</font><font style="display: inline;"> of the Company Disclosure Schedule sets forth a list of all real property currently leased, subleased or licensed by or from the Company or any of the Company Subsidiaries or otherwise used or occupied by the Company or any of the Company Subsidiaries (the &#x201C;</font><font style="display: inline;font-weight:bold;">Leased Real Property</font><font style="display: inline;">&#x201D;), and sets forth all leases, lease guaranties, licenses, subleases, Contracts for the leasing, use or occupancy of, or otherwise granting a right in or relating to the Leased Real Property, including all amendments thereof (&#x201C;</font><font style="display: inline;font-weight:bold;">Lease Agreements</font><font style="display: inline;">&#x201D;). The Company has made available to Buyer true, correct and complete copies of all Lease Agreements. All such Lease Agreements are in full force and effect and are valid and enforceable against the Company or the relevant Company Subsidiary, as applicable, in accordance with their respective terms.&nbsp;&nbsp;T</font><font style="display: inline;">o the Knowledge of the Company, t</font><font style="display: inline;">here is not, under any of the Lease Agreements, any existing material default or material event of default (or event which with notice or lapse of time, or both, would constitute a material default) </font><font style="display: inline;">of the Company or any of the Company Subsidiaries, as applicable, or to the </font><font style="display: inline;">Knowledge of the Company</font><font style="display: inline;">, any other party thereto.&nbsp;&nbsp;The Company and the Company Subsidiaries, as applicable, currently occupy all of the Leased Real Property for the operation of their businesses, and there are no other parties occupying, or with a right to occupy, the Leased Real Property.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">All Leased Real Property is in commercially reasonable operating condition and repair and is suitable for the conduct of the Company&#x2019;s business or the business of the applicable Company Subsidiary as presently conducted therein.&nbsp;&nbsp;Neither the operation of the Company or any of the Company Subsidiaries on their respective Leased Real Property nor, to the </font><font style="display: inline;">Knowledge of the Company</font><font style="display: inline;">, such Leased Real Property, violates any Law relating to such property or operations thereon.&nbsp;&nbsp;Neither the Company nor any Company Subsidiary is a party to any Contract or subject to any claim that could require the payment of any real estate brokerage commissions, and no such commission is owed with respect to any of the Leased Real Property.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref493785082"></a><a name="_Ref492398478"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(c)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">The Company and each of the Company Subsidiaries has good and valid title to, or, in the case of leased properties and assets, valid leasehold interests in, all of their properties and assets, real, personal and mixed, used or held for use in its business, free and clear of any Liens, except (i) as reflected in the Year-End Financials, (ii) Liens for Taxes not yet due and payable, and (iii) such imperfections of title and encumbrances, if any, which do not detract from the value or interfere with the present use of the property subject thereto or affected thereby.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(d)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">All equipment owned or leased by the Company or any Company Subsidiary currently in use and held for future use is (i)&nbsp;adequate for the conduct of the business of the Company or such Company Subsidiary as currently conducted and as currently proposed </font>
		</font></p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">30</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">to be conducted, and (ii)&nbsp;in commercially reasonable operating condition, regularly and properly maintained, subject to normal wear and tear.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288597960"></a><a name="_Ref288597981"></a><a name="_Toc374597683"></a><a name="_Toc487751046"></a><a name="_Toc487788501"></a><a name="_Toc487788693"></a><a name="_Toc487788826"></a><a name="_Toc491721303"></a><a name="_Toc493797753"></a><a name="_Toc493797876"></a><a name="_Toc493844661"></a><a name="_Toc493869155"></a><a name="_Toc493869399"></a><a name="_Toc495394250"></a><a name="_Ref444682262"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.14</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="intellectualproperty"></a><font style="display: inline;font-weight:bold;font-style:italic;">Intellectual Property</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref487608889"></a><a name="_Ref491551951"></a><a name="_Ref493720251"></a><a name="_Ref288598175"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">The Company presently owns all right, title, and interest in and to, or has a valid and enforceable license to use all Intellectual Property </font><font style="display: inline;">currently </font><font style="display: inline;">used by the Company or any Company Subsidiary in their respective businesses (the &#x201C;</font><font style="display: inline;font-weight:bold;">Company Intellectual Property</font><font style="display: inline;">&#x201D;).</font><font style="display: inline;"> The Company or the Company Subsidiaries exclusively own all of the Company Intellectual Property the Company or the Company Subsidiaries purport to own. </font><font style="display: inline;">Except as set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(a)</font><font style="display: inline;"> of the Company Disclosure Schedule, neither the Company nor any Company Subsidiary has entered into any Contract or transaction (or taken any other action that has a similar effect) with any Securityholder, Employee, or, in each case, their respective Affiliates or family members that transferred ownership of, or granted any li</font><font style="display: inline;">cense of any rights, title or interest in, or any right or permission to use Company Intellectual Property to any </font><font style="display: inline;">such Person</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref487733419"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(b)</font><font style="display: inline;"> of the Company Disclosure Schedule lists all Registered Intellectual Property Rights owned by, or filed in the name of, the Company or any of the Company Subsidiaries (the &#x201C;</font><font style="display: inline;font-weight:bold;">Company Registered Intellectual Property Rights</font><font style="display: inline;">&#x201D;) and in each case listing, as applicable </font><font style="display: inline;">(i)</font><font style="display: inline;"> the name of the applicant or registrant and current owner of record, </font><font style="display: inline;">(ii)</font><font style="display: inline;"> the date of application or issuance, </font><font style="display: inline;">(iii)</font><font style="display: inline;"> the registration or application number, and </font><font style="display: inline;">(iv)</font><font style="display: inline;"> the r</font><font style="display: inline;">elevant jurisdiction as to each </font><font style="display: inline;">and any material proceedings or actions before any court, tribunal (including the European Patent Office (the &#x201C;</font><font style="display: inline;font-weight:bold;">EPO</font><font style="display: inline;">&#x201D;), the United States Patent and Trademark Office (the &#x201C;</font><font style="display: inline;font-weight:bold;">PTO</font><font style="display: inline;">&#x201D;) or equivalent authority anywhere in the world) related to any of the Company Registered Intellectual Property Rights or Company Intellectual Property.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444796007"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(c)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(c)</font><font style="display: inline;"> of the Company Disclosure Schedule accurately and fully identifies each Company Product that is, has been, or is currently proposed to be made commercially available or otherwise provided to end users</font><font style="display: inline;"> and each research and development project that the Company has proposed to commercialize</font><font style="display: inline;"> (by name, title, version number, and other appropriate identifiers)</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref446781235"></a><a name="_Ref487620101"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(d)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">To the Knowledge of the Company, e</font><font style="display: inline;">ach item of Company Registered Intellectual Property Rights is valid and subsisting</font><font style="display: inline;">. &nbsp;</font><font style="display: inline;">To the Knowledge of the Company</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">all necessary filing, registration, maintenance and renewal fees in connection with such Company Registered Intellectual Property Rights have been paid and all necessary documents and certificates in connection with such Company Registered Intellectual Property Rights have been filed with the relevant patent, copyright, trademark or other authorities in Europe, the United States, or foreign jurisdictions, as the case may be, for the purposes of maintaining such Company Registered Intellectual Property Rights.</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">During the prosecution of any Patents within the Company Registered Intellectual Property Rights (&#x201C;</font><font style="display: inline;font-weight:bold;">Company Patents</font><font style="display: inline;">&#x201D;), </font><font style="display: inline;">to the Knowledge of the Company, </font><font style="display: inline;">all material prior art to Company Patents </font><font style="display: inline;">of which the Company was aware </font><font style="display: inline;">was adequately disclosed to or considered by the respective patent offices.&nbsp; </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288597869"></a><a name="_Ref288598428"></a><a name="_Toc374597684"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(e)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">In each case in which the Company or any of the Company Subsidiaries has acquired or purported to acquire ownership of any Intellectual Property from any Person, the </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">31</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">Company or such Company Subsidiary, as applicable, has obtained a valid and enforceable assignment under applicable Law sufficient to irrevocably transfer all right, title, and interest in that Intellectual Property to the Company or the Company Subsidiary, as applicable, and, to the extent that Intellectual Property constitutes Registered Intellectual Property, to </font><font style="display: inline;">the Knowledge of the Company, </font><font style="display: inline;">in accordance with, applicable Laws, the Company has recorded each such assignment with each relevant Governmental Authority, including the PTO, EPO, the U.S. Copyright Office, or their respective equivalents in any relevant jurisdiction, as the case may be.</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:25pt;"><font style="display: inline;color:#010000;">(f)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">[Intentionally omitted]</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288598219"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(g)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Each item of the Company Intellectual Property is free and clear of any Liens other than those set forth on </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(g</font><font style="display: inline;">)</font><font style="display: inline;"> of the Company Disclosure Schedule.&nbsp; </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(h)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Neither the Company nor any Company Subsidiary has </font><font style="display: inline;">(i)</font><font style="display: inline;"> transferred ownership of, or granted any exclusive license of or exclusive right to use (in any field of use), or authorized the retention of any exclusive rights to use or joint ownership of, any Technology or Intellectual Property Rights that are or were Company Intellectual Property, to any other Person, or </font><font style="display: inline;">(ii)</font><font style="display: inline;"> permitted the Company&#x2019;s or any Company Subsidiary&#x2019;s rights in any Company Intellectual Property to enter into the public domain. Either the Company or a Company Subsidiary has the exclusive right to bring infringement actions with respect to the Company Intellectual Property</font><font style="display: inline;"> if any Person has the right to bring any such infringement actions</font><font style="display: inline;">.&nbsp; </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444771118"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;color:#010000;">(i)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(i)</font><font style="display: inline;"> of the Company Disclosure Schedule accurately identifies each Contract pursuant to which any Intellectual Property is or has been licensed, sold, assigned or otherwise conveyed or provided or made available to the Company or any of the Company Subsidiaries (or Contract pursuant to which the Company or any Company Subsidiary receives an authorization, immunity, covenant not to sue, access to, or some other license or right with respect to Intellectual Property, including any implied or statutory licenses arising by virtue of any applicable Law), other than (a) Invention Assignment Agreements and Contracts with third parties who have validly and irrevocably assigned all of their rights, including all Intellectual Property Rights therein, to the Company or a Company Subsidiary, and (b) non-exclusive licenses to third-party software that are not otherwise material to the Business (the &#x201C;</font><font style="display: inline;font-weight:bold;">In-Licensed Intellectual Property</font><font style="display: inline;">&#x201D;). Complete and correct copies of all Contracts required to be listed on </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(i)</font><font style="display: inline;"> of the Company Disclosure Schedule have been made available to Buyer.&nbsp;&nbsp;Except for Contracts required to be listed on </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(i)</font><font style="display: inline;"> of the Company Disclosure Schedule, </font><font style="display: inline;">to the Knowledge of the Company </font><font style="display: inline;">(i) all Technology used in the Business was written and created solely by either (a)&nbsp;Employees acting within the scope of their employment who have signed Invention Assignment Agreements and waived their right to sue for any moral rights that they may have in any of the Company Intellectual Property or (b)&nbsp;by third parties who have validly and irrevocably assigned all of their rights, including all Intellectual Property Rights therein, to the Company or a Company Subsidiary, and, to </font><font style="display: inline;">the Knowledge of the Company</font><font style="display: inline;">, waived any and all claims that they may have in connection with any non-assignable Intellectual Property Rights, including any moral rights, and (ii) no third party owns or has any rights to any of the Company Intellectual Property.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444771126"></a><a name="_Ref288598314"></a><a name="_Ref372641912"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">32</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="text-indent:0pt;margin-left:0pt; padding-right:25pt;"><font style="display: inline;color:#010000;">(j)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(j)</font><font style="display: inline;"> of the Company Disclosure Schedule accurately identifies all milestones, royalties, fees, commissions and other amounts payable by the Company or a Company Subsidiary, including identification of the payee, to any other Person for the use, exploitation, modification or maintenance of any of the In-Licensed Intellectual Property or other Intellectual Property used by the Company or any Company Subsidiary or in connection with the Business.</font><a name="_Ref444611843"></a><font style="display: inline;font-weight:bold;text-decoration:underline;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444612778"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(k)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(k)</font><font style="display: inline;font-weight:bold;">(i)</font><font style="display: inline;"> of the Company Disclosure Schedule accurately identifies each Company IP Contract, other than Company IP Contracts on the Company&#x2019;s or any Company Subsidiary&#x2019;s standard form and other than Company IP Contracts under which neither the Company nor any Company Subsidiary has any ongoing rights or obligations.&nbsp; </font><a name="_cp_text_1_112"></a><font style="display: inline;">Neither the Company, any of the Company Subsidiaries, nor any predecessors of the foregoing, have exclusively licensed, sold, or exclusively assigned any Technology Intellectual Property Right to any Person not identified in </font><font style="display: inline;font-weight:bold;">Section</font><a name="_cp_field_47_113"></a><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(k)</font><font style="display: inline;font-weight:bold;">(ii)</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">of the Company Disclosure Schedule.&nbsp; </font><font style="display: inline;">Except as set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(k)</font><font style="display: inline;font-weight:bold;">(ii</font><font style="display: inline;font-weight:bold;">i</font><font style="display: inline;font-weight:bold;">)</font><font style="display: inline;"> of the Company Disclosure</font><font style="display: inline;"> Schedule,</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">neither </font><font style="display: inline;">the Company nor any Company Subsidiary is bound by, and none of the Company Intellectual Property is subject to, any Contract containing any covenant or other provision that in any way limits or restricts the ability of the Company or any Company Subsidiary to use, exploit, license, transfer, assert or enforce any of the Company Intellectual Property anywhere in the world, other than pursuant to non-exclusive licenses under the Company Intellectual Property granted by the Company or the Company Subsidiaries in the ordinary course of business, consistent with their respective past practices.&nbsp;&nbsp;Complete and correct copies of all Contracts required to be listed on </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(k)</font><font style="display: inline;font-weight:bold;">(i) </font><font style="display: inline;">of the Company Disclosure Schedule have been made available to Buyer.</font><font style="display: inline;"> &nbsp; &nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444796154"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;color:#010000;">(l)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">The Company Intellectual Property, together with the In-Licensed Intellectual Property constitutes all of the Technology and Intellectual Property Rights used in the conduct of the Business, including the design, development, marketing, manufacture, use, import and sale of any Company Product (including, to the Knowledge of the Company, Company Products currently under development).&nbsp;&nbsp;Except as set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(l)</font><font style="display: inline;"> of the Company Disclosure Schedule, upon the Closing, </font><font style="display: inline;">to the Knowledge of the Company, </font><font style="display: inline;">the Company will own or possess sufficient rights to all Technology and Intellectual Property Rights that are used in the operation of the Business and without infringing, misusing, or misappropriating the Intellectual Property Rights of any Person</font><font style="display: inline;">.</font><font style="display: inline;"> &nbsp; &nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref491552232"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:21pt;"><font style="display: inline;color:#010000;">(m)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Except as disclosed in</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(m)</font><font style="display: inline;"> of the Company Disclosure</font><font style="display: inline;"> Schedule,</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">n</font><font style="display: inline;">one of the Contracts relating to In-Licensed</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Intellectual Property will terminate, or may be terminated by a third party, solely by the passage of time within 120 days after the Closing Date.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(n)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">There are no licenses or other Contracts between the Company or any Company Subsidiary, on the one hand, and any other Person with respect to Company Intellectual Property or other Technology or Intellectual Property Rights used in the Business under which there is any material dispute regarding the scope of such Contract, or either party&#x2019;s performance under such Contract including with respect to any payments to be made or received by the Company or any Company Subsidiary thereunder.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref487609461"></a><a name="_Ref368556554"></a><a name="_Ref288668730"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">33</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(o)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">To the Knowledge of the Company, the</font><font style="display: inline;"> operation of the Business, including the design, development, use, import, branding, advertising, promotion, marketing, distribution, manufacture and sale of any Company Product (other than Company Products currently under development)</font><font style="display: inline;">,</font><font style="display: inline;"> has not infringed, misappropriated or otherwise violated, does not infringe, misappropriate or otherwise violate, and </font><font style="display: inline;">to the Knowledge of the Company, </font><font style="display: inline;">will not infringe, misappropriate or otherwise violate, when conducted by the Company and/or any Company Subsidiary following the Acquisition in a manner consistent with the operation of the Company and the Company Subsidiaries prior to the Acquisition, any Intellectual Property Rights of any Person, violate any applicable right of any Person (including any right to privacy or publicity), or constitute unfair competition or trade practices under the Laws of any applicable jurisdiction.&nbsp; </font><font style="display: inline;">N</font><font style="display: inline;">either the Company nor any Company Subsidiary has received notice from any Person claiming that such operation or any act, any Company Product (including Company Products currently under development) or Technology of the Company or any Company Subsidiary infringes, misappropriates or otherwise violates any Intellectual Property Rights of any Person, or constitutes unfair competition or trade practices under the Laws of any jurisdiction (nor does the Company have Knowledge of any basis therefor). Neither the Company nor any Company Subsidiary is bound by any Contract to indemnify, defend, hold harmless or reimburse any other Person with respect to, or otherwise assumed or agreed to discharge or otherwise take responsibility for, any existing or potential infringement, misappropriation or other violation or unlawful use claim (other than indemnification provisions in Company IP Contracts that are materially consistent with the standard forms of Company IP Contracts made available to Buyer).</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref445032411"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(p)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">[Intentionally omitted]</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(q)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">To the Knowledge of the Company, no Person has infringed or misappropriated or is infringing or misappropriating any Company Intellectual Property.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444774206"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:25pt;"><font style="display: inline;color:#010000;">(r)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">The Company has taken reasonable steps that</font><font style="display: inline;">, to the Knowledge of the Company,</font><font style="display: inline;"> are required to protect the Company&#x2019;s rights in confidential information and trade secrets of the Company or any Company Subsidiary or provided by any other Person to the Company or any Company Subsidiary.&nbsp;&nbsp;Without limiting the foregoing, the Company or a Company Subsidiary, as applicable, has</font><a name="_Ref425884324"></a><font style="display: inline;"> obtained from each Employee and/or any other Person (including any consultant, service provider or intern) who has contributed independently or jointly to the creation, development, invention, conception, or discovery of any Company Intellectual Property a signed, valid and enforceable Contract that includes </font><font style="display: inline;">(i)</font><font style="display: inline;"> confidentiality obligations in favor of the Company or such Company Subsidiary, as applicable, </font><font style="display: inline;">(ii)</font><font style="display: inline;"> an effective and valid assignment to the Company or such Company Subsidiary, as applicable of all right, title and interest in and to all Intellectual Property Rights and Technology created, developed, invented, conceived or discovered by such Person relating to the Business (including the rights to transfer, license, amend and modify such Intellectual Property and including all claims and demands that may be associated with such Intellectual Property), and </font><font style="display: inline;">(iii)</font><font style="display: inline;"> a waiver of any and all moral rights (to the extent possible under applicable Law) or a consent to use the Company Intellectual Property in connection with the Business and addressing the moral rights that such </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">34</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">Person may possess in such Intellectual Property (collectively, the &#x201C;</font><font style="display: inline;font-weight:bold;">Invention Assignment Agreements</font><font style="display: inline;">&#x201D;).&nbsp; </font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444774200"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:24pt;"><font style="display: inline;color:#010000;">(s)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Except as disclosed in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(s) </font><font style="display: inline;">of the </font><font style="display: inline;">Company Disclosure Schedule, n</font><font style="display: inline;">o Company Intellectual Property or Company Product is subject to any proceeding or outstanding decree, order, judgment or settlement Contract or stipulation that restricts in any manner the use, transfer or licensing thereof by the Company or any of the Company Subsidiaries or may affect the validity, use or enforceability of such Company Intellectual Property.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:25pt;"><font style="display: inline;color:#010000;">(t)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">To the Knowledge of the Company, no </font><font style="display: inline;">(i)</font><font style="display: inline;">&nbsp;Company Product or publication of the Company or any Company Subsidiary, </font><font style="display: inline;">(ii)</font><font style="display: inline;">&nbsp;material published or distributed by the Company or any Company Subsidiary, or </font><font style="display: inline;">(iii)</font><font style="display: inline;">&nbsp;conduct or statement of the Company or any Company Subsidiary constitutes false advertising or otherwise violates any Law</font><font style="display: inline;">, except for immaterial violations of a Law</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288598336"></a><a name="_Ref374328580"></a><a name="_Ref372729401"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(u)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Except as set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(u)</font><font style="display: inline;"> of the Company Disclosure Schedule, no government funding, facilities or resources of a university, college, other educational institution or research center was used in the development of the Company Intellectual Property and</font><font style="display: inline;">, to the Knowledge of the Company,</font><font style="display: inline;"> no Governmental Authority, university, college, other educational institution or research center has any claim or right in or to the Company Intellectual Property.</font><font style="display: inline;"> &nbsp;No rights have been granted by the Company or, to the Knowledge of the Company,</font><font style="display: inline;"> are due under applicable Law to any Governmental Authority with respect to any Company Product, or under any Company Intellectual Property other than the same standard commercial rights as are granted by the Company or the Company Subsidiaries to commercial end users of the services of the Company and/or the Company Subsidiaries in the ordinary course of business, consistent with their respective past practices.&nbsp;&nbsp;Except as set forth on </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(u)</font><font style="display: inline;"> of the Company Disclosure Schedule, to the Knowledge of the Company, no Employee who was involved in, or who contributed to, the creation or development of any Company Intellectual Property, has performed services for the government, a university, college or other educational institution, or a research center, or was under any grants from any Governmental Authority or private source, performing research sponsored by any Governmental Authority or private source or subject to any employment Contract or invention assignment or nondisclosure Contract or other obligation with any third party that could adversely affect the rights of the Company or a Company Subsidiary, as applicable, in such Intellectual Property Rights or the ability to consummate the Acquisition, during a period of time during which such Employee was also performing services for the Company or a Company Subsidiary.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444761713"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(v)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">To the Knowledge of the Company, n</font><font style="display: inline;">either the Company nor any Company Subsidiary has collected, used or disclosed any Personal Information in violation of any Company Privacy Policy.&nbsp; </font><font style="display: inline;">To the Knowledge of the Company, t</font><font style="display: inline;">he Company and each Company Subsidiary has complied with all applicable Laws, privacy rights of third parties, contractual obligations and privacy policies relating to the privacy of users of Company Products and websites and/or to the collection, use, storage, registration and transfer of an</font><font style="border-bottom-style:solid;border-bottom-width:1pt;height:100%;text-indent:0pt;">y Personal Information</font><font style="display: inline;"> collected by or on behalf of the Company or any Company Subsidiary (collectively,</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Privacy Obligations</font><font style="display: inline;">&#x201D;).&nbsp;&nbsp;T</font><font style="display: inline;">o the Knowledge of the Company, t</font><font style="display: inline;">he execution, delivery and </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">35</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">performance of this Agreement complies with all applicable Privacy Obligations.&nbsp;&nbsp;True and correct copies of all Company Privacy Policies and all customer or other third-party privacy policies with which the Company or any Company Subsidiary is obligated to comply are attached to </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(v)</font><font style="display: inline;"> of the Company Disclosure Schedule.&nbsp;&nbsp;T</font><font style="display: inline;">o the Knowledge of the Company, t</font><font style="display: inline;">he Company and the Company Subsidiaries have at all times made all disclosures to users or customers required by applicable Laws, and none of such disclosures made or contained in any Company Privacy Policy or in any such materials has been inaccurate, misleading, or deceptive or in violation of any applicable Laws.&nbsp;&nbsp;T</font><font style="display: inline;">o the Knowledge of the Company, t</font><font style="display: inline;">he Company and each Company Subsidiary has reasonable and appropriate security measures in place to protect</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">any Personal Information they receive from illegal or unauthorized access, use, or disclosure </font><font style="display: inline;">(except for immaterial illegal or unauthorized access, use or disclosure) </font><font style="display: inline;">including a written information security program that includes appropriate controls that have been r</font><font style="display: inline;">egularly tested and reviewed.&nbsp;&nbsp;To the Knowledge of the Company, n</font><font style="display: inline;">o person has gained unauthorized access to any Personal Information held by the Company or any Company Subsidiary, or otherwise held or processed on their behalf.&nbsp;&nbsp;T</font><font style="display: inline;">o the Knowledge of the Company, t</font><font style="display: inline;">he consummation of the contemplated transactions, including any transfer of Personal Information resulting from such transactions will not </font><font style="display: inline;">materially </font><font style="display: inline;">violate any applicable Privacy Obligation as it currently exists or as it existed at any time during which any of such Personal Information was collected or obtained.&nbsp;&nbsp;Neither the Company nor any Company Subsidiary has been notified of, nor is the subject of, any regulatory investigation or proceeding related to data security or privacy.&nbsp; </font><font style="display: inline;">To the Knowledge of the Company, n</font><font style="display: inline;">o Person (including any Governmental Authority) has made any claim or commenced any proceeding with respect to loss, damage, or unauthorized access, use, modification, or other misuse of any such Personal Information by the Company, a Company Subsidiary, or any of the Employees.</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288598414"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:21pt;"><font style="display: inline;color:#010000;">(w)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(w)</font><font style="display: inline;"> of the Company Disclosure Schedule lists all industry standards bodies and similar organizations of which either the Company or any Company Subsidiary is a member, to which any of them has been a contributor or in which any of them has been a participant.&nbsp;&nbsp;Neither the Company nor any Company Subsidiary is or ever was a member in, a contributor to, or participant in any industry standards body or similar organization that could require or obligate the Company or any Company Subsidiary to grant or offer to any other Person any license or right to any Technology or Intellectual Property Rights.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref491553052"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(x)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(x)</font><font style="display: inline;"> of the Company Disclosure Schedule accurately identifies all Social Media Accounts that the Company or any of the Company Subsidiaries use, operate or maintain, including in connection with marketing or promoting, in connection with any Company Products or the Business.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref445061417"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(y)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">To the Knowledge of the Company, none of the Company Products</font><font style="display: inline;"> (other than Company Products currently under development) </font><a name="_cp_text_1_215"></a><font style="display: inline;">(i)</font><font style="display: inline;"> contains any defect, vulnerability, or error that materially and adversely affects the use, functionality, security, or performance of such Company Product or the Company Intellectual Property or any product or system containing or used in conjunction with such Company Product or the Company Intellectual Property; or </font><font style="display: inline;">(ii)</font><font style="display: inline;"> fails to</font><font style="display: inline;"> comply with any applicable warranty or other contractual commitment relating to the use, functionality, security, or performance of such Company Product or the Company Intellectual </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">36</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">Property or any product or system containing or used in conjunction with such Company Product or the Company Intellectual Property. </font><font style="display: inline;">To the Knowledge of the Company, </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(y)</font><font style="display: inline;"> of the Company Disclosure Schedule accurately identifies all known bugs, defects, vulnerabilities, and errors in each version of Company Product.</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc487788502"></a><a name="_Toc487788694"></a><a name="_Toc487788827"></a><a name="_Toc491721304"></a><a name="_Ref493721569"></a><a name="_Toc493797754"></a><a name="_Toc493797877"></a><a name="_Toc493844662"></a><a name="_Toc493869156"></a><a name="_Toc493869400"></a><a name="_Toc495394251"></a><a name="_Toc487751047"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.15</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="agreementscontracts"></a><font style="display: inline;font-weight:bold;font-style:italic;">Agreements</font><font style="display: inline;font-weight:bold;font-style:italic;">, Contracts and Commitments</font><font style="display: inline;">.</font><font style="display: inline;"> &nbsp; &nbsp;</font><a name="_Ref288598450"></a><font style="display: inline;">All Material Contracts are listed in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.15</font><font style="display: inline;"> of the Company Disclosure Schedule.&nbsp;&nbsp;&nbsp;True, correct</font><font style="display: inline;">,</font><font style="display: inline;"> and co</font><font style="display: inline;">mplete copies of all Material Contracts have been made available to </font><font style="display: inline;">CryoLife</font><font style="display: inline;">. T</font><font style="display: inline;">he Company and each of the Company Subsidiaries is in material compliance with and is not in material breach or material default under and have not received written notice that they have materially breached or materially defaulted under, any of the terms or conditions of any Material Contract, nor does the Company have Knowledge of any event that could reasonably be expected to constitute such a material breach or material default by the Company or any Company Subsidiary with the lapse of time, giving of notice or both.&nbsp;&nbsp;Each Material Contract is in full force and effect with respect to the Company and the relevant Company Subsidiary, and, to the Knowledge of the Company, no third party obligated to the Company or any Company Subsidiary pursuant to any such Material Contract is subject to any material default thereunder.&nbsp;&nbsp;To the Knowledge of the Company, no party to a Material Contract has any intention of terminating such Material Contract or reducing </font><font style="display: inline;">by more than five percent (5%) </font><font style="display: inline;">the volume of business such party conducts with the Company or the relevant Company Subsidiary.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288598473"></a><a name="_Toc374597685"></a><a name="_Toc487788503"></a><a name="_Toc487788695"></a><a name="_Toc487788828"></a><a name="_Toc491721305"></a><a name="_Toc493797755"></a><a name="_Toc493797878"></a><a name="_Toc493844663"></a><a name="_Toc493869157"></a><a name="_Toc493869401"></a><a name="_Toc495394252"></a><a name="_Toc487751048"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.16</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Related Party Transactions</font><a name="_Toc374597686"></a><a name="_Ref379811412"></a><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref491703410"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Except as set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.16</font><font style="display: inline;"> of the Company Disclosure Schedule and other than </font><font style="display: inline;">(i)</font><font style="display: inline;"> standard benefits generally made available to all Employees, </font><font style="display: inline;">and (ii)</font><font style="display: inline;"> standard director, manager and/or officer indemnification Contracts approved by the Company or the relevant Company Subsidiary, , in each instance, approved and reflected in the written minutes of the Board of Directors or the governing body of such Company Subsidiary (in either case, as made available to </font><font style="display: inline;">CryoLife</font><font style="display: inline;">), there are no Contracts </font><font style="display: inline;">or </font><font style="display: inline;">understandings between the Company or any Company Subsidiary, on the one hand, and </font><font style="display: inline;">the Relevant </font><font style="display: inline;">Employee or any Affiliate or family member thereof, on the other</font><font style="display: inline;"> hand (each, a &#x201C;</font><font style="display: inline;font-weight:bold;">Related Party</font><font style="display: inline;">&#x201D;)</font><font style="display: inline;">.</font><a name="_Toc384369688"></a><font style="display: inline;">&nbsp;</font><font style="display: inline;">Neither the Company nor any of the </font><font style="display: inline;">Company </font><font style="display: inline;">Subsidiaries has any Accounts Receivable from any Person that is a Related Party.</font><font style="display: inline;"> The Company is not in violation or breach of, nor to the Knowledge of the Company has any </font><font style="display: inline;">event</font><font style="display: inline;"> occurred that</font><font style="display: inline;">, with or without notice or lapse of time or both, would constitute a </font><font style="display: inline;">violation or breach under,</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">any Contract or understanding listed or required to be listed in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.16</font><font style="display: inline;"> of the Company Disclosure Schedule</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Except as set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.16</font><font style="display: inline;"> of the Company Disclosure Schedule</font><font style="display: inline;">,</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">n</font><font style="display: inline;">either the Company nor any Company Subsidiary is indebted, directly or indirectly, to any </font><font style="display: inline;">Related Party</font><font style="display: inline;">, other than in connection with expenses or advances of expenses incurred in the ordinary course of business or employee relocation expenses and for other customary employee benefits made generally available to all Employees employed by the Company or such Company Subsidiary, as applicable.&nbsp; </font><font style="display: inline;">Except as set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.16</font><font style="display: inline;"> of the Company Disclosure Schedule</font><font style="display: inline;">, n</font><font style="display: inline;">o &nbsp;</font><font style="display: inline;">Related Party is</font><font style="display: inline;"> directly or indirectly, indebted to the Company or any Company Subsidiary or</font><font style="display: inline;"> has any (i) to the Knowledge of the Company</font><font style="display: inline;">, commercial, industrial, banking, consulting, legal, accounting, charitable or familial relationship with any customers, suppliers, </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">37</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">service providers, joint venture partners, licensees or competitors of the Company or any Company Subsidiary; </font><font style="display: inline;">(ii)</font><font style="display: inline;"> direct or indirect ownership interest in any firm or corporation of which the Company or any Company Subsidiary is an Affiliate or with which the Company or any Company Subsidiary has a business relationship, or any firm or corporation which competes with the Company or any Company Subsidiary, except that </font><font style="display: inline;">the Key </font><font style="display: inline;">Employee may own stock in (but not exceeding one percent (1%) of the </font><font style="display: inline;">issued and </font><font style="display: inline;">outstanding capital stock of) publicly traded companies that may compete with the Company or a Company Subsidiary; or </font><font style="display: inline;">(iii)</font><font style="display: inline;"> financial interest in any contract with the Company or any Company Subsidiary.</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc487788504"></a><a name="_Toc487788696"></a><a name="_Toc487788829"></a><a name="_Toc491721306"></a><a name="_Toc493797756"></a><a name="_Toc493797879"></a><a name="_Toc493844664"></a><a name="_Toc493869158"></a><a name="_Toc493869402"></a><a name="_Toc495394253"></a><a name="_Ref487740884"></a><a name="_Toc487751049"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.17</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="healthcarelegalcompliance"></a><font style="display: inline;font-weight:bold;font-style:italic;">Health Care Legal Compliance</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">To the Knowledge of the Company, n</font><font style="display: inline;">either the Company, the Company Subsidiaries nor any of their respective Employees</font><font style="display: inline;"> or distributors</font><font style="display: inline;">, directly or indirectly, has committed any violation of any Health Care Legal Requirement, including but not limited to using any funds for any illegal contribution, gift, entertainment or other unlawful expense to a healthcare provider or customer</font><font style="display: inline;">, except for an immaterial violation of a Law</font><font style="display: inline;">.&nbsp;&nbsp;To the Knowledge of the Company, no event has occurred or is likely to occur that could reasonably be expected to constitute any violation of any Health Care Legal Requirement by the Company or any of the Company Subsidiaries in connection with the Company Products. &nbsp;T</font><font style="display: inline;">o the Knowledge of the Company, t</font><font style="display: inline;">he Company and each of the Company Subsidiaries is complying with all Laws applicable to privacy or security of individually id</font><font style="display: inline;">entifiable health information, </font><font style="display: inline;">except for a</font><font style="display: inline;">n</font><font style="display: inline;"> immaterial violation of a Law</font><font style="display: inline;">.&nbsp;&nbsp;To the Knowledge of the Company, n</font><font style="display: inline;">either the Company nor any of the Company Subsidiaries has suffered any unauthorized acquisition, access, use or disclosure of any individually identifiable health information that, individually or in the aggregate, compromises the security or privacy of such individually identifiable health information.&nbsp; </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Neither the Company, the Company Subsidiaries, nor</font><font style="display: inline;">, to the Knowledge of the Company,</font><font style="display: inline;"> any of the Employees has been excluded, suspended or debarred from participating in any state-run health care program or been subject to any sanction by any Governmental Authority or been convicted of a</font><font style="display: inline;">ny health care related crime. &nbsp;To the Knowledge of the Company, n</font><font style="display: inline;">o such exclusions or suspensions are threatened nor is there any basis for such exclusions or suspensions.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref487614212"></a><a name="_Toc487751050"></a><a name="_Toc487788505"></a><a name="_Toc487788697"></a><a name="_Toc487788830"></a><a name="_Toc491721307"></a><a name="_Toc493797757"></a><a name="_Toc493797880"></a><a name="_Toc493844665"></a><a name="_Toc493869159"></a><a name="_Toc493869403"></a><a name="_Toc495394254"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.18</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Company Authorizations</font><font style="display: inline;">.&nbsp;&nbsp;Each consent, license, permit, grant, clearance, approval or other authorization under applicable Law </font><font style="display: inline;">(i)</font><font style="display: inline;">&nbsp;pursuant to which the Company or any Company Subsidiary currently operates or holds any interest in any of its properties, </font><font style="display: inline;">(ii)</font><font style="display: inline;">&nbsp;which is required for the operation of the business of the Company and the Company Subsidiaries as currently conducted, or </font><font style="display: inline;">(iii)</font><font style="display: inline;"> which provides the Company or a Company Subsidiary a benefit in the operation of their respective business as currently conducted (each a &#x201C;</font><font style="display: inline;font-weight:bold;">Company Authorization</font><font style="display: inline;">&#x201D; and collectively, &#x201C;</font><font style="display: inline;font-weight:bold;">Company Authorizations</font><font style="display: inline;">&#x201D;), has been issued or granted to the Company or one or more of the Company Subsidiaries, as applicable</font><font style="display: inline;">. &nbsp;</font><font style="display: inline;">The Company Authorizations are in full force and effect.&nbsp;&nbsp;No suspension, cancellation or other lapse of any Company Authorization is pending by or at the behest of any Governmental Authority or other Person, or to the Knowledge of the Company, threatened. </font><font style="display: inline;">&nbsp;</font><font style="display: inline;">All Company Authorizations shall remain in full force and effect immediately after giving effect to the Acquisition.</font><font style="display: inline;"> &nbsp;Neither the Company nor </font><font style="display: inline;">any of the Company Subsidiaries has received any communication from any </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">38</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">Governmental Authority or been notified that any Company Authorization related to any of the Company Products has been withdrawn or modified or that such an action is under consideration.&nbsp;&nbsp;There has been no recall, detention, withdrawal, seizure, or termination or suspension of manufacturing requested or threatened relating to the Company Products, and no field notifications</font><font style="display: inline;">, field corrections or alerts.&nbsp;&nbsp;To the Knowledge of the Company, n</font><font style="display: inline;">o Governmental Authority is considering limiting, suspending, or revoking any Company Authorizations or changing the marketing classification or labeling of any Company Products. </font><font style="display: inline;">&nbsp;</font><font style="display: inline;">To the Knowledge of the Company, there is no false information or significant omission in any product</font><font style="display: inline;"> application </font><font style="display: inline;">or product-related submission to any Governmental Authority.&nbsp;&nbsp;The Company and each of the Company Subsidiaries have obtained all necessary Company Authorizations related to the Company Products distributed and sold by the Company or any of the Company Subsidiaries, and neither the Company nor any of the Company Subsidiaries has received any notice that any Governmental Authority seeks any additional conditions on the distribution or sale of Company Products in a jurisdiction covered by a Company Authorization. Without limiting the foregoing: </font><font style="display: inline;">(i) JOTEC </font><font style="display: inline;">Brazil has provided a written request to Neomex, or the Company shall or shall cause </font><font style="display: inline;">JOTEC </font><font style="display: inline;">Brazil to provide a written request to Neomex prior to Closing, for the transfer to </font><font style="display: inline;">JOTEC </font><font style="display: inline;">Brazil of the product registries in Brazil for the </font><font style="display: inline;">Specified Company Product</font><font style="display: inline;">s</font><font style="display: inline;">; &nbsp;</font><font style="display: inline;">(ii)</font><font style="display: inline;"> the Company or Company Subsidiaries have obtained and currently maintain all required registrations from each applicable medicinal or public health Governmental Authority in the </font><font style="display: inline;">Specified Countries;</font><font style="display: inline;"> and </font><font style="display: inline;">(iii)</font><font style="display: inline;"> no product registrations (except as provided in Section 5.18 of the Company Disclosure Schedule) are expired nor shall any product registrations expire within twelve (</font><font style="display: inline;">12) months of the date hereof. </font><font style="display: inline;"> To the Knowledge of the Company, any third party that is a manufacturer, contractor, or agent for the Company or any of the Company Subsidiaries is in compliance with all Laws insofar as they pertain to the manufacture of the Company Products or any related product components or </font><font style="display: inline;">inputs, except for any immaterial violations of any Law.&nbsp; </font><font style="display: inline;">T</font><font style="display: inline;">he distributors on behalf of the Company or any of the Company Subsidiaries have obtained and currently</font><font style="display: inline;"> maintain all required registrations from each applicable medicinal or public health Governmental Authority having jurisdiction over any geographic area in which the Company or any of the Company Subsidiaries or the distributors currently sells the Company Products.</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">&nbsp;</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref368556746"></a><a name="_Toc374597687"></a><a name="_Toc487751051"></a><a name="_Toc487788506"></a><a name="_Toc487788698"></a><a name="_Toc487788831"></a><a name="_Toc491721308"></a><a name="_Toc493797758"></a><a name="_Toc493797881"></a><a name="_Toc493844666"></a><a name="_Toc493869160"></a><a name="_Toc493869404"></a><a name="_Toc495394255"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.19</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="litigation"></a><font style="display: inline;font-weight:bold;font-style:italic;">Litigation</font><font style="display: inline;">.&nbsp;&nbsp;Except as set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.19</font><font style="display: inline;"> of the Company Disclosure Schedule</font><font style="display: inline;">,</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">t</font><font style="display: inline;">here is no action, suit, claim or proceeding of any nature pending, or to the Knowledge of the Company, threatened, against the Company, the Company Subsidiaries, any of their respective properties (tangible or intangible) or any of their respective officers, managers or directors (in their capacity as such). To the Knowledge of the Company there is no investigation, audit, or other proceeding pending or threatened, against the Company, the Company Subsidiaries, any of their respective properties (tangible or intangible) or any of their respective officers, managers or directors (in their capacity as such) by or before any Governmental Authority.&nbsp;&nbsp;No Governmental Authority has, in writing, at any time challenged or questioned the legal right of the Company or the Company Subsidiaries to conduct their respective operations as presently or previously conducted. </font><font style="display: inline;">To the Knowledge of the Company, there is no action, suit, claim or proceeding of any nature pending or threatened against any individual or entity who has a right pursuant to applicable Law or Contract to indemnification from the Company or any Company Subsidiary related to facts and circumstances existing prior to the Closing, nor are </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">39</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">there, to the Knowledge of the Company, any facts or circumstances that could reasonably be expected to give rise to such an action, suit, claim or proceeding.</font><font style="display: inline;">&nbsp;</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc374597688"></a><a name="_Toc487751052"></a><a name="_Toc487788507"></a><a name="_Toc487788699"></a><a name="_Toc487788832"></a><a name="_Toc491721309"></a><a name="_Toc493797759"></a><a name="_Toc493797882"></a><a name="_Toc493844667"></a><a name="_Toc493869161"></a><a name="_Toc493869405"></a><a name="_Toc495394256"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.20</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="corporateandbusinessrecords"></a><font style="display: inline;font-weight:bold;font-style:italic;">Corporate and Business Records</font><font style="display: inline;">.&nbsp;&nbsp;The corporate and business records of the Company and each Company Subsidiary made available to </font><font style="display: inline;">CryoLife </font><font style="display: inline;">contain materially complete and accurate records of the corporate actions and proceedings and business activity of the Company.</font><font style="display: inline;"> &nbsp; &nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc374597689"></a><a name="_Ref487620130"></a><a name="_Ref487620182"></a><a name="_Toc487751053"></a><a name="_Toc487788508"></a><a name="_Toc487788700"></a><a name="_Toc487788833"></a><a name="_Toc491721310"></a><a name="_Toc493797760"></a><a name="_Toc493797883"></a><a name="_Toc493844668"></a><a name="_Toc493869162"></a><a name="_Toc493869406"></a><a name="_Toc495394257"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.21</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Environmental Matters</font><a name="_Ref288598491"></a><a name="_Ref288598506"></a><a name="_Toc374597690"></a><font style="display: inline;">.&nbsp;&nbsp;The Company and each Company Subsidiary </font><font style="display: inline;">(i)</font><font style="display: inline;">&nbsp;is and, during the surviving time periods of all applicable statutes of limitation, has been in compliance in all material respects with all Environmental Laws; </font><font style="display: inline;">(ii)</font><font style="display: inline;"> has not received any written notice of any alleged claim, complaint, violation of, or Liability under, any Environmental Law (including any claim or complaint from any employee alleging exposure to Hazardous Materials) (collectively, an &#x201C;</font><font style="display: inline;font-weight:bold;">Environmental Claim</font><font style="display: inline;">&#x201D;) and, to the Knowledge of the Company, there are no conditions, occurrences or circumstances related to the operations of the Company or any Company Subsidiary that are or are reasonably likely to result in the receipt of such notice; </font><font style="display: inline;">(iii)</font><font style="display: inline;">&nbsp;has not disposed of, emitted, discharged, or released (collectively, &#x201C;</font><font style="display: inline;font-weight:bold;">Released</font><font style="display: inline;">&#x201D;), or handled, stored, transported or used any Hazardous Materials or arranged for the Release or handling, storage or transportation of any Hazardous Materials in a manner that has resulted, or is reasonably likely to result, in an Environmental Claim; </font><font style="display: inline;">(iv)</font><font style="display: inline;"> has not entered into any Contract that may require it to guarantee, reimburse, pledge, defend, hold harmless or indemnify any other party with respect to Liabilities arising out of </font><font style="display: inline;">(A)</font><font style="display: inline;"> Environmental Laws or </font><font style="display: inline;">(B)</font><font style="display: inline;"> Hazardous Materials related to activities of the Company or any Company Subsidiary; and </font><font style="display: inline;">(v)</font><font style="display: inline;">&nbsp;has made available to </font><font style="display: inline;">CryoLife </font><font style="display: inline;">complete an</font><font style="display: inline;">d correct copies of all records</font><font style="display: inline;"> and all environmental audits and environmental assessments of any facility owned, leased or used at any time by the Company or any Company Subsidiary conducted at the request of, or otherwise in the possession or control of the Company or any Company Subsidiary.&nbsp; </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc487751054"></a><a name="_Toc487788509"></a><a name="_Toc487788701"></a><a name="_Toc487788834"></a><a name="_Ref487818019"></a><a name="_Toc491721311"></a><a name="_Toc493797761"></a><a name="_Toc493797884"></a><a name="_Toc493844669"></a><a name="_Toc493869163"></a><a name="_Toc493869407"></a><a name="_Toc495394258"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.22</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Brokers&#x2019; and Finders&#x2019; Fee</font><font style="display: inline;font-weight:bold;font-style:italic;">s</font><font style="display: inline;">.&nbsp;&nbsp;Neither the Company nor any Company Subsidiary has incurred, nor will any of the foregoing incur, directly or indirectly, any liability for brokerage or finders&#x2019; fees or agents&#x2019; commissions, fees related to investment banking or similar advisory services or any similar charges in connection with this Agreement or the Related Agreements or any transaction contemplated in this Agreement or the Related Agreements.&nbsp; </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc374597691"></a><a name="_Ref444772716"></a><a name="_Ref444772729"></a><a name="_Ref444773137"></a><a name="_Toc487788510"></a><a name="_Toc487788702"></a><a name="_Toc487788835"></a><a name="_Toc491721312"></a><a name="_Toc493797762"></a><a name="_Toc493797885"></a><a name="_Toc493844670"></a><a name="_Toc493869164"></a><a name="_Toc493869408"></a><a name="_Toc495394259"></a><a name="_Toc487751055"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.23</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Employee Benefit Plans and Compensation</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288598534"></a><a name="_Ref447044457"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Schedule</font><font style="display: inline;">.&nbsp; </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.23(a)</font><font style="display: inline;font-weight:bold;">(1)</font><font style="display: inline;"> of the Company Disclosure Schedule contains an accurate and complete list of each Company Employee Plan</font><a name="_cp_text_1_488"></a><font style="display: inline;">, in each case pursuant to which the Company or any Company Subsidiary has any obligation</font><font style="display: inline;">.&nbsp; </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref491682029"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Documents</font><font style="display: inline;">.&nbsp;&nbsp;The Company has made available to </font><font style="display: inline;">CryoLife (i)</font><font style="display: inline;">&nbsp;correct and complete copies of all documents</font><font style="display: inline;"> in effect from and after the date of this Agreement</font><font style="display: inline;"> embodying each Company Employee Plan</font><font style="display: inline;"> and all related trust documents</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">including all amendments thereto (ii)</font><font style="display: inline;">&nbsp;all material written Contracts </font><font style="display: inline;">in effect from and after the date of this Agreement </font><font style="display: inline;">relating to each Company Employee Plan, including administrative service agreements and group insurance C</font><font style="display: inline;">ontracts</font><font style="display: inline;">, and </font><font style="display: inline;">(iii)</font><font style="display: inline;"> all</font><font style="display: inline;"> reports filed with any Governmental Authority and any other</font><font style="display: inline;"> material </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">40</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">correspondence to or from any Governmental Authority relating to any Company Employee Plan</font><font style="display: inline;">, in each case with respect to this clause </font><font style="display: inline;">&#x200E;</font><font style="display: inline;">(iii) in the five (5) years preceding the date of this Agreement</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Each Company Employee Plan is not subject to United States Law</font><font style="display: inline;"> and</font><font style="display: inline;"> is maintained primarily in respect to Employees who are located outside the United States (each, a &#x201C;</font><font style="display: inline;font-weight:bold;">Foreign Benefit Plan</font><font style="display: inline;">&#x201D;)</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Neither the Company nor any Company Subsidiary has made any plan or commitment to establish any new Company Employee Plan, to modify any Company Employee Plan (except to the extent required by Law or to conform any such Company Employee Plan to the requirements of any applicable Law, in each case as previously disclosed to Buyer, or as required by this Agreement), or to enter into any Company Employee Plan.</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref487620223"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(c)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Employee Plan Compliance</font><font style="display: inline;">.&nbsp;&nbsp;Each Company Employee Plan has been established, maintained and administered in </font><font style="display: inline;">material </font><font style="display: inline;">compliance with its terms and conditions and with the requirements prescribed by any and all statutory or regulatory Laws that are applicable to such Company Employee Plan.&nbsp; </font><font style="display: inline;">N</font><font style="display: inline;">o Company Employee Plan has unfunded liabilities that, as of the Closing, will not be offset by insurance or fully accrued.&nbsp;&nbsp;Except as required by Law, no condition exists that</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">would prevent the Company</font><font style="display: inline;"> or</font><font style="display: inline;"> any Company Subsidiary from terminating or amending any Company Employee Plan at any time for any reason without liability to the Company or any of the Company Subsidiaries (other than ordinary administration expenses or routine claims for benefits).</font><font style="display: inline;"> &nbsp;A</font><font style="display: inline;">ll employer and employee contributions to each Foreign Benefit Plan required by its terms or by applicable Law have been made or, if applicable, accrued in accordance with generally accepted accounting practices in the applicable jurisdiction and any other payments (including insurance premiums) otherwise due in respect to a Foreign Benefit Plan have been paid in full</font><font style="display: inline;"> or will be paid in full prior to the Closing.&nbsp;&nbsp;T</font><font style="display: inline;">he fair market value of the assets of each funded Foreign Benefit Plan, the liability of each insurer for any Foreign Benefit Plan funded through insurance or the book reserve established for any Foreign Benefit Plan, together with any accrued contributions, is</font><font style="display: inline;">, to the Knowledge of the Company,</font><font style="display: inline;"> sufficient to procure or provide for the accrued benefit obligations, as of the date of this Agreement, with respect to all current and former participants in such plan according to the actuarial assumptions and valuations most recently used to determine employer contributions to such Foreign Benefit Plan, and no transaction contemplated in this Agreement shall cause such assets or insurance obligations to be less than suc</font><font style="display: inline;">h benefit obligations.&nbsp;&nbsp;E</font><font style="display: inline;">ach Foreign Benefit Plan required to be registered has been registered and has been maintained in good standing with applicable regulatory authorities.</font><font style="display: inline;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(d)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">No U.S. Employees or Plans</font><font style="display: inline;">.&nbsp;&nbsp;Neither the Company nor </font><font style="display: inline;">any of the Company Subsidiaries </font><font style="display: inline;">has ever maintained, established sponsored, participated in or contributed to any &#x201C;employee benefit plan&#x201D; (as defined in Section 3(3) of ERISA) subject to ERISA or any other Company Employee Plan benefiting Employees located in the United States or subject to United States Law.&nbsp;&nbsp;Neither the Company nor any of the Company Subsidiaries have any Employees located in the United States or subject to any Law of the United States or any state or locality within the United States.&nbsp; </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(e)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">No Post-Employment Obligations</font><font style="display: inline;">.&nbsp;&nbsp;No Company Employee Plan or Employee Agreement provides, or reflects or represents any liability to provide, retiree life insurance, retiree health or other retiree employee welfare benefits to any person for any reason, </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">41</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">except as may be required by applicable Law, and neither the Company nor any Company Subsidiary has ever represented, promised or contracted (whether in oral or written form) to any Employee (either individually or to Employees as a group) or any other person that such Employee(s) or other person would be provided with retiree life insurance, retiree health or other retiree employee welfare benefits, except to the extent required </font><a name="_cp_text_1_518"></a><font style="display: inline;">by</font><font style="display: inline;"> applicable Law</font><font style="display: inline;">.</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:25pt;"><font style="display: inline;color:#010000;">(f)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Effect of Transaction</font><font style="display: inline;">.&nbsp;&nbsp;The execution of this Agreement and the Related Agreements and the consummation of the transactions contemplated in this Agreement and the Related Agreements will not (either alone or upon the occurrence of any additional or subsequent events) constitute an event under any Company Employee Plan, Employee Agreement, trust, loan or </font><font style="display: inline;">Law</font><font style="display: inline;"> that will or may result in any payment (whether of severance pay, bonus or otherwise), acceleration, forgiveness of indebtedness, vesting, distribution, increase in compensation, increase in benefits or obligation to fund benefits with respect to any Current Employee.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288598635"></a><a name="_Ref379832113"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(g)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Employment Matters</font><font style="display: inline;">.&nbsp; </font><font style="display: inline;">The Company has provided </font><font style="display: inline;">an anonymized list of the </font><font style="display: inline;">hiring date, annual salary, commissions, </font><font style="display: inline;">and </font><font style="display: inline;">bonus </font><font style="display: inline;">of each </font><font style="display: inline;">the Current </font><font style="display: inline;">Employee </font><font style="display: inline;">(except for Current Employees who are paid on an hourly wage) </font><font style="display: inline;">as of the date </font><font style="display: inline;">made available to CryoLife</font><font style="display: inline;">.</font><font style="display: inline;"> &nbsp;To the Knowledge of the Company, </font><font style="display: inline;">no Relevant </font><font style="display: inline;">Employee </font><font style="display: inline;">intends</font><font style="display: inline;"> to terminate his or her employment for any reason. The Company and each Company Subsidiary is in </font><font style="display: inline;">material </font><font style="display: inline;">compliance</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">with all applicable foreign, federal, state and local Laws </font><font style="display: inline;">(except for immaterial violation of a Law)</font><font style="display: inline;"> respecting employment, employment practices, terms and conditions of employment, worker or employee classification, tax withholding, prohibited discrimination, equal employment, fair employment practices, meal and rest periods, immigration status, employee safety and health, wages (including overtime wages), compensation, plant closings or mass layoffs, and hours of work, and in each case, with respect to Employees: </font><font style="display: inline;">(i)</font><font style="display: inline;">&nbsp;has withheld and reported all amounts required by Law or by Contract to be withheld and reported with respect to wages, salaries and other payments to Employees, </font><font style="display: inline;">(ii)</font><font style="display: inline;">&nbsp;is not liable for any arrears of wages, holiday pay, bonuses, commissions, benefits, severance pay or any Taxes or any penalty for failure to comply with any of the foregoing, and </font><font style="display: inline;">(iii)</font><font style="display: inline;">&nbsp;is not liable for any payment to any trust or other fund governed by or maintained by or on behalf of any Governmental Authority, with respect to unemployment compensation benefits, social security or other benefits or obligations for Employees (other than routine payments to be made in the normal course of business and consistent with past practice and applicable Law).&nbsp;&nbsp;Except as set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.23(g)</font><font style="display: inline;"> of the Company Disclosure Schedule</font><font style="display: inline;">, since December 31, 2016, t</font><font style="display: inline;">here </font><font style="display: inline;">have been no and there </font><font style="display: inline;">are no actions, suits, claims, audits, investigations, or administrative matters pending</font><font style="display: inline;"> or, to the Knowledge of the Company</font><font style="display: inline;">, threatened or reasonably anticipated against the Company, the Company Subsidiaries, or any of the Employees relating to any Employee, Employee Agreement or Company Employee Plan.&nbsp; </font><font style="display: inline;">Since December 31, 2016, there have been no and there </font><font style="display: inline;">are no pending or threatened or reasonably anticipated claims or actions against the Company, the Company Subsidiaries, or any Company trustee under any worker&#x2019;s compensation policy or long-term disability policy.&nbsp;&nbsp;Neither the Company nor any Company Subsidiary is party to a conciliation agreement, consent decree, or Contract or order with any federal, state, or local agency or Governmental Authority with respect to employment practices.&nbsp; </font><font style="display: inline;">N</font><font style="display: inline;">either the Company nor any Company Subsidiary has any liability with respect to any misclassification of: </font><font style="display: inline;">(a)</font><font style="display: inline;">&nbsp;any </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">42</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">person as an independent contractor rather than as an employee, </font><font style="display: inline;">(b)</font><font style="display: inline;">&nbsp;any Employee leased from another employer, or </font><font style="display: inline;">(c)</font><font style="display: inline;">&nbsp;any Employee currently or formerly classified as exempt from overtime wages in accordance with the applicable Law.</font><font style="display: inline;"> &nbsp; &nbsp;</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref493851793"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(h)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Labor</font><font style="display: inline;">.&nbsp;&nbsp;No strike, labor dispute, slowdown, concerted refusal to work overtime, or work stoppage against the Company or any Company Subsidiary is pending, or to the Knowledge of the Company, threatened</font><font style="display: inline;"> or reasonably anticipated</font><font style="display: inline;">.&nbsp;&nbsp;The Company has no Knowledge of any activities or proceedings of any labor union to organize any Employees and any such activities or proceedings.&nbsp;&nbsp;Except as set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.23(h)</font><font style="display: inline;"> of the Company Disclosure Schedule</font><font style="display: inline;">, t</font><font style="display: inline;">here are no actions, suits, claims, audits, investigations, administrative matters, labor disputes or grievances pending or, to the Knowledge of the Company, threatened </font><font style="display: inline;">or reasonably anticipated </font><font style="display: inline;">relating to any labor matters, wages, benefits, medical or family leave, classification, safety or discrimination matters involving any Employee, including claims of wage and/or hour violations, unfair business practices, unfair labor practices, discrimination, harassment or wrongful termination complaints.&nbsp; </font><font style="display: inline;">Neither the Company nor any Company Subsidiary</font><font style="display: inline;"> is a party to a current </font><font style="display: inline;">re</font><font style="display: inline;">conciliation agreement, consent decree, or Contract or order with any Governmental Authority with respect to employment practices.</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Neither the Company nor any Company Subsidiary has engaged in any unfair labor practices within the meaning of applicable Law. Neither the Company nor any Company Subsidiary is presently, nor have they in the past, been a party to, or bound by, any collective bargaining agreement or union Contract with respect to Employees and no collective bargaining agreement is being negotiated by the Company or any Company Subsidiary.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;color:#010000;">(i)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">No Interference or Conflict</font><font style="display: inline;">.&nbsp;&nbsp;To the Knowledge of the Company, no Securityholder, </font><font style="display: inline;">Current </font><font style="display: inline;">Employee, or equity holder of the Company or any Company Subsidiary is obligated under any Contract, subject to any judgment, decree, or order of any court or administrative agency that would interfere with such Person&#x2019;s efforts to promote the interests of the Company or that would interfere with the Company&#x2019;s business.&nbsp;&nbsp;Neither the execution nor delivery of this Agreement, nor the carrying on of the Business as currently conducted or as currently proposed to be conducted nor any activity of </font><font style="display: inline;">any of the Current </font><font style="display: inline;">Employee</font><font style="display: inline;">s</font><font style="display: inline;"> in connection with the carrying on of the Business as presently conducted or as currently proposed to be conducted will, to the Knowledge of the Company, conflict with or result in a breach of the terms, conditions, or provisions of, or constitute a default under, any Contract under which any of </font><font style="display: inline;">the Current </font><font style="display: inline;">Employee</font><font style="display: inline;">s</font><font style="display: inline;"> is now bound.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288598659"></a><a name="_Toc374597692"></a><a name="_Toc487751056"></a><a name="_Toc487788511"></a><a name="_Toc487788703"></a><a name="_Toc487788836"></a><a name="_Toc491721313"></a><a name="_Toc493797763"></a><a name="_Toc493797886"></a><a name="_Toc493844671"></a><a name="_Toc493869165"></a><a name="_Toc493869409"></a><a name="_Toc495394260"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.24</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="insurance"></a><font style="display: inline;font-weight:bold;font-style:italic;">Insurance</font><font style="display: inline;">.&nbsp; </font><font style="display: inline;font-weight:bold;">Section</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.24</font><font style="display: inline;"> of the Company Disclosure Schedule lists all insurance policies </font><font style="display: inline;">(</font><font style="display: inline;">except </font><font style="display: inline;">for</font><font style="display: inline;"> car insurances policies</font><font style="display: inline;">)</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">and fidelity bonds covering the assets, business, equipment, properties, operations, and Current Employees of the Company or any of the Company Subsidiaries.&nbsp;&nbsp;There is no claim by the Company or any Company Subsidiary pending under any of such policies or bonds as to which coverage has been questioned, denied or disputed or that the Company has a reason to believe will be denied or disputed by the underwriters of such policies or bonds.&nbsp;&nbsp;In addition, there is no pending claim of which its total value (inclusive of defense expenses) will exceed the policy limits.&nbsp;&nbsp;All premiums due and payable under all such policies and bonds have been paid (or if installment payments are due, will be paid if incurred prior to the Closing Date) and the Company and the Company </font>
		</font></p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">43</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">Subsidiaries are otherwise in material compliance with the terms of such policies and bonds.&nbsp;&nbsp;Such policies and bonds are enforceable in accordance with their terms.&nbsp; </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc374597693"></a><a name="_Ref487490195"></a><a name="_Toc487788512"></a><a name="_Toc487788704"></a><a name="_Toc487788837"></a><a name="_Toc491721314"></a><a name="_Toc493797764"></a><a name="_Toc493797887"></a><a name="_Toc493844672"></a><a name="_Toc493869166"></a><a name="_Toc493869410"></a><a name="_Toc495394261"></a><a name="_Toc487751057"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.25</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="compliancewithlaws"></a><font style="display: inline;font-weight:bold;font-style:italic;">Compliance with Laws</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">The Company and each of the Company Subsidiaries have complied</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">with, are not in violation of, and have not received any written notices of any suspected, potential or actual violation with respect to, any applicable Law by the Company, any of the Company Subsidiaries or any Employee or other representative of the Company or any of the Company Subsidiaries</font><font style="display: inline;">, except for immaterial violation of a Law</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref379811559"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">The Company and each of the Company Subsidiaries have been, within the preceding five (5) years, and are currently, fully in compliance with all applicable Anti-Corruption and Anti-Bribery Laws in any jurisdiction in which the Company or any Company Subsidiary conducts business</font><font style="display: inline;">, except for immaterial violation of a Law</font><font style="display: inline;">. To the Knowledge of the Company, there are no </font><font style="display: inline;">current </font><font style="display: inline;">actions, conditions or circumstances pertaining to the Company&#x2019;s or the Company Subsidiaries&#x2019; activities that could reasonably be expected to give rise to any legitimate future legal claims, charges, investigations, violations, settlements, civil or criminal actions, lawsuits, or other court actions against the Company or any Company Subsidiary under any applicable Anti-Corruption and Anti-Bribery Laws.</font><font style="display: inline;"> &nbsp;The Company and each Company Subsidiary has established and maintains a compliance program and reasonable internal controls and procedures </font><font style="display: inline;">which, to the Knowledge of the Company, are </font><font style="display: inline;">appropriate to the requirements of Anti-Corruption and Anti-Bribery Laws.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(c)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">To the Knowledge of the Company, no officer, director or manager of the Company or any Company Subsidiary has been:&nbsp;&nbsp;(i)&nbsp;convicted in a criminal proceeding or named as a subject of a pending criminal proceeding (excluding traffic violations and other minor offenses); (ii)&nbsp;subject to any order, judgment, or decree (not subsequently reversed, suspended or vacated) of any court of competent jurisdiction permanently or temporarily enjoining him/her from, or otherwise imposing limits or conditions on his or her engaging in any securities, investment advisory, banking, insurance or other type of business or acting as an officer or director of a public company; or (iii)&nbsp;found by a court of competent jurisdiction in a civil action to have violated any applicable commodities, securities or unfair trade practices law, which such judgment or finding has not been subsequently reversed, suspended, or vacated.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc487751058"></a><a name="_Toc487788513"></a><a name="_Toc487788705"></a><a name="_Toc487788838"></a><a name="_Toc491721315"></a><a name="_Toc493797765"></a><a name="_Toc493797888"></a><a name="_Toc493844673"></a><a name="_Toc493869167"></a><a name="_Toc493869411"></a><a name="_Toc495394262"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.26</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Export and Import Control Laws</font><font style="display: inline;">.&nbsp;&nbsp;The Company and the Company Subsidiaries have, within the preceding five (5) years, conducted their respective export and import transactions in accordance with all applicable Export and Import Control Laws</font><font style="display: inline;">, except for immaterial violation of a Law</font><font style="display: inline;">. Without limiting the foregoing: </font><font style="display: inline;">(i)</font><font style="display: inline;"> each of the Company and the Company Subsidiaries has obtained all material export licenses, registrations and other approvals required for its respective exports of products, software, services, and technologies under applicable Export and Import Control Laws; </font><font style="display: inline;">(ii)</font><font style="display: inline;"> each of the Company and the Company Subsidiaries is in material compliance with the terms of all applicable Export and Import Approvals; </font><font style="display: inline;">(iii)</font><font style="display: inline;"> neither the Company nor any of the Company Subsidiaries has received any communication alleging that it is not or may not be in compliance with, or has, or may have, any liability under any such applicable export licenses, registrations or other approvals, or otherwise </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">44</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">in respect of any applicable Export and Import Control Laws; </font><font style="display: inline;">(iv)</font><font style="display: inline;"> there are no pending or</font><font style="display: inline;">, to the Knowledge of the Company,</font><font style="display: inline;"> threatened claims, charges, investigations, violations, settlements, civil or criminal enforcement actions, lawsuits, or other court actions against either the Company or any of the Company Subsidiaries with respect to any applicable Export and Import Control Laws; and </font><font style="display: inline;">(v)</font><font style="display: inline;"> there are no actions, conditions or circumstances pertaining to the Company&#x2019;s or any of the Company Subsidiaries&#x2019; export or import transactions that could reasonably be expected to give rise to any legitimate future legal claims, charges, investigations, violations, settlements, civil or criminal actions, lawsuits, or other court actions against the Company or any Company Subsidiary under any applicable Export and Import Control Laws.&nbsp;&nbsp;Further, without limiting the foregoing: </font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref492378122"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Except as set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.26(a) </font><font style="display: inline;">of the Company Disclosure Schedule</font><font style="display: inline;">, t</font><font style="display: inline;">he Company and the Company Subsidiaries have never conducted business, including but not limited to exporting, reexporting, transferring or otherwise providing any products, software, services, or technologies to a person in a country subject to a comprehensive embargo by the United States for end-use in any such country.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Except as set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.26(a) </font><font style="display: inline;">of the Company Disclosure Schedule</font><font style="display: inline;">, t</font><font style="display: inline;">he Company and the Company Subsidiaries have not, without any required approval or authorization from any Governmental Authority, conducted business, directly or indirectly, including but not limited to exporting, reexporting, transferring or otherwise providing any products, software, services, or technologies, to a person subject to sanctions imposed by any Governmental Authority, including but not limited to a person listed on or owned or controlled by a person listed on the U.S. Treasury Department&#x2019;s List of Specially Designated Nationals, and the U.S. Commerce Department&#x2019;s List of Denied Persons or Entity List. </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(c)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">No approvals from a Governmental Authority are required for the Company or any of the Company Subsidiaries to retain any Export and Import Approvals following the consummation of the</font><font style="display: inline;"> Acquisition</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288598679"></a><a name="_Ref288598692"></a><a name="_Toc374597694"></a><a name="_Toc487751059"></a><a name="_Toc487788514"></a><a name="_Toc487788706"></a><a name="_Toc487788839"></a><a name="_Toc491721316"></a><a name="_Toc493797766"></a><a name="_Toc493797889"></a><a name="_Toc493844674"></a><a name="_Toc493869168"></a><a name="_Toc493869412"></a><a name="_Toc495394263"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.27</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="bankaccounts"></a><font style="display: inline;font-weight:bold;font-style:italic;">Bank Accounts,</font><font style="display: inline;font-weight:bold;font-style:italic;"> Letters of Credit and Powers of Attorney</font><font style="display: inline;">.&nbsp; </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.27</font><font style="display: inline;"> of the Company Disclosure Schedule lists </font><font style="display: inline;">(a)</font><font style="display: inline;">&nbsp;all bank accounts, lock boxes and safe deposit boxes relating to the respective businesses and operations of the Company and the Company Subsidiaries (including the name of the bank or other institution where such account or box is located and the name of each authorized signatory thereto), </font><font style="display: inline;">(b)</font><font style="display: inline;">&nbsp;all outstanding letters of credit issued by financial institutions for the account of the Company or any Company Subsidiary (setting forth, in each case, the financial institution issuing such letter of credit and the party or parties in whose favor such letter of credit was issued), and </font><font style="display: inline;">(c)</font><font style="display: inline;">&nbsp;the name and address of each person who has a power of attorney to act on behalf of the Company or any Company Subsidiary.&nbsp;&nbsp;The Company has made available to Buyer true, correct and complete copies of each letter of credit and each power of attorney described in </font><font style="display: inline;font-weight:bold;">Section</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.27</font><font style="display: inline;"> of the Company Disclosure Schedule.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc374597695"></a><a name="_Toc487788515"></a><a name="_Toc487788707"></a><a name="_Toc487788840"></a><a name="_Toc491721317"></a><a name="_Toc493797767"></a><a name="_Toc493797890"></a><a name="_Toc493844675"></a><a name="_Toc493869169"></a><a name="_Toc493869413"></a><a name="_Toc495394264"></a><a name="_Toc487751060"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.28</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Customers and Suppliers</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref289175124"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">45</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.28(a</font><font style="display: inline;">)</font><font style="display: inline;"> of the Company Disclosure Schedule sets forth the top ten (10) customers, resellers, and/or distributors by revenue, of the Company and each Company Subsidiary for the fiscal years ended December 31, 2015 and December 31, 2016, (collectively, the &#x201C;</font><font style="display: inline;font-weight:bold;">Customers</font><font style="display: inline;">&#x201D; and each, a &#x201C;</font><font style="display: inline;font-weight:bold;">Customer</font><font style="display: inline;">&#x201D;).&nbsp;&nbsp;Except to the extent disclosed on </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.28(a</font><font style="display: inline;">)</font><font style="display: inline;"> of the Company Disclosure Schedule, during the last twelve (12) months, no Customer has canceled or otherwise terminated its relationship with the Company or the Company Subsidiary with which it has a relationship, or has decreased materially its usage or purchases of the Company Products.&nbsp;&nbsp;To the </font><font style="display: inline;">Knowledge of the Company</font><font style="display: inline;">, no Customer has any plan or intention to terminate, to cancel or otherwise materially and adversely modify its relationship with the Company or the Company Subsidiary with which it has a relationship or to decrease materially its usage, purchase or distribution of the Company Products.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref289175247"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.28(b</font><font style="display: inline;">)</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">of the Company Disclosure Schedule sets forth a list of the top ten (10) suppliers, by aggregate purchase value, of the Company and each of the Company Subsidiaries to whom the Company or a Company Subsidiary made payments during the fiscal year ended December 31, 2016 showing, with respect to each, the name, address and dollar volume involved (collectively, the &#x201C;</font><font style="display: inline;font-weight:bold;">Suppliers</font><font style="display: inline;">&#x201D;).&nbsp;&nbsp;During the last twelve (12) months, no Supplier has terminated or materially reduced its business with the Company or any Company Subsidiary.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref289175495"></a><a name="_Toc374597696"></a><a name="_Toc487751061"></a><a name="_Toc487788516"></a><a name="_Toc487788708"></a><a name="_Toc487788841"></a><a name="_Toc491721318"></a><a name="_Toc493797768"></a><a name="_Toc493797891"></a><a name="_Toc493844676"></a><a name="_Toc493869170"></a><a name="_Toc493869414"></a><a name="_Toc495394265"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.29</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="warrantiestocustomers"></a><font style="display: inline;font-weight:bold;font-style:italic;">Warranties to Customers</font><font style="display: inline;">.&nbsp;&nbsp;The Company has made available to Buyer a copy of the standard terms and conditions of sale, lease or license by the Company and each of the Company Subsidiaries (including applicable warranty and indemnity provisions).&nbsp;&nbsp;No Company Product is subject to any guaranty, warranty, or other indemnity that extends beyond, in any material respect, the applicable standard terms and conditions of sale, lease or license other than ordinary remedies for breach of contract pursuant to general principles of applicable Law. </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc487751062"></a><a name="_Toc487788517"></a><a name="_Toc487788709"></a><a name="_Toc487788842"></a><a name="_Ref487795807"></a><a name="_Toc491721319"></a><a name="_Toc493797769"></a><a name="_Toc493797892"></a><a name="_Toc493844677"></a><a name="_Toc493869171"></a><a name="_Toc493869415"></a><a name="_Ref494376220"></a><a name="_Toc495394266"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.30</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Products</font><font style="display: inline;">.&nbsp; </font><font style="display: inline;">Except as set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.30</font><font style="display: inline;"> of the Company Disclosure Schedule</font><font style="display: inline;">, s</font><font style="display: inline;">ince December 31, 2016, neither the Company nor any of the Company Subsidiaries, nor, to the Knowledge of the Company, any distributor of the Company or any of the Company Subsidiaries, has received a claim for or based upon </font><font style="display: inline;">(i)</font><font style="display: inline;"> breach of product or service warranty or guaranty or similar claim; </font><font style="display: inline;">(ii)</font><font style="display: inline;"> strict liability in tort; </font><font style="display: inline;">(iii)</font><font style="display: inline;"> negligent design of product, negligent provision of services; or </font><font style="display: inline;">(iv)</font><font style="display: inline;"> any other complaint or allegation of liability, including or arising from the materials, design, testing, manufacture, packaging, labeling (including instructions for use), or sale of the Company Products, in each case that would result in material liability to the Company or any Company Subsi</font><font style="display: inline;">diary in excess of the warranty reserve reflected on the Financials. There is no claim, action, suit, investigation or proceeding pending against the Company or any Company Subsidiary, or to the Knowledge of the Company, threatened, relating to alleged defects in the Company Products.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444682316"></a><a name="_Toc445224621"></a><a name="_Toc487751063"></a><a name="_Toc487788518"></a><a name="_Toc487788710"></a><a name="_Toc487788843"></a><a name="_Toc491721320"></a><a name="_Toc493797770"></a><a name="_Toc493797893"></a><a name="_Toc493844678"></a><a name="_Toc493869172"></a><a name="_Toc493869416"></a><a name="_Toc495394267"></a><a name="_Ref289175542"></a><a name="_Toc427705044"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.31</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Utilization</font><font style="display: inline;font-weight:bold;font-style:italic;"> of Assets</font><font style="display: inline;">.&nbsp; </font><font style="display: inline;">At</font><font style="display: inline;"> the Closing, </font><font style="display: inline;">the assets owned by the Company and the Company Subsidiaries and used to make Products and conduct the Business will materially be the same as the Company and Company Subsidiaries have utilized during the two (2) years prior to the Closing Date.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc445224622"></a><a name="_Toc487751064"></a><a name="_Toc487788519"></a><a name="_Toc487788711"></a><a name="_Toc487788844"></a><a name="_Toc491721321"></a><a name="_Toc493797771"></a><a name="_Toc493797894"></a><a name="_Toc493844679"></a><a name="_Toc493869173"></a><a name="_Toc493869417"></a><a name="_Toc495394268"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">46</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.32</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="disclosure"></a><font style="display: inline;font-weight:bold;font-style:italic;">Disclosure</font><font style="display: inline;">. To the Knowledge of the Company, no representation or warranty made by the Company, nor any document, written information, statement, financial statement, certificate, schedule or exhibit prepared and furnished or to be prepared and furnished by the Company, any Company Subsidiary, any Securityholder or their respective Affiliates pursuant to this Agreement or the Related Agreements or in connection with the Acquisition, contains or will contain any untrue statement of a material fact, or omits or will omit to state a material fact necessary to make the statements of facts contained herein or therein not misleading in light of the circumstances un</font><font style="display: inline;">der which they were furnished.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc493797895"></a><a name="_Ref493801792"></a><a name="_Toc493844680"></a><a name="_Toc493869174"></a><a name="_Toc493869418"></a><a name="_Toc495394269"></a><a name="_Toc493797772"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">5.33</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Fair Disclosure</font><font style="display: inline;font-style:italic;">.</font><font style="display: inline;font-style:italic;">&nbsp;</font><font style="display: inline;">Solely with respect to the Company&#x2019;s representations and warranties in this </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;V</font><font style="display: inline;"> that are not Fundamental Representations (it being understood and agreed that this </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.33</font><font style="display: inline;"> shall not apply to the Fundamental Representations):</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Such representations and warranties that are not Fundamental Representations are subject to the matters that are fairly disclosed in the Company Disclosure Schedule or the materials made available to Buyer in the VDR; provided, however, that, in so far the VDR is concerned, only matters that were fairly disclosed in the VDR as of 11:59 p.m. Eastern Time on August 31, 2017 shall receive the benefit of the fair disclosure treatment set forth in this Section, and materials subsequently added to the VDR shall not qualify the representations or warranties;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Any document to the extent included in the VDR (as of 11:59 p.m. Eastern Time on August 31, 2017) is deemed to be disclosed generally for the purposes of this </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;V</font><font style="display: inline;"> and will be deemed an exception for all applicable representations and warranties contained in this </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;V </font><font style="display: inline;">that are not Fundamental Representations, solely with respect to the portion of the document included in the VDR;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(c)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Except with respect to Fundamental Representations, as to which this </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.33</font><font style="display: inline;"> shall not apply, a matter is deemed to be fairly disclosed for the purposes of this </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;V</font><font style="display: inline;"> if such matter is included in the VDR (as of 11:59 p.m. Eastern Time on August 31, 2017) or in the Company Disclosure Schedule in sufficient detail to enable Buyer, Parent and CryoLife, upon a diligent review of the documents included in the VDR or included in the Company Disclosure Schedule (together with documents and information included therein that have been made available to Buyer), to reasonably assess the nature, scope, importance and relevance of the disclosed matter and the impact of such disclosure on the Company, the Company Subsidiaries, CryoLife, Parent and Buyer; and </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(d)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">In the event that the Company Disclosure Schedule omits disclosure with respect to the applicable representations and warranties provided in this </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;V</font><font style="display: inline;">, but fair disclosure is provided in the VDR (as of 11:59 p.m. Eastern Time on August 31, 2017), the materials in the VDR will take precedence.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="articlevi"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">47</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#010000;">Article&nbsp;VI</font><br /><font style="display: inline;font-weight:bold;text-transform:uppercase;"></font><br /><font style="display: inline;font-weight:bold;text-transform:uppercase;"></font><a name="_Ref451526026"></a><a name="_Toc487751065"></a><a name="_Toc487788520"></a><a name="_Toc487788712"></a><a name="_Toc487788845"></a><a name="_Toc491721322"></a><a name="_Toc493797773"></a><a name="_Toc493797896"></a><a name="_Toc493844681"></a><a name="_Toc493869175"></a><a name="_Toc493869419"></a><a name="_Toc495394270"></a><a name="_Toc374597701"></a><font style="display: inline;font-weight:bold;text-transform:uppercase;">REPRESENTATIONS AND WARRANTIES OF </font><font style="display: inline;font-weight:bold;text-transform:uppercase;">CRYOLIFE</font><font style="display: inline;font-weight:bold;text-transform:uppercase;">, PARENT, AND BUYER</font><font style="display: inline;font-weight:bold;text-transform:uppercase;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, and Buyer hereby</font><font style="display: inline;"> severally</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">and jointly </font><font style="display: inline;">represent and warrant to the Securityholders that on the date hereof and as of the Closing Date, as follows (other than the representations and warrants which are made as of a specified date, which speak only as of such date), subject to such exceptions as are specifically disclosed in the disclosure schedule (referencing the appropriate section and paragraph numbers) supplied by </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, and Buyer to the Company on the date hereof (the &#x201C;</font><font style="display: inline;font-weight:bold;">Parent</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">Disclosure Schedule</font><font style="display: inline;">&#x201D;) (it being understood and hereby agreed that the disclosure set forth in each section and subsection of the Parent </font><font style="display: inline;color:#000000;">Disclosure Schedule </font><font style="display: inline;">shall qualify </font><font style="display: inline;color:#000000;">(a)&nbsp;</font><font style="display: inline;">the representations and warranties set forth in the corresponding section or subsection of this </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;VI</font><font style="display: inline;"> and </font><font style="display: inline;color:#000000;">(b)&nbsp;</font><font style="display: inline;">any other representations and warranties set forth in this </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;VI </font><font style="display: inline;">if it is reasonably apparent on the face of such disclosure that the disclosure applies to such other representations and warranties), as follows:</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc374597702"></a><a name="_Ref444704931"></a><a name="_Ref448573470"></a><a name="_Toc487751066"></a><a name="_Toc487788521"></a><a name="_Toc487788713"></a><a name="_Toc487788846"></a><a name="_Toc491721323"></a><a name="_Toc493797774"></a><a name="_Toc493797897"></a><a name="_Toc493844682"></a><a name="_Toc493869176"></a><a name="_Toc493869420"></a><a name="_Toc495394271"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">6.1</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Organization, Standing and Power</font><font style="display: inline;">.&nbsp; </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> is a corporation duly organized and validly existing and in good standing under the Laws of the State of Florida.&nbsp; </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> has the corporate power to own its properties and to carry on its business as now being conducted and is duly qualified or licensed to do business and is in good standing in each jurisdiction in which the failure to be so qualified or licensed would </font><font style="display: inline;">not reasonably be expected to </font><font style="display: inline;">have a </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Material Adverse Effect.&nbsp;&nbsp;Parent is a German GmbH duly organized and validly existing under the laws of Germany.&nbsp;&nbsp;Buyer is a Swiss GmbH duly organized and validly existing under the laws of Switzerland.</font><font style="display: inline;font-size:11pt;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc374597703"></a><a name="_Ref445045901"></a><a name="_Ref448573473"></a><a name="_Toc487751067"></a><a name="_Toc487788522"></a><a name="_Toc487788714"></a><a name="_Toc487788847"></a><a name="_Toc491721324"></a><a name="_Toc493797775"></a><a name="_Toc493797898"></a><a name="_Toc493844683"></a><a name="_Toc493869177"></a><a name="_Toc493869421"></a><a name="_Toc495394272"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">6.2</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Authority</font><font style="display: inline;">.&nbsp;&nbsp;Each of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, and Buyer has all requisite corporate power and authority to enter into this Agreement and any Related Agreements to which it is a party and to consummate the transactions contemplated in this Agreement and the Related Agreements.&nbsp;&nbsp;The execution and delivery of this Agreement and any Related Agreements to which it is a party and the consummation of the transactions contemplated in this Agreement and the Related Agreements have been duly authorized by all necessary corporate action on the part of each of </font><font style="display: inline;">CryoLife, </font><font style="display: inline;">Parent and Buyer. This Agreement and any Related Agreements to which </font><font style="display: inline;">CryoLife, </font><font style="display: inline;">Parent or Buyer is a party have been duly executed and delivered by </font><font style="display: inline;">CryoLife, </font><font style="display: inline;">Parent or Buyer, as applicable, and constitute the valid and binding obligations of </font><font style="display: inline;">CryoLife, </font><font style="display: inline;">Parent or Buyer, as applicable, enforceable against </font><font style="display: inline;">CryoLife, </font><font style="display: inline;">Parent or Buyer, as applicable, in accordance with their terms, except as such enforceability may be limited by principles of public policy and subject to the laws of general application relating to bankruptcy, insolvency and the relief of debtors and rules of law governing specific performance, injunctive relief or other equitable remedies.&nbsp;&nbsp;At the Closing, </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> shall have authorized the issuance of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock to be delivered to the Securityholders.</font><font style="display: inline;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc491721325"></a><a name="_Toc493797776"></a><a name="_Toc493797899"></a><a name="_Ref493802118"></a><a name="_Toc493844684"></a><a name="_Toc493869178"></a><a name="_Toc493869422"></a><a name="_Toc495394273"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">6.3</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">No Conflict</font><font style="display: inline;">.&nbsp;The</font><font style="display: inline;"> execution and delivery by </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent,</font><font style="display: inline;"> and</font><font style="display: inline;"> Buyer of this Agreement and any Related Agreement to which </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent,</font><font style="display: inline;"> or</font><font style="display: inline;"> Buyer is a party, and the consummation of the transactions contemplated in this Agreement and su</font><font style="display: inline;">ch Related Agreements, will not conflict with or result in any violation of or default under (with or without </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">48</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">notice, laps of time, or both) or give rise to a right of termination, cancellation, modification or acceleration of any obligation or loss of any benefit under</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">(i)</font><font style="display: inline;">&nbsp;any provision of the </font><font style="display: inline;">c</font><font style="display: inline;">harter </font><font style="display: inline;">d</font><font style="display: inline;">ocuments</font><font style="display: inline;"> of CryoLife</font><font style="display: inline;">, Parent,</font><font style="display: inline;"> and</font><font style="display: inline;"> Buyer, </font><font style="display: inline;">or (ii)</font><font style="display: inline;">&nbsp;any Law applicable to </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent,</font><font style="display: inline;"> and</font><font style="display: inline;"> Buyer or any of their respective properties (whether tangible or intangible) or assets</font><font style="display: inline;">, except with respect to (ii) for any immaterial violations of Law</font><font style="display: inline;">.&nbsp;&nbsp;As of the date hereof, </font><font style="display: inline;">each of CryoLife, Parent and Buyer</font><font style="display: inline;"> is in compliance with and has not breached, violated or defaulted under, or received written notice that it has breached, violated or defaulted under, any of the terms or conditions of any </font><font style="display: inline;">of its material contracts </font><font style="display: inline;">(as filed with the SEC and referenced as exhibits to </font><font style="display: inline;">CryoLife</font><font style="display: inline;">&#x2019;s most recent Annual Report on Form 10-K, or as subsequently filed in SEC Documents filed by </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> prior to the date of this Agreement)</font><font style="display: inline;">, nor</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">has any event occurred or become likely to occur that could reasonably be expected to constitute such a breach, violation or default with the lapse of time, giving of notice or both.&nbsp;&nbsp;As of the date hereof, to the Knowledge of </font><font style="display: inline;">CryoLife, Parent and Buyer</font><font style="display: inline;">, no party obligated to </font><font style="display: inline;">CryoLife, Parent or Buyer</font><font style="display: inline;"> pursuant to any </font><font style="display: inline;">such material contract</font><font style="display: inline;"> is in default thereunder.</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref448573475"></a><a name="_Toc487751068"></a><a name="_Toc487788523"></a><a name="_Toc487788715"></a><a name="_Toc487788848"></a><a name="_Toc491721326"></a><a name="_Toc493797777"></a><a name="_Toc493797900"></a><a name="_Toc493844685"></a><a name="_Toc493869179"></a><a name="_Toc493869423"></a><a name="_Toc495394274"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">6.4</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="capitalization"></a><font style="display: inline;font-weight:bold;font-style:italic;">Capitalization</font><font style="display: inline;">.&nbsp; </font><font style="display: inline;">CryoLife</font><font style="display: inline;">&#x2019;s Form 10-Q filed with the SEC on </font><font style="display: inline;">July 25</font><font style="display: inline;">, 2017 accurately describes </font><font style="display: inline;">CryoLife</font><font style="display: inline;">&#x2019;s authorized and issued and outstanding capital stock as of June 30, 2017 and shares of common stock reserved for issuance pursuant to </font><font style="display: inline;">CryoLife</font><font style="display: inline;">&#x2019;s incentive equity plans and other similar arrangements. There have been no material changes in </font><font style="display: inline;">CryoLife</font><font style="display: inline;">&#x2019;s capitalization since June 30, 2017.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc487751070"></a><a name="_Toc487788525"></a><a name="_Toc487788717"></a><a name="_Toc487788850"></a><a name="_Toc491721327"></a><a name="_Toc493797778"></a><a name="_Toc493797901"></a><a name="_Toc493844686"></a><a name="_Toc493869180"></a><a name="_Toc493869424"></a><a name="_Toc495394275"></a><a name="_Ref288598721"></a><a name="_Toc374597704"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">6.5</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Litigation</font><font style="display: inline;font-style:italic;">.&nbsp; </font><font style="display: inline;">Except as described in the SEC Documents, there are no actions, suits, proceedings or investigations pending against </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">a CryoLife Subsidiary, </font><font style="display: inline;">Parent or Buyer or any of their respective properties (nor has </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent or Buyer received written notice of any threat thereof) before any Governmental Authority. Except as described in the SEC Documents, neither </font><font style="display: inline;">CryoLife, nor any CryoLife Subsidiary, nor </font><font style="display: inline;">Parent nor Buyer is a party or subject to the provisions of any order, writ, injunction, judgment or decree of any Government Authority. Except as described in the SEC Documents, there is no action, suit or proceeding initiated by </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">any CryoLife Subsidiary, </font><font style="display: inline;">Parent or Buyer currently pending or which </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">a CryoLife Subsidiary, </font><font style="display: inline;">Parent or Buyer currently intends to initiate. </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref451294426"></a><a name="_Ref451295740"></a><a name="_Toc487751071"></a><a name="_Toc487788526"></a><a name="_Toc487788718"></a><a name="_Toc487788851"></a><a name="_Toc491721328"></a><a name="_Toc493797779"></a><a name="_Toc493797902"></a><a name="_Toc493844687"></a><a name="_Toc493869181"></a><a name="_Toc493869425"></a><a name="_Toc495394276"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">6.6</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Consents</font><font style="display: inline;">.&nbsp;&nbsp;No consent, waiver, approval, order or authorization of, or registration, declaration or filing with, any Governmental Authority, is required by or with respect to </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, or Buyer in connection with the execution and delivery of this Agreement and any Related Agreements to which </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, or Buyer is a party or the consummation of the transactions contemplated in this Agreement and the Related Agreements</font><font style="display: inline;">, except for immaterial consents, notices, waivers, approvals, orders or authorizations and except </font><font style="display: inline;">as may be required under applicable securities Laws </font><font style="display: inline;color:#000000;">which will be timely filed within the applicable periods therefor</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref448573481"></a><a name="_Toc487751073"></a><a name="_Toc487788528"></a><a name="_Toc487788720"></a><a name="_Toc487788853"></a><a name="_Toc491721329"></a><a name="_Toc493797780"></a><a name="_Toc493797903"></a><a name="_Toc493844688"></a><a name="_Toc493869182"></a><a name="_Toc493869426"></a><a name="_Toc495394277"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">6.7</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Issuance of </font><font style="display: inline;font-weight:bold;font-style:italic;">CryoLife</font><font style="display: inline;font-weight:bold;font-style:italic;"> Common Stock</font><font style="display: inline;">.&nbsp;&nbsp;The shares of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock to be issued pursuant to </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;II</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">upon the Closing will have been, when issued in accordance with the terms of this Agreement, duly authorized and validly issued and will be fully paid and non-assessable and the issuance thereof will not be subject to any preemptive rights.&nbsp; </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc487751074"></a><a name="_Toc487788529"></a><a name="_Toc487788721"></a><a name="_Toc487788854"></a><a name="_Toc491721330"></a><a name="_Toc493797781"></a><a name="_Toc493797904"></a><a name="_Toc493844689"></a><a name="_Toc493869183"></a><a name="_Toc493869427"></a><a name="_Toc495394278"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">49</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">6.8</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="privateplacement"></a><font style="display: inline;font-weight:bold;font-style:italic;">Private Placement</font><font style="display: inline;">.&nbsp;&nbsp;Assuming the accuracy of the representations made by the Securityholders pursuant to</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">4.7</font><font style="display: inline;"> of</font><font style="display: inline;"> this Agreement, no registration under the Securities Act is required for the offer and issuance of the </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock by </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> as contemplated in this Agreement.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc487751075"></a><a name="_Toc487788530"></a><a name="_Toc487788722"></a><a name="_Toc487788855"></a><a name="_Toc491721331"></a><a name="_Toc493797782"></a><a name="_Toc493797905"></a><a name="_Toc493844690"></a><a name="_Toc493869184"></a><a name="_Toc493869428"></a><a name="_Toc495394279"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">6.9</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Operations of </font><font style="display: inline;font-weight:bold;font-style:italic;">Parent and </font><font style="display: inline;font-weight:bold;font-style:italic;">Buyer</font><font style="display: inline;">.&nbsp;&nbsp;Each of Parent and Buyer was formed solely for the purpose of engaging in the Acquisition.&nbsp;&nbsp;Each of Parent and Buyer has engaged only in business activities in contemplation of the Acquisition and has conducted its operations only as contemplated in this Agreement.</font></font><a name="_Toc445455682"></a><a name="_Toc445489325"></a>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref487491225"></a><a name="_Toc487751076"></a><a name="_Toc487788531"></a><a name="_Toc487788723"></a><a name="_Toc487788856"></a><a name="_Toc491721332"></a><a name="_Toc493797783"></a><a name="_Toc493797906"></a><a name="_Toc493844691"></a><a name="_Toc493869185"></a><a name="_Toc493869429"></a><a name="_Toc495394280"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">6.10</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">SEC Documents</font><font style="display: inline;">.&nbsp; </font><a name="_Toc341995361"></a><font style="display: inline;">For at least twelve (12) calendar months </font><font style="display: inline;">immediately preceding the date hereof,</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">CryoLife</font><font style="display: inline;"> has timely filed all reports, schedules, forms, statements and other documents required to be filed by it with the Securities and Exchange Commission (the &#x201C;</font><font style="display: inline;font-weight:bold;">SEC</font><font style="display: inline;">&#x201D;) pursuant to the reporting requirements of the Securities Exchange Act of 1934 (the &#x201C;</font><font style="display: inline;font-weight:bold;">Exchange Act</font><font style="display: inline;">&#x201D;) (all of the foregoing filed prior to the date hereof, and all exhibits included therein and financial statements, notes and schedules thereto and documents incorporated by reference therein being hereinafter referred to as the &#x201C;</font><font style="display: inline;font-weight:bold;">SEC Documents</font><font style="display: inline;">&#x201D;). True, correct and complete copies of the SEC Documents are available on the EDGAR system. As of their respective filing dates, the SEC Documents complied in all material respects with the requirements of the Exchange Act and the rules and regulations of the SEC promulgated thereunder applicable to the SEC Documents, and none of the SEC Documents, at the time they were filed with the SEC, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. As of their respective filing dates, the financial statements of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> included in the SEC Documents complied as to form in all material respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto. Such financial statements have been prepared in accordance with U.S. generally accepted accounting principles, consistently applied, during the periods involved (except </font><font style="display: inline;">(A)</font><font style="display: inline;"> as may be otherwise indicated in such financial statements or the notes thereto, or </font><font style="display: inline;">(B)</font><font style="display: inline;"> in the case of unaudited interim statements, to the extent they may exclude footnotes or may be condensed or summary statements) and fairly present in all material respects the consolidated financial position of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> as of the dates thereof and the consolidated results of operations and cash flows of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments.</font><font style="display: inline;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref491673560"></a><a name="_Toc491721333"></a><a name="_Toc493797784"></a><a name="_Toc493797907"></a><a name="_Toc493844692"></a><a name="_Toc493869186"></a><a name="_Toc493869430"></a><a name="_Toc495394281"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">6.11</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Solvency</font><font style="display: inline;">. &nbsp;</font><font style="display: inline;">Assuming </font><font style="display: inline;">(a)</font><font style="display: inline;"> the accuracy of the representations and warranties of </font><font style="display: inline;">the Company</font><font style="display: inline;"> set forth</font><font style="display: inline;"> in</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;IV</font><font style="display: inline;"> and </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;V </font><font style="display: inline;">(ignoring for the purposes of this </font><font style="display: inline;font-weight:bold;">Section</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">&#x200E;</font><font style="display: inline;">6.11</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">all materiality qualifiers</font><font style="display: inline;">, such as &#x201C;material&#x201D;, &#x201C;in all material respects&#x201D; and &#x201C;Material Adverse Effect&#x201D;,</font><font style="display: inline;"> in</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;IV</font><font style="display: inline;"> and </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;V)</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">(b)</font><font style="display: inline;"> the accuracy of the financial information (both historical and projected) provided to </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent </font><font style="display: inline;">and</font><font style="display: inline;"> Buyer</font><font style="display: inline;"> by </font><font style="display: inline;">the Company and the Company Subsidiaries</font><font style="display: inline;"> prior to the date </font><font style="display: inline;">of this Agreement</font><font style="display: inline;"> and </font><font style="display: inline;">(c)</font><font style="display: inline;"> the satisfaction or waiver of the conditions set forth in </font><font style="display: inline;font-weight:bold;">Sections </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">8.1 </font><font style="display: inline;">and </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">8.2</font><font style="display: inline;">, and after giving effect to </font><font style="display: inline;">the transactions contemplated in</font><font style="display: inline;"> this Agreement, including the Financing and the payment of the Closing </font><font style="display: inline;">Consideration</font><font style="display: inline;">, payment of all amounts required to be paid </font><font style="display: inline;">by CryoLife, Parent or Buyer at the Closing pursuant to </font><font style="display: inline;">this Agreement, and payment of all </font><font style="display: inline;">of CryoLife&#x2019;s, Parent&#x2019;s and Buyer&#x2019;s </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">50</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">related fees and expenses, </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">the CryoLife</font><font style="display: inline;"> Subsidiaries</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">Parent </font><font style="display: inline;">and</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Buyer, taken together as a whole,</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">will be Solvent as of the Closing and immediately after the consummation of the Closing. For purposes of the foregoing, the term &#x201C;</font><font style="display: inline;font-weight:bold;">Solvent</font><font style="display: inline;">&#x201D;, when used with respect to any Person, means that, as of any date of determination, </font><font style="display: inline;">(i)</font><font style="display: inline;"> the amount of the &#x201C;fair saleable value&#x201D; of the assets of such Person will, as of such date, exceed the sum of </font><font style="display: inline;">(A)</font><font style="display: inline;"> the value of all &#x201C;liabilities of such Person, including contingent and other liabilities,&#x201D; as of such date, as such quoted terms are generally determined in accordance with applicable Laws governing determinations of the insolvency of debtors, and </font><font style="display: inline;">(B)</font><font style="display: inline;"> the amount that will be required to pay the probable liabilities of such Person, as of </font><font style="display: inline;">the Closing D</font><font style="display: inline;">ate, on its existing debts (including contingent and other liabilities) as such debts become absolute and mature, </font><font style="display: inline;">(ii)</font><font style="display: inline;"> such Person will not have, as of such date, an unreasonably small amount of capital for the operation of the businesses in which it is engaged or proposed to be engaged following such date, and </font><font style="display: inline;">(iii)</font><font style="display: inline;"> such Person will be able to pay its liabilities, as of such date, including contingent and other liabilities, as they mature. For purposes of the definition of &#x201C;Solvent&#x201D;, &#x201C;not have an unreasonably small amount of capital for the operation of the businesses in which it is engaged or proposed to be engaged&#x201D; and &#x201C;able to pay its liabilities, as of such date, including contingent and other liabilities, as they mature&#x201D; means that such Person will be able to generate enough cash from operations, asset dispositions or refinancing, or a combination thereof, to meet its obligations as they become due. No transfer of property is being made and no obligation is being incurred in connection with </font><font style="display: inline;">the transactions contemplated in t</font><font style="display: inline;">his Agreement with the intent to hinder, delay or defraud either present or future creditors of </font><font style="display: inline;">CryoLife, Parent or Buyer</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref491673455"></a><a name="_Toc491721334"></a><a name="_Toc493797785"></a><a name="_Toc493797908"></a><a name="_Toc493844693"></a><a name="_Toc493869187"></a><a name="_Toc493869431"></a><a name="_Toc495394282"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">6.12</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="financing"></a><font style="display: inline;font-weight:bold;font-style:italic;">Financing</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref491555738"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">CryoLife has delivered to the Company complete and correct copies of (i) the executed debt commitment letter (including all exhibits, annexes, schedules and term sheets and the executed fee letter (which have been redacted to omit fees, expenses, price caps, securities demand and economic &#x201C;flex&#x201D; terms) (the &#x201C;</font><font style="display: inline;font-weight:bold;">Fee Letter</font><font style="display: inline;">&#x201D;) attached thereto or contemplated thereby (the &#x201C;</font><font style="display: inline;font-weight:bold;">Commitment Letter</font><font style="display: inline;">&#x201D;) that have been issued to CryoLife, Parent or Buyer or to which CryoLife, Parent or Buyer is a party, pursuant to which the certain Financing Sources (&#x201C;</font><font style="display: inline;font-weight:bold;">Committed Lenders</font><font style="display: inline;">&#x201D;) have committed to provide the debt financing contemplated thereby (the &#x201C;</font><font style="display: inline;font-weight:bold;">Financing</font><font style="display: inline;">&#x201D;) for the purpose of, among other things,&nbsp;&nbsp;funding the cash portion of the Closing Consideration contemplated in this Agreement.</font></font><a name="_Ref491555858"></a>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref493831027"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">The aggregate net cash proceeds to CryoLife, Parent or Buyer of the Financing (after giving effect to any related fees or expenses) will, if funded in accordance with the terms of the Commitment Letter, provide sufficient funds to CryoLife, Parent or Buyer to pay the cash portion of the Closing Consideration at the Closing and the other amounts due and payable at the Closing by CryoLife, Parent or Buyer pursuant to the terms and provisions of this Agreement. To the Knowledge of CryoLife, Parent and Buyer, the obligations of the Commitment Letter to fund the entire amount of the Financing under the Commitment Letter are not subject to any condition or contingency, including any subsequent approval process, other than the conditions explicitly set forth in the Commitment Letter (such conditions, as so explicitly set forth in the Commitment Letters as of the date hereof or as amended in accordance with the provisions hereof, the &#x201C;</font><font style="display: inline;font-weight:bold;">Financing Conditions</font><font style="display: inline;">&#x201D;). Assuming due authorization, </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">51</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">execution and delivery by each other Person party thereto (other than CryoLife, Parent or Buyer), the Commitment Letter (and the commitments of the Committed Lenders to provide the Financing set forth therein) has been duly executed by CryoLife, Parent or Buyer and, to the Knowledge of CryoLife, Parent and Buyer, each other Person party thereto, and constitutes a legal, valid and binding obligation of CryoLife, Parent or Buyer and, to the Knowledge of CryoLife, Parent and Buyer, each other Person party thereto, enforceable against CryoLife, Parent or Buyer and, to the Knowledge of CryoLife, Parent and Buyer, each other Person party thereto in accordance with its terms, except as such enforceability may be subject to the Laws of general application relating to bankruptcy, insolvency, and the relief of debtors and rules of Law governing specific performance, injunctive relief, or other equitable remedies.</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent or Buyer</font><font style="display: inline;color:#000000;"> has fully paid, or caused to be fully paid, any and all commitment or other fees or amounts which are due and payable on or prior to the date of this Agreement pursuant to the Commitment Letter. </font><font style="display: inline;color:#000000;">There are no side letters or other agreements, contracts or arrangements related to the funding or investing, as applicable, of the Financing except for the Commitment Letter and Fee Letter.</font><font style="display: inline;color:#000000;">&nbsp;</font></p><a name="_Ref492399209"></a><a name="_Toc491721335"></a>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref493792158"></a><a name="_Toc493797786"></a><a name="_Toc493797909"></a><a name="_Toc493844694"></a><a name="_Toc493869188"></a><a name="_Toc493869432"></a><a name="_Toc495394283"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">6.13</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="cryolifeoperational"></a><font style="display: inline;font-weight:bold;font-style:italic;">CryoLife</font><font style="display: inline;font-weight:bold;font-style:italic;">&nbsp;</font><font style="display: inline;font-weight:bold;font-style:italic;">Operational</font><font style="display: inline;font-weight:bold;font-style:italic;">&nbsp;</font><font style="display: inline;font-weight:bold;font-style:italic;">Representations</font><font style="display: inline;">. &nbsp;</font><font style="display: inline;"> With respect to changes, events or effects, in each case solely to the extent arising during the period commencing on the date of the </font><font style="display: inline;">last filing of a SEC Document prior to the date of this Agreement</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">and the Closing Date, and excepting (i) changes, events or effects </font><font style="display: inline;">disclosed in the SEC Documents or Parent Disclosure Schedule</font><font style="display: inline;"> and (ii) changes, events or effects that</font><font style="display: inline;"> would not be material to investors in the </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock:</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref493792639"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Buyer Authorizations</font><font style="display: inline;">.&nbsp;&nbsp;Each consent, license, permit, grant, clearance, approval or other authorization under applicable Law </font><font style="display: inline;">(i)</font><font style="display: inline;"> pursuant to which </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, any </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Subsidiary, Parent or Buyer currently operates or holds any interest in any of its properties, </font><font style="display: inline;">(ii)</font><font style="display: inline;"> which is required for the operation of the business of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, any </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Subsidiary Parent or Buyer as currently conducted, or </font><font style="display: inline;">(iii)</font><font style="display: inline;"> which provides </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, any </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Subsidiary Parent or Buyer&nbsp;&nbsp;a benefit in the operation of their respective business as currently conducted (each a &#x201C;</font><font style="display: inline;font-weight:bold;">Buyer Authorization</font><font style="display: inline;">&#x201D; and, collectively, the &#x201C;</font><font style="display: inline;font-weight:bold;">Buyer Authorizations</font><font style="display: inline;">&#x201D;) is in full force and effect. No suspension, cancellation or other lapse of any Buyer Authorization is pending by or at the behest of any Governmental Authority or other Person, or to the Knowledge of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, or Buyer, threatened. All Buyer Authorizations shall remain in full force and effect immediately after giving effect to the Acquisition.&nbsp;&nbsp;Neither </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, nor any </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Subsidiary, nor Parent nor Buyer has received any communication from any Governmental Authority or been notified that any Buyer Authorization related to any of the products of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, any </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Subsidiary, Parent or Buyer has been withdrawn or modified or that such an action is under consideration.&nbsp;&nbsp;There has been no recall, detention, withdrawal, seizure, or termination or suspension of manufacturing requested or threatened relating to the products of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, a </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Subsidiary, Parent, or Buyer, and no field notifications, field corrections or alerts.&nbsp;&nbsp;To the Knowledge of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent and Buyer, no Governmental Authority is considering limiting, suspending, or revoking any Buyer Authorizations or changing the marketing classification or labeling of any products of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, any </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Subsidiary, Parent or Buyer.&nbsp;&nbsp;To the Knowledge of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, and Buyer, there is no false information or significant omission in any product application or product-related </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">52</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">submission to any Governmental Authority.&nbsp; </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, each </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Subsidiary</font><font style="display: inline;">,</font><font style="display: inline;"> Parent, </font><font style="display: inline;">or</font><font style="display: inline;"> Buyer possess all necessary </font><font style="display: inline;">Buyer</font><font style="display: inline;"> Authorizations related to the products of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, any </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Subsidiary Parent, and Buyer distributed and sold by </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, and Buyer, and neither </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, nor Parent, nor Buyer has received any notice that any Governmental Authority seeks any additional conditions on the distribution or sale of the products of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, any </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Subsidiary Parent, or Buyer in a jurisdiction covered by a Buyer Authorization. To the Knowledge of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, and Buyer, any third party that is a manufacturer, contractor, or agent for </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, any </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Subsidiary Parent, or Buyer is in compliance with all Laws insofar as they pertain to the manufacture of the products of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, any </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Subsidiary Parent, or Buyer or any related product components or inputs.&nbsp;&nbsp;To the Knowledge of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent and Buyer, the distributors on behalf of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, any </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Subsidiary, Parent or Buyer currently maintain all required registrations from each applicable medicinal or public health Governmental Authority having jurisdiction over any geographic area in which </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, the </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Subsidiaries, Parent or Buyer or the distributors currently sells the products of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, any of the </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Subsidiaries, Parent, or Buyer.</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Compliance with Laws.&nbsp; </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, each </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Subsidiary, Parent, and Buyer have complied with, are not in violation of, and have not received any written notices of any suspected, potential or actual violation with respect to, any applicable Law by </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, such </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Subsidiary, Parent, Buyer or any of their respective employees or other representative of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, such </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Subsidiary, Parent or Buyer, except for immaterial violation of a Law.&nbsp; </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, each </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Subsidiary, </font><font style="display: inline;">Parent, and Buyer are currently</font><font style="display: inline;"> fully in compliance with all applicable Anti-Corruption and Anti-Bribery Laws in any jurisdiction in which </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, such </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Subsidiary, Parent or Buyer conducts business, except for immaterial violation of a Law. To the Knowledge of the </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, and Buyer, there are no actions, conditions or circumstances pertaining to </font><font style="display: inline;">CryoLife</font><font style="display: inline;">&#x2019;s, the </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Subsidiaries&#x2019;, Parent&#x2019;s, or Buyer&#x2019;s activities that could reasonably be expected to give rise to any legitimate future legal claims, charges, investigations, violations, settlements, civil or criminal actions, lawsuits, or other court actions against </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, any such </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Subsidiary, Parent, or Buyer under any applicable Anti-Corruption and Anti-Bribery Laws. </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, each </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Subsidiary, Parent, and Buyer maintain a compliance program and reasonable internal controls and procedures which, to the Knowledge of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, and Buyer, are appropriate to the requirements of Anti-Corruption and Anti-Bribery Laws. To the Knowledge of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, and Buyer, no officer, director or manager of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, any </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Subsidiary, Parent, or Buyer has been:&nbsp;&nbsp;(i)&nbsp;convicted in a criminal proceeding or named as a subject of a pending criminal proceeding (excluding traffic violations and other minor offenses); (ii)&nbsp;subject to any order, judgment, or decree (not subsequently reversed, suspended or vacated) of any court of competent jurisdiction permanently or temporarily enjoining him/her from, or otherwise imposing limits or conditions on his or her engaging in any securities, investment advisory, banking, insurance or other type of business or acting as an officer or director of a public company; or (iii)&nbsp;found by a court of competent jurisdiction in a civil action to have violated any applicable commodities, securities or unfair trade practices law, which such judgment or finding has not been subsequently reversed, suspended, or vacated.</font></font><a name="_Ref492563144"></a>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref494192531"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">53</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(c)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Products.</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Since the date of the </font><font style="display: inline;">last filing of a SEC Document prior to the date of this Agreement</font><font style="display: inline;">, n</font><font style="display: inline;">either </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, nor any </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Subsidiary, nor Parent, nor Buyer, nor, to the Knowledge of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, and Buyer, any distributor of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, any </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Subsidiary, Parent, or Buyer, has received a claim for or based upon (i) breach of product or service warranty or guaranty or similar claim; (ii) strict liability in tort; (iii) negligent design of product, negligent provision of services; or (iv) any other complaint or allegation of liability, including or arising from the materials, design, testing, manufacture, packaging, labeling (including instructions for use), or sale of the products of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, any </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Subsidiary, Parent, or Buyer, in each case that would result in material liability to </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, any </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Subsidiary, Parent, or Buyer in excess of the </font><font style="display: inline;">incurred but not reported (IBNR)</font><font style="display: inline;"> reserve</font><font style="display: inline;"> for product liability claims</font><font style="display: inline;"> reflected in the financial statements of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> contained in the SEC Documents.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc493797787"></a><a name="_Toc493797910"></a><a name="_Toc493844695"></a><a name="_Toc493869189"></a><a name="_Toc493869433"></a><a name="_Toc495394284"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">6.14</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Disclosure</font><font style="display: inline;">.</font><font style="display: inline;"> &nbsp; &nbsp;</font><font style="display: inline;">To the Knowledge of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, and Buyer, no representation or warranty made by </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, and Buyer, nor any document, written information, statement, financial statement, certificate, schedule or exhibit prepared and furnished or to be prepared and furnished by </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, Buyer, or their respective Affiliates pursuant to this Agreement or the Related Agreements or in connection with the Acquisition, contains or will contain any untrue statement of a material fact, or omits or will omit to state a material fact necessary to make the statements of facts contained herein or therein not misleading in light of the circumstances un</font><font style="display: inline;">der which they were furnished. </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc379363655"></a><a name="_Toc379365624"></a><a name="_Toc379385838"></a><a name="_Toc379435980"></a><a name="_Toc379436086"></a><a name="_Toc379474840"></a><a name="_Toc379475815"></a><a name="articlevii"></a><a name="_Toc374597712"></a><a name="_Ref288602504"></a><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#010000;">Article&nbsp;VII</font><br /><font style="display: inline;font-weight:bold;text-transform:uppercase;"></font><br /><font style="display: inline;font-weight:bold;text-transform:uppercase;"></font><a name="_Toc487751077"></a><a name="_Toc487788532"></a><a name="_Toc487788724"></a><a name="_Toc487788857"></a><a name="_Toc491721336"></a><a name="_Toc493797788"></a><a name="_Toc493797911"></a><a name="_Toc493844696"></a><a name="_Toc493869190"></a><a name="_Toc493869434"></a><a name="_Toc495394285"></a><font style="display: inline;font-weight:bold;text-transform:uppercase;">ADDITIONAL AGREEMENTS</font><font style="display: inline;font-weight:bold;text-transform:uppercase;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref427080549"></a><a name="_Toc427081932"></a><a name="_Toc438546050"></a><a name="_Toc487751078"></a><a name="_Toc487788533"></a><a name="_Toc487788725"></a><a name="_Toc487788858"></a><a name="_Toc491721337"></a><a name="_Toc493797789"></a><a name="_Toc493797912"></a><a name="_Toc493844697"></a><a name="_Toc493869191"></a><a name="_Toc493869435"></a><a name="_Toc495394286"></a><a name="_Toc374597715"></a><a name="_Ref379811629"></a><a name="_Ref444771856"></a><a name="_Ref445044480"></a><a name="_Ref445044538"></a><a name="_Ref445048330"></a><a name="_Ref450308652"></a><a name="_Ref487620254"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">7.1</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Preservation of Business</font><font style="display: inline;">.&nbsp; </font><font style="display: inline;">During the Interim Period, except </font><font style="display: inline;">(a)</font><font style="display: inline;"> as required or expressly permitted by this Agreement, </font><font style="display: inline;">(b)</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">subject to applicable Law, </font><font style="display: inline;">with the prior written consent of Buyer</font><font style="display: inline;"> (such consent not to be unreasonably withheld)</font><font style="display: inline;">, &nbsp;</font><a name="DocXTextRef406"></a><font style="display: inline;">or </font><font style="display: inline;">(c)</font><font style="display: inline;"> as required by applicable Law, the Company shall, and shall cause each of the Company Subsidiaries to, be operated only in the ordinary course of businesses and consistent with their respective past practices, and preserve intact their respective businesses and assets, including, but not limited to: </font><font style="display: inline;">(1)</font><font style="display: inline;"> maintaining their material assets and properties in the ordinary course of business in substantially the same manner historically maintained, reasonable wear and tear, damage by fire and other casualty excepted; </font><font style="display: inline;">(2)</font><font style="display: inline;"> promptly repairing, restoring or replacing all material assets and properties in the ordinary course of business consistent with past practice; </font><font style="display: inline;">(3)</font><font style="display: inline;"> upon any damage, destruction or loss to any of their material assets or properties, applying any and all insurance proceeds, if any, received with respect thereto to the prompt repair, replacement and restoration thereof as reasonably necessary for the operation of the business of the Company and the Company Subsidiaries; </font><font style="display: inline;">(4)</font><font style="display: inline;"> complying in all material respects with all applicable Laws; </font><font style="display: inline;">(5)</font><font style="display: inline;"> taking all actions necessary to be in compliance in all material respects with all Material Contracts and to maintain the effectiveness of all Company Authorizations; </font><font style="display: inline;">(6)</font><font style="display: inline;"> notifying Buyer in writing of the commencement of any Litigation by or against the Company</font><font style="display: inline;"> or any of the Company Subsidiaries; and</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">(7)</font><font style="display: inline;"> paying all accounts payable and pursuing collection of its accounts receivable in the ordinary course of business, consistent with past practices. </font><font style="display: inline;">The </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">54</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">Company shall not issue any Company Securities during the Interim Period and shall cause the Company Subsidiaries not to issue any securities during the Interim Period.</font><font style="display: inline;">&nbsp;</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc487751079"></a><a name="_Toc487788534"></a><a name="_Toc487788726"></a><a name="_Toc487788859"></a><a name="_Toc491721338"></a><a name="_Toc493797790"></a><a name="_Toc493797913"></a><a name="_Toc493844698"></a><a name="_Toc493869192"></a><a name="_Toc493869436"></a><a name="_Toc495394287"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">7.2</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="exclusivity"></a><font style="display: inline;font-weight:bold;font-style:italic;">Exclusivity</font><font style="display: inline;">.</font><font style="display: inline;"> &nbsp; &nbsp;</font><font style="display: inline;">During the Interim Period, except as otherwise provided herein, the Company shall not, and shall cause the Company Subsidiaries and its and their respective Affiliates and Representatives not to, directly or indirectly, solicit, initiate, knowingly encourage or assist, or respond to the submission of any proposal or offer from any Person relating, with respect to the Company or any of the Company Subsidiaries, to any </font><font style="display: inline;">(i)</font><font style="display: inline;"> liquidation, dissolution or recapitalization, </font><font style="display: inline;">(ii)</font><font style="display: inline;"> merger or consolidation, </font><font style="display: inline;">(iii)</font><font style="display: inline;"> acquisition or purchase of all or a significant portion of the assets of, or any equity interest in, the Company or any of the Company Subsidiaries or </font><font style="display: inline;">(iv)</font><font style="display: inline;"> similar transaction or business combination (a &#x201C;</font><font style="display: inline;font-weight:bold;">Competing Transaction</font><font style="display: inline;">&#x201D;), nor participate in any or continue any ongoing discussions or negotiations regarding, or furnish to any other Person any information with respect to, or otherwise cooperate in any way with, or assist or participate in, or knowingly facilitate or encourage, any effort or attempt by any Person to pursue or effect a Competing Transaction or enter into any </font><font style="display: inline;">Contract</font><font style="display: inline;"> with respect to a Competing Transaction.&nbsp;&nbsp;The Company shall, and shall instruct the Company Subsidiaries and all Representatives and Affiliates acting on its and their behalves to immediately cease any existing activities, discussions and negotiations with any Persons with respect to any of the foregoing.&nbsp;&nbsp;Immediately upon the commencement of the Interim Period, the Company shall instruct each Person (other than </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, Buyer and their Representatives) in possession of confidential information about the Company </font><font style="display: inline;">or any of the Company Subsidiaries </font><font style="display: inline;">that was furnished pursuant to a confidentiality </font><font style="display: inline;">Contract</font><font style="display: inline;"> within the prior twelve (</font><a name="DocXTextRef421"></a><font style="display: inline;">12</font><font style="display: inline;">) months in connection with any actual or potential Competing Transaction or other proposal by such Person to acquire the Company </font><font style="display: inline;">or any of the Company Subsidiaries </font><font style="display: inline;">(or any portion thereof) to promptly return or destroy all such information, subject to the terms of such confidentiality </font><font style="display: inline;">Contract</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc487751080"></a><a name="_Ref487784687"></a><a name="_Ref487785506"></a><a name="_Ref487785997"></a><a name="_Toc487788535"></a><a name="_Toc487788727"></a><a name="_Toc487788860"></a><a name="_Toc491721339"></a><a name="_Toc493797791"></a><a name="_Toc493797914"></a><a name="_Toc493844699"></a><a name="_Toc493869193"></a><a name="_Toc493869437"></a><a name="_Toc495394288"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">7.3</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Confidentiality</font><font style="display: inline;">.&nbsp;&nbsp;Each of Parent, Buyer and the Company hereby agrees that the information obtained in any investigation pursuant to the negotiation and execution of this Agreement or the effectuation of the transactions contemplated in this Agreement, shall be governed by the terms of the Non-Disclosure Agreement entered into by and between the Company and </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> as of May 24, 2017 (the &#x201C;</font><font style="display: inline;font-weight:bold;">Confidentiality Agreement</font><font style="display: inline;">&#x201D;) and by the confidentiality restrictions set forth in the first sentence of Section 6 of Exhibit A to the letter of intent dated May 23, 2017 by and between the Company and </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> (the &#x201C;</font><font style="display: inline;font-weight:bold;">Letter of Intent</font><font style="display: inline;">&#x201D;).&nbsp;&nbsp;Notwithstanding such provision of the Letter of Intent, the</font><font style="display: inline;"> Securityholders or the Company may contact the other shareholders of the Company so that the Securityholders may acquire from such shareholders as many Shares as possible, not owned by the Securityholders as of the date hereof</font><font style="display: inline;">. &nbsp;</font><font style="display: inline;">The Securityholders will be solely responsible for any and all Liability arising from communications between the Securityholders and </font><font style="display: inline;">the </font><font style="display: inline;">Minority Shareholders that are not approved by </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> in advance.</font><font style="display: inline;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288597061"></a><a name="_Ref288599372"></a><a name="_Ref288599476"></a><a name="_Ref288599613"></a><a name="_Toc374597716"></a><a name="_Toc487751081"></a><a name="_Toc487788536"></a><a name="_Toc487788728"></a><a name="_Toc487788861"></a><a name="_Toc491721340"></a><a name="_Toc493797792"></a><a name="_Toc493797915"></a><a name="_Toc493844700"></a><a name="_Toc493869194"></a><a name="_Toc493869438"></a><a name="_Toc495394289"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">7.4</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Expenses</font><font style="display: inline;">.&nbsp;&nbsp;If</font><font style="display: inline;"> the Acquisition is </font><font style="display: inline;">not </font><font style="display: inline;">consummated, all costs, fees and expenses incurred in connection with the Acquisition including all legal, accounting, financial advisory, consulting, and all other costs, fees and expenses of third parties (including, in the case of the Company and the Company Subsidiaries, any costs incurred to obtain consents, waivers or </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">55</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">approvals as a result of the compliance with </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.8</font><font style="display: inline;"> hereof) incurred by a Party, or for which a Party is responsible, in connection with the negotiation and effectuation of the terms and conditions of this Agreement and the transactions contemplated in this Agreement shall be the obligation of the respective Party incurring such costs, fees and expenses</font><font style="display: inline;">; provided, however, that CryoLife shall reimburse the Company for reasonable out-of-pocket costs and expenses incurred by the Company in connection with the preparation of the Audited Annual Financials and Quarterly Financials and reasonable out-of-pocket costs and expenses </font><font style="display: inline;">incurred by the Company </font><font style="display: inline;">to fulfill the duties of the Company, the Company Subsidiaries and the Representatives set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.9(b)</font><font style="display: inline;">. If the Acquisition is consummated, in addition to any obligations set forth</font><font style="display: inline;"> in </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;IX</font><font style="display: inline;">,</font><font style="display: inline;"> the Securityholders on a Pro Rata Basis shall bear all costs, fees and expenses they incurred </font><font style="display: inline;">in connection with the Acquisition with respect to third party providers</font><font style="display: inline;"> of any of the Securityholders (the &#x201C;</font><font style="display: inline;font-weight:bold;">Securityholder Expenses</font><font style="display: inline;">&#x201D;).&nbsp; </font><font style="display: inline;">The costs, fees and expenses incurred by the Company or the Company Subsidiaries in connection with the Acquisition, including the preparation, negotiation and effectuation of the terms and conditions of this Agreement, and the transactions contemplated in this Agreement with respect to third party providers, including the fees and expenses incurred by the Company and/or any of the Company Subsidiaries in engaging legal, accounting, audit, investment banking, and tax advisors, and the portion of the any Securityholder&#x2019;s expenses the Company or any Company Subsidiary is obligated to pay (if any) are collectively referred to in this Agreement as &#x201C;</font><font style="display: inline;font-weight:bold;">Third Party Expenses</font><font style="display: inline;">&#x201D;.&nbsp;&nbsp;All such Third Party Expenses will be paid by the Company and/or the Company Subsidiaries prior to the Closing; provided, however, that: (i) prior to the Closing, </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> shall reimburse the Company for reasonable out-of-pocket costs and expenses incurred by the Company for the preparation of the Audited Annual Financials and Quarterly Financials and any reasonable out-of-pocket costs and expenses incurred by the Company to fulfill the duties of Company, the Company Subsidiaries and the Representatives set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.9(b)</font><font style="display: inline;">; (ii) the fees and expenses of the Escrow Agent and Paying Agent will be borne 50% by </font><font style="display: inline;">Buyer</font><font style="display: inline;"> and 50% by the Securityholders (in accordance with their respective Pro Rata Portions), (iii) the costs incurred obtaining third party consents required in connection with or as a result of the consummation of the Acquisition, including a consent fee, &#x201C;profit sharing&#x201D; payment or other consideration, including increased rent payments or other payments under any Material Contract, shall be borne 50% by </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> and 50% by the Securityholders (in accordance with their respective Pro Rata Portions), provided, however, that (A) all such costs incurred in obtaining third party consents from Persons who are Related Parties shall be borne by the Securityholders (in accordance with their respective Pro Rata Portions), and (B) all amounts payable in connection with the Acquisition with respect to the </font><font style="display: inline;">loans described in clauses (i) and (ii) of the definition of &#x201C;Company Debt,&#x201D; including any consent fees, shall be borne by the Securityholders, to the extent not already included in the Company Debt and the Acquisition Consideration adjustment set forth in </font><font style="display: inline;">&#x200E;</font><font style="display: inline;">Article&nbsp;III</font><font style="display: inline;">.</font><font style="display: inline;"> &nbsp; &nbsp;</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc493844701"></a><a name="_Ref493848508"></a><a name="_Toc493869195"></a><a name="_Toc493869439"></a><a name="_Toc495394290"></a><a name="_Toc493797793"></a><a name="_Toc493797916"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">7.5</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="transfertaxes"></a><font style="display: inline;font-weight:bold;font-style:italic;">Transfer Taxes</font><font style="display: inline;font-style:italic;">. &nbsp;</font><font style="display: inline;font-style:italic;">&nbsp;</font><font style="display: inline;">If the Company and the Securityholders are not, and have not engaged an intermediary that is, a registered Swiss securities dealer for the purposes of Swiss securities </font><font style="display: inline;">transfer tax (i.e., </font><font style="display: inline;font-style:italic;">Umsatzabgabe</font><font style="display: inline;">) and have not taken any other action that would result in (or failed to take an action that would have avoided) the imposition of such Swiss securities transfer tax, the</font><font style="display: inline;"> Buyer shall bear any such Swiss securities transfer tax that is imposed by Law on t</font><font style="display: inline;">he transfer of the Sold Shares </font><font style="display: inline;">contemplated by this Agreement as a result of the </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">56</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">Buyer being, or engaging an intermediary that is, a registered Swiss securities dealer. If the Buyer bears such Swiss securities transfer tax pursuant to this </font><font style="display: inline;font-weight:bold;">Section</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.5</font><font style="display: inline;">, such Swiss securities transfer tax </font><font style="display: inline;">shall not (a) be a credit against payment of the Acquisition Consideration, (b) result in an adjustment to the Acquisition Consideration, or (c) entitle CryoLife, Parent, Buyer, or any Affiliate thereof to any indemnification hereunder</font><font style="display: inline;">.</font><font style="display: inline;font-weight:bold;font-style:italic;">&nbsp;</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref368669226"></a><a name="_Ref368911323"></a><a name="_Toc374597728"></a><a name="_Toc487751082"></a><a name="_Toc487788537"></a><a name="_Toc487788729"></a><a name="_Toc487788862"></a><a name="_Toc491721341"></a><a name="_Toc493797794"></a><a name="_Toc493797917"></a><a name="_Toc493844702"></a><a name="_Toc493869196"></a><a name="_Toc493869440"></a><a name="_Toc495394291"></a><a name="_Ref288600600"></a><a name="_Ref288602522"></a><a name="_Toc374597717"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">7.6</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">[Intentionally omitted]</font><a name="_Toc493797795"></a><a name="_Toc493797918"></a><a name="_Toc493844703"></a><font style="display: inline;">.</font><font style="display: inline;"> &nbsp; &nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc487751083"></a><a name="_Toc487788538"></a><a name="_Toc487788730"></a><a name="_Toc487788863"></a><a name="_Toc491721343"></a><a name="_Toc493797796"></a><a name="_Toc493797919"></a><a name="_Toc493844704"></a><a name="_Toc493869197"></a><a name="_Toc493869441"></a><a name="_Toc495394292"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">7.7</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="publicdisclosure"></a><font style="display: inline;font-weight:bold;font-style:italic;">Public Disclosure</font><font style="display: inline;">.&nbsp;&nbsp;Except as may be required to comply with the requirements of any applicable Law, neither the Company nor the Securityholders nor their respective agents, representatives or advisors shall issue any press release or other public announcement relating to the subject matter of this Agreement or the transactions contemplated in this Agreement without the prior approval (which approval will not be unreasonably withheld or delayed) of Buyer.&nbsp;&nbsp;Notwithstanding anything in this Agreement to the contrary, </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent and Buyer may issue press releases or other public announcements and make such filings as required by or appropriate under applicable Law.&nbsp; </font><font style="display: inline;">CryoLife </font><font style="display: inline;">and </font><font style="display: inline;">the Company </font><font style="display: inline;">shall issue a press release </font><font style="display: inline;">following the Closing that is mutually agreeable to CryoLife and the Securityholder Representative</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288599715"></a><a name="_Toc374597718"></a><a name="_Toc487751084"></a><a name="_Toc487788539"></a><a name="_Toc487788731"></a><a name="_Toc487788864"></a><a name="_Toc491721344"></a><a name="_Toc493797797"></a><a name="_Toc493797920"></a><a name="_Toc493844705"></a><a name="_Toc493869198"></a><a name="_Toc493869442"></a><a name="_Toc495394293"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">7.8</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Consents</font><font style="display: inline;">.&nbsp;&nbsp;The Company and each of the Company Subsidiaries shall use reasonable efforts to obtain all necessary consents, waivers and approvals of any parties to any Material Contract as are required under such Material Contract in connection with the Acquisition or for any such Material Contracts to remain in full force and effect so as to preserve all rights of, and benefits to, the Company and the Company Subsidiaries under such Material Contract from and after the Closing.&nbsp; </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc374597720"></a><a name="_Ref377060979"></a><a name="_Ref377061020"></a><a name="_Toc487751085"></a><a name="_Toc487788540"></a><a name="_Toc487788732"></a><a name="_Toc487788865"></a><a name="_Toc491721345"></a><a name="_Ref492390126"></a><a name="_Toc493797798"></a><a name="_Toc493797921"></a><a name="_Toc493844706"></a><a name="_Toc493869199"></a><a name="_Toc493869443"></a><a name="_Toc495394294"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">7.9</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Additional Documents and Further Assurances; Reasonable Efforts</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Subject to the terms and conditions provided in this Agreement, each of the </font><font style="display: inline;">CryoLife, </font><font style="display: inline;">Parent, Buyer and Company shall use commercially reasonable efforts to take promptly, or cause to be taken, all actions, and to do promptly, or cause to be done, all things necessary, proper or advisable under applicable Laws to consummate and make effective the transactions contemplated in this Agreement, to satisfy the conditions to the obligations to consummate the Acquisition, to obtain all necessary waivers, consents and approvals and to effect all necessary </font><font style="display: inline;">or appropriate </font><font style="display: inline;">registrations and filings and to remove any injunctions or other impediments or delays, legal or otherwise, in order to consummate and make effective the transactions contemplated in this Agreement for the purpose of securing to the Parties the benefits contemplated in this Agreement</font><font style="display: inline;"> and for the purposes of enabling CryoLife to satisfy the financial statement requirements required in connection with the Acquisition, including CryoLife&#x2019;s obligation to file a Form 8-K in connection with the Closing and to file on a timely basis a Form 8-K/A, including the Company&#x2019;s Audited Annual Financial Statements and Quarterly Financials (in each case as defined </font><font style="display: inline;">in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.9(b)</font><font style="display: inline;">)</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref493766635"></a><a name="_Ref487489011"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Without limiting the foregoing, </font><font style="display: inline;">the Company shall,</font><font style="display: inline;"> and</font><font style="display: inline;"> shall cause the Company Subsidiaries to, </font><font style="display: inline;">and shall </font><font style="display: inline;">use commercially reasonable efforts to cause the Current Employees and other representatives of the Company and the Company Subsidiaries </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">57</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">(collectively, &#x201C;</font><font style="display: inline;font-weight:bold;">Representatives</font><font style="display: inline;">&#x201D;) to, cooperate with reasonable requests from CryoLife</font><font style="display: inline;">, Parent or Buyer to assist in the arrangement and consummation of </font><font style="display: inline;">the Financing</font><font style="display: inline;">, including but not limited to </font><font style="display: inline;">(i)</font><font style="display: inline;"> promptly furnishing to </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, Buyer and their respective </font><font style="display: inline;">Financing Sources</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">such financial, marketing and other information and materials relating to the Company and each of the Company Subsidiaries that is customary or </font><font style="display: inline;">reasonably requested </font><font style="display: inline;">for the completion of the Financing, or for the preparation of offering</font><font style="display: inline;">, marketing</font><font style="display: inline;"> or information documents to be used in connection with the same; </font><font style="display: inline;">(ii)</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">actively assist</font><font style="display: inline;"> with the marketing efforts of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, Buyer, and the Financing Sources, including participation in meetings with, and delivering management reports to, the </font><font style="display: inline;">Financing Sources </font><font style="display: inline;">acting as lead arrangers or agents for the prospective lenders and purchasers of the Financing, and attending presentations, roadshows, due diligence sessions, drafting sessions and sessions with rating agencies in connection with the Financing; </font><font style="display: inline;">(iii)</font><font style="display: inline;"> delivering </font><a name="DocXTextRef443"></a><font style="display: inline;">in English </font><font style="display: inline;">(A)</font><font style="display: inline;"> audited consolidated balance sheets and related audited statements of comprehensive income (loss), stockholders&#x2019; equity and cash flows of the Company and the Company Subsidiaries (including notes to the consolidated financial statements in accordance with </font><font style="display: inline;">U.S. generally accepted accounting principles</font><font style="display: inline;"> (the &#x201C;</font><font style="display: inline;font-weight:bold;">Audited Annual Financials</font><font style="display: inline;">&#x201D;) for each of the&nbsp;</font><font style="display: inline;">two (2)</font><font style="display: inline;"> most recently ended fiscal years that have ended at least&nbsp;ninety (90) days prior to the Closing Date, and </font><font style="display: inline;">(B)</font><font style="display: inline;"> unaudited consolidated balance sheets and related unaudited statements of comprehensive income (loss) and cash flows of the Company and the Company Subsidiaries</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">(</font><font style="display: inline;">including notes to the consolidated financial statements in accordance with </font><font style="display: inline;">U.S. generally accepted accounting principles)</font><font style="display: inline;"> (the &#x201C;</font><font style="display: inline;font-weight:bold;">Quarterly Financials</font><font style="display: inline;">&#x201D;) for the year-to-date period for each fiscal quarter </font><font style="display: inline;">beginning with</font><font style="display: inline;"> the quarter ended June 30, 2017</font><font style="display: inline;"> and for any subsequent fiscal quarter that ends forty-five (45) or more calendar days prior to the Closing Date</font><font style="display: inline;">; &nbsp;</font><font style="display: inline;">(iv)</font><font style="display: inline;"> causing the Company&#x2019;s independent accountants to provide reasonable assistance to </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, and the Buyer consistent with their customary practice (including to consent to the use of their audit reports on the consolidated financial statements of the Company and the Company Subsidiaries in any materials relating to the Financing</font><font style="display: inline;">, in CryoLife&#x2019;s </font><font style="display: inline;">Form 8-K in connection with the Closing and related </font><font style="display: inline;">Form 8-K/A, and in CryoLife&#x2019;s future registration statements and proxy statements if required to be filed with such documents</font><font style="display: inline;">); </font><font style="display: inline;">(v)</font><font style="display: inline;"> using reasonable best efforts to assist </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, and Buyer in connection with the preparation of pro forma financial information and financial statements necessary or reasonably required by the Financing Sources;</font><font style="display: inline;"> (vi)</font><font style="display: inline;"> to the extent requested reasonably in advance, providing to the Financing Sources, at least five (5) Business Days prior to the Closing Date, all customary and reasonable documentation and other information required by regulatory authorities with respect to the Company and each of the Company Subsidiaries under applicable &#x201C;know your customer&#x201D; and anti</font><font style="display: inline;">&#8209;money laundering rules and regulations, including without limitation the USA PATRIOT Act of&nbsp;2001, as amended</font><font style="display: inline;">; &nbsp;</font><font style="display: inline;">and (vii) take all actions as may be reasonably requested by the </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent or the Buyer in connection with the repayment of existing </font><font style="display: inline;">I</font><font style="display: inline;">ndebtedness of the Company and the Company Subsidiaries that is contemplated to be repaid, or commitments with respect thereto, terminated, pursuant to this Agreement or the Commitment Letter</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(c)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Nothing in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.9(b)</font><font style="display: inline;"> shall require such cooperation to the extent it would </font><a name="DocXTextRef449"></a><font style="display: inline;">(i)</font><font style="display: inline;"> cause any representation or warranty in this Agreement to be breached, or (ii) cause any condition to Closing set forth in </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;VIII</font><font style="display: inline;"> to fail to be satisfied or otherwise cause any </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">58</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">breach of this Agreement.</font><font style="display: inline;"> &nbsp;None of the Company or any of the Company Subsidiaries shall have any Liabilities for any breach any obligation under </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.9(b)</font><font style="display: inline;">. &nbsp;</font><font style="display: inline;"> &nbsp; </font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(d)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">The Company hereby consents to the use of its and the Company Subsidiaries&#x2019; logos in connection with the Financing, provided such logos are used in a customary manner that </font><font style="display: inline;">would not be reasonably expected </font><font style="display: inline;">to harm or disparage the Company or any Company Subsidiary or the reputation or goodwill of the Company or any Company Subsidiary</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(e)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Notwithstanding anything to the contrary provided herein or in the Confidentiality Agreement, </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, and Buyer shall be permitted to share all information subject to such Contracts with its potential financing sources, subject to customary confidentiality undertakings by such potential financing sources with respect thereto.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc493797799"></a><a name="_Toc493797922"></a><a name="_Toc493844707"></a><a name="_Toc493869200"></a><a name="_Toc493869444"></a><a name="_Toc495394295"></a><a name="_Toc487751086"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">7.10</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="section338"></a><font style="display: inline;font-weight:bold;font-style:italic;">Section 338(g) Election</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref447050269"></a><a name="_Ref379812524"></a><a name="_Ref451276840"></a><a name="_Ref447044769"></a><a name="_Ref245202492"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">The parties acknowledge and agree that the transactions contemplated in this Agreement are fully taxable transactions for U.S. federal income Tax purposes.&nbsp; </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, in its sole discretion, may make or cause to be made an election pursuant to Section 338(g) of the Code with respect to the </font><font style="display: inline;">acquisition of the Company and the Company Subsidiaries pursuant to this Agreement.</font><font style="display: inline;"> &nbsp; &nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc493869201"></a><a name="_Toc493869445"></a><a name="_Ref494440527"></a><a name="_Ref494954189"></a><a name="_Toc495394296"></a><a name="_Ref450308778"></a><a name="_Toc493797800"></a><a name="_Toc493797923"></a><a name="_Toc493844708"></a><a name="_Ref493848973"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">7.11</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Indirect Partial Liquidation</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref494953296"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent and the Buyer covenant and undertake to the Securityholders and Minority Shareholders who sold their Shares between the date hereof and the Closing Date to one or several Securityholders that they will refrain, and will cause their Affiliates and any purchaser of any Sold Shares after the Closing Date to refrain, from any action which could reasonably be expected to result in a so-called "indirect partial liquidation" in accordance with Swiss tax law and the practice of the Swiss tax authorities. In particular, and without limitation, from the Closing Date until the fifth (5</font><font style="display: inline;font-size:6pt;vertical-align:super;line-height:100%">th</font><font style="display: inline;">) anniversary of the Closing Date, </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent and the Buyer shall not, and shall not permit their Affiliates or any purchaser of any Sold Shares after the Closing Date to take any action that results in an &#x201C;indirect partial liquidation&#x201D;.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">CryoLife</font><font style="display: inline;">&#x2019;s, Parent&#x2019;s and the Buyer&#x2019;s obligations in accordance with this</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.11</font><font style="display: inline;"> do not apply if and to </font><font style="display: inline;">the extent the Buyer provides to the Securityholder Representative binding tax rulings for the three Swiss tax resident Securityholders and the Minority Shareholders who are Swiss tax resident in Aargau and Waadt </font><font style="display: inline;">(also known as Vaud) </font><font style="display: inline;">from the competent tax authorities confirming that the relevant transaction does not result in </font><font style="display: inline;">an &#x201C;indirect partial liquidation&#x201D; at the federal and cantonal/communal level in accordance with the practice of the Swiss tax authorities</font><font style="display: inline;">; provided that CryoLife&#x2019;s, Parent&#x2019;s and Buyer&#x2019;s obligations shall remain in effect under </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.11(c)</font><font style="display: inline;"> with respect to each of the Minority Shareholders who are Swiss tax resident in cantons other than Aargau and Waadt (also known as Vaud) until </font><font style="display: inline;">the Buyer provides to the Securityholder Representat</font><font style="display: inline;">ive binding tax rulings for each such Minority Shareholder</font><font style="display: inline;"> from the competent tax authorities confirming that the relevant transaction </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">59</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">does not result in </font><font style="display: inline;">an &#x201C;indirect partial liquidation&#x201D; at the federal and cantonal/communal level </font><font style="display: inline;">for such Minority Shareholder </font><font style="display: inline;">in accordance with the practice of the Swiss tax authorities. The Buyer is entitled to file tax rulings for all Securityholders </font><font style="display: inline;">and Minority Shareholders </font><font style="display: inline;">with respect to the &#x201C;indirect partial liquidation&#x201D; as per this</font><font style="display: inline;font-weight:bold;"> Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.11</font><font style="display: inline;">.</font><font style="display: inline;"> For that purpose, the Securityholders (also on behalf of the Minority Shareholders who sold their Shares between the date hereof and the Closing Date to one or several Securityholders) hereby agree to sign all necessary powers of attorney, when reasonably requested by the Buyer to do so in writing. Buyer shall only communicate with the competent tax authorities on behalf of Securityholders and the Minority Shareholders who sold their Shares between the date hereof and the Closing Date to one or several Securityholders upon prior written approval by the Securityholders and such Minority Shareholders, such approval, if any, shall not to be unreasonably withheld or delayed by Securityholders or such Minority Shareholders. </font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref494270057"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(c)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">&nbsp;</font><a name="_Ref495045514"></a><font style="display: inline;">I</font><font style="display: inline;">f during the period from the Closing Date until the fifth (5</font><font style="display: inline;font-size:6pt;vertical-align:super;line-height:100%">th</font><font style="display: inline;">) anniversary of the Closing Date, </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, Buyer or any of their respective Affiliates engages in any transaction that results in an "indirect partial liquidation", </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent and Buyer shall, regardless of whether there was any fault of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, Buyer or any of their respective Affiliates, jointly and severally fully indemnify the Securityholders and the Minority Shareholders who sold their Shares between the date of this Agreement and the Closing Date to one or several Securityholders for</font><font style="display: inline;">,</font><font style="display: inline;"> and hold them harmless from</font><font style="display: inline;">,</font><font style="display: inline;"> all Swiss income </font><font style="display: inline;">t</font><font style="display: inline;">axes, including </font><font style="display: inline;">default interest and </font><font style="display: inline;">all reasonable legal fees, cost and expenses incurred in connection therewith and in cooperation between the Parties as per this </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.11</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;">.</font><font style="display: inline;"> &nbsp; &nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref494377417"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(d)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">In case an "indirect partial liquidation" issue as defined above arises, the </font><font style="display: inline;">respective </font><font style="display: inline;">Securityholder or Minority Shareholder will inform the Buyer without delay and within five (5) </font><font style="display: inline;">Business D</font><font style="display: inline;">ays after </font><font style="display: inline;">the earlier of (i) </font><font style="display: inline;">receipt </font><font style="display: inline;">or (ii) knowledge </font><font style="display: inline;">of the written or oral information of the Tax authorities on such issue</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">in order to afford the Buyer reasonable opportunity to take note of all relevant facts i</font><font style="display: inline;">n connection with the relevant T</font><font style="display: inline;">ax claims and to direct the respective Securityholder or Minority Shareholder to reasonably contest such </font><font style="display: inline;">T</font><font style="display: inline;">ax claims under reasonable direction and at the cost of the Buyer</font><font style="display: inline;">. Securityholders and Minority Shareholders acknowledge the sensitivity of the timing, in particular in case of formal assessments and/or running time limits to respond or appeal. </font><font style="display: inline;"> If an unjustified or excessive </font><font style="display: inline;">T</font><font style="display: inline;">ax claim cannot be defended (as would be reasonably expected) because the respective time limit has elapsed due to late notice of the respective Securityholder or Minority Shareholder, the liabilities of </font><font style="display: inline;">CryoLife, Parent and </font><font style="display: inline;">the Buyer under this </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.11 </font><font style="display: inline;">shall be</font><font style="display: inline;"> reduced or eliminated if and to the extent the failure of the respective Securityholder or Minority Shareholder is not excusable in the individual case</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">and/or if and to the extent the failure of the respective Securityholder or Minority Shareholder increased the liabilities of </font><font style="display: inline;">CryoLife, Parent,</font><font style="display: inline;"> Buyer </font><font style="display: inline;">or any of their respective Affiliates </font><font style="display: inline;">under this</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.11</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(e)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent and Buyer undertake to fully impose their obligations as per this </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.11</font><font style="display: inline;"> on any subsequent buyer of the Sold Shares and remains jointly and severally liable for any and all claims arising out of, relating to or in connection with the tax indemnity in accordance with this </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.11</font><font style="display: inline;">.</font><font style="display: inline;font-weight:bold;font-style:italic;font-size:8pt;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref487617639"></a><a name="_Toc487751087"></a><a name="_Toc487788544"></a><a name="_Toc487788736"></a><a name="_Toc487788869"></a><a name="_Toc491721347"></a><a name="_Toc493797801"></a><a name="_Toc493797924"></a><a name="_Toc493844709"></a><a name="_Toc493869202"></a><a name="_Toc493869446"></a><a name="_Toc495394297"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">60</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">7.12</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="indemnificationofofficers"></a><font style="display: inline;font-weight:bold;font-style:italic;">Indemnification of Officers and Directors</font><font style="display: inline;">.</font><font style="display: inline;"> &nbsp; &nbsp;</font><a name="_Ref451524691"></a><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent and Buyer covenant and undertake to use best efforts to cause the Company to maintain the D&amp;O Insurance until the sixth anniversary of the Closing occurs existing as of the date hereof in favor of those Persons who are directors and officers of the Company as of the date of this Agreement (the &#x201C;</font><font style="display: inline;font-weight:bold;">D&amp;O Indemnified Persons</font><font style="display: inline;">&#x201D;) for their acts and omissions that occurred or accrued prior to the Closing.</font><font style="display: inline;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc493797802"></a><a name="_Toc493797925"></a><a name="_Toc493844710"></a><a name="_Toc493869203"></a><a name="_Toc493869447"></a><a name="_Ref494313586"></a><a name="_Toc495394298"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">7.13</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">No Claims against Directors and Officers; Release</font><font style="display: inline;font-weight:bold;font-style:italic;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent and Buyer covenant and undertake to cause the Company or any Company Subsidiary not to, and Buyer shall not, make any claim, except for any fraud</font><font style="display: inline;">,</font><font style="display: inline;"> willful misconduct</font><font style="display: inline;">,</font><font style="display: inline;"> or with respect to their respective obligations under this Agreement as Securityholders (to</font><font style="display: inline;"> the extent applicable)</font><font style="display: inline;">:</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;color:#010000;">(i)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">against any director or officer of the Company or any Company Subsidiary who is a Securityholder, a Minority Shareholder or controls a Securityholder or Minority Shareholder in connection with his or her acts or omissions before the Closing Date in his or her capacity as a director or officer of the Company or any Company Subsidiary; and</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:24pt;"><font style="display: inline;color:#010000;">(ii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">against the Securityholders solely in their capacity as shareholders of the Company until the Closing Date (excluding, for the avoidance of doubt, any claim the Company or a Company Subsidiary may have against a Securityholder arising&nbsp;&nbsp;under the provisions of the Contracts identified in </font><font style="display: inline;font-weight:bold;">Schedule 6</font><font style="display: inline;"> attached hereto.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Promptly following the Closing Date (or on the Closing Date immediately following Closing if the Securityholders were selling all Shares to the Buyer), the Buyer shall cause</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;color:#010000;">(i)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">the Company and each Company Subsidiary to hold an extraordinary shareholders' meeting; and</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref492566583"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:24pt;"><font style="display: inline;color:#010000;">(ii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">a resolution to be passed at such extraordinary meeting granting unconditional discharge, except for any fraud</font><font style="display: inline;"> or</font><font style="display: inline;"> willful misconduct, to the directors and officers of the Company and each Company Subsidiary for their known and disclosed acts or omissions as directors and officers</font><font style="display: inline;"> of the Company or Company Subsidiary before the Closing Date (the &#x201C;</font><font style="display: inline;font-weight:bold;">Discharge</font><font style="display: inline;">&#x201D;).</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(c)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Granting of the Discharge to the directors and officers of the Company and the Company Subsidiaries shall be repeated on the occasion of the next ordinary shareholders&#x2019; meeting of the Company or the respective Company Subsidiary following the Closing and any further ordinary shareholders&#x2019; meeting covering the period until Closing Date.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(d)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">A copy of each resolution of the shareholders of the Company and each Company Subsidiary granting Discharge shall be delivered to the Securityholder Representative within ten (10) Business Days after the date of the relevant meeting.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">61</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(e)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">The Buyer shall procure that the Company and each Company Subsidiary will, as soon as practicable but not later than five (5) Business Day after the Closing Date, take the necessary steps to file with the respective commercial register authorities an application for deregistration of their directors and officers who resign as of the Closing Date in the commercial register.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref448523714"></a><a name="_Toc487788545"></a><a name="_Toc487788737"></a><a name="_Toc487788870"></a><a name="_Toc491721348"></a><a name="_Toc493797803"></a><a name="_Toc493797926"></a><a name="_Toc493844711"></a><a name="_Toc493869204"></a><a name="_Toc493869448"></a><a name="_Toc495394299"></a><a name="_Toc487751088"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">7.14</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="securityholderrelease"></a><font style="display: inline;font-weight:bold;font-style:italic;">Securityholder Releas</font><font style="display: inline;font-weight:bold;font-style:italic;">e</font><font style="display: inline;">.</font><a name="_Ref450308525"></a><font style="display: inline;"> &nbsp; &nbsp;</font><font style="display: inline;">Effective as of the Closing</font><font style="display: inline;"> Date, subject to Closing occurring</font><font style="display: inline;">, each Securityholder, on behalf of himself/itself and his/its heirs, executors, estates, devisees, Affiliates, and each of their respective heirs, executors, estates, devisees, successors and assigns (each, a &#x201C;</font><font style="display: inline;font-weight:bold;color:#000000;">Releasing Person</font><font style="display: inline;">&#x201D;), hereby releases, acquits and forever discharges and covenants not to sue, to the fullest extent permitted by applicable Law, </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent and Buyer and each of their respective current and past managers, officers, directors, equity holders, partners, Affiliates, service providers, employees, accountants, attorneys and representatives (each, a &#x201C;</font><font style="display: inline;font-weight:bold;color:#000000;">CryoLife</font><font style="display: inline;font-weight:bold;color:#000000;"> Released Person</font><font style="display: inline;">&#x201D;) of, from and against any and all liabilities, obligations, actions, causes of action, claims, demands, damages, judgments, debts, dues and suits of every kind, nature and description whatsoever, which such Releasing Person </font><font style="display: inline;">has as of the Closing Date or has had at any time prior to the Closing Date</font><font style="display: inline;"> on or by reaso</font><font style="display: inline;">n of any matter, cause or thing, in each case occurring on or prior to the Closing Date </font><font style="display: inline;">(the &#x201C;</font><font style="display: inline;font-weight:bold;">Released Holder Claims</font><font style="display: inline;">&#x201D;), including matters arising in connection with such Securityholder&#x2019;s ownership prior to the Closing Date of any Company Securities or such Securityholder&#x2019;s contractual or other arrangements with the Company or any of the Company Subsidiaries prior to the Closing Date; provided, however, unless specifically provided in this Agreement or in the Related Agreements to which the Releasing Person is a party, nothing contained in this </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.14</font><font style="display: inline;"> shall be deemed to release any claims or rights pursuant to </font><font style="display: inline;">(a)</font><font style="display: inline;">&nbsp;if the Releasing Person is an Employee, accrued benefits under employee benefit plans under applicable Law to which such Releasing Person is entitled or for any unpaid salary, expense reimbursement, or any similar employee-related benefits for the period that commenced prior to the Closing Date, </font><font style="display: inline;">(b)</font><font style="display: inline;color:#000000;"> any rights each Securityholder has to receive their respective Pro Rata Portion of the Acquisition</font><font style="display: inline;color:#000000;"> Consideration </font><font style="display: inline;color:#000000;">, &nbsp;</font><font style="display: inline;color:#000000;">as is reflected in the Consideration Schedule and </font><font style="display: inline;color:#000000;">becomes due and payable pursuant to the terms of this Agreement</font><font style="display: inline;color:#000000;">, (c) any other claim arising under the provisions of this Agreement, and (d) claims arising under the provisions of the Contracts between the Company or a Company Subsidiary, on one hand, and a Securityholder or any of its Affiliates, on the other, that are listed on </font><font style="display: inline;font-weight:bold;color:#000000;">Schedule 6</font><font style="display: inline;color:#000000;"> attached hereto</font><font style="display: inline;color:#000000;">. Each Securityholder </font><font style="display: inline;color:#000000;">(x)</font><font style="display: inline;color:#000000;"> understands that the release contained in this </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.14</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;color:#000000;">is binding on such Securityholder and its </font><font style="display: inline;">heirs, executors, estates, devisees, Affiliates, and each of their respective heirs, executors, estates, devisees, successors and assigns</font><font style="display: inline;color:#000000;">, &nbsp;</font><font style="display: inline;color:#000000;">(y)</font><font style="display: inline;color:#000000;"> represents and warrants that </font><font style="display: inline;color:#000000;">(i)</font><font style="display: inline;color:#000000;"> it has had the opportunity to consult with counsel of its choice, </font><font style="display: inline;color:#000000;">(ii)</font><font style="display: inline;color:#000000;"> it is fully informed of the nature and contents of this release and </font><font style="display: inline;color:#000000;">(iii)</font><font style="display: inline;color:#000000;"> it has entered into this release freely and without any thre</font><font style="display: inline;color:#000000;">at or coercion whatsoever and (z)</font><font style="display: inline;color:#000000;"> further agrees and covenants not to participate in any action or proceeding against the Company, any of the Company Subsidiaries or any </font><font style="display: inline;color:#000000;">CryoLife</font><font style="display: inline;color:#000000;"> Released Person based upon any of the Released Holder Claims.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref491547035"></a><a name="_Toc491721349"></a><a name="_Toc493797804"></a><a name="_Toc493797927"></a><a name="_Toc493844712"></a><a name="_Toc493869205"></a><a name="_Toc493869449"></a><a name="_Toc495394300"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">7.15</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Squeeze-Out Merger</font><font style="display: inline;">.&nbsp; </font><font style="display: inline;">From and after the</font><font style="display: inline;"> date of this Agreement</font><font style="display: inline;">, the Securityholders shall use reasonable commercial efforts</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">to cause all </font><font style="display: inline;">remaining shareholders of the Company to sell them their Shares</font><font style="display: inline;">, with</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">the intent </font><font style="display: inline;">the Securityholders </font><font style="display: inline;">obtaining one hundred </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">62</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">percent (100%) of all</font><font style="display: inline;"> Shares.&nbsp;&nbsp;In the event that </font><font style="display: inline;">less than one hundred percent (100%) of all </font><font style="display: inline;">Shares </font><font style="display: inline;">w</font><font style="display: inline;">ould be </font><font style="display: inline;">own</font><font style="display: inline;">ed</font><font style="display: inline;"> immediately after the Closing </font><font style="display: inline;">by the Buyer (such S</font><font style="display: inline;">hares that are not held by Buyer, the &#x201C;</font><font style="display: inline;font-weight:bold;">Minority Shares</font><font style="display: inline;">&#x201D;), then, </font><font style="display: inline;">Buyer may, subject to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.11</font><font style="display: inline;">, initiate a squeeze-out merger. Upon Buyer&#x2019;s election to initiate a squeeze-out merger, (a) </font><font style="display: inline;">the </font><font style="display: inline;">Buyer </font><font style="display: inline;">shall </font><font style="display: inline;">then </font><font style="display: inline;">take all </font><font style="display: inline;">necessary and appropriate action to </font><font style="display: inline;">(i)</font><font style="display: inline;"> cause a subsidiary of Buyer (formed under the laws of Switzerland) to merge with the Company in accordance with </font><font style="display: inline;">article 8 para. 2 of the Swiss Merger Act </font><font style="display: inline;">(the &#x201C;</font><font style="display: inline;font-weight:bold;">S</font><font style="display: inline;font-weight:bold;">queeze-Out</font><font style="display: inline;font-weight:bold;"> Merger</font><font style="display: inline;">&#x201D;), </font><font style="display: inline;">(ii)</font><font style="display: inline;"> cause the </font><font style="display: inline;">Squeeze-Out</font><font style="display: inline;"> Merger to become effective </font><font style="display: inline;">(the effective time of the </font><font style="display: inline;">Squeeze-Out</font><font style="display: inline;"> Merger being referred to herein as the &#x201C;</font><font style="display: inline;font-weight:bold;">Effective Time</font><font style="display: inline;">&#x201D;), and </font><font style="display: inline;">(iii)</font><font style="display: inline;"> structure the </font><font style="display: inline;">Squeeze-Out</font><font style="display: inline;"> Merger such that at the Effective Time, each Minority Share is converted into the right to receive </font><font style="display: inline;">in cash</font><font style="display: inline;"> the same economic benefits</font><font style="display: inline;"> as the Securityholders received for the Sold Shares; and (b) the reasonable out-of-pocket fees and expenses (but, for the avoidance of doubt, not the consideration) incurred by CryoLife, Parent, Buyer and the Company in implementing such Squeeze-Out Merger shall be borne by the Securityholders</font><font style="display: inline;">. &nbsp;</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc492967772"></a><a name="_Toc492967898"></a><a name="_Toc492968064"></a><a name="_Toc492968187"></a><a name="_Toc492968309"></a><a name="_Toc492968430"></a><a name="_Toc492968627"></a><a name="_Ref493010721"></a><a name="_Toc493011645"></a><a name="_Ref493808300"></a><a name="_Toc493797805"></a><a name="_Toc493797928"></a><a name="_Toc493844713"></a><a name="_Toc493869206"></a><a name="_Toc493869450"></a><a name="_Toc495394301"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">7.16</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="restrictionsonothershares"></a><font style="display: inline;font-weight:bold;font-style:italic;">Restrictions on Other Share Transfers</font><font style="display: inline;">.&nbsp; </font><font style="display: inline;">From the date of this Agreement through the earlier of the Closing or the termination of this Agreement, the Securityholders will not sell or transfer any Shares held by them or authorize, consent to or approve any transfer or sale of Shares by any other Securityholder, other than transfers or sales of Shares from Minority Shareholders to any of the Securityholders (an &#x201C;</font><font style="display: inline;font-weight:bold;">Other Transfer</font><font style="display: inline;">&#x201D;), including by withholding consent to any such Other Transfer if such consent is required under applicable Law or the Shareholders Agreement</font><font style="display: inline;">. &nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc493844714"></a><a name="_Toc493869207"></a><a name="_Toc493869451"></a><a name="_Ref494994277"></a><a name="_Toc495394302"></a><a name="_Toc493797806"></a><a name="_Toc493797929"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">7.17</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Escrow Agent</font><font style="display: inline;">. &nbsp;</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">CryoLife and Buyer shall use best efforts to procure from the Escrow Agent the execution and delivery to the Securityholder Representative of the Escrow Agreement, and the Securityholder Representative shall provide the documentation reasonably required by the Escrow Agent with respect to &#x201C;Know-Your-Customer&#x201D; requirements; provided, however, if the Securityholder Representative fails to deliver the documentation reasonably required by the Escrow Agent with respect to &#x201C;Know-Your-Customer&#x201D; requirements, neither CryoLife nor Buyer shall be in breach of this </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.17</font><font style="display: inline;"> if the Escrow Agent refuses to execute and deliver the Escrow Agreement.</font><font style="display: inline;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc444731626"></a><a name="_Toc444731738"></a><a name="_Toc444731870"></a><a name="_Toc444732221"></a><a name="articleviii"></a><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#010000;">Article&nbsp;VIII</font><br /><font style="display: inline;font-weight:bold;text-transform:uppercase;"></font><br /><font style="display: inline;font-weight:bold;text-transform:uppercase;"></font><a name="_Ref288596074"></a><a name="_Toc374597729"></a><a name="_Toc487751089"></a><a name="_Toc487788546"></a><a name="_Toc487788738"></a><a name="_Toc487788871"></a><a name="_Toc491721350"></a><a name="_Toc493797807"></a><a name="_Toc493797930"></a><a name="_Toc493844715"></a><a name="_Toc493869208"></a><a name="_Toc493869452"></a><a name="_Toc495394303"></a><font style="display: inline;font-weight:bold;text-transform:uppercase;">CONDITIONS TO THE ACQUISITION</font><font style="display: inline;font-weight:bold;text-transform:uppercase;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc374597730"></a><a name="_Toc487751090"></a><a name="_Toc487788547"></a><a name="_Toc487788739"></a><a name="_Toc487788872"></a><a name="_Ref491673482"></a><a name="_Toc491721351"></a><a name="_Toc493797808"></a><a name="_Toc493797931"></a><a name="_Toc493844716"></a><a name="_Toc493869209"></a><a name="_Toc493869453"></a><a name="_Toc495394304"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">8.1</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Conditions to Obligations of Each Party to Effect the Acquisition</font><font style="display: inline;">.&nbsp;&nbsp;The respective obligations of the Company and the Securityholders, on the one hand, and of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent and Buyer, on the other hand, to effect the Acquisition shall be subject to the satisfaction, at or prior to the Closing, of the following conditions:</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">No Order</font><font style="display: inline;">.&nbsp;&nbsp;No Governmental Authority shall have enacted, issued, promulgated, enforced or entered any Law (whether temporary, preliminary or permanent) which is in effect and which has the effect of making the Acquisition illegal or otherwise prohibiting consummation of the Acquisition.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">63</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">No Injunctions or Restraints; Illegality</font><font style="display: inline;">.&nbsp;&nbsp;No temporary restraining order, preliminary or permanent injunction or other order issued by any court of competent jurisdiction or other legal restraint or prohibition preventing the consummation of the Acquisition shall be in effect, nor shall any proceeding brought by any Governmental Authority, seeking any of the foregoing be threatened or pending.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288601057"></a><a name="_Toc374597731"></a><a name="_Toc487751091"></a><a name="_Toc487788548"></a><a name="_Toc487788740"></a><a name="_Toc487788873"></a><a name="_Toc491721352"></a><a name="_Toc493797809"></a><a name="_Toc493797932"></a><a name="_Toc493844717"></a><a name="_Toc493869210"></a><a name="_Toc493869454"></a><a name="_Toc495394305"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">8.2</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="conditionstoobligationsparent"></a><font style="display: inline;font-weight:bold;font-style:italic;">Conditions</font><font style="display: inline;font-weight:bold;font-style:italic;"> to the Obligations of Parent and Buyer</font><font style="display: inline;">.&nbsp;&nbsp;The obligations of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, and Buyer to consummate and effect this Agreement and the transactions contemplated in this Agreement shall be subject to the satisfaction at or prior to the Closing of each of the following conditions, any of which may be waived, in writing, by Buyer:</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288602390"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Representations, Warranties and Covenants</font><font style="display: inline;">.&nbsp; </font><font style="display: inline;">(i)</font><font style="display: inline;">&nbsp;Each of the representations and warranties made by the Securityholders and the Company in this Agreement shall be true and correct in all material respects (except for any portion of those representations and warranties that are qualified by materiality, Company Material Adverse Effect or any similar standard or qualification, which portion shall be true and correct in all respects)</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">on and as of the date of this Agreement and as of the Closing Date as though made on and as of the Closing Date (except to the extent expressly made as of a specified date, in which case as of such date), and </font><font style="display: inline;">(ii)</font><font style="display: inline;">&nbsp;the Company and the Securityholders shall have performed and complied in all material respects with all covenants and obligations under this Agreement required to be performed and complied with by it as of the Closing.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444771727"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Governmental Approval</font><font style="display: inline;">.&nbsp;&nbsp;Approvals from any Governmental Authority </font><font style="display: inline;">required to be obtained by any of the Securityholders, the Company or any of the Company Subsidiaries for the consummation of the transactions contemplated in this Agreement </font><font style="display: inline;">shall have been timely obtained.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(c)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Board of Directors Approva</font><font style="display: inline;font-weight:bold;font-style:italic;">l</font><font style="display: inline;">.&nbsp;&nbsp;This Agreement </font><font style="display: inline;">shall have been approved by </font><font style="display: inline;">the Bo</font><font style="display: inline;">ard of Directors of the Company</font><font style="display: inline;">.</font><font style="display: inline;font-weight:bold;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(d)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Third Party Consents and Notices</font><font style="display: inline;">.&nbsp;&nbsp;The Company shall have delivered to Buyer all consents, waivers and approvals of, and notices to, parties to any Contract that are set forth on </font><font style="display: inline;font-weight:bold;">Schedule&nbsp;</font><font style="display: inline;font-weight:bold;">7</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">to this Agreement, in form and substance reasonably satisfactory to Buyer.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(e)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Payoff Letters; Release of Liens</font><font style="display: inline;">.&nbsp; </font><font style="display: inline;">The </font><font style="display: inline;">Buyer shall receive from the Company payoff letters in a form reasonably acceptable to Buyer with respect to any and all Company Debt</font><font style="display: inline;">, to the extent to be repaid at or following Closing and</font><font style="display: inline;"> Buyer shall receive from the Company a duly and validly executed copy of all Contracts, instruments, certificates and other documents, in form and substance reasonably satisfactory to Buyer, that are necessary or appropriate to evidence the release of all Liens identified in </font><font style="display: inline;font-weight:bold;">Schedule&nbsp;8</font><font style="display: inline;"> to this Agreement</font><font style="display: inline;">, the effectiveness of which is subject to the payments contemplated in the applicable payoff letter</font><font style="display: inline;">.&nbsp; </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:25pt;"><font style="display: inline;color:#010000;">(f)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">No Material Adverse Effect</font><font style="display: inline;">.&nbsp; </font><font style="display: inline;">Since the date hereof</font><font style="display: inline;">, there shall not have occurred any event or condition of any character that has had, or is reasonably likely to have, a Company Material Adverse Effect.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref491547380"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">64</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(g)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Company Certificate</font><font style="display: inline;">. The Company shall deliver to Buyer a true and correct certificate, validly executed by the Chief Executive Officer of the Company for and on the Company&#x2019;s behalf, which (i) represents that the conditions to the obligations of Buyer set forth in this </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;">8.2</font><font style="display: inline;"> have been satisfied in full (unless otherwise waived in accordance with the terms hereof), (ii) sets forth the </font><font style="display: inline;">Estimated </font><font style="display: inline;">Net Company Debt </font><font style="display: inline;">and Adjustment Amount </font><font style="display: inline;">as of immediately prior to the Closing (the &#x201C;</font><font style="display: inline;font-weight:bold;">Company Certificate</font><font style="display: inline;">&#x201D;).</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288602663"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(h)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">FIRPTA Certificate</font><font style="display: inline;">. With respect to the Company, Buyer shall have received a certificate to the effect that Company is not, and has not been during the applicable time period set forth in Section&nbsp;897(c)(1)(A)(ii) of the Code, a United States real property holding corporation and, accordingly, the securities of the Company are not U.S. real property interests, which meets the requirements of Treasury Regulation Section 1.1445-2(c)(3).</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref289162424"></a><a name="_Ref368667813"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;color:#010000;">(i)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Key </font><font style="display: inline;font-weight:bold;font-style:italic;">Employee</font><font style="display: inline;">.&nbsp;&nbsp;The </font><font style="display: inline;">Key Employee</font><font style="display: inline;"> (i) shall have signed the applicable Employment Documents and such Contracts shall be in full force and effect as of the Closing, (ii)&nbsp;shall still be employees of the Company or the applicable Company Subsidiary and performing their usual and customary duties for the Company or such Company Subsidiary during the period before the Closing&nbsp;&nbsp;and (iii)&nbsp;shall not have notified (whether formally or informally) Parent, Buyer, the Company, or the applicable Company Subsidiary of such Employee&#x2019;s intention of leaving the employ of Parent, Buyer, the Company, or the applicable Company Subsidiary following the Closing.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:25pt;"><font style="display: inline;color:#010000;">(j)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Termination of Agreements</font><font style="display: inline;">.&nbsp;&nbsp;Buyer shall have received from the Company a duly and validly executed copy of all Contracts, instruments, certificates and other documents, in form and substance reasonably satisfactory to Buyer, that are necessary or appropriate to evidence the termination of the Contracts set forth in </font><font style="display: inline;font-weight:bold;">Schedule&nbsp;</font><font style="display: inline;font-weight:bold;">9</font><font style="display: inline;"> to this Agreement.</font><font style="display: inline;font-size:6pt;vertical-align:super;line-height:100%">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref361339203"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(k)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Amendment of Agreements</font><font style="display: inline;">.&nbsp;&nbsp;Buyer shall have received from the Company a duly and validly executed copy of all Contracts, instruments, certificates and other documents, in form and substance reasonably satisfactory to Buyer, that are necessary or appropriate to evidence the amendment of the Contracts set forth in </font><font style="display: inline;font-weight:bold;">Schedule&nbsp;</font><font style="display: inline;font-weight:bold;">10</font><font style="display: inline;"> to this Agreement.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref368663560"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;color:#010000;">(l)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Securityholder </font><font style="display: inline;font-weight:bold;font-style:italic;">Agreements.&nbsp; </font><font style="display: inline;">Buyer shall have received duly and validly executed Securityholder Agreements from each of the Securityholders and such Contracts shall be in full force and effect as of the Closing.</font><a name="_BPDC_LN_INS_1005"></a><font style="display: inline;"> &nbsp; &nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288601106"></a><a name="_Toc374597732"></a><a name="_Toc487751092"></a><a name="_Toc487788549"></a><a name="_Toc487788741"></a><a name="_Toc487788874"></a><a name="_Ref487815720"></a><a name="_Toc491721353"></a><a name="_Toc493797810"></a><a name="_Toc493797933"></a><a name="_Toc493844718"></a><a name="_Toc493869211"></a><a name="_Toc493869455"></a><a name="_Toc495394306"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">8.3</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="conditionstoobligationscompany"></a><font style="display: inline;font-weight:bold;font-style:italic;">Conditions to Obligations</font><font style="display: inline;font-weight:bold;font-style:italic;"> of the Company</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;font-style:italic;">and the Securityholders</font><font style="display: inline;">.&nbsp;&nbsp;The obligations of the Company and the Securityholders to consummate and effect this Agreement and the transactions contemplated in this Agreement shall be subject to the satisfaction at or prior to the Closing of each of the following conditions, any of which may be waived, in writing, exclusively by the Company:</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288602409"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Representations, Warranties and Covenants</font><font style="display: inline;">.&nbsp;&nbsp;(i)&nbsp;Each of the representations and warranties of </font><font style="display: inline;">CryoLife, </font><font style="display: inline;">Parent and Buyer in this Agreement shall be true and </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">65</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">correct in all material respects (except for any portion of those representations and warranties that are qualified by materiality, Material Adverse Effect or any similar standard or qualification, which portion shall be true and correct in all respects) on and as of the date of this Agreement and as of the Closing Date as though made on and as of the Closing Date (except to the extent expressly made as of a specified date, in which case as of such date), and (ii) </font><font style="display: inline;">CryoLife, </font><font style="display: inline;">Parent and Buyer shall have performed and complied in all material respects with all covenants and obligations under this Agreement required to be performed and complied with by </font><font style="display: inline;">CryoLife, Parent and </font><font style="display: inline;">Buyer as of the Closing.</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref446779273"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Governmental Approval</font><font style="display: inline;">.&nbsp;&nbsp;Approvals from any Governmental Authority </font><font style="display: inline;">required to be obtained by CryoLife, Parent or Buyer for the consummation of the transactions contemplated in this Agreement </font><font style="display: inline;">shall have been timely obtained.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref493830180"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(c)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Certificate of Buyer</font><font style="display: inline;">.&nbsp;&nbsp;Company shall have received a certificate, validly executed on behalf of Buyer to the effect that, as of the Closing the conditions set forth in </font><font style="display: inline;font-weight:bold;">Section</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">8.3</font><font style="display: inline;"> hereof have been satisfied (the &#x201C;</font><font style="display: inline;font-weight:bold;">Buyer Certificate</font><font style="display: inline;">&#x201D;).</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="articleix"></a><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#010000;">Article&nbsp;IX</font><br /><font style="display: inline;font-weight:bold;text-transform:uppercase;"></font><br /><font style="display: inline;font-weight:bold;text-transform:uppercase;"></font><a name="_Ref288596050"></a><a name="_Ref288596319"></a><a name="_Ref288596533"></a><a name="_Ref288596552"></a><a name="_Toc374597733"></a><a name="_Toc487751093"></a><a name="_Toc487788550"></a><a name="_Toc487788742"></a><a name="_Toc487788875"></a><a name="_Toc491721354"></a><a name="_Toc493797811"></a><a name="_Toc493797934"></a><a name="_Toc493844719"></a><a name="_Toc493869212"></a><a name="_Toc493869456"></a><a name="_Toc495394307"></a><font style="display: inline;font-weight:bold;text-transform:uppercase;">SURVIVAL OF REPRESENTATIONS, WARRANTIES AND COVENANTS</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref341702071"></a><a name="_Toc374597734"></a><a name="_Toc487751094"></a><a name="_Toc487788551"></a><a name="_Toc487788743"></a><a name="_Toc487788876"></a><a name="_Toc491721355"></a><a name="_Toc493797812"></a><a name="_Toc493797935"></a><a name="_Toc493844720"></a><a name="_Toc493869213"></a><a name="_Toc493869457"></a><a name="_Toc495394308"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">9.1</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Survival of Representations, Warranties and Covenants</font><font style="display: inline;">.&nbsp; </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref493794787"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">All representations, warranties, agreements, covenants and obligations of the Securityholders or the Company contained </font><font style="display: inline;">in this Agreement, </font><font style="display: inline;">the Related Agreements, the Comp</font><font style="display: inline;">any Disclosure Schedule, e</font><font style="display: inline;">xhibit to this Agreement or any Contract, instrument, certificate or document specifically required to be delivered under this Agreement </font><font style="display: inline;">or any Related Agreement to any Party </font><font style="display: inline;">incident to the transactions contemplated in this Agreement or </font><font style="display: inline;">any </font><font style="display: inline;">Related Agreement are material and shall be deemed to have been relied upon by </font><font style="display: inline;">such Party</font><font style="display: inline;">.&nbsp;&nbsp;The representations and warranties of the Securityholders and the Comp</font><font style="display: inline;">any contained in this Agreement</font><font style="display: inline;"> and in the Company Certificate as it pertains to the conditions to Closing set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">8.2(a)</font><font style="display: inline;"> shall survive the Closing </font><font style="display: inline;">for the following periods </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref493785333"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;color:#010000;">(i)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">the representations and warranties contained in</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">Sections&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;">4.1</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">(Authority; Non-Contravention; Approvals),</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">4.2</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">(Title to Company Securities),</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">4.4</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">(Interest in Intellectual Property),</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">4.5</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">(Brokers&#x2019; and Finders&#x2019; Fees),</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;">5.1</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">(Organization of the Company),</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.2</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">(Company Capital Structure),</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.4</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">(Authority),</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.5</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">(No Conflict),</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.11</font><font style="display: inline;">(</font><font style="display: inline;">Taxes</font><font style="display: inline;">; with respect to </font><font style="display: inline;font-weight:bold;">subsection</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.11(b)(iii)</font><font style="display: inline;"> only</font><font style="display: inline;">),</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.13</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">(Title to Properties;</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">Absence of Liens and Encumbrances, with respect to </font><font style="display: inline;font-weight:bold;">subsection</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.13(c)</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">only)</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14 </font><font style="display: inline;">(Intellectual Property; with respect to </font><font style="display: inline;font-weight:bold;">subsection</font><font style="display: inline;font-weight:bold;">s</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(a)</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">and</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(o) </font><font style="display: inline;">only)</font><font style="display: inline;font-style:italic;">,</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.18</font><font style="display: inline;"> (Company Authorizations), </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.21</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">(Brokers&#x2019; and Finders&#x2019; Fees), </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.30</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">(Products),</font><font style="display: inline;"> and </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.31</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">(</font><font style="display: inline;">Utilization </font><font style="display: inline;">of Assets)</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">(collectively, the</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Fundamental Representations</font><font style="display: inline;">&#x201D;), shall</font><font style="display: inline;"> survive until 12:01 a.m. Eastern </font><font style="display: inline;">Time </font><font style="display: inline;">on the </font><font style="display: inline;">fifth (5</font><font style="display: inline;font-size:6pt;vertical-align:super;line-height:100%">th</font><font style="display: inline;">)</font><font style="display: inline;"> anniversary of the Closing Date</font><font style="display: inline;">; &nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:24pt;"><font style="display: inline;color:#010000;">(ii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">the representations and warranties contained in </font><font style="display: inline;font-weight:bold;">Section</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">(Intellectual Property</font><font style="display: inline;">; with the exception of for </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(a)</font><font style="display: inline;font-weight:bold;"> and </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(o)</font><font style="display: inline;">, which shall survive </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">66</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">for the period provided in </font><font style="display: inline;">&#x200E;</font><font style="display: inline;">(i) above</font><font style="display: inline;">) &nbsp;</font><font style="display: inline;">which shall survive until 12:01 a.m. </font><font style="display: inline;">Eastern </font><font style="display: inline;">Time </font><font style="display: inline;">on the </font><font style="display: inline;">third </font><font style="display: inline;">(</font><font style="display: inline;">3</font><font style="display: inline;font-size:6pt;vertical-align:super;line-height:100%">rd</font><font style="display: inline;">)</font><font style="display: inline;"> anniversary of the Closing Date;</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref493785651"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;color:#010000;">(iii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">the representations and warranties contained in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.11</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">(Taxes)</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">which </font><font style="display: inline;">shall survive until 12:01 a.m. Eastern </font><font style="display: inline;">Time </font><font style="display: inline;">on the fifth (5</font><font style="display: inline;font-size:6pt;vertical-align:super;line-height:100%">th</font><font style="display: inline;">) anniversary of the Closing Date</font><font style="display: inline;">; except that </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.11(b)(iii)</font><font style="display: inline;"> is a Fundamental Representations and shall survive for the period specified in </font><font style="display: inline;">&#x200E;</font><font style="display: inline;">(i) above;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;color:#010000;">(iv)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">the representations and warranties of the Securityholders not addressed in </font><font style="display: inline;">&#x200E;</font><font style="display: inline;">(i) through </font><font style="display: inline;">&#x200E;</font><font style="display: inline;">(iii) above shall survive the Closing </font><font style="display: inline;">until 12:01 a.m. </font><font style="display: inline;">Eastern </font><font style="display: inline;">Time </font><font style="display: inline;">on the date that is eighteen (18) calendar months after the Closing Date (the &#x201C;</font><font style="display: inline;font-weight:bold;">Expiration Date</font><font style="display: inline;">&#x201D;)</font><font style="display: inline;">. &nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">The representations and warranties of </font><font style="display: inline;">CryoLife, </font><font style="display: inline;">Parent and Buyer contained in this Agreement, or in the</font><font style="display: inline;"> Parent Certificate shall survive until 12:01 a.m. </font><font style="display: inline;">Eastern </font><font style="display: inline;">Time on the Expiration Date</font><font style="display: inline;">, provided however that the representations and warranties of </font><font style="display: inline;">CryoLife, </font><font style="display: inline;">Parent and Buyer contained in Sections </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">6.1</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">(Organizati</font><font style="display: inline;">on, Standing and Power),</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">6.2</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">(Authority),</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">6.4</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">(Capitali</font><font style="display: inline;">zation),</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">6.6</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">(No Conflict)</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">6.7</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">(Issuance of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock),</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">and </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">6.13</font><font style="display: inline;"> &nbsp;(</font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Operational Representations</font><font style="display: inline;">; with respect to </font><font style="display: inline;font-weight:bold;">subsection</font><font style="display: inline;font-weight:bold;">s</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">6.13(a)</font><font style="display: inline;"> and </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">6.13(c)</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">only</font><font style="display: inline;">) &nbsp;</font><font style="display: inline;">shall survive until 12:01 a.m. Eastern </font><font style="display: inline;">Time </font><font style="display: inline;">on the </font><font style="display: inline;">fifth (5</font><font style="display: inline;font-size:6pt;vertical-align:super;line-height:100%">th</font><font style="display: inline;">)</font><font style="display: inline;"> anniversary of the Closing</font><font style="display: inline;"> Date</font><font style="display: inline;">. &nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(c)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">All covenants and agreements contained in this Agreement shall survive the Closing and shall continue to remain in full force and effect after the Closing Date, unless they terminate earlier in accordance with their express terms</font><font style="display: inline;">, and all claims arising out of, resulting from or related to the matters described in </font><font style="display: inline;font-weight:bold;">Sections</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(a)(ii)</font><font style="display: inline;"> or </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(b)(ii)</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">shall survive until the third (3</font><font style="display: inline;font-size:6pt;vertical-align:super;line-height:100%">rd</font><font style="display: inline;">) anniversary of the expiration or termination of such covenants and agreements.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(d)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">The indemnification rights of the Buyer Indemnified Parties with respect to claims </font><font style="display: inline;">arising out of, resulting from or related to</font><font style="display: inline;"> the matters described in </font><font style="display: inline;font-weight:bold;">Sections </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(a)(iii)</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">shall survive until 12:01 a.m. Eastern </font><font style="display: inline;">Time </font><font style="display: inline;">on the </font><font style="display: inline;">third (3</font><font style="display: inline;font-size:6pt;vertical-align:super;line-height:100%">rd</font><font style="display: inline;">)</font><font style="display: inline;"> anniversary of the Closing</font><font style="display: inline;"> Date. </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(e)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">The indemnification rights of the Buyer Indemnified Parties with respect to claims </font><font style="display: inline;">arising out of, resulting from or related to</font><font style="display: inline;"> Special Indemnification Matters (as defined below) </font><font style="display: inline;">survive until 12:01 a.m. </font><font style="display: inline;">Eastern </font><font style="display: inline;">Time on the applicable </font><font style="display: inline;">anniversary</font><font style="display: inline;"> referred to </font><font style="display: inline;">in </font><font style="display: inline;font-weight:bold;">Schedule 1</font><font style="display: inline;font-weight:bold;">1</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:25pt;"><font style="display: inline;color:#010000;">(f)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">The indemnification rights of the Buyer Indemnified Parties and the Seller Indemnified Parties with respect to claims arising out of, resulting from or related to the matters described in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(a)(v)</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">or</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(b)(iii)</font><font style="display: inline;font-weight:bold;">,</font><font style="display: inline;"> respectively,</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">until 12:01 a.m. Eastern </font><font style="display: inline;">Time</font><font style="display: inline;"> on the </font><font style="display: inline;">sixth (6</font><font style="display: inline;font-size:6pt;vertical-align:super;line-height:100%">th</font><font style="display: inline;">)</font><font style="display: inline;"> anniversary of the Closing</font><font style="display: inline;"> Date. </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(g)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">The date until which any representation</font><font style="display: inline;">,</font><font style="display: inline;"> warranty</font><font style="display: inline;">, agreement, covenant or obligation</font><font style="display: inline;"> survives shall be referred to as the &#x201C;</font><font style="display: inline;font-weight:bold;">Survival Date</font><font style="display: inline;">&#x201D; for such representation</font><font style="display: inline;">,</font><font style="display: inline;"> warranty</font><font style="display: inline;">, agreement, covenant or obligation</font><font style="display: inline;">.&nbsp; </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">67</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(h)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Notwithstanding anything in this </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.1</font><font style="display: inline;"> to the contrary, (i) if, </font><font style="display: inline;">subject to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.4(b)(i)</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">at any time prior to 12:01 a.m. </font><font style="display: inline;">Eastern </font><font style="display: inline;">Time </font><font style="display: inline;">on the applicable Survival Date, an Officer&#x2019;s Certificate (as defined in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.4(b</font><font style="display: inline;">)</font><font style="display: inline;">) &nbsp;</font><font style="display: inline;">or a Claim Certificate (as defined in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.4(b</font><font style="display: inline;">)) </font><font style="display: inline;">is delivered alleging Losses and a claim for recovery under </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.4(b</font><font style="display: inline;">)</font><font style="display: inline;">, then </font><font style="display: inline;">the Survival Date shall extend automatically with respect to </font><font style="display: inline;">the specific claim asserted in such notice </font><font style="display: inline;">and </font><font style="display: inline;">shall survive </font><font style="display: inline;">beyond </font><font style="display: inline;">the applicable Survival Date until such claim is fully and finally resolved.</font><font style="display: inline;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288597322"></a><a name="_Ref288599530"></a><a name="_Toc374597735"></a><a name="_Toc487751095"></a><a name="_Toc487788552"></a><a name="_Toc487788744"></a><a name="_Toc487788877"></a><a name="_Toc491721356"></a><a name="_Toc493797813"></a><a name="_Toc493797936"></a><a name="_Toc493844721"></a><a name="_Toc493869214"></a><a name="_Toc493869458"></a><a name="_Toc495394309"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">9.2</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="indemnification"></a><font style="display: inline;font-weight:bold;font-style:italic;">Indemnification</font><font style="display: inline;">.&nbsp; </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref488149281"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">F</font><font style="display: inline;">rom and after the Closing, </font><font style="display: inline;">each of </font><font style="display: inline;">the Securityholders (</font><font style="display: inline;">each a &#x201C;</font><font style="display: inline;font-weight:bold;">Seller Indemnifying Person</font><font style="display: inline;">&#x201D; and collectively </font><font style="display: inline;">the &#x201C;</font><font style="display: inline;font-weight:bold;">Seller Indemnifying Persons</font><font style="display: inline;">&#x201D;) </font><font style="display: inline;">shall</font><font style="display: inline;"> (subject to</font><font style="display: inline;"> the limitations set forth in this Agreement) </font><font style="display: inline;">indemnify and hold harmless </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, Buyer</font><font style="display: inline;">, and their respective officers, directors and Affiliates</font><font style="display: inline;">, including, after the Closing, the Company and each Company Subsidiary (the &#x201C;</font><font style="display: inline;font-weight:bold;">Buyer Indemnified Persons</font><font style="display: inline;">&#x201D;), against L</font><font style="display: inline;">iabilities, including reasonable accounting and auditors&#x2019; fees, attorneys&#x2019; fees and expenses of investigation and defe</font><font style="display: inline;">nse, interest, fines, penalties, </font><font style="display: inline;">d</font><font style="display: inline;">iminution in value, or restriction (each</font><font style="display: inline;"> a &#x201C;</font><font style="display: inline;font-weight:bold;">Loss</font><font style="display: inline;">&#x201D; and collectively &#x201C;</font><font style="display: inline;font-weight:bold;">Losses</font><font style="display: inline;">&#x201D;) paid, incurred or sustained by </font><font style="display: inline;">any of </font><font style="display: inline;">the Buyer Indemnified Persons, directly or indirectly, arising out of, resulting from or related to:</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444709776"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;color:#010000;">(i)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">any breach or inaccuracy of any representation or warranty of the Securityholders contained in this Agreement, any of the Related Agreements, the Company Certificate or in any certificate or instrument delivered in connection with the transactions contemplated in this Agreement, including the Acquisition;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref445048503"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:24pt;"><font style="display: inline;color:#010000;">(ii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">any breach by the Company </font><font style="display: inline;">or a Securityholder </font><font style="display: inline;">of, or any failure by the Company </font><font style="display: inline;">or a Securityholder </font><font style="display: inline;">to perform, fulfill or comply with, any covenant or obligation applicable to the Company </font><font style="display: inline;">or such Securityholder </font><font style="display: inline;">contained in this Agreement</font><font style="display: inline;">, for the purposes of clarification excluding any representation or warranty referred to in </font><font style="display: inline;">&#x200E;</font><font style="display: inline;">(i) above</font><font style="display: inline;">;</font><font style="display: inline;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref448582199"></a><a name="_Ref492401104"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;color:#010000;">(iii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">any claims made by a Securityholder or a former securityholder of the Company or any Company Subsidiary in such Securityholder&#x2019;s or former securityholder&#x2019;s capacity as a current or former securityholder of the Company or any Company Subsidiary, or by any other Person, seeking to assert, or based upon: </font><font style="display: inline;">(A)</font><font style="display: inline;"> ownership or rights to ownership of any securities of the Company or any Company Subsidiary; </font><font style="display: inline;">(B) any rights of a s</font><font style="display: inline;">ecurityholder of the Company (other than the right to receive any portion of the Acquisition Consideration pursuant to this Agreement), including any option, preemptive rights or rights to notice or to vote; </font><font style="display: inline;">(C)</font><font style="display: inline;"> any rights under the Charter Documents, including a claim that any distribution of proceeds pursuant to this Ag</font><font style="display: inline;">reement, whether by CryoLife, Parent, </font><font style="display: inline;">Buyer, the Securityholder Representative or otherwise, violates the terms of the Charter Documents; </font><font style="display: inline;">(D)</font><font style="display: inline;"> any claim that such Person&#x2019;s securities were wrongfully </font><font style="display: inline;">redeemed or </font><font style="display: inline;">repurchased by the Company; </font><font style="display: inline;">(E)</font><font style="display: inline;"> any breach of any Contract between the Company and such Securityholder or former securityholder, in each case in his, her or its capacity as such, occurring prior to the Closing; </font><font style="display: inline;">(F)</font><font style="display: inline;"> any claim with respect to the conversion or cancellation of its Shares;</font><font style="display: inline;"> and </font><font style="display: inline;">(G)</font><font style="display: inline;"> the purchase or sale of Company Securities by one or more Persons (other than the Buye</font><font style="display: inline;">r) prior to or upon the Closing;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref448582209"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">68</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;color:#010000;">(iv)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">the matters described in Schedule 1</font><font style="display: inline;">1</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">(the &#x201C;</font><font style="display: inline;font-weight:bold;">Special Indemnification Matters</font><font style="display: inline;">&#x201D;)</font><font style="display: inline;">; or</font><font style="display: inline;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444702580"></a><a name="_Ref444704155"></a><a name="_Ref488156946"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(v)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">fraud</font><font style="display: inline;"> committed on or prior to the Closing Date by the Securityholders, the Company, any Company Subsidiary or their respective officers, directors, </font><font style="display: inline;">managers, </font><font style="display: inline;">employees, </font><font style="display: inline;">contractors, </font><font style="display: inline;">agents or Affiliates.</font><font style="display: inline;"> &nbsp; &nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref488149299"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">From and after the Closing, </font><font style="display: inline;">CryoLife shall or shall cause </font><font style="display: inline;">Buyer </font><font style="display: inline;">to </font><font style="display: inline;">(subject to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.6(f)</font><font style="display: inline;">) &nbsp;</font><font style="display: inline;">indemnify and hold harmless the Securityholders</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">and their respective officers, directors&nbsp;&nbsp;&nbsp;and Affiliates</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">(the &#x201C;</font><font style="display: inline;font-weight:bold;">Seller Indemnified Persons</font><font style="display: inline;">&#x201D;), against all Losses paid, incurred or sustained by </font><font style="display: inline;">any of </font><font style="display: inline;">the Seller Indem</font><font style="display: inline;">nified Perso</font><font style="display: inline;">n</font><font style="display: inline;">s, </font><font style="display: inline;">directly or indirectly, arising out of, resulting from or related to:</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref493787413"></a><a name="_Ref488151100"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;color:#010000;">(i)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">any breach or inaccuracy of any representation or warranty of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent or Buyer contained in this Agreement, any of the Related Agreements, or in any certificate or instrument delivered in connection with the transactions contemplated in this Agreement, including the Acquisition;</font><font style="display: inline;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref492401301"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:24pt;"><font style="display: inline;color:#010000;">(ii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">any breach by </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, or Buyer of, or any failure by </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, or Buyer to perform, fulfill or comply with, any covenant or obligation applicable to </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, or Buyer contained in this Agreement</font><font style="display: inline;">, for the purposes of clarification, excluding any representation or warranty referred to in </font><font style="display: inline;">&#x200E;</font><font style="display: inline;">(i) above</font><font style="display: inline;">;</font><font style="display: inline;"> or</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref492401304"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;color:#010000;">(iii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">fraud committed on or prior to the Closing Date by </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, Buyer, or their respective officers, directors, </font><font style="display: inline;">managers, </font><font style="display: inline;">employees, </font><font style="display: inline;">contractors, </font><font style="display: inline;">agents or Affiliates (excluding the Company and the Company Subsidiaries).</font><font style="display: inline;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288597225"></a><a name="_Ref288597356"></a><a name="_Toc374597736"></a><a name="_Toc487751096"></a><a name="_Toc487788553"></a><a name="_Toc487788745"></a><a name="_Toc487788878"></a><a name="_Toc491721357"></a><a name="_Toc493797814"></a><a name="_Toc493797937"></a><a name="_Toc493844722"></a><a name="_Toc493869215"></a><a name="_Toc493869459"></a><a name="_Toc495394310"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">9.3</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="escrowarrangements"></a><font style="display: inline;font-weight:bold;font-style:italic;">Escrow Arrangements</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref374723248"></a><a name="_Ref379794295"></a><a name="_Ref448575452"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Indemnity E</font><font style="display: inline;font-weight:bold;font-style:italic;">scrow Fund</font><font style="display: inline;">.&nbsp;&nbsp;On the Closing Date, </font><font style="display: inline;">CryoLife </font><font style="display: inline;">shall </font><font style="display: inline;">or shall cause Buyer to </font><font style="display: inline;">deposit with the Escrow Agent an amount in cash equal to the Escrow Amount, consisting of each Securityholder&#x2019;s Pro Rata Portion of the Escrow Amount (which amounts shall be set forth in the Consideration Schedule)</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">and shall confirm such deposit in writing with the Escrow Agent, which notice shall confirm the Closing Date.&nbsp; </font><font style="display: inline;">CryoLife shall or shall cause </font><font style="display: inline;">Buyer </font><font style="display: inline;">to </font><font style="display: inline;">pay fifty percent (50%) of the administrative fees and expenses of the Escrow Agent in connection with the </font><font style="display: inline;">Escrow Amount</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">with</font><font style="display: inline;"> the remainder of the administrative fees and expenses </font><font style="display: inline;">to be paid by the Securityholders</font><font style="display: inline;">.&nbsp;&nbsp;The aggregate contributions of the Securityholders&#x2019; respective Pro Rata Portion of the Escrow Amount shall equal the amount of the Escrow Amount.&nbsp;&nbsp;Such deposit of the Escrow Amount, together with all interest and earnings thereon, shall constitute an escrow fund (the &#x201C;</font><font style="display: inline;font-weight:bold;">Indemnity Escrow Fund</font><font style="display: inline;">&#x201D;) to be governed solely by the terms </font><font style="display: inline;">of the Escrow Agreement</font><font style="display: inline;">.&nbsp;&nbsp;The Indemnity Escrow Fund shall be partial security for the indemnity obligations provided for in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(a)</font><font style="display: inline;"> hereof and for any other obligations pursuant to&nbsp;&nbsp;this Agreement or the Related Agreements, subject to the limitations </font><font style="display: inline;">herein, including </font><font style="display: inline;font-weight:bold;">S</font><font style="display: inline;font-weight:bold;">ection </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.6</font><font style="display: inline;">, and the Indemnity Escrow Fund shall be available to compensate the Buyer Indemnified Persons for any claims by such Buyer Indemnified Persons for any Losses for which they are entitled to recovery under this </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;IX</font><font style="display: inline;">. &nbsp;</font><a name="_Ref288601208"></a><a name="_Ref379382517"></a><a name="_Ref379813189"></a><font style="display: inline;">Interest in the </font><font style="display: inline;">Indemnity </font><font style="display: inline;">Escrow Fund may not be sold, exchanged, </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">69</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">transferred or otherwise disposed of, other than by the laws of descent and distribution or succession, and any transfer in violation of this </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.3(a)</font><font style="display: inline;"> shall be null and void.</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref487620671"></a><a name="_Ref450307878"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Indemnity Escrow Period; Distribution upon Termination of Escrow Periods.&nbsp; </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref493803378"></a><a name="_Ref488157819"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;color:#010000;">(i)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Subject to the following requirements, the Indemnity Escrow Fund shall be in existence immediately following the Closing and shall terminate at 12:01 a.m. </font><font style="display: inline;">Eastern </font><font style="display: inline;">Time</font><font style="display: inline;"> on the Expiration Date (the &#x201C;</font><font style="display: inline;font-weight:bold;">Indemnity</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">Escrow Period</font><font style="display: inline;">&#x201D;); </font><font style="display: inline;font-style:italic;">provided, however</font><font style="display: inline;">, that the Indemnity Escrow Period shall not terminate with respect to any amount, which is or could reasonably be necessary to satisfy any unsatisfied claims specified in any Officer&#x2019;s Certificate delivered to the Escrow Agent and the Securityholder Representative </font><font style="display: inline;">in accordance with the provisions of this Agreement </font><font style="display: inline;">prior to 12:01 a.m. </font><font style="display: inline;">Eastern </font><font style="display: inline;">Time </font><font style="display: inline;">on the Expiration Date</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">(each, an &#x201C;</font><font style="display: inline;font-weight:bold;">Unsatisfied Claim</font><font style="display: inline;">&#x201D;).&nbsp; </font><font style="display: inline;">Any distribution of all or a portion of the cash in the Indemnity Escrow Fund </font><font style="display: inline;">if </font><font style="display: inline;">to </font><font style="display: inline;">Buyer</font><font style="display: inline;"> shall be made by wire transfer of immediately available funds equal to the amount of cash being distributed, and if to </font><font style="display: inline;">the Securityholders shall be made to the Paying Agent for further distribution to each of the Securityholders by delivery of payment by check or wire transfer of immediately available funds to each such Securityholder equal to the amount of cash being distributed</font><font style="display: inline;">.</font><font style="display: inline;"> &nbsp; &nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref488157653"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:24pt;"><font style="display: inline;color:#010000;">(ii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">The Paying Agent will be responsible for the allocation and delivery of </font><font style="display: inline;">cash amounts out of the Indemnity Escrow Fund</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">to the Securityholders pursuant to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.3(b)(i)</font><font style="display: inline;">, if any,</font><font style="display: inline;"> in proportion to the Securityholders&#x2019; respective Pro Rata Portion, with the amount of cash delivered to each Securityholder r</font><font style="display: inline;">ounded down to the nearest cent </font><font style="display: inline;">and mailed by first class mail or sent via wire transfer as requested by the Securityholder Representative (and, in the case of a wire transfer, at the expense of the Securityholder) to such Securityholders&#x2019; address as set forth on the Consideration Schedule (or to such other address as any such Securityholder or the Securityholder Representative may have previously instructed the Securityholder Representative or Parent in writing). </font><a name="_Ref379813256"></a><font style="display: inline;">The Parties agree to provide the Paying Agent with a certified Tax identification number by signing and returning the appropriate series of Form&nbsp;W-8, or Form W-9, in case of U.S. Persons, to the Paying Agent, immediately upon completion of the Closing.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc374597737"></a><a name="_Ref376999180"></a><a name="_Toc487788554"></a><a name="_Toc487788746"></a><a name="_Toc487788879"></a><a name="_Toc491721358"></a><a name="_Toc493797815"></a><a name="_Toc493797938"></a><a name="_Toc493844723"></a><a name="_Toc493869216"></a><a name="_Toc493869460"></a><a name="_Toc495394311"></a><a name="_Toc487751097"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">9.4</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="indemnificationclaims"></a><font style="display: inline;font-weight:bold;font-style:italic;">Indemnification Claims</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288597339"></a><a name="_Ref372639663"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Threshold Amount</font><font style="display: inline;">.&nbsp;&nbsp;Notwithstanding any provision of this Agreement to the contrary, except as set forth in the sec</font><font style="display: inline;">o</font><font style="display: inline;">nd sentence of this </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.4(a</font><font style="display: inline;">)</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">(i)</font><font style="display: inline;"> a Buyer Indemnified Person may not recover any Losses under clause&nbsp;(i) of </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(a)</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">unless (a)</font><font style="display: inline;"> one or more Officer&#x2019;s Certificates (as defined below) identifying Losses under </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(a)</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">exceed on a</font><font style="display: inline;"> stand-alone basis </font><font style="display: inline;">the amount of </font><font style="display: inline;">$2</font><font style="display: inline;">25,</font><font style="display: inline;">000 (the </font><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Qualifying Claim</font><font style="display: inline;">&#x201D;</font><font style="display: inline;">)</font><font style="display: inline;">; provided that the Qualifying Claim limitation shall no longer apply once </font><font style="display: inline;">one or more Officer&#x2019;s Certificates (as defined below) identifying Losses under </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(a)</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">exceed in the aggregate the amount of </font><font style="display: inline;">$</font><font style="display: inline;">1,000,000 have been delivered and (b) </font><font style="display: inline;">until one or more Officer&#x2019;s Certificates (as defined below) identifying Losses under </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(a)</font><font style="display: inline;"> in excess of </font><font style="display: inline;">$2,500,000 </font><font style="display: inline;">(the &#x201C;</font><font style="display: inline;font-weight:bold;">Threshold Amount</font><font style="display: inline;">&#x201D;) has or have been delivered to the Securityholder Representative and the Escrow Agent as provided in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.4(b</font><font style="display: inline;">)</font><font style="display: inline;"> hereof, in which case t</font><font style="display: inline;">he Buyer Indemnified Persons shall </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">70</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">be entitled to recover all Losses so identified without regard to the Threshold Amount from the first dollar of such Losses, and </font><font style="display: inline;">(ii)</font><font style="display: inline;"> a Seller Indemnified Person may not recover any Losses under clause (i) of </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(b)</font><font style="display: inline;"> unless </font><font style="display: inline;">(a)</font><font style="display: inline;"> one or more Claim Certificates (as defined below) identifying Losses under </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(b)</font><font style="display: inline;"> exceed on a stand-alone basis the amount of a Qualifying Claim</font><font style="display: inline;"> have been delivered</font><font style="display: inline;">; provided that the Qualifying Claim</font><font style="display: inline;"> limitation</font><font style="display: inline;"> shall no </font><font style="display: inline;">longer </font><font style="display: inline;">apply once one or more Claim Certificates (as defined below) identifying Losses under </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(b)</font><font style="display: inline;"> exceed in the aggregate the amount of $1,000,000</font><font style="display: inline;"> have been delivered</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">and </font><font style="display: inline;">(b) </font><font style="display: inline;">until one or more Claim Certificates (as defined below) identifying Losses under </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(b)</font><font style="display: inline;"> in excess of the Threshold Amount has or have been delivered to </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> as provided in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.4(b</font><font style="display: inline;">)</font><font style="display: inline;"> hereof, in which case the Seller Indemnified Persons shall be entitled to recover all Losses so identified without regard to the Threshold Amount from the first dollar of such Losses.&nbsp;&nbsp;Notwithstanding the foregoing, </font><font style="display: inline;">(i)</font><font style="display: inline;"> a Buyer Indemnified Person shall be entitled to recover for, and the </font><font style="display: inline;">Qualifying Claim or the </font><font style="display: inline;">Threshold Amount shall not apply as a </font><font style="display: inline;">limit or </font><font style="display: inline;">threshold to, any and all claims or payments made with respect to Losses paid, incurred or sustained arising out of or resulting from or related to clauses </font><font style="display: inline;">&#x200E;</font><font style="display: inline;">(ii)</font><font style="display: inline;"> through </font><font style="display: inline;">&#x200E;</font><font style="display: inline;">(v)</font><font style="display: inline;"> of </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(a)</font><font style="display: inline;"> or any breach or inaccuracy of a representation or warranty contained in any of the Fundamental Representations, and </font><font style="display: inline;">(ii)</font><font style="display: inline;"> a Seller Indemnified Person shall be entitled to recover for, and the Threshold Amount shall not apply as a threshold to, any and all claims or payments made with respect to Losses paid, incurred or sustained arising out of or resulting from or related to clauses </font><font style="display: inline;">&#x200E;</font><font style="display: inline;">(ii)</font><font style="display: inline;"> through </font><font style="display: inline;">&#x200E;</font><font style="display: inline;">(iii)</font><font style="display: inline;"> of </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(b)</font><font style="display: inline;">.</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref374636021"></a><a name="_Ref487620693"></a><a name="_Ref288601156"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Claims for Indemnification</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref379813395"></a><a name="_Ref492563277"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;color:#010000;">(i)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">In order to seek indemnification pursuant to </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(a)</font><font style="display: inline;"> (including with regard to a Third Party Claim (as defined below))</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">CryoLife </font><font style="display: inline;">shall</font><font style="display: inline;"> or shall cause Buyer to</font><font style="display: inline;"> deliver an Officer&#x2019;s Certificate to the Securityholder Representative and, if such claim involves a claim against the Indemnity Escrow Fund, </font><font style="display: inline;">to the Escrow Agent, and </font><font style="display: inline;">such Officer&#x2019;s Certificate must be delivered prior to the applicable Survival Date;</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">CryoLife</font><font style="display: inline;"> shall </font><font style="display: inline;">or shall cause Buyer to</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">deliver an Officer&#x2019;s Certificate promptly upon </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> concluding it intends to assert a claim for indemnification </font><font style="display: inline;">provided, however, the failure to promptly deliver an Officer&#x2019;s Certificate shall not affect </font><font style="display: inline;">the Buyer Indemnified Persons&#x2019;</font><font style="display: inline;"> right to recover Losses under Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(a)</font><font style="display: inline;">, except to the extent the Seller </font><font style="display: inline;">Indemnifying</font><font style="display: inline;"> Parties are prejudiced by such failure. </font><font style="display: inline;"> &nbsp;For the purposes hereof, &#x201C;</font><font style="display: inline;font-weight:bold;">Officer&#x2019;s Certificate</font><font style="display: inline;">&#x201D; shall mean a certificate signed by any officer of </font><font style="display: inline;">CryoLife or Buyer</font><font style="display: inline;">: &nbsp;</font><font style="display: inline;">(x)</font><font style="display: inline;"> stating that a Buyer Indemnified Person has paid, sustained or incurred or reasonably anticipates that it will have to pay, sustain or incur Losses, and </font><font style="display: inline;">(y)</font><font style="display: inline;"> specifying in reasonable detail the individual items of Losses included in the amount so stated, the date each such item was paid, sustained or incurred, or the basis for such anticipated liability, and the nature of the </font><font style="display: inline;">(1)</font><font style="display: inline;"> misrepresentation, </font><font style="display: inline;">(2)</font><font style="display: inline;"> breach or inaccuracy of a representation or warranty, </font><font style="display: inline;">(3)</font><font style="display: inline;"> breach or failure to perform a covenant or other agreement, or </font><font style="display: inline;">(4)</font><font style="display: inline;"> other basis for indemnity to which such item is related, but in each case only to the extent such information is reasonably available to </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> as of the date of such Officer&#x2019;s Certificate.</font><font style="display: inline;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref488152030"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:24pt;"><font style="display: inline;color:#010000;">(ii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">In order to seek indemnification pursuant to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(b)</font><font style="display: inline;">, the Securityholder Representative shall deliver a Claim Certificate to </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> at any time prior to the applicable Survival Date; the Securityholder Representative shall deliver a Claim Certificate </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">71</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">promptly upon the Securityholder Representative (on behalf of the Seller Indemnified Persons) concluding he intends to assert a claim for indemnification</font><font style="display: inline;">;</font><font style="display: inline;"> provided, however, the failure to promptly deliver a Claim Certificate shall not affect the Seller Indemnified Persons&#x2019; right to recover Losses under </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(b)</font><font style="display: inline;">, except to the extent the Buyer </font><font style="display: inline;">Indemnifying</font><font style="display: inline;"> Parties are prejudiced by such failure.&nbsp; </font><font style="display: inline;">For the purposes hereof, &#x201C;</font><font style="display: inline;font-weight:bold;">Claim Certificate</font><font style="display: inline;">&#x201D; shall mean a certificate signed by the Securityholder Representative: </font><font style="display: inline;">(x)</font><font style="display: inline;"> stating that a Seller Indemnified Person has paid, sustained or incurred or reasonably anticipates that it will have to pay, sustain or incur Losses, and </font><font style="display: inline;">(y)</font><font style="display: inline;"> specifying in reasonable detail the individual items of Losses included in the amount so stated, the date each such item was paid, sustained or incurred, or the basis for such anticipated liability, and the nature of the </font><font style="display: inline;">(1)</font><font style="display: inline;"> misrepresentation, </font><font style="display: inline;">(2)</font><font style="display: inline;"> breach or inaccuracy of a representation or warranty, </font><font style="display: inline;">(3)</font><font style="display: inline;"> breach or failure to perform a covenant or other agreement, or </font><font style="display: inline;">(4)</font><font style="display: inline;"> other basis for indemnity to which such item is related, but in each case only to the extent such information is reasonably available to the Securityholder Representative as of the date of such Claim Certificate.</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;color:#010000;">(iii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">If a Buyer Indemnified Person is entitled to recover a Loss pursuant to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(a)</font><font style="display: inline;"> then, subject to the limitations set forth in </font><font style="display: inline;">this Agreement</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">the Buyer Indemnified Person shall, except for indemnification (a) pursuant to </font><font style="display: inline;font-weight:bold;">Sections </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(a)(ii)</font><font style="display: inline;"> through </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(a)(v)</font><font style="display: inline;">, and (b) for breach or misrepresentation of a Fundamental Representation, first receive proceeds from the Indemnity Escrow Fund, and then, if the Indemnity Escrow Fund is insufficient to the cover the Loss, </font><font style="display: inline;">the Securityholders shall be directly liable for </font><font style="display: inline;">the remaining excess amount of such Loss</font><font style="display: inline;">, in which case the Securityholders shall make payment </font><font style="display: inline;color:#000000;">directly to such Buyer Indemnified Person by wire transfer of immediately available cash funds to an account designated by such Buyer Indemnified Person.&nbsp; </font><font style="display: inline;">If a Seller Indemnified Person is entitled to recover a Loss pursuant to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(b)</font><font style="display: inline;">, then, subject to the limitations set forth in</font><font style="display: inline;"> this Agreement</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">CryoLife shall or shall cause </font><font style="display: inline;">Buyer </font><font style="display: inline;">to </font><font style="display: inline;">pay </font><font style="display: inline;">the amount of such Loss </font><font style="display: inline;color:#000000;">directly to such Seller Indemnified Person by wire transfer of immediately available cash funds to an account designated by such Seller Indemnified Person.&nbsp; </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288601768"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(c)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Securityholders Right to Cure</font><font style="display: inline;">.&nbsp;&nbsp;With respect </font><font style="display: inline;">to any claim for indemnification pursuant to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(a)</font><font style="display: inline;"> notified by CryoLife </font><font style="display: inline;">pursuant to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.4(b)(i)</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">CryoLife</font><font style="display: inline;"> shall use commercially reasonable efforts to give the Securityholder Representative the </font><font style="display: inline;">reasonable </font><font style="display: inline;">opportunity to cure the source of the potential Loss</font><font style="display: inline;">es in connection with such claim.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref493831386"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(d)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Objections to Claims for Indemnification</font><font style="display: inline;">.&nbsp;&nbsp;The payment of any amount under </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.4(b</font><font style="display: inline;">)</font><font style="display: inline;"> shall be delayed pending resolution pursuant to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.4(e)</font><font style="display: inline;"> if </font><font style="display: inline;">(i)</font><font style="display: inline;"> with respect to any claim for indemnification pursuant to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(a)</font><font style="display: inline;">, the Securityholder Representative shall object to the claim made in the Officer&#x2019;s Certificate in a written statement labeled &#x201C;Objection Notice&#x201D; (an &#x201C;</font><font style="display: inline;font-weight:bold;">Objection Notice</font><font style="display: inline;">&#x201D;), and such Objection Notice shall have been received by </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> and the Escrow Agent prior to 12:01 a.m. </font><font style="display: inline;">Eastern Time</font><font style="display: inline;"> on </font><font style="display: inline;">the sixty-fifth </font><font style="display: inline;">(</font><font style="display: inline;">65</font><font style="display: inline;font-size:6pt;vertical-align:super;line-height:100%">th</font><font style="display: inline;">) &nbsp;</font><font style="display: inline;">Business D</font><font style="display: inline;">ay after its receipt of the Officer&#x2019;s Certificate, or </font><font style="display: inline;">(ii)</font><font style="display: inline;"> with respect to any claim for indemnification pursuant to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(b)</font><font style="display: inline;">,</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">CryoLife</font><font style="display: inline;"> shall object to the claim made in the Claim Certificate in an Objection Notice, and such Objection Notice shall have been received by the Securityholder Representative prior to 12:01 a.m. </font><font style="display: inline;">Eastern Time</font><font style="display: inline;"> on the </font><font style="display: inline;">sixty-fifth </font><font style="display: inline;">(</font><font style="display: inline;">65</font><font style="display: inline;font-size:6pt;vertical-align:super;line-height:100%">th</font><font style="display: inline;">) &nbsp;</font><font style="display: inline;">Business D</font><font style="display: inline;">ay after its receipt of the Claim Certificate.&nbsp;&nbsp;If the Securityholder Representative </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">72</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">(with respect to any claim for indemnification pursuant to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(a)</font><font style="display: inline;">) or </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> (with respect to any claim for indemnification pursuant to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(b)</font><font style="display: inline;">) (as applicable, the &#x201C;</font><font style="display: inline;font-weight:bold;">Responding Party</font><font style="display: inline;">&#x201D;) does not object in writing within such </font><font style="display: inline;">sixty-five (65) Business D</font><font style="display: inline;">ay period, such failure to so object shall be an irrevocable acknowledgment by the Responding Party that the Buyer Indemnified Person or Seller Indemnified Person, as applicable, is entitled to the full amount of the claim for Losses set forth in such Officer&#x2019;s Certificate or Claim Certificate, and payment in respect of such Losses shall thereafter be made in accordance with </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.4(b</font><font style="display: inline;">)</font><font style="display: inline;">.</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288601361"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(e)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Resolution of Conflicts</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;color:#010000;">(i)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">In case the Responding Party delivers an Objection Notice in accordance with </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.4(c</font><font style="display: inline;">)</font><font style="display: inline;">, the Securityholder Representative and </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> shall attempt in good faith to agree upon the rights of the respective Persons with respect to each of such claims.&nbsp;&nbsp;If the Securityholder Representative and </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> should so agree, and such claim involves a claim against the Indemnity Escrow Fund, a document setting forth such agreement shall be prepared and signed by both the Securityholder Representative and </font><font style="display: inline;">CryoLife or Buyer</font><font style="display: inline;"> and furnished to the Escrow Agent</font><font style="display: inline;"> in accordance with the Escrow Agreement</font><font style="display: inline;">.&nbsp; </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:24pt;"><font style="display: inline;color:#010000;">(ii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">At any time following delivery of an Objection Notice by the Responding Party or in the event of any dispute arising pursuant to this </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;">Article&nbsp;IX</font><font style="display: inline;">, either </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, on the one hand, or the Securityholder Representative, on the other hand, may pursue any and all legal or equitable remedies available to them under applicable Law.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288602210"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:25pt;"><font style="display: inline;color:#010000;">(f)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Third-Party Claims</font><font style="display: inline;">.&nbsp;&nbsp;If </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> becomes aware of a third party claim (a &#x201C;</font><font style="display: inline;font-weight:bold;">Third Party Claim</font><font style="display: inline;">&#x201D;) that </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> reasonably believes may result in a demand for indemnification pursuant to this </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;">Article&nbsp;IX</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">CryoLife</font><font style="display: inline;"> shall </font><font style="display: inline;">or shall cause Buyer to </font><font style="display: inline;">notify the Escrow Agent (if the Third Party Claim is made by </font><font style="display: inline;">CryoLife</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">or a Buyer Indemnified Person </font><font style="display: inline;">prior to the release of the Indemnity Escrow Fund and may result in a claim against the Indemnity Escrow Fund) and the Securityholder Representative in writing of such claim.&nbsp;&nbsp;If the Third Party Claim may result in a claim against the Indemnity Escrow Fund, the Securityholder Representative, on behalf of the Securityholders, shall be entitled, at its expense, to participate in, but not to determine or conduct, the defense of such Third Party Claim; </font><font style="display: inline;font-style:italic;">provided, however</font><font style="display: inline;">, that the Securityholders agree and consent, as a condition of such entitlement of participation, that </font><font style="display: inline;">CryoLife</font><font style="display: inline;">&#x2019;s legal counsel in the Third Party Claim shall not be precluded from representing </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> as against the Securityholders in the event that the Securityholders dispute the fact or amount of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">&#x2019;s claim of a Loss related to such matter.&nbsp; </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> shall have the right in its sole discretion to conduct the defense of, and to settle, any such claim; </font><font style="display: inline;font-style:italic;">provided, that</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">in the event that any claim is settled without the written consent of the Securityholder Representative, such settlement shall not be dispositive of the existence of an indemnifiable claim or the amount of Losses.&nbsp;&nbsp;In the event that the Securityholder Representative has consented to any su</font><font style="display: inline;">ch settlement, the</font><font style="display: inline;"> Securityholders shall have no power or authority to object to the amount of any Third Party Claim.&nbsp;&nbsp;If </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> does not use commercially reasonable efforts to conduct or assume the defense of a Third Party Claim, then the Securityholder Representative, on behalf of the Securityholders, may, by providing written notice to </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, assume the defense of such </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">73</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">Third Party Claim at the Securityholders&#x2019; expense, and all legal fees and costs incurred by the Securityholder Representative shall be timely paid by the Securityholders</font><font style="display: inline;">.</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc487788555"></a><a name="_Toc487788747"></a><a name="_Toc487788880"></a><a name="_Ref491560070"></a><a name="_Toc491721359"></a><a name="_Toc493797816"></a><a name="_Toc493797939"></a><a name="_Toc493844724"></a><a name="_Toc493869217"></a><a name="_Toc493869461"></a><a name="_Toc495394312"></a><a name="_Toc487751098"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">9.5</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="securityholderrepresentative"></a><font style="display: inline;font-weight:bold;font-style:italic;">Securityholder Representative</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">By virtue of the approval of the Acquisition and this Agreement by each of the Securityholders, each of the Securityholders shall be deemed to have agreed to appoint </font><font style="display: inline;">Lars Sunnanv&#xE4;der</font><font style="display: inline;"> as </font><font style="display: inline;">his, her or </font><font style="display: inline;">its</font><font style="display: inline;">, as applicable,</font><font style="display: inline;"> agent and attorney-in-fact, as the Securityholder Representative for and on behalf of the Securityholders to take all actions under this Agreement that are to be taken by the Securityholder Representative, including to amend this Agreement, to waive any provision of this Agreement, to negotiate payments due pursuant to this </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;">Article&nbsp;IX</font><font style="display: inline;">, to give and receive notices and communications, to authorize payment to any Buyer Indemnified Person from the Indemnity Escrow Fund in satisfaction of claims by any Buyer Indemnified Person, to object to such payments, to agree to, negotiate, enter into settlements and compromises of, and comply with orders of courts with respect to such claims, to assert, negotiate, enter into settlements and compromises of, and comply with orders of courts with respect to, any other claim by any Buyer Indemnified Person against any of the Securityholders or by any of the Securityholders against any Buyer Indemnified Person or any dispute between any Buyer Indemnified Person and any of the Securityholders, in each case relating to this Agreement or the transactions contemplated in this Agreement, and to take all other actions that are either </font><font style="display: inline;">(i)</font><font style="display: inline;">&nbsp;necessary or appropriate in the judgment of the Securityholder Representative for the accomplishment of the foregoing or </font><font style="display: inline;">(ii)</font><font style="display: inline;">&nbsp;specifically mandated by the terms of this Agreement.&nbsp;&nbsp;Such agency may be changed by the Securityholders from time to time upon not less than thirty (30) days prior written notice to </font><font style="display: inline;">CryoLife, Parent and Buyer</font><font style="display: inline;">; &nbsp;</font><font style="display: inline;font-style:italic;">provided, however</font><font style="display: inline;">, that the Securityholder Representative may not be removed unless Securityholders representing the holders of at least a two-thirds interest of the </font><font style="display: inline;">Indemnity </font><font style="display: inline;">Escrow Fund agree to such removal and to the identity of the substituted agent.&nbsp;&nbsp;A vacancy in the position of Securityholder Representative may be filled by the Securityholders representing the holders of a majority in interest of the </font><font style="display: inline;">Indemnity </font><font style="display: inline;">Escrow Fund.&nbsp;&nbsp;In the event a vacancy in the position of Securityholder Representative exists for </font><font style="display: inline;">thirty</font><font style="display: inline;"> &nbsp;(</font><font style="display: inline;">30</font><font style="display: inline;">) or more days</font><font style="display: inline;"> or Securityholder Representative breaches or fails to perform its obligations under this Agreement (after a 30 calendar day advance notice period to cure, which period shall not apply in exigent circumstances)</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">CryoLife, Parent and Buyer</font><font style="display: inline;"> shall have the right to petition a court of competent jurisdiction to appoint a replacement Securityholder Representative, and Securityholder Representative shall not receive any compensation for its services from </font><font style="display: inline;">CryoLife, Parent, Buyer </font><font style="display: inline;">or the Company.&nbsp;&nbsp;No bond shall be required of the Securityholder Representative.&nbsp;&nbsp;Notices or communications to or from the Securityholder Representative shall constitute notice to or from the Securityholders.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Each of t</font><font style="display: inline;">he </font><font style="display: inline;">Securityholders </font><font style="display: inline;">represents and warrants to </font><font style="display: inline;">CryoLife, Parent and Buyer that the Securityholder</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Representative </font><font style="display: inline;">has the irrevocable right, power and authority (i) to enter into and perform this Agreement and to bind each of the Securityholders to its terms, (ii) to give and receive directions and notices hereunder and (iii) to make all determinations that may be required or that it deems appropriate under this Agreement.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">74</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(c)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Until notified in writing by the Securityholder Representative that it has resigned, or that it has been removed by at least two-thirds in interest of the </font><font style="display: inline;">Indemnity </font><font style="display: inline;">Escrow Fund, </font><font style="display: inline;">CryoLife, Parent, Buyer</font><font style="display: inline;"> and the Escrow Agent may rely conclusively and act upon the directions, instructions and notices of the Securityholder Representative named above and, thereafter, upon the directions, instructions and notices of any successor named in a writing executed by a majority-in-interest of the </font><font style="display: inline;">Indemnity </font><font style="display: inline;">Escrow Fund filed with the Escrow Agent</font><font style="display: inline;"> or a successor appointed by a court of competent jurisdiction</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(d)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">The Securityholders each hereby authorize the Securityholder Representative to:</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;color:#010000;">(i)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Receive all notices or documents given or to be given to the Securityholders pursuant hereto or in connection herewith and to receive and accept service of legal process and file pleadings on behalf of the Securityholders in connection with any suit or proceeding arising under this Agreement</font><font style="display: inline;">; provided, however, that the Securityholders acknowledge and agree that even if Securityholder Representative is unable, unwilling, refuses, resists or objects to receiving notice or receiving or accepting service of process, notice to and service of process with respect to each of the Securityholders shall be effective if made pursuant to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">11.1</font><font style="display: inline;">;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:24pt;"><font style="display: inline;color:#010000;">(ii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Engage counsel, and such accountants and other advisors and incur such other expenses in connection with this Agreement and the transactions contemplated in this Agreement as the Securityholder Representative may in its sole discretion deem appropriate; and</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;color:#010000;">(iii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Take such action as the Securityholder Representative may in its sole discretion deem appropriate in respect of: </font><font style="display: inline;">(A)</font><font style="display: inline;"> waiving any inaccuracies in the representations or warranties of </font><font style="display: inline;">CryoLife, Parent or Buyer</font><font style="display: inline;"> contained in this Agreement or in any document delivered by </font><font style="display: inline;">Buyer</font><font style="display: inline;"> pursuant hereto; </font><font style="display: inline;">(B)</font><font style="display: inline;">&nbsp;taking such other action as the Securityholder Representative is authorized to take under this Agreement; </font><font style="display: inline;">(C)</font><font style="display: inline;"> receiving all documents or certificates and making all determinations, in its capacity as Securityholder Representative, required under this Agreement; and </font><font style="display: inline;">(D)</font><font style="display: inline;"> all such actions as may be necessary to carry out any of the transactions contemplated in this Agreement, including the defense and/or settlement of any claims for which indemnification is sought pursuant to this </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;">Article&nbsp;IX</font><font style="display: inline;"> and any waiver of any obligation of </font><font style="display: inline;">Buyer</font><font style="display: inline;font-style:italic;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(e)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">A decision, act, consent or instruction of the Securityholder Representative, including an amendment, extension or waiver of this Agreement, shall constitute a decision of the Securityholders and shall be final, binding and conclusive upon the Securityholders; and the Escrow Agent and </font><font style="display: inline;">CryoLife, Parent and Buyer</font><font style="display: inline;"> may rely upon any such decision, act, consent or instruction of the Securityholder Representative as being the decision, act, consent or instruction of the Securityholders.&nbsp;&nbsp;The Escrow Agent and </font><font style="display: inline;">CryoLife, Parent and Buyer</font><font style="display: inline;"> are hereby relieved from any liability to any person for any decision, act, consent or instruction of the Securityholder Representative. </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref450307843"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:25pt;"><font style="display: inline;color:#010000;">(f)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">The Securityholders shall indemnify, defend and hold harmless the Securityholder Representative and its directors, officers, agents and employees from and against </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">75</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">any and all Losses arising out of or in connection with the Securityholder Representative&#x2019;s execution and performance of this Agreement, or otherwise in connection with acting as the Securityholder Representative, in each case as such Losses are incurred.&nbsp;&nbsp;Any such Losses shall be recovered </font><font style="display: inline;">(i)</font><font style="display: inline;"> first from any distribution of the Indemnity Escrow Fund, but only if and when required to be distributed to the Securityholders, pursuant to the terms of this Agreement at the time of distribution in accordance with written instructions delivered by the Securityholder Representative to the Escrow Agent (the &#x201C;</font><font style="display: inline;font-weight:bold;">Distributable Funds</font><font style="display: inline;">&#x201D;), and (ii)</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">secondly</font><font style="display: inline;">, directly from the Securityholders severally and not jointly and in accordance with their respective Pro Rata Portion.</font><font style="display: inline;">&nbsp;</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288599561"></a><a name="_Toc374597739"></a><a name="_Toc487788556"></a><a name="_Toc487788748"></a><a name="_Toc487788881"></a><a name="_Toc491721360"></a><a name="_Toc493797817"></a><a name="_Toc493797940"></a><a name="_Toc493844725"></a><a name="_Toc493869218"></a><a name="_Toc493869462"></a><a name="_Toc495394313"></a><a name="_Toc487751099"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">9.6</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="maximumpayments"></a><font style="display: inline;font-weight:bold;font-style:italic;">Maximum Payments</font><font style="display: inline;font-weight:bold;font-style:italic;">; Remedy</font><font style="display: inline;">.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref374561790"></a><a name="_Ref445044655"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Except as set forth in </font><font style="display: inline;font-weight:bold;">Sections&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.6(b</font><font style="display: inline;">)</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">through </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.6(d)</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">hereof, the maximum amount a Buyer Indemnified Person may recover from the Securityholders pursuant to clause (i) of </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(a)</font><font style="display: inline;"> hereof shall be limited to </font><font style="display: inline;">the amounts comprising the Indemnity Escrow Fund.</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Except as set forth in </font><font style="display: inline;font-weight:bold;">Sections&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.6(b</font><font style="display: inline;">) through </font><font style="display: inline;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.6(c</font><font style="display: inline;">)</font><font style="display: inline;">,</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">the aggregate maximum amount the Seller Indemnified Persons may recover from </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent or Buyer pursuant to clause (i) of </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(b)</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">shall be limited to $22,500,000.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288602240"></a><a name="_Ref445048542"></a><a name="_Ref493794359"></a><a name="_Ref368553555"></a><a name="_Ref368555105"></a><a name="_Ref374642291"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Notwithstanding </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.6(a)</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">and except as set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.6(c)</font><font style="display: inline;">:</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">(i) </font><font style="display: inline;">the maximum amount a Buyer Indemnified Person may recover from a Securityholder (i) pursuant to clause (i) of </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(a)</font><font style="display: inline;"> in respect of any breach or inaccuracy of a representation or warranty contained in any of the Fundamental Representations</font><font style="display: inline;">,</font><font style="display: inline;"> or (ii) pursuant to clauses </font><font style="display: inline;">&#x200E;</font><font style="display: inline;">(ii) and </font><font style="display: inline;">&#x200E;</font><font style="display: inline;">(iii) </font><font style="display: inline;">of </font><font style="display: inline;font-weight:bold;">Section</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(a)</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">shall be limited, in the aggregate, to the Pro Rata Portion of the Acquisition Consideration</font><font style="display: inline;">;</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">and (ii) </font><font style="display: inline;">the maximum amount </font><font style="display: inline;">Seller</font><font style="display: inline;"> Indemnified Person</font><font style="display: inline;">s</font><font style="display: inline;"> may recover from </font><font style="display: inline;">CryoLife, Parent or Buyer (A) pursuant to clause (i) of </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(b) </font><font style="display: inline;">in respect of any breach or inaccuracy of a representation or warranty </font><font style="display: inline;">contained in </font><font style="display: inline;font-weight:bold;">Sections </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">6.1</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">(Organizati</font><font style="display: inline;">on, Standing and Power),</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">6.2</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">(Authority),</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">6.4</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">(Capitalization),</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">6.6</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">(No Conflict)</font><font style="display: inline;">, or</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">6.13 </font><font style="display: inline;">(CryoLife Operational Representations) or (B) pursuant </font><font style="display: inline;">to clause (ii) of </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(b)</font><font style="display: inline;">, shall be limited, in the aggregate,</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">the amount of the Acquisition Consideration</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref493794311"></a><a name="_Ref492407048"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(c)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">The liability of a Securityholder in respect of Losses paid, incurred, or sustained, arising out of, resulting from, or related to the matters described in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(a)(v) </font><font style="display: inline;">shall be limited </font><font style="display: inline;">in the aggregate, to the Pro Rata Portion</font><font style="display: inline;"> amount of the Acquisition Consideration</font><font style="display: inline;">. The liability of</font><font style="display: inline;"> CryoLife, Parent and Buyer in respect of Losses paid, incurred, or sustained, arising out of, resulting from, or related to the matters described in </font><font style="display: inline;font-weight:bold;">Section 9.2(b)(iii)</font><font style="display: inline;"> shall be limited </font><font style="display: inline;">to an amount equal to </font><font style="display: inline;">the Acquisition Consideration</font><font style="display: inline;">.</font><font style="display: inline;font-weight:bold;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref493794198"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(d)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Notwithstanding </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.6(a) </font><font style="display: inline;">and </font><font style="display: inline;">except as set forth in </font><font style="display: inline;font-weight:bold;">Section</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.6(b</font><font style="display: inline;">)</font><font style="display: inline;">, the maximum amount a Buyer Indemnified Person may recover from a Securityholder (i) pursuant to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(a)(iv)</font><font style="display: inline;">, shall be limited,</font><font style="display: inline;"> by the respective amounts set forth in </font><font style="display: inline;font-weight:bold;">Schedule 1</font><font style="display: inline;font-weight:bold;">1</font><font style="display: inline;">; provided, however, that the Company or the relevant Company Subsidiary must </font><font style="display: inline;">first </font><font style="display: inline;">resolve respective accruals, </font><font style="display: inline;">provision</font><font style="display: inline;">s</font><font style="display: inline;">, reserve</font><font style="display: inline;">s</font><font style="display: inline;"> or allowance</font><font style="display: inline;">s set forth in the Financials</font><font style="display: inline;">, and then, </font><font style="display: inline;">the Securityholders shall only be liable, subject to the limitations set forth in </font><font style="display: inline;font-weight:bold;">Schedule 1</font><font style="display: inline;font-weight:bold;">1</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">if </font><font style="display: inline;">such </font><font style="display: inline;">accruals, provisions, reserves or allowances </font><font style="display: inline;">is insufficient to the cover the Loss</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444702301"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">76</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(e)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">The Parties&#x2019; respective liability for indemnification for a claim for Losses under this Agreement shall be reduced or excluded to the extent the party seeking indemnification: </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;color:#010000;">(i)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">has recovered any amount in respect of such claim for Losses under an insurance policy, in an amount equal to the amount of such actual recovery, provided that this clause (i) shall not require any party to seek recovery under an insurance policy; or </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:24pt;"><font style="display: inline;color:#010000;">(ii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">such claim arises or the Losses related to such claim are increased by, in each case, any Law that becomes effective only after the date hereof</font><font style="display: inline;">. &nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref448686770"></a><a name="_Ref445048547"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:25pt;"><font style="display: inline;color:#010000;">(f)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Each Securityholder&#x2019;s indemnification obligations pursuant to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(a)</font><font style="display: inline;">, other than from the </font><font style="display: inline;">Indemnity </font><font style="display: inline;">Escrow Fund, shall be in accordance with such Securityholder&#x2019;s Pro Rata Portion and not joint and several with respect to Losses.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(g)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">Each of the Parties shall use commercially reasonable efforts to mitigate the Losses sustained by such Party. In no event shall a Buyer Indemnified Person or a Seller Indemnified Person be entitled to recover the same Loss twice.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc374597740"></a><a name="_Toc487751100"></a><a name="_Toc487788557"></a><a name="_Toc487788749"></a><a name="_Toc487788882"></a><a name="_Toc491721361"></a><a name="_Toc493797818"></a><a name="_Toc493797941"></a><a name="_Toc493844726"></a><a name="_Toc493869219"></a><a name="_Toc493869463"></a><a name="_Toc495394314"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">9.7</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="purchasepriceadjustments"></a><font style="display: inline;font-weight:bold;font-style:italic;">Purchase Price Adjustments</font><font style="display: inline;">.&nbsp;&nbsp;Amounts paid to or on behalf of any person as indemnification under this Agreement shall be treated </font><font style="display: inline;">for all purposes </font><font style="display: inline;">as adjustments to the Acquisition Consideration</font><font style="display: inline;">,</font><font style="display: inline;"> except as otherwise required by applicable Law.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc374597741"></a><a name="_Toc487751101"></a><a name="_Toc487788558"></a><a name="_Toc487788750"></a><a name="_Toc487788883"></a><a name="_Toc491721362"></a><a name="_Toc493797819"></a><a name="_Toc493797942"></a><a name="_Toc493844727"></a><a name="_Toc493869220"></a><a name="_Toc493869464"></a><a name="_Ref494311304"></a><a name="_Toc495394315"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">9.8</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Sole Remedy</font><font style="display: inline;">.&nbsp;&nbsp;Following the Closing, the Parties agree that, except for </font><font style="display: inline;">(i)</font><font style="display: inline;"> the availability of injun</font><font style="display: inline;">ctive or other equitable relief, (ii)</font><font style="display: inline;"> the provisions of </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">3.1</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">and (iii) fraud, </font><font style="display: inline;">the rights to indemnification under this </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;">Article&nbsp;IX</font><font style="display: inline;"> shall be the sole remedy that any Buyer Indemnified Person or Seller Indemnified Person will have in connection with the transactions under this Agreement. </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc487751102"></a><a name="_Toc487788559"></a><a name="_Toc487788751"></a><a name="_Toc487788884"></a><a name="_Ref487815811"></a><a name="_Ref487816439"></a><a name="_Toc491721363"></a><a name="_Toc493797820"></a><a name="_Toc493797943"></a><a name="_Toc493844728"></a><a name="_Toc493869221"></a><a name="_Toc493869465"></a><a name="_Toc495394316"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;font-size:11pt;">9.9</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;font-size:11pt;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Termination</font><font style="display: inline;">.&nbsp; </font><font style="display: inline;">This Agreement may be terminated at any time prior to the Closing:</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref427080635"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(a)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">With the mutual written consent of each of the</font><font style="display: inline;"> Securityholder Representative (on behalf of the Securityholders) and CryoLife</font><font style="display: inline;">;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref427080636"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(b)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">By either </font><font style="display: inline;">the Securityholder Representative (on behalf of the Securityholders) or CryoLife</font><font style="display: inline;">, if the Closing shall not have occurred </font><font style="display: inline;">by 12:01 a.m. </font><font style="display: inline;">Eastern Time</font><font style="display: inline;"> on the date that is </font><font style="display: inline;">ninety </font><font style="display: inline;">(</font><font style="display: inline;">9</font><font style="display: inline;">0) days after the date of this Agreement</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">(the &#x201C;</font><font style="display: inline;font-weight:bold;">Termination Date</font><font style="display: inline;">&#x201D;);</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref427080637"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(c)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">By the</font><font style="display: inline;"> Securityholder Representative (on behalf of the Securityholders)</font><font style="display: inline;">, if </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, or Buyer shall have breached or failed to perform any of their respective representations, warranties, covenants or other agreements contained in this Agreement, which breach or failure to perform </font><font style="display: inline;">(A)</font><font style="display: inline;"> would give rise, if occurring or continuing on the Closing Date, to the failure of a condition set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">8.3</font><font style="display: inline;"> and </font><font style="display: inline;">(B)</font><font style="display: inline;">&nbsp;has not been or is incapable of being cured by such Party prior to the earlier of the </font><font style="display: inline;">(x)</font><font style="display: inline;">&nbsp;Termination Date and </font><font style="display: inline;">(y)</font><font style="display: inline;"> thirtieth (30th) calendar day after such Party&#x2019;s receipt of written notice thereof from the Company;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref427080638"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">77</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(d)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">By </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, if the Company </font><font style="display: inline;">or any of the Securityholders </font><font style="display: inline;">shall have breached or failed to perform any of its representations, warranties, covenants or other agreements contained in this Agreement, which breach or failure to perform </font><font style="display: inline;">(A)</font><font style="display: inline;"> would give rise, if occurring or continuing on the Closing Date, to the failure of a condition set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">8.2</font><font style="display: inline;"> and </font><font style="display: inline;">(B)</font><font style="display: inline;">&nbsp;has not been or is incapable of being cured by the Company prior to the earlier of the </font><font style="display: inline;">(x)</font><font style="display: inline;"> Termination Date and </font><font style="display: inline;">(y)</font><font style="display: inline;"> thirtieth (30th) calendar day after its receipt of written notice thereof from Buyer;</font><font style="display: inline;"> or</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref427080640"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(e)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">By</font><font style="display: inline;"> the Securityholder Representative (on behalf of the Securityholders) </font><font style="display: inline;"> or </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, if </font><font style="display: inline;">(i)</font><font style="display: inline;"> any Governmental Authority shall have enacted, issued, promulgated, enforced or entered any Law (whether temporary, preliminary or permanent) which is then in effect and which has the effect of making the Acquisition illegal or otherwise prohibiting consummation of the Acquisition; or </font><font style="display: inline;">(ii)</font><font style="display: inline;"> any temporary restraining order, preliminary or permanent injunction or other order issued by any court of competent jurisdiction or other legal restraint or prohibition preventing the consummation of the Acquisition shall then be in effect, or any proceeding brought by any Governmental Authority, seeking any of the foregoing shall be then threatened or pending.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Notwithstanding anything else contained in this Agreement, the right to terminate this Agreement under this </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.9</font><font style="display: inline;"> shall not be available to any Party whose breach of its representations or warranties set forth herein or whose failure to fulfill its obligations or to comply with its covenants under this Agreement has been the primary cause of, or primarily resulted in, the failure to satisfy any condition to the obligations of the other Party or Parties hereunder.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="articlex"></a><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#010000;">Article&nbsp;X</font><br /><font style="display: inline;font-weight:bold;text-transform:uppercase;"></font><br /><font style="display: inline;font-weight:bold;text-transform:uppercase;"></font><a name="_Toc341995392"></a><a name="_Ref379485727"></a><a name="_Toc487751103"></a><a name="_Toc487788560"></a><a name="_Toc487788752"></a><a name="_Toc487788885"></a><a name="_Toc491721364"></a><a name="_Toc493797821"></a><a name="_Toc493797944"></a><a name="_Toc493844729"></a><a name="_Toc493869222"></a><a name="_Toc493869466"></a><a name="_Ref494183994"></a><a name="_Ref494211034"></a><a name="_Toc495394317"></a><font style="display: inline;font-weight:bold;text-transform:uppercase;">AMENDMENT AND WAIVER</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc379365657"></a><a name="_Ref288602580"></a><a name="_Toc374597750"></a><a name="_Toc487751104"></a><a name="_Toc487788561"></a><a name="_Toc487788753"></a><a name="_Toc487788886"></a><a name="_Toc491721365"></a><a name="_Toc493797822"></a><a name="_Toc493797945"></a><a name="_Toc493844730"></a><a name="_Toc493869223"></a><a name="_Toc493869467"></a><a name="_Toc495394318"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">10.1</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Amendment</font><font style="display: inline;">.&nbsp;&nbsp;This Agreement</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">may be amended by the Parties hereto at any time by execution of an instrument in writing signed on behalf of the Parties</font><font style="display: inline;">; provided that none of </font><font style="display: inline;">&#x200E;</font><font style="display: inline;">Article&nbsp;X (Amendment and Waiver), </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">11.7</font><font style="display: inline;"> (Governing Law; Venue), this </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">11.11</font><font style="display: inline;"> (Third Party Beneficiaries), </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">11.12</font><font style="display: inline;"> (No Recourse; Certain Limitations on Remedies), and </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">11.13</font><font style="display: inline;"> (Waiver of Jury Trial) may be amended, modified or supplemented in any way that is adverse to the Financing Sources</font><font style="display: inline;">.&nbsp;&nbsp;For purposes of this </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">10.1</font><font style="display: inline;">, the Securityholders agree that any amendment of this Agreement signed by the Securityholder Representative shall be binding upon and effective against each of the Securityholders whether or not they have signed such amendment.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288602606"></a><a name="_Toc374597751"></a><a name="_Toc487751105"></a><a name="_Toc487788562"></a><a name="_Toc487788754"></a><a name="_Toc487788887"></a><a name="_Toc491721366"></a><a name="_Toc493797823"></a><a name="_Toc493797946"></a><a name="_Toc493844731"></a><a name="_Toc493869224"></a><a name="_Toc493869468"></a><a name="_Toc495394319"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">10.2</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Extension; Waiver</font><font style="display: inline;">.&nbsp; </font><font style="display: inline;">CryoLife, Parent and the </font><font style="display: inline;">Buyer</font><font style="display: inline;"> (as a group)</font><font style="display: inline;">, on the one hand, </font><font style="display: inline;">and the </font><font style="display: inline;">Securityholder Representative, on the other hand, may, to the extent legally allowed, (a)&nbsp;extend the time for the performance of any of the obligations of the other Party, (b)&nbsp;waive any inaccuracies in the representations and warranties made by the other Party contained herein or in any document delivered pursuant hereto, and (c)&nbsp;waive compliance with any of the covenants, agreements or conditions for the benefit of such Party contained herein</font><font style="display: inline;">; provided that no waiver or extension shall be valid with respect to </font><font style="display: inline;">&#x200E;</font><font style="display: inline;">Article&nbsp;X (Amendment and </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">78</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">Waiver), </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">11.7</font><font style="display: inline;"> (Governing Law; Venue), this </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">11.11</font><font style="display: inline;"> (Third Party Beneficiaries), </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">11.12</font><font style="display: inline;"> (No Recourse; Certain Limitations on Remedies), and </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">11.13</font><font style="display: inline;"> (Waiver of Jury Trial) without the prior written consent of the Financing Sources</font><font style="display: inline;">.&nbsp;&nbsp;Any agreement on the part of a Party to any such extension or waiver shall be valid only if set forth in an instrument in writing signed on behalf of such Party.&nbsp;&nbsp;For purposes of this </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">10.2</font><font style="display: inline;">, the Securityholders agree that any extension or waiver signed by the Securityholder Representative shall</font><font style="display: inline;">, subject to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">11.11</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">be binding upon and effective against each of the Securityholders whether or not they have signed such extension or waiver.</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="articlexi"></a><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#010000;">Article&nbsp;XI</font><br /><font style="display: inline;font-weight:bold;text-transform:uppercase;"></font><br /><font style="display: inline;font-weight:bold;text-transform:uppercase;"></font><a name="_Ref288596571"></a><a name="_Toc374597752"></a><a name="_Toc487751106"></a><a name="_Toc487788563"></a><a name="_Toc487788755"></a><a name="_Toc487788888"></a><a name="_Toc491721367"></a><a name="_Toc493797824"></a><a name="_Toc493797947"></a><a name="_Toc493844732"></a><a name="_Toc493869225"></a><a name="_Toc493869469"></a><a name="_Toc495394320"></a><font style="display: inline;font-weight:bold;text-transform:uppercase;">GENERAL PROVISIONS</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref289161494"></a><a name="_Toc374597753"></a><a name="_Toc487751107"></a><a name="_Toc487788564"></a><a name="_Toc487788756"></a><a name="_Toc487788889"></a><a name="_Toc491721368"></a><a name="_Toc493797825"></a><a name="_Toc493797948"></a><a name="_Toc493844733"></a><a name="_Toc493869226"></a><a name="_Toc493869470"></a><a name="_Toc495394321"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">11.1</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Notices</font><font style="display: inline;">.&nbsp;&nbsp;All notices and other communications hereunder shall be in writing and shall be deemed given: (i) upon delivery, if delivered personally or by commercial messenger; (ii) one (1) Business Day after deposited with an overnight courier service of international reputation (including Federal Express); (iii) upon successful transmission of </font><font style="display: inline;font-style:italic;text-decoration:underline;">both</font><font style="display: inline;font-style:italic;">&nbsp;</font><font style="display: inline;">facsimile (with confirmation of complete transmission) </font><font style="display: inline;font-style:italic;text-decoration:underline;">and</font><font style="display: inline;"> electronic mail (upon acknowledgment from recipient or reception of read receipt), in each case during ordinary business hours of the recipient, or, if outside the recipient&#x2019;s ordinary business hours, the next Business Day to the Parties at the following addresses (or at such other address for a Party as shall be specified by like notice); or (iv) upon receipt, if sent by mail; in each case if addressed to:</font></font>
		</p>
		<p style="margin:0pt 0pt 0pt 72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">(a)</font><font style="display: inline;color:#000000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;color:#000000;"></font><font style="display: inline;color:#000000;">if to </font><font style="display: inline;color:#000000;">CryoLife, </font><font style="display: inline;color:#000000;">Parent or Buyer, to:</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">CryoLife, Inc.</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">1655 Roberts Blvd.</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Kennesaw, GA 30144</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">U.S.A</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Attention:</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">General Counsel</font>
		</p>
		<p style="margin:0pt 0pt 0pt 108pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Facsimile No. and email address: </font><font style="display: inline;">770-429-5250; </font><font style="display: inline;">Holloway.jean@cryolife.com</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">with a copy (which shall not constitute notice) to:</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Vinson &amp; Elkins LLP</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">2801 Via Fortuna, Suite 100</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Austin, TX 78746-7568</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">U.S.A.</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Attention: </font><font style="display: inline;">Paul R. Tobias</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Facsimile No. and email address: </font><font style="display: inline;">512.236.3266 </font><font style="display: inline;">and ptobias@velaw.com</font>
		</p>
		<p style="margin:0pt 0pt 0pt 72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">(b)</font><font style="display: inline;color:#000000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;color:#000000;"></font><font style="display: inline;color:#000000;">if to the Company</font><font style="display: inline;color:#000000;">, a Securityholder</font><font style="display: inline;color:#000000;"> or the Securityholder Representative, to:</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Mr. Lars Sunnanv</font><font style="display: inline;">&#xE4;</font><font style="display: inline;">der</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">79</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;">c/o LS medcap GmbH</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Lotzen</font><font style="display: inline;">&#xE4;</font><font style="display: inline;">ker 3</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">72379 Hechingen</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Germany</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">with a copy (which shall not constitute notice) to:</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Walder Wyss Ltd</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Seefeldstrasse 123, P.O. Box, 8034 Zurich, Switzerland</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Attention: Markus Vischer and Urs Gnos</font>
		</p>
		<p style="margin:0pt 0pt 12pt 108pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Facsimile No. and email address: </font><font style="display: inline;">+41 58 658 59 59</font><font style="display: inline;"> and </font><font style="display: inline;">markus.vischer@walderwyss.com</font><font style="display: inline;"> and urs.gnos@walderwyss.com</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">And </font><font style="display: inline;">with a copy (which shall not constitute notice) to:</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">SmithAmundsen LLC</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">150 North Michigan Avenue</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">Suite 3300</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Chicago, </font><font style="display: inline;">IL </font><font style="display: inline;">60601</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">U.S.A.</font><font style="display: inline;"> &nbsp; </font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Attention:</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Eric M. Fogel</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Facsimile No. and email address: </font><font style="display: inline;">312-997-1791</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">and efogel@salawus.com</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">or</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">the applicable Securityholder at the address of the Securityholder listed in the Company Disclosure Schedule</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">with a copy (which shall not constitute notice) to:</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Walder Wyss Ltd</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Seefeldstrasse 123, P.O. Box, 8034 Zurich, Switzerland</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Attention: Markus Vischer and Urs Gnos</font>
		</p>
		<p style="margin:0pt 0pt 12pt 108pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Facsimile No. and email address: </font><font style="display: inline;">+41 58 658 59 59</font><font style="display: inline;"> and </font><font style="display: inline;">markus.vischer@walderwyss.com</font><font style="display: inline;"> and urs.gnos@walderwyss.com</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">And </font><font style="display: inline;">with a copy (which shall not constitute notice) to:</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">SmithAmundsen LLC</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">150 North Michigan Avenue</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">Suite 3300</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Chicago, </font><font style="display: inline;">IL </font><font style="display: inline;">60601</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">U.S.A.</font><font style="display: inline;"> &nbsp; </font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Attention:</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Eric M. Fogel</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Facsimile No. and email address: </font><font style="display: inline;">312-997-1791</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">and efogel@salawus.com</font>
		</p>
		<p style="margin:0pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc374597754"></a><a name="_Toc487751108"></a><a name="_Toc487788565"></a><a name="_Toc487788757"></a><a name="_Toc487788890"></a><a name="_Toc491721369"></a><a name="_Toc493797826"></a><a name="_Toc493797949"></a><a name="_Toc493844734"></a><a name="_Toc493869227"></a><a name="_Toc493869471"></a><a name="_Toc495394322"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">80</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">11.2</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="interpretation"></a><font style="display: inline;font-weight:bold;font-style:italic;">Interpretation</font><font style="display: inline;">.&nbsp;&nbsp;The words &#x201C;include,&#x201D; &#x201C;includes&#x201D; and &#x201C;including&#x201D; when used herein shall be deemed in each case to be followed by the words &#x201C;without limitation.&#x201D;&nbsp; </font><font style="display: inline;">Except for the section references or headings in the Company Disclosure Schedule or Parent Disclosure Schedule, t</font><font style="display: inline;">he table of contents and headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc374597755"></a><a name="_Toc487751109"></a><a name="_Toc487788566"></a><a name="_Toc487788758"></a><a name="_Toc487788891"></a><a name="_Toc491721370"></a><a name="_Toc493797827"></a><a name="_Toc493797950"></a><a name="_Toc493844735"></a><a name="_Toc493869228"></a><a name="_Toc493869472"></a><a name="_Toc495394323"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">11.3</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Counterparts</font><font style="display: inline;">.&nbsp;&nbsp;This Agreement may be executed in one or more counterparts, all of which shall be considered one and the same Contract and shall become effective when one or more counterparts have been signed by each of the Parties and delivered to the other Party, it being understood that all Parties need not sign the same counterpart.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc374597756"></a><a name="_Toc487751110"></a><a name="_Toc487788567"></a><a name="_Toc487788759"></a><a name="_Toc487788892"></a><a name="_Ref491720347"></a><a name="_Toc491721371"></a><a name="_Toc493797828"></a><a name="_Toc493797951"></a><a name="_Toc493844736"></a><a name="_Toc493869229"></a><a name="_Toc493869473"></a><a name="_Toc495394324"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">11.4</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Entire Agreement; Assignment</font><font style="display: inline;">.&nbsp;&nbsp;This Agreement, the Related Agreements, the Exhibits </font><font style="display: inline;">and Schedules </font><font style="display: inline;">hereto, the Company Disclosure Schedule, the Parent Disclosure Schedule</font><font style="display: inline;"> and</font><font style="display: inline;"> the Confidentiality Agreement: </font><font style="display: inline;">(a)</font><font style="display: inline;">&nbsp;constitute the entire agreement among the Parties with respect to the subject matter hereof and supersede all prior agreements and understandings both written and oral, among the Parties with respect to the subject matter hereof, </font><font style="display: inline;">(b)</font><font style="display: inline;">&nbsp;are not intended to confer upon any other person any rights or remedies hereunder, and </font><font style="display: inline;">(c)</font><font style="display: inline;">&nbsp;shall not be assigned by operation of law or otherwise without the consent of the Parties</font><font style="display: inline;">; &nbsp;</font><font style="display: inline;font-style:italic;">provided, however</font><font style="display: inline;">, that each of </font><font style="display: inline;">CryoLife </font><font style="display: inline;">Parent and Buyer may </font><font style="display: inline;">assign this Agreement and any of the Related Agreements to which </font><font style="display: inline;">CryoLife, </font><font style="display: inline;">Parent or Buyer is a party to an Affiliate of </font><font style="display: inline;">CryoLife or </font><font style="display: inline;">Parent; </font><font style="display: inline;font-style:italic;">provided further</font><font style="display: inline;"> that no such assignment by </font><font style="display: inline;">CryoLife </font><font style="display: inline;">will relieve </font><font style="display: inline;">CryoLife </font><font style="display: inline;">of its obligations hereunder.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc374597757"></a><a name="_Toc487751111"></a><a name="_Toc487788568"></a><a name="_Toc487788760"></a><a name="_Toc487788893"></a><a name="_Toc491721372"></a><a name="_Toc493797829"></a><a name="_Toc493797952"></a><a name="_Toc493844737"></a><a name="_Toc493869230"></a><a name="_Toc493869474"></a><a name="_Toc495394325"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">11.5</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Severability</font><font style="display: inline;">.&nbsp;&nbsp;In the event that any provision of this Agreement or the application thereof, becomes or is declared by a court of competent jurisdiction to be illegal, void or unenforceable, the remainder of this Agreement will continue in full force and effect and the application of such provision to other persons or circumstances will be interpreted so as reasonably to effect the intent of the Parties.&nbsp;&nbsp;The Parties further agree to replace such void or unenforceable provision of this Agreement with a valid and enforceable provision that will achieve, to the extent possible, the economic, business and other purposes of such void or unenforceable provision.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc374597758"></a><a name="_Toc487751112"></a><a name="_Toc487788569"></a><a name="_Toc487788761"></a><a name="_Toc487788894"></a><a name="_Ref491720166"></a><a name="_Toc491721373"></a><a name="_Toc493797830"></a><a name="_Toc493797953"></a><a name="_Toc493844738"></a><a name="_Toc493869231"></a><a name="_Toc493869475"></a><a name="_Toc495394326"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">11.6</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Other Remedies</font><font style="display: inline;font-weight:bold;font-style:italic;">; Specific Performance</font><font style="display: inline;">. Except as otherwise provided in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.8 </font><font style="display: inline;">of this Agreement</font><font style="display: inline;">, a</font><font style="display: inline;">ny and all remedies herein expressly conferred upon a Party will be deemed cumulative with and not</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">exclusive of any other remedy conferred in this Agreement, or by law or equity upon such Party, and the exercise by a Party of any one remedy will not preclude the exercise of any other remedy and </font><font style="display: inline;">nothing in this Agreement </font><font style="display: inline;">shall be deemed a waiver by any Party of any right to specific performance or injunctive relief.&nbsp; </font><font style="display: inline;">The Parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached.&nbsp;&nbsp;It is accordingly agreed that the Parties shall be entitled to seek an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof, this being in addition to any other remedy to which they are entitled at law or in equity.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc374597759"></a><a name="_Toc487751113"></a><a name="_Toc487788570"></a><a name="_Toc487788762"></a><a name="_Toc487788895"></a><a name="_Ref491720180"></a><a name="_Toc491721374"></a><a name="_Toc493797831"></a><a name="_Toc493797954"></a><a name="_Toc493844739"></a><a name="_Toc493869232"></a><a name="_Toc493869476"></a><a name="_Toc495394327"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">81</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">11.7</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="governinglaw"></a><font style="display: inline;font-weight:bold;font-style:italic;">Governing Law</font><font style="display: inline;font-weight:bold;font-style:italic;">; Venue</font><font style="display: inline;">.&nbsp;&nbsp;This Agreement shall be governed by and construed in accordance with the Laws of the State of Delaware, regardless of the Laws that might otherwise govern under applicable principles of conflicts of laws thereof.&nbsp;&nbsp;Each of the Parties irrevocably </font><font style="display: inline;">and unconditionally </font><font style="display: inline;">consents to </font><font style="display: inline;">and submits, for itself and its assets and properties, to </font><font style="display: inline;">the exclusive jurisdiction </font><font style="display: inline;">(including personal jurisdiction) </font><font style="display: inline;">and venue of any court within the State of Delaware in connection with any matter based upon or arising out of this Agreement or the matters contemplated herein, agrees that process may be served upon them in any manner authorized by the Laws of the State of Delaware for such persons and waives and covenants not to assert or plead any objection which they might otherwise have to such jurisdiction, venue and such process.</font><a name="_Ref427080722"></a><font style="display: inline;"> &nbsp;Each of the Parties irrevocably consents to service of process in the manner provided for notices in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">11.1</font><font style="display: inline;">.&nbsp;&nbsp;NOTWITHSTANDING THE FOREGOING, EACH PARTY AGREES THAT SUCH PARTY SHALL NOT BRING OR SUPPORT ANY DISPUTE, CONTROVERSY, CLAIM OR ACTION OF ANY KIND OR DESCRIPTION, WHETHER IN LAW OR IN EQUITY, AGAINST ANY MEMBER OF THE FINANCING GROUP IN ANY WAY RELATING TO THIS AGREEMENT, THE COMMITMENT LETTER, THE FEE LETTER OR THE FINANCING AGREEMENTS OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY (INCLUDING THE FINANCING), INCLUDING ANY DISPUTE, CONTROVERSY, CLAIM OR ACTION ARISING OUT OF OR RELATING TO THE FINANCING OR THE PERFORMANCE THEREOF, IN ANY FORUM OTHER THAN THE SUPREME COURT OF THE STATE OF NEW YORK, COUNTY OF NEW YORK, OR IF UNDER APPLICABLE LAWS EXCLUSIVE JURISDICTION IS VESTED IN THE FEDERAL COURTS, THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK (AND THE APPELLATE COURTS THEREOF).&nbsp;&nbsp;EACH OF THE PARTIES TO THIS AGREEMENT </font><a name="DocXTextRef561"></a><font style="display: inline;">(I)</font><font style="display: inline;"> IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF EACH SUCH COURT IN ANY SUCH DISPUTE, CONTROVERSY, CLAIM OR ACTION, (II) WAIVES ANY OBJECTION IT MAY NOW OR HEREAFTER HAVE TO VENUE OR TO AN INCONVENIENT FORUM, (III) AGREES THAT ALL SUCH DISPUTES, CONTROVERSIES, CLAIMS AND ACTIONS SHALL BE HEARD AND DETERMINED ONLY IN SUCH COURTS AND (IV) WAIVES ANY RIGHT TO TRIAL BY JURY IN RESPECT OF ANY SUCH DISPUTE, CONTROVERSY, CLAIM OR ACTION.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc374597760"></a><a name="_Ref444776345"></a><a name="_Toc487751114"></a><a name="_Toc487788571"></a><a name="_Toc487788763"></a><a name="_Toc487788896"></a><a name="_Toc491721375"></a><a name="_Toc493797832"></a><a name="_Toc493797955"></a><a name="_Toc493844740"></a><a name="_Toc493869233"></a><a name="_Toc493869477"></a><a name="_Toc495394328"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">11.8</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Rules of Construction</font><font style="display: inline;">.&nbsp;&nbsp;The Parties agree that they have been represented by counsel during the negotiation and execution of this Agreement and, therefore, waive the application of any Law, regulation, holding or rule of construction providin</font><font style="display: inline;">g that ambiguities in a</font><font style="display: inline;"> Contract or other document will be construed against the Party drafting such Contract or document. For purposes of this Agreement, references to the terms &#x201C;delivered to Buyer&#x201D;, &#x201C;delivered to Parent&#x201D;, &#x201C;made available to Buyer&#x201D; or &#x201C;made Available to Parent&#x201D; will mean that the Company has pos</font><font style="display: inline;">t</font><font style="display: inline;">ed true, complete and accurate copies of such materials to the appropriate folder that corresponds with the subject matter of such materials of the </font><font style="display: inline;">VDR </font><font style="display: inline;">and has given </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, Buyer and each of their representatives access to the materials so posted</font><font style="display: inline;">, no later than 11:59 p.m. Eastern Time on October 9, 2017</font><font style="display: inline;">.&nbsp;&nbsp;The Parties intend that each representation, warranty and covenant contained herein shall have independent significance.</font><font style="display: inline;"> &nbsp; &nbsp;</font><font style="display: inline;">If any Party has breached any representation, warranty or covenant contained in this Agreement or any of the Related Agreements in any respect, the fact that there exists another representation, </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">82</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">warranty or covenant relating to the same subject matter (regardless of the relative levels of specificity) that the Party has not breached shall not detract from or mitigate the fact that the Party is in breach of the first representation, warranty or covenant.&nbsp;&nbsp;In addition, each of the Parties acknowledges and agrees that any purchase price adjustment as a result of the application of any provision of this Agreement, the Related Agreements or any of the other Contracts contemplated in this Agreement or the Related Agreements does not prejudice or limit in any respect whatsoever any Person&#x2019;s rights to indemnification under any other provision of this Agreement, the Related Agreements or any other Contracts contemplated in this Agreement or the Related Agreements.</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">All references to dollars or &#x201C;$&#x201D; shall refer to United States Dollars unless otherwise indicated.&nbsp;&nbsp;All references to </font><font style="display: inline;">Euros</font><font style="display: inline;"> or &#x201C;</font><font style="display: inline;">&#x20AC;</font><font style="display: inline;">&#x201D; shall refer to </font><font style="display: inline;">Eurozone Euros</font><font style="display: inline;"> unless otherwise indicated</font><font style="display: inline;">.&nbsp;&nbsp;Unless otherwise specified in this Agreement, c</font><font style="display: inline;">ash payments made by the Parties pursuant to this Agreement </font><font style="display: inline;">first </font><font style="display: inline;">will be </font><font style="display: inline;">c</font><font style="display: inline;">alculated in United States Dollars </font><font style="display: inline;">and then </font><font style="display: inline;">converted </font><font style="display: inline;">prior to payment </font><font style="display: inline;">into Euros</font><font style="display: inline;"> as of the close of business in New York two Business Days prior to the date such payment is made based on the foreign-exchange rate published </font><font style="display: inline;">by the Wall Street Journal on its website at http://online.wsj.com on the &#x201C;Exchange Rates: New York Closing Snapshot&#x201D; page</font><font style="display: inline;color:#000000;"> (or such other page as may replace such page on such service for the purpose of displaying the </font><font style="display: inline;">New York Closing foreign-</font><font style="display: inline;color:#000000;">exchange </font><font style="display: inline;">rate</font><font style="display: inline;color:#000000;"> for the conversion of </font><font style="display: inline;color:#000000;">United States </font><font style="display: inline;color:#000000;">Dollars into Euros or Euros into</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">United States</font><font style="display: inline;color:#000000;"> Dollars)</font><font style="display: inline;color:#000000;">; provided, however, that the cash portion of the Closing Consideration shall be paid to the Paying Agent in Dollars by wire transfer of immediately available funds</font><font style="display: inline;">.</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc374597761"></a><a name="_Toc487751115"></a><a name="_Toc487788572"></a><a name="_Toc487788764"></a><a name="_Toc487788897"></a><a name="_Toc491721376"></a><a name="_Toc493797833"></a><a name="_Toc493797956"></a><a name="_Toc493844741"></a><a name="_Toc493869234"></a><a name="_Toc493869478"></a><a name="_Toc495394329"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">11.9</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="successorsandassigns"></a><font style="display: inline;font-weight:bold;font-style:italic;">Successors and Assigns</font><font style="display: inline;">.&nbsp;&nbsp;The provisions of this Agreement shall be binding upon and inure to the benefit of the Parties hereto and their res</font><a name="_Toc445454891"></a><a name="_Toc374597762"></a><font style="display: inline;">pective successors and assigns. </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc487751116"></a><a name="_Toc487788573"></a><a name="_Toc487788765"></a><a name="_Toc487788898"></a><a name="_Toc491721377"></a><a name="_Toc493797834"></a><a name="_Toc493797957"></a><a name="_Toc493844742"></a><a name="_Toc493869235"></a><a name="_Toc493869479"></a><a name="_Toc495394330"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">11.10</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Taking of Necessary Action</font><font style="display: inline;">.&nbsp;&nbsp;If at any time after the Closing, any further action is necessary or desirable to carry out the purposes of this Agreement and to vest the </font><font style="display: inline;">B</font><font style="display: inline;">uyer with full right, title and possession to all assets, property, rights privileges, powers and franchises of the </font><font style="display: inline;">Securityholders, the </font><font style="display: inline;">Company, </font><font style="display: inline;">the Company Subsidiaries, CryoLife, Parent, and </font><font style="display: inline;">Buyer and the officers and directors of the Company and Buyer are fully authorized in the name of their respective entities or otherwise to take, and </font><font style="display: inline;">together with their respective subsidiaries, </font><font style="display: inline;">will take, all such lawful and necessary action.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc487751117"></a><a name="_Toc487788574"></a><a name="_Toc487788766"></a><a name="_Toc487788899"></a><a name="_Ref491720208"></a><a name="_Ref491720885"></a><a name="_Toc491721378"></a><a name="_Toc493797835"></a><a name="_Toc493797958"></a><a name="_Toc493844743"></a><a name="_Toc493869236"></a><a name="_Toc493869480"></a><a name="_Ref494183868"></a><a name="_Toc495394331"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">11.11</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Third Party Beneficiaries</font><font style="display: inline;">.&nbsp;&nbsp;Except for the provisions of </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.10(a)</font><font style="display: inline;"> and </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;IX</font><font style="display: inline;"> relating to the Buyer Indemnified Persons, Seller Indemnified Persons, and the Securityholders, </font><font style="display: inline;">the provisions of </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.11 </font><font style="display: inline;">relating to</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">the Minority Shareholders that sell their Shares to the Securityholders for delivery by the Securityholders to Buyer at the Closing, and the immediately following proviso, </font><font style="display: inline;">this Agreement shall be binding upon and inure solely to the benefit of the Parties and their respective successors and permitted assigns and nothing herein, express or implied, is intended to or shall confer upon any other person, any legal or equitable right, benefit or remedy of any nature whatsoever, including any rights of employment for any specified period, under or by reason of this Agreement</font><font style="display: inline;">; &nbsp;</font><font style="display: inline;font-style:italic;">provided, however, </font><font style="display: inline;">that each agent, arranger, bookrunner, lender, letter of credit issuer or other financing party that is a party to the Commitment Letter (including the Financing Sources), any of their respective Affiliates or any of their respective officers, directors, employees, agents and representatives and their </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">83</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">successors and assigns (collectively, the &#x201C;</font><font style="display: inline;font-weight:bold;">Financing Group</font><font style="display: inline;">&#x201D;) is an intended third-party beneficiary of</font><font style="display: inline;">, and only with respect to,</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">(i)</font><font style="display: inline;"> any liability cap or other limitation on remedies or damages in this Agreement that are for the benefit of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, or Buyer, and </font><font style="display: inline;">(ii)</font><font style="display: inline;"> the provisions of </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;X</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">(Amendment and Waiver), </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">11.7</font><font style="display: inline;"> (Governing Law; Venue), this </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">11.11</font><font style="display: inline;"> (Third Party Beneficiaries), </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">11.12</font><font style="display: inline;"> (No Recourse; Certain Limitations on Remedies), and </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">11.13</font><font style="display: inline;"> (Waiver of Jury Trial), and each such Section will be enforceable by eac</font><font style="display: inline;">h member of the Financing Group</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref491721265"></a><a name="_Toc491721379"></a><a name="_Toc492967803"></a><a name="_Toc492967929"></a><a name="_Toc492968095"></a><a name="_Toc492968218"></a><a name="_Toc492968340"></a><a name="_Toc492968461"></a><a name="_Toc492968658"></a><a name="_Toc493011676"></a><a name="_Toc493869481"></a><a name="_Toc495394332"></a><a name="_Toc493869237"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">11.12</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><a name="norecourse"></a><font style="display: inline;font-weight:bold;font-style:italic;">No Recourse</font><font style="display: inline;font-weight:bold;font-style:italic;">; Certain Limitations on Remedies</font><font style="display: inline;"> &nbsp; &nbsp;</font><a name="_Toc493869238"></a><font style="display: inline;">Notwithstanding anything to the contrary herein, no member of the Financing Group shall have any liability to the Company or the Securityholders for any obligation or liability, or for any claim for any loss suffered as a result of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">&#x2019;s, Parent&#x2019;s or Buyer&#x2019;s breach of this Agreement or the Commitment Letter, or any document related thereto (including any willful breach thereof) or the failure of the transactions contemplated hereby or thereby to be consummated, or in respect of any oral or written representation made or alleged to have been made, in connection herewith or therewith, whether at equity, at law, in contract, in tort or otherwise. In no event shall any member of the Financing Group have liability to the Company or any Securityholder under this Agreement for any consequential, special, incidental, indirect or punitive damages or for any damages of a tortious nature.</font><a name="_Ref427080699"></a><a name="_Toc374597763"></a><a name="_Toc487751118"></a><a name="_Toc487788575"></a><a name="_Toc487788767"></a><a name="_Toc487788900"></a><a name="_Ref491720378"></a><a name="_Toc491721380"></a><a name="_Toc493797836"></a><a name="_Toc493797959"></a><a name="_Toc493844744"></a><font style="display: inline;"> &nbsp; &nbsp;</font><a name="_Toc493869239"></a><font style="display: inline;">Notwithstanding anything to the contrary contained in this Agreement, the Company and each of the Securityholders acknowledges and agrees that </font><a name="DocXTextRef549"></a><font style="display: inline;">(i)</font><font style="display: inline;"> none of the Securityholders derive, and neither the Company nor any of the Company Subsidiaries derive, any contractual rights, whether as third party beneficiary or otherwise, under the Commitment Letter and will not be entitled to enforce the Commitment Letter against any member of the Financing Group, (ii) the Company and each Company Subsidiary and each Securityholder waives and agrees not to pursue any claim (including any claim under contracts, any claim in tort and any claim for specific performance) it may have against any member of the Financing Group with respect to the failure of the Financing to close, (iii) no member of the Financing Group shall have any liability to the Company, any Company Subsidiary or any of their respective Affiliates or any of the Participating Securityholders hereunder, and (iv) the members of the Financing Group will have no obligation to provide any Financing except in accordance with the terms and conditions of the Commitment Letter</font><font style="display: inline;">.</font><a name="_Ref427080698"></a><font style="display: inline;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:72pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc493869240"></a><a name="_Toc493869482"></a><a name="_Ref494210868"></a><a name="_Ref494376631"></a><a name="_Ref494387175"></a><a name="_Ref494446981"></a><a name="_Toc495394333"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display: inline;color:#010000;">11.13</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;font-weight:bold;font-style:italic;">Waiver of Jury Trial</font><font style="display: inline;">.&nbsp;&nbsp;EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM (WHETHER BASED ON CONTRACT, TORT, OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE ACTIONS OF ANY PARTY IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE OR ENFORCEMENT HEREOF.</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;font-style:italic;">[remainder of page intentionally left blank]</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="text-indent:0pt;margin-left:0pt; padding-right:227pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:center"><font style="display: inline;">-</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">84</font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;">-</font></font>

		</p>

		<p style="margin:6pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;">IN WITNESS </font><font style="display: inline;">WHEREOF</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">the Parties</font><font style="display: inline;"> have caused this </font><font style="display: inline;">Securities</font><font style="display: inline;"> Purchase Agreement to be signed, all as of the </font><font style="display: inline;">date</font><font style="display: inline;"> first written above.</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">CRYOLIFE GERMANY HOLDCO GMBH</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; overflow: hidden; white-space: nowrap;"><font style="display: inline;">By:</font>_________________________________________________________________________________________</font><font style="text-indent:0pt;margin-left:0pt;text-align:right"><font style="display: inline;"></font><br /><font style="display: inline;text-decoration:underline;"></font><font style="display: inline;">Name:</font><br /><font style="display: inline;">Title:</font></font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">JOLLY BUYER ACQUISITION GMBH</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; overflow: hidden; white-space: nowrap;"><font style="display: inline;">By:</font>_________________________________________________________________________________________</font><font style="text-indent:0pt;margin-left:0pt;text-align:right"><font style="display: inline;"></font><br /><font style="display: inline;text-decoration:underline;"></font><font style="display: inline;">Name:</font><br /><font style="display: inline;">Title:</font></font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">CRYOLIFE, INC.</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; overflow: hidden; white-space: nowrap;"><font style="display: inline;">By:</font>_________________________________________________________________________________________</font><font style="text-indent:0pt;margin-left:0pt;text-align:right"><font style="display: inline;"></font><br /><font style="display: inline;text-decoration:underline;"></font><font style="display: inline;">Name:</font><br /><font style="display: inline;">Title:</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;font-size:11pt;">Project Jolly</font>

		</p>

		<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;font-size:11pt;">Securities Purchase Agreement</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;"></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">IN WITNESS WHEREOF, </font><font style="display: inline;">the Parties</font><font style="display: inline;"> have caused this </font><font style="display: inline;">Securities</font><font style="display: inline;"> Purchase Agreement to be signed, all as of the date first written above.</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">JOTEC AG</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:465.95pt;text-align:left"><font style="display: inline;"></font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;color:#000000;">Power of Attorney Confirmation</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">This Agreement has been executed by</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Lars Sunnanv</font><font style="display: inline;">&#xE4;</font><font style="display: inline;">der</font><font style="display: inline;color:#000000;"> on behalf of</font><font style="display: inline;"> the Company </font><font style="display: inline;color:#000000;">pursuant to the power of attorney granted under that certain Proxy between the undersigned and the Company, dated on or about October 9, 2017, a copy of which has been made available to Buyer.&nbsp; By executing this Agreement on behalf of the Company pursuant to such power of attorney, the undersigned represents and warrants to CryoLife, Parent and Buyer that the power of attorney granted pursuant to such Proxy is valid and enforceable and has not been revoked by the Company, and that the Company has reviewed and understands the terms of the Agreement and agrees to be bound hereby.&nbsp; </font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;text-decoration:underline;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">By: </font><font style="display: inline;">Lars Sunnanv</font><font style="display: inline;">&#xE4;</font><font style="display: inline;">der</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;font-size:11pt;">Project Jolly</font>

		</p>

		<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;font-size:11pt;">Securities Purchase Agreement</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;"></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">IN WITNESS WHEREOF, </font><font style="display: inline;">the Parties</font><font style="display: inline;"> have caused this </font><font style="display: inline;">Securities</font><font style="display: inline;"> Purchase Agreement to be signed, all as of the date first written above.</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">SECURITYHOLDER REPRESENTATIVE</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;text-decoration:underline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; overflow: hidden; white-space: nowrap;"><font style="display: inline;">By:</font>_________________________________________________________________________________________________________________</font><font style="text-indent:0pt;margin-left:0pt;text-align:right"><font style="display: inline;"></font></font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lars Sunnanv</font><font style="display: inline;">&#xE4;</font><font style="display: inline;">der</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;font-size:11pt;">Project Jolly</font>

		</p>

		<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;font-size:11pt;">Securities Purchase Agreement</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;"></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">IN WITNESS WHEREOF, each of the undersigned </font><font style="display: inline;">Parties has caused this</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Securities</font><font style="display: inline;"> Purchase Agreement to be signed, all as of the date first written above.</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">SECURITYHOLDERS</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; overflow: hidden; white-space: nowrap;"><font style="display: inline;">By:</font>_________________________________________________________________________</font><font style="text-indent:0pt;margin-left:0pt;text-align:right"><font style="display: inline;"></font><br /><font style="display: inline;text-decoration:underline;"></font><font style="display: inline;">Name: Urs Christen</font></font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;color:#000000;">Power of Attorney Confirmation</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">This Agreement has been executed by</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Lars Sunnanv</font><font style="display: inline;">&#xE4;</font><font style="display: inline;">der</font><font style="display: inline;color:#000000;"> on behalf of </font><font style="display: inline;">Urs Christen</font><font style="display: inline;color:#000000;"> (the &#x201C;Represented Securityholder&#x201D;) pursuant to the power of attorney granted under that certain Proxy between the undersigned and the Represented Securityholder, dated on or about October 9, 2017, a copy of which has been made available to Buyer.&nbsp; By executing this Agreement on behalf of the Represented Securityholder pursuant to such power of attorney, the undersigned represents and warrants to CryoLife, Parent and Buyer that the power of attorney granted pursuant to such Proxy is valid and enforceable and has not been revoked by the Represented Securityholder, and that the Represented Securityholder has reviewed and understands the terms of the Agreement and agrees to be bound hereby.&nbsp; </font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;text-decoration:underline;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">By: </font><font style="display: inline;">Lars Sunnanv</font><font style="display: inline;">&#xE4;</font><font style="display: inline;">der</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;font-size:11pt;">Project Jolly</font>

		</p>

		<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;font-size:11pt;">Securities Purchase Agreement</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;"></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">IN WITNESS WHEREOF, each of the undersigned </font><font style="display: inline;">Parties has caused this</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Securities</font><font style="display: inline;"> Purchase Agreement to be signed, all as of the date first written above.</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">SECURITYHOLDERS</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; overflow: hidden; white-space: nowrap;"><font style="display: inline;">By:</font>_______________________________________________________________</font><font style="text-indent:0pt;margin-left:0pt;text-align:right"><font style="display: inline;"></font><br /><font style="display: inline;text-decoration:underline;"></font><font style="display: inline;">Name: Dr. med. Josef Gut</font></font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;color:#000000;">Power of Attorney Confirmation</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">This Agreement has been executed by</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Lars Sunnanv</font><font style="display: inline;">&#xE4;</font><font style="display: inline;">der</font><font style="display: inline;color:#000000;"> on behalf of </font><font style="display: inline;">Dr. med. Josef Gut</font><font style="display: inline;color:#000000;"> (the &#x201C;Represented Securityholder&#x201D;) pursuant to the power of attorney granted under that certain Proxy between the undersigned and the Represented Securityholder, dated on or about October 9, 2017, a copy of which has been made available to Buyer.&nbsp; By executing this Agreement on behalf of the Represented Securityholder pursuant to such power of attorney, the undersigned represents and warrants to CryoLife, Parent and Buyer that the power of attorney granted pursuant to such Proxy is valid and enforceable and has not been revoked by the Represented Securityholder, and that the Represented Securityholder has reviewed and understands the terms of the Agreement and agrees to be bound hereby.&nbsp; </font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;text-decoration:underline;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">By: </font><font style="display: inline;">Lars Sunnanv</font><font style="display: inline;">&#xE4;</font><font style="display: inline;">der</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;font-size:11pt;">Project Jolly</font>

		</p>

		<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;font-size:11pt;">Securities Purchase Agreement</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-weight:bold;"></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">IN WITNESS WHEREOF, each of the undersigned </font><font style="display: inline;">Parties has caused this</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Securities</font><font style="display: inline;"> Purchase Agreement to be signed, all as of the date first written above.</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">SECURITYHOLDERS</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">LS MEDCAP GMBH</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; overflow: hidden; white-space: nowrap;"><font style="display: inline;">By:</font>___________________________________________________________________________________________________</font><font style="text-indent:0pt;margin-left:0pt;text-align:right"><font style="display: inline;"></font><br /><font style="display: inline;text-decoration:underline;"></font><font style="display: inline;">Name: </font></font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Title: </font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;font-size:11pt;">Project Jolly</font>

		</p>

		<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;font-size:11pt;">Securities Purchase Agreement</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;"></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">IN WITNESS WHEREOF, each of the undersigned </font><font style="display: inline;">Parties has caused this</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Securities</font><font style="display: inline;"> Purchase Agreement to be signed, all as of the date first written above.</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">SECURITYHOLDERS</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; overflow: hidden; white-space: nowrap;"><font style="display: inline;">By:</font>_______________________________________________________________</font><font style="text-indent:0pt;margin-left:0pt;text-align:right"><font style="display: inline;"></font><br /><font style="display: inline;text-decoration:underline;"></font><font style="display: inline;">Name: Anna Sunnanv</font><font style="display: inline;">&#xE4;</font><font style="display: inline;">der</font></font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;color:#000000;">Power of Attorney Confirmation</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">This Agreement has been executed by</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Lars Sunnanv</font><font style="display: inline;">&#xE4;</font><font style="display: inline;">der</font><font style="display: inline;color:#000000;"> on behalf of </font><font style="display: inline;">Anna Sunnanv</font><font style="display: inline;">&#xE4;</font><font style="display: inline;">der</font><font style="display: inline;color:#000000;"> (the &#x201C;Represented Securityholder&#x201D;) pursuant to the power of attorney granted under that certain Proxy between the undersigned and the Represented Securityholder, dated on or about October 9, 2017, a copy of which has been made available to Buyer.&nbsp; By executing this Agreement on behalf of the Represented Securityholder pursuant to such power of attorney, the undersigned represents and warrants to CryoLife, Parent and Buyer that the power of attorney granted pursuant to such Proxy is valid and enforceable and has not been revoked by the Represented Securityholder, and that the Represented Securityholder has reviewed and understands the terms of the Agreement and agrees to be bound hereby.&nbsp; </font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;text-decoration:underline;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">By: </font><font style="display: inline;">Lars Sunnanv</font><font style="display: inline;">&#xE4;</font><font style="display: inline;">der</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;font-size:11pt;">Project Jolly</font>

		</p>

		<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;font-size:11pt;">Securities Purchase Agreement</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;"></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">IN WITNESS WHEREOF, each of the undersigned </font><font style="display: inline;">Parties has caused this</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Securities</font><font style="display: inline;"> Purchase Agreement to be signed, all as of the date first written above.</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">SECURITYHOLDERS</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; overflow: hidden; white-space: nowrap;"><font style="display: inline;">By:</font>_________________________________________________________</font><font style="text-indent:0pt;margin-left:0pt;text-align:right"><font style="display: inline;"></font><br /><font style="display: inline;text-decoration:underline;"></font><font style="display: inline;">Name: Monika Sunnanv</font><font style="display: inline;">&#xE4;</font><font style="display: inline;">der</font></font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;color:#000000;">Power of Attorney Confirmation</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">This Agreement has been executed by</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Lars Sunnanv</font><font style="display: inline;">&#xE4;</font><font style="display: inline;">der</font><font style="display: inline;color:#000000;"> on behalf of </font><font style="display: inline;">Monika Sunnanv</font><font style="display: inline;">&#xE4;</font><font style="display: inline;">der</font><font style="display: inline;color:#000000;"> (the &#x201C;Represented Securityholder&#x201D;) pursuant to the power of attorney granted under that certain Proxy between the undersigned and the Represented Securityholder, dated on or about October 9, 2017, a copy of which has been made available to Buyer.&nbsp; By executing this Agreement on behalf of the Represented Securityholder pursuant to such power of attorney, the undersigned represents and warrants to CryoLife, Parent and Buyer that the power of attorney granted pursuant to such Proxy is valid and enforceable and has not been revoked by the Represented Securityholder, and that the Represented Securityholder has reviewed and understands the terms of the Agreement and agrees to be bound hereby.&nbsp; </font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;text-decoration:underline;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">By: </font><font style="display: inline;">Lars Sunnanv</font><font style="display: inline;">&#xE4;</font><font style="display: inline;">der</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;font-size:11pt;">Project Jolly</font>

		</p>

		<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;font-size:11pt;">Securities Purchase Agreement</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;"></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">IN WITNESS WHEREOF, each of the undersigned </font><font style="display: inline;">Parties has caused this</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Securities</font><font style="display: inline;"> Purchase Agreement to be signed, all as of the date first written above.</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">SECURITYHOLDERS</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; overflow: hidden; white-space: nowrap;"><font style="display: inline;">By:</font>___________________________________________________________</font><font style="text-indent:0pt;margin-left:0pt;text-align:right"><font style="display: inline;"></font><br /><font style="display: inline;text-decoration:underline;"></font><font style="display: inline;">Name: Annika Sunnanv</font><font style="display: inline;">&#xE4;</font><font style="display: inline;">der</font></font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;color:#000000;">Power of Attorney Confirmation</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">This Agreement has been executed by</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Lars Sunnanv</font><font style="display: inline;">&#xE4;</font><font style="display: inline;">der</font><font style="display: inline;color:#000000;"> on behalf of </font><font style="display: inline;">Annika Sunnanv</font><font style="display: inline;">&#xE4;</font><font style="display: inline;">der</font><font style="display: inline;color:#000000;"> (the &#x201C;Represented Securityholder&#x201D;) pursuant to the power of attorney granted under that certain Proxy between the undersigned and the Represented Securityholder, dated on or about October 9, 2017, a copy of which has been made available to Buyer.&nbsp; By executing this Agreement on behalf of the Represented Securityholder pursuant to such power of attorney, the undersigned represents and warrants to CryoLife, Parent and Buyer that the power of attorney granted pursuant to such Proxy is valid and enforceable and has not been revoked by the Represented Securityholder, and that the Represented Securityholder has reviewed and understands the terms of the Agreement and agrees to be bound hereby.&nbsp; </font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;text-decoration:underline;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">By: </font><font style="display: inline;">Lars Sunnanv</font><font style="display: inline;">&#xE4;</font><font style="display: inline;">der</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;font-size:11pt;">Project Jolly</font>

		</p>

		<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;font-size:11pt;">Securities Purchase Agreement</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;"></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">IN WITNESS WHEREOF, each of the undersigned </font><font style="display: inline;">Parties has caused this</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Securities</font><font style="display: inline;"> Purchase Agreement to be signed, all as of the date first written above.</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">SECURITYHOLDERS</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; overflow: hidden; white-space: nowrap;"><font style="display: inline;">By:</font>_________________________________________________________</font><font style="text-indent:0pt;margin-left:0pt;text-align:right"><font style="display: inline;"></font><br /><font style="display: inline;text-decoration:underline;"></font><font style="display: inline;">Name: Thomas Bogensch</font><font style="display: inline;">&#xFC;</font><font style="display: inline;">tz</font></font>
		</p>
		<p style="margin:24pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="schedule1"></a><a name="_Ref288752390"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;font-size:11pt;">Project Jolly</font>

		</p>

		<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;font-size:11pt;">Securities Purchase Agreement</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-weight:bold;color:#010000;text-decoration:underline;">Schedule&nbsp;1</font><br /><font style="display: inline;font-weight:bold;"></font><br /><font style="display: inline;font-weight:bold;"></font><font style="display: inline;font-weight:bold;">Securityhol</font><font style="display: inline;font-weight:bold;">ders</font><font style="display: inline;font-weight:bold;font-size:6pt;vertical-align:super;line-height:100%">&nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:428.75pt;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:74.35pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:15.00pt;padding:0pt 4.2pt;">
					<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Surname/Company</font></p>
				</td>
				<td valign="top" style="width:56.20pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:15.00pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">First Name</font></p>
				</td>
				<td valign="top" style="width:116.80pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:15.00pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Address</font></p>
				</td>
				<td valign="top" style="width:80.40pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:15.00pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Country, ZIP, City</font></p>
				</td>
				<td valign="top" style="width:44.30pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:15.00pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Shares</font></p>
				</td>
				<td valign="top" style="width:56.70pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:15.00pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Ownership</font></p>
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">(in %)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:74.35pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:56.20pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:116.80pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:80.40pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:44.30pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:56.70pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:74.35pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Christen</font></p>
				</td>
				<td valign="top" style="width:56.20pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Urs</font></p>
				</td>
				<td valign="top" style="width:116.80pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Hagenmatt</font></p>
				</td>
				<td valign="top" style="width:80.40pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">CH-5637 Geltwil</font></p>
				</td>
				<td valign="top" style="width:44.30pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;color:#000000;font-size:8pt;">31,803</font></p>
				</td>
				<td valign="top" style="width:56.70pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;color:#000000;font-size:8pt;">29.4%</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:74.35pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:25.50pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Gut</font></p>
				</td>
				<td valign="top" style="width:56.20pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:25.50pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Josef</font><br /><font style="display: inline;font-size:8pt;">Dr. med.</font></p>
				</td>
				<td valign="top" style="width:116.80pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:25.50pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Heideggstrasse 12</font></p>
				</td>
				<td valign="top" style="width:80.40pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:25.50pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">CH-5630 Muri AG</font></p>
				</td>
				<td valign="top" style="width:44.30pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:25.50pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;color:#000000;font-size:8pt;">13,200</font></p>
				</td>
				<td valign="top" style="width:56.70pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:25.50pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;color:#000000;font-size:8pt;">12.2%</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:74.35pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">LS MedCap GmbH</font></p>
				</td>
				<td valign="top" style="width:56.20pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:116.80pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Lotzen&#xE4;cker 3</font></p>
				</td>
				<td valign="top" style="width:80.40pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">D-72379 Hechingen</font></p>
				</td>
				<td valign="top" style="width:44.30pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">27,740</font></p>
				</td>
				<td valign="top" style="width:56.70pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;color:#000000;font-size:8pt;">25.7%</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:74.35pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Sunnanv&#xE4;der</font></p>
				</td>
				<td valign="top" style="width:56.20pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Anna</font></p>
				</td>
				<td valign="top" style="width:116.80pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Silberburgstrasse 12</font></p>
				</td>
				<td valign="top" style="width:80.40pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">D-72379 Hechingen</font></p>
				</td>
				<td valign="top" style="width:44.30pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;color:#000000;font-size:8pt;">9,600</font></p>
				</td>
				<td valign="top" style="width:56.70pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;color:#000000;font-size:8pt;">8.9%</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:74.35pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Sunnanv&#xE4;der</font></p>
				</td>
				<td valign="top" style="width:56.20pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Monika</font></p>
				</td>
				<td valign="top" style="width:116.80pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Sumatrakade 185</font></p>
				</td>
				<td valign="top" style="width:80.40pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">NL-1019 PJ Amsterdam</font></p>
				</td>
				<td valign="top" style="width:44.30pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;color:#000000;font-size:8pt;">9,600</font></p>
				</td>
				<td valign="top" style="width:56.70pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;color:#000000;font-size:8pt;">8.9%</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:74.35pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Sunnanv&#xE4;der</font></p>
				</td>
				<td valign="top" style="width:56.20pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Annika</font></p>
				</td>
				<td valign="top" style="width:116.80pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Rue de Lausanne 11, App. 19 B</font></p>
				</td>
				<td valign="top" style="width:80.40pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">CH-1110 Morges</font></p>
				</td>
				<td valign="top" style="width:44.30pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;color:#000000;font-size:8pt;">9,600</font></p>
				</td>
				<td valign="top" style="width:56.70pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;color:#000000;font-size:8pt;">8.9%</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:74.35pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Bogensch&#xFC;tz</font></p>
				</td>
				<td valign="top" style="width:56.20pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Thomas</font></p>
				</td>
				<td valign="top" style="width:116.80pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Ortsteil Stein, Staigstrasse 22</font></p>
				</td>
				<td valign="top" style="width:80.40pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">D-72379 Hechingen</font></p>
				</td>
				<td valign="top" style="width:44.30pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;color:#000000;font-size:8pt;">380</font></p>
				</td>
				<td valign="top" style="width:56.70pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;color:#000000;font-size:8pt;">0.4%</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="4" valign="top" style="width:327.75pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Total Shareholding as of the date of this Agreement</font></p>
				</td>
				<td valign="top" style="width:44.30pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;color:#000000;font-size:8pt;">101,923</font></p>
				</td>
				<td valign="top" style="width:56.70pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:14.25pt;padding:0pt 4.2pt;">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;color:#000000;font-size:8pt;">94.4%</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt 0pt 10pt;line-height:115%;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="schedule2"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 1-</font><font style="display: inline;">1</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-weight:bold;color:#010000;text-decoration:underline;">Schedule&nbsp;2</font><br /><font style="display: inline;font-weight:bold;"></font><br /><font style="display: inline;font-weight:bold;"></font><font style="display: inline;font-weight:bold;">Company Subsidiaries</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">JOTEC GmbH</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">Lotzen&#xE4;cker 23</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">72379 Hechingen</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">Germany</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">An entity organized under the laws of Germany, also having operations in Belgium, the Netherlands, Luxembourg, and Austria</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">JOTEC sales AG</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">Luzernerstrasse 91</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">5630 Muri</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">Switzerland</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">An entity organized under the laws of Switzerland</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">JOTEC S.r.l. </font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">Vicolo Valtellina n.15</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">20092 Milano, Cinisello Balsamo</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">Italy</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">An entity organized under the laws of Italy</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">JOTEC Polska Sp. z o.o.</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">ul. Pory 78</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">02-757 Warszawa</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">Poland</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">An entity organized under the laws of Poland</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">JOTEC UK Limited</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">6 Abbey Lane Court</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">Evesham WR11 4BY</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">United Kingdom</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">A limited company organized under the laws of England and Wales</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">JOTEC Cardiovascular, S.L.</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">Av. Castilla, 2 P.E. San Fernando</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">28830 San Fernando de Henares,</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">Madrid</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">Spain</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">An entity organized under the laws of Spain</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">JOTEC do Brasil Importa&#xE7;&#xE3;o e Com&#xE9;rcio de Equipamentos Hospitalares Ltda.</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">Rua Doutor Eraldo Aur&#xE9;lio Franzese,</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">nr. 215, Paiquer&#xEA;, CEP 13271-608,</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">Valinhos</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">Brazil</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">An entity organized under the laws of Brazil</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="schedule3"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 2-</font><font style="display: inline;">1</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-weight:bold;color:#010000;text-decoration:underline;">Schedule&nbsp;3</font><br /><font style="display: inline;font-weight:bold;"></font><br /><font style="display: inline;font-weight:bold;"></font><font style="display: inline;font-weight:bold;">Company Products</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-indent: -17.85pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:-17.85pt; padding-right:325.55pt;"><font style="display: inline;color:#FF6600;font-size:8pt;"></font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#FF6600;font-size:8pt;"></font><font style="display: inline;font-weight:bold;">JOTEC</font><font style="display: inline;font-weight:bold;font-size:10pt;font-size:5pt;vertical-align:super;line-height:100%">&#xAE; &nbsp;</font><font style="display: inline;">FlowLine Bipore; ePTFE Vascular Grafts</font><font style="display: inline;"></font></font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-indent: -17.85pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:-17.85pt; padding-right:325.55pt;"><font style="display: inline;color:#FF6600;font-size:8pt;"></font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#FF6600;font-size:8pt;"></font><font style="display: inline;font-weight:bold;">JOTEC</font><font style="display: inline;font-weight:bold;font-size:10pt;font-size:5pt;vertical-align:super;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;">FlowLine Bipore HEPARIN; ePTFE Vascular Grafts</font><font style="display: inline;font-size:10pt;"></font></font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-indent: -17.85pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:-17.85pt; padding-right:325.55pt;"><font style="display: inline;color:#FF6600;font-size:8pt;"></font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#FF6600;font-size:8pt;"></font><font style="display: inline;font-weight:bold;">JOTEC</font><font style="display: inline;font-weight:bold;font-size:10pt;font-size:5pt;vertical-align:super;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;">Flow Weave; Textile Vascular Grafts</font><font style="display: inline;font-size:10pt;"></font></font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-indent: -17.85pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:-17.85pt; padding-right:325.55pt;"><font style="display: inline;color:#FF6600;font-size:8pt;"></font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#FF6600;font-size:8pt;"></font><font style="display: inline;font-weight:bold;">JOTEC</font><font style="display: inline;font-weight:bold;font-size:10pt;font-size:5pt;vertical-align:super;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;">FlowWeave Bioseal; Textile Vascular Grafts</font><font style="display: inline;font-size:10pt;"></font></font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-indent: -17.85pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:-17.85pt; padding-right:325.55pt;"><font style="display: inline;color:#FF6600;font-size:8pt;"></font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#FF6600;font-size:8pt;"></font><font style="display: inline;font-weight:bold;">JOTEC</font><font style="display: inline;font-weight:bold;font-size:10pt;font-size:5pt;vertical-align:super;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;">Flow Weave PLUS; Textile Vascular Grafts</font><font style="display: inline;font-size:10pt;"></font></font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-indent: -17.85pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:-17.85pt; padding-right:325.55pt;"><font style="display: inline;color:#FF6600;font-size:8pt;"></font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#FF6600;font-size:8pt;"></font><font style="display: inline;font-weight:bold;">JOTEC</font><font style="display: inline;font-weight:bold;font-size:10pt;font-size:5pt;vertical-align:super;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;">FlowNit; Textile Vascular Grafts</font><font style="display: inline;font-size:10pt;"></font></font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-indent: -17.85pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:-17.85pt; padding-right:325.55pt;"><font style="display: inline;color:#FF6600;font-size:8pt;"></font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#FF6600;font-size:8pt;"></font><font style="display: inline;font-weight:bold;">JOTEC</font><font style="display: inline;font-weight:bold;font-size:10pt;font-size:5pt;vertical-align:super;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;">FlowNit Bioseal; Textile Vascular Grafts</font><font style="display: inline;font-size:10pt;"></font></font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-indent: -17.85pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:-17.85pt; padding-right:325.55pt;"><font style="display: inline;color:#FF6600;font-size:8pt;"></font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#FF6600;font-size:8pt;"></font><font style="display: inline;font-weight:bold;">JOTEC</font><font style="display: inline;font-weight:bold;font-size:10pt;font-size:5pt;vertical-align:super;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;">E-vita thoracic 3G; TAA Stent Graft System</font><font style="display: inline;"></font></font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-indent: -17.85pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:-17.85pt; padding-right:325.55pt;"><font style="display: inline;color:#FF6600;font-size:8pt;"></font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#FF6600;font-size:8pt;"></font><font style="display: inline;font-weight:bold;">JOTEC</font><font style="display: inline;font-weight:bold;font-size:10pt;font-size:5pt;vertical-align:super;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;">E-vita open plus; Hybrid Stent Graft System</font><font style="display: inline;font-size:10pt;"></font></font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-indent: -17.85pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:-17.85pt; padding-right:325.55pt;"><font style="display: inline;color:#FF6600;font-size:8pt;"></font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#FF6600;font-size:8pt;"></font><font style="display: inline;font-weight:bold;">JOTEC</font><font style="display: inline;font-weight:bold;font-size:10pt;font-size:5pt;vertical-align:super;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;">E-vita abdominal XT; AAA Stent Graft System; MB (Main Body), CL (Contralateral leg), AE (Aortic Extension), IE (Iliac Extension)</font><font style="display: inline;font-size:10pt;"></font></font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-indent: -17.85pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:-17.85pt; padding-right:325.55pt;"><font style="display: inline;color:#FF6600;font-size:8pt;"></font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#FF6600;font-size:8pt;"></font><font style="display: inline;font-weight:bold;">JOTEC</font><font style="display: inline;font-weight:bold;font-size:10pt;font-size:5pt;vertical-align:super;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;">E-tegra; AAA Stent Graft System; MB (Main Body), CL (Contralateral leg), AE (Aortic Extension), IE (Iliac Extension)</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-indent: -17.85pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:-17.85pt; padding-right:325.55pt;"><font style="display: inline;color:#FF6600;font-size:8pt;"></font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#FF6600;font-size:8pt;"></font><font style="display: inline;font-weight:bold;">JOTEC</font><font style="display: inline;font-weight:bold;font-size:10pt;font-size:5pt;vertical-align:super;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;">E-liac; Stent Graft System</font><font style="display: inline;font-size:10pt;"></font></font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-indent: -17.85pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:-17.85pt; padding-right:325.55pt;"><font style="display: inline;color:#FF6600;font-size:8pt;"></font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#FF6600;font-size:8pt;"></font><font style="display: inline;font-weight:bold;">JOTEC</font><font style="display: inline;font-weight:bold;font-size:10pt;font-size:5pt;vertical-align:super;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;">E-XL; Aortic Bare Stent</font><font style="display: inline;font-size:10pt;"></font></font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-indent: -17.85pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 3-</font><font style="display: inline;"></font><font style="display: inline;">1</font><font style="display: inline;"></font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-indent: -17.85pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="text-indent:0pt;margin-left:-17.85pt; padding-right:325.55pt;"><font style="display: inline;color:#FF6600;font-size:8pt;"></font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#FF6600;font-size:8pt;"></font><font style="display: inline;font-weight:bold;">JOTEC</font><font style="display: inline;font-weight:bold;font-size:10pt;font-size:5pt;vertical-align:super;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;">E-xpand; Stentgraft Balloon Catheter</font><font style="display: inline;font-size:10pt;"></font></font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-indent: -17.85pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:-17.85pt; padding-right:325.55pt;"><font style="display: inline;color:#FF6600;font-size:8pt;"></font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#FF6600;font-size:8pt;"></font><font style="display: inline;font-weight:bold;">JOTEC</font><font style="display: inline;font-weight:bold;font-size:10pt;font-size:5pt;vertical-align:super;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;">E-wire; Guidewire to TAA Stent Graft</font></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-weight:bold;font-size:10pt;"></font><font style="display: inline;font-weight:bold;font-size:10pt;"></font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-indent: -17.85pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:-17.85pt; padding-right:325.55pt;"><font style="display: inline;color:#FF6600;font-size:8pt;"></font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#FF6600;font-size:8pt;"></font><font style="display: inline;font-weight:bold;">JOTEC</font><font style="display: inline;font-weight:bold;font-size:10pt;font-size:5pt;vertical-align:super;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;">E-ventus BX; Peripheral Stent Graft System</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 35.7pt;text-indent: -17.85pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:-17.85pt; padding-right:325.55pt;"><font style="display: inline;color:#FF6600;font-size:8pt;"></font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#FF6600;font-size:8pt;"></font><font style="display: inline;">E-xtra Design Engineering services</font><font style="display: inline;font-size:8pt;"></font></font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;"><img src="c199-20171010xex2_1g001.jpg" style="width: 6.579706in; height: 3.40493in" alt="Picture 1"></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 3-</font><font style="display: inline;"></font><font style="display: inline;">2</font><font style="display: inline;"></font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 10pt"><font style="display: inline;font-size:10pt;"></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="schedule4"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 3-</font><font style="display: inline;"></font><font style="display: inline;">3</font><font style="display: inline;"></font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-weight:bold;color:#010000;text-decoration:underline;">Schedule&nbsp;4</font><br /><font style="display: inline;font-weight:bold;"></font><br /><font style="display: inline;font-weight:bold;"></font><font style="display: inline;font-weight:bold;">Consideration Schedule</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">[circulated separately]</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="schedule5"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 4-</font><font style="display: inline;">1</font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-weight:bold;color:#010000;text-decoration:underline;">Schedule&nbsp;5</font><br /><font style="display: inline;font-weight:bold;"></font><br /><font style="display: inline;font-weight:bold;"></font><font style="display: inline;font-weight:bold;">Defined Terms</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">$</font><font style="display: inline;">&#x201D; shall have the meaning set forth in Section&nbsp;</font><font style="display: inline;">&#x200E;</font><font style="display: inline;">11.8</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Accounts Payable</font><font style="display: inline;">&#x201D; shall mean </font><font style="display: inline;">each of the </font><font style="display: inline;">accounts payable, notes payable and other payables ge</font><font style="display: inline;">nerated in connection with the B</font><font style="display: inline;">usiness of the Co</font><font style="display: inline;">mpany and the Company Subsidiaries</font><font style="display: inline;">. &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Accounts Receivable</font><font style="display: inline;">&#x201D; shall mean </font><font style="display: inline;">each of the </font><font style="display: inline;">accounts receivable, notes receivable and other receivables generated in connection with the </font><font style="display: inline;">B</font><font style="display: inline;">usiness of the Company and the Company Subsidiar</font><font style="display: inline;">ies</font><font style="display: inline;">.</font><a name="_Ref289351084"></a>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288599502"></a><a name="_Ref368647149"></a><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Acquisition</font><font style="display: inline;">&#x201D; shall have the meaning set forth in</font><font style="display: inline;"> the Recitals.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Acquisition Consideration</font><font style="display: inline;">&#x201D; &nbsp;</font><font style="display: inline;">shall mean the sum of</font><font style="display: inline;"> (a) the Cash Base Amount plus (b) the Equity Base Amount </font><font style="display: inline;text-decoration:underline;">minus</font><font style="display: inline;"> (c) </font><font style="display: inline;">the</font><font style="display: inline;"> Estimated Net Company Debt as of the Closing, as adjusted pursuant to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">3.1</font><font style="display: inline;">; &nbsp;</font><font style="display: inline;font-style:italic;">provided, however</font><font style="display: inline;">, that, for the avoidance of doubt, </font><font style="display: inline;">(x) the aggregate amount specified in (c) </font><font style="display: inline;">will</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">first reduce </font><font style="display: inline;">the Cash Base Amount</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">until the Cash Base Amount has been reduced to zero </font><font style="display: inline;">before reducing the </font><font style="display: inline;">Equity </font><font style="display: inline;">Base Amount </font><font style="display: inline;">and (y) </font><font style="display: inline;">any reduction of the Equity Base Amount shall </font><font style="display: inline;">equal the amount of the reduction divided by </font><font style="display: inline;">the </font><font style="display: inline;">Deemed </font><font style="display: inline;">Share Price, rounded up to the nearest whole share of </font><font style="display: inline;">CryoLife Common Stock</font><font style="display: inline;">. &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Adjustment Amount</font><font style="display: inline;">&#x201D; shall </font><font style="display: inline;">mean the Upward Adjustment Amount or the Downward Adjustment Amount, as applicable</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Adjustment Item</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;font-weight:bold;">Statement</font><font style="display: inline;">&#x201D; shall have the meaning as set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">3.1(a)</font><font style="display: inline;font-weight:bold;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;"> &nbsp;&#x201C;</font><font style="display: inline;font-weight:bold;">Affiliate</font><font style="display: inline;">&#x201D; means any Person that is controlled by, controls, or is under common control with a Party, for so long as such control continues. For purposes of this definition, &#x201C;</font><font style="display: inline;font-weight:bold;">control</font><font style="display: inline;">&#x201D; means the possession, directly or indirectly, of power to direct or cause the direction of management or policies </font><font style="display: inline;">(</font><font style="display: inline;">whether through ownership of securities or other ownership interests, by contract or otherwise)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Agreement</font><font style="display: inline;">&#x201D; shall have the meaning set forth in the first sentence of this Agreement.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Anti-Corruption and Anti-Bribery Laws</font><font style="display: inline;">&#x201D; shall mean any anti-corruption or anti-bribery Law, including the Foreign Corrupt Practices Act of 1977, as amended, </font><font style="display: inline;color:#000000;">Swiss Criminal Code, Title Nineteen, Bribery</font><font style="display: inline;color:#000000;">, i.e. Art. 322</font><font style="display: inline;color:#000000;font-size:6pt;vertical-align:super;line-height:100%">ter </font><font style="display: inline;color:#000000;">&#x2013; Art. 322</font><font style="display: inline;color:#000000;font-size:6pt;vertical-align:super;line-height:100%">decies</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">Swiss Criminal Code, Section 331-338 of the German Criminal Code (</font><font style="display: inline;font-style:italic;color:#000000;">Strafgesetzbuch</font><font style="display: inline;color:#000000;">), Section 299b of the German Criminal Code, and the U.K. Bribery Act</font><font style="display: inline;">. &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Applicable Tax Law</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.11(a</font><font style="display: inline;">)</font><font style="display: inline;font-weight:bold;">(ii)</font><font style="display: inline;">. &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Arbitration Firm</font><font style="display: inline;">&#x201D; shall mean PricewaterhouseCoopers LLP.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 5-</font><font style="display: inline;"></font><font style="display: inline;">1</font><font style="display: inline;"></font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Audited Annual Financials</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.9(b)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Balance Sheet Date</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.7(a)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Board of Directors</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">2.6(a)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Bonus Payor</font><font style="display: inline;">&#x201D; and &#x201C;</font><font style="display: inline;font-weight:bold;">Bonus Payors</font><font style="display: inline;">&#x201D; shall each have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">2.2</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Business</font><font style="display: inline;">&#x201D; shall </font><font style="display: inline;">have the meaning set forth in the Recitals.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Business Day(s)</font><font style="display: inline;">&#x201D; shall mean each day that is not a Saturday, Sunday or holiday on which banking institutions located in </font><font style="display: inline;">Atlanta, Georgia, </font><font style="display: inline;">New York, New York</font><font style="display: inline;"> or Zurich, Switzerland </font><font style="display: inline;">are close</font><font style="display: inline;">d</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Buyer</font><font style="display: inline;">&#x201D; shall </font><font style="display: inline;">have the meaning set forth in the first sentence of this Agreement.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Buyer Authorization</font><font style="display: inline;">&#x201D; and</font><font style="display: inline;"> &nbsp;&#x201C;</font><font style="display: inline;font-weight:bold;">Buyer Authorizations</font><font style="display: inline;">&#x201D; &nbsp;</font><font style="display: inline;">shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">6.13(a).</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Buyer Certificate</font><font style="display: inline;">&#x201D;</font><font style="display: inline;"> shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">8.3(c)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Buyer</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">Indemnified Persons</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Cash</font><font style="display: inline;font-weight:bold;"> Base Amount</font><font style="display: inline;">&#x201D; shall mean an amount equal to </font><font style="display: inline;">(a) </font><font style="display: inline;">$</font><font style="display: inline;">168</font><font style="display: inline;">,</font><font style="display: inline;">75</font><font style="display: inline;">0,000 </font><font style="display: inline;">in cash&nbsp;&nbsp;divided by the number of all Shares issued and outstanding as of immediately prior to the Closing and (b) multiplied by the number of Sold Shares</font><font style="display: inline;">. &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Charter Documents</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.1</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Claim Certificate</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.4(b)(ii)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Closing</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">2.3</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Closing Adjustment Statement</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;">3.1</font><font style="display: inline;font-weight:bold;">(b)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref374565467"></a><font style="display: inline;"> &nbsp;&#x201C;</font><font style="display: inline;font-weight:bold;">Closing Consideration</font><font style="display: inline;">&#x201D; shall mean</font><font style="display: inline;">, subject to adjustment pursuant to </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;">3.1,</font><font style="display: inline;"> (a)&nbsp;the </font><font style="display: inline;">Cash Base Amount</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;text-decoration:underline;">plus</font><font style="display: inline;"> (b) </font><font style="display: inline;">the Equity Base Amount, </font><font style="display: inline;text-decoration:underline;">minus</font><font style="display: inline;"> (c) </font><font style="display: inline;">the</font><font style="display: inline;"> Estimated Net Debt as of the Closing, </font><font style="display: inline;text-decoration:underline;">minus</font><font style="display: inline;"> (d) a cash amount equal to the Escrow Amount</font><font style="display: inline;">; &nbsp;</font><font style="display: inline;font-style:italic;">provided, however</font><font style="display: inline;">, that, for the avoidance of doubt, </font><font style="display: inline;">(x) the aggregate amount specified in (c) </font><font style="display: inline;">will</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">first reduce </font><font style="display: inline;">the Cash Base Amount</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">until the Cash Base Amount has been reduced to zero </font><font style="display: inline;">before reducing the </font><font style="display: inline;">Equity </font><font style="display: inline;">Base Amount </font><font style="display: inline;">and (y) </font><font style="display: inline;">any reduction of the Equity Base Amount shall </font><font style="display: inline;">equal the amount of the reduction divided by </font><font style="display: inline;">the </font><font style="display: inline;">Deemed </font><font style="display: inline;">Share Price, rounded up to the nearest whole share of </font><font style="display: inline;">CryoLife Common Stock</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Closing Date</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">2.3</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 5-</font><font style="display: inline;"></font><font style="display: inline;">2</font><font style="display: inline;"></font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Code</font><font style="display: inline;">&#x201D; shall mean the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Commitment Letter</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">6.12(a)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Committed Lenders</font><font style="display: inline;">&#x201D; shall have the meaning set forth in</font><font style="display: inline;font-weight:bold;"> Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">6.12(a)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Company</font><font style="display: inline;">&#x201D; shall have the meaning set forth in the </font><font style="display: inline;">first sentence of this Agreement</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Company Authorizations</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.18</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Company Certificate</font><font style="display: inline;">&#x201D;</font><font style="display: inline;"> shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">8.2(g)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Company Debt</font><font style="display: inline;">&#x201D; &nbsp;</font><font style="display: inline;">shall mean </font><font style="display: inline;">any Indebtedness of the Company or any of the Company Subsidiaries</font><font style="display: inline;">,</font><font style="display: inline;"> including the following: </font><font style="display: inline;">(i) (A) </font><font style="display: inline;">the outstanding principal and accrued but unpaid interest on the </font><font style="display: inline;color:#000000;">&#x20AC;1.6</font><font style="display: inline;">&nbsp;</font><font style="display: inline;color:#000000;">m</font><font style="display: inline;">illion Sparkasse government subsidized innovation loan for specific research and development projects </font><font style="display: inline;color:#000000;">having an interest at a rate of approximately 2.5% and a maturity date of March 30, 2024</font><font style="display: inline;">, for which Kredi</font><font style="display: inline;">ta</font><font style="display: inline;">nstalt f&#xFC;r Wiederaufbau, a German government-owned development bank&nbsp;&nbsp;(&#x201C;</font><font style="display: inline;font-weight:bold;">KfW</font><font style="display: inline;">&#x201D;) subs</font><font style="display: inline;">idizes the interest, plus (B) the applicable prepayment penalty, if any;</font><font style="display: inline;"> (ii) (A) </font><font style="display: inline;">the outstanding principal and accrued but unpaid interest on the </font><font style="display: inline;color:#000000;">&#x20AC;1.4 million</font><font style="display: inline;"> Sparkasse government-subsidized innovation loan </font><font style="display: inline;color:#000000;">having an interest at a rate of approximately </font><font style="display: inline;">1.4</font><font style="display: inline;color:#000000;">% and a maturity date of </font><font style="display: inline;">September 30, 2025, for which KfW subsid</font><font style="display: inline;">izes the interest, plus (B) the </font><font style="display: inline;">applicable prepayment penalty</font><font style="display: inline;">, if any; and </font><font style="display: inline;">(iii) </font><font style="display: inline;">the Shareholders Loans</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Company</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">Disclosure Schedule</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;V</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Company Employee Plan</font><font style="display: inline;">&#x201D; &nbsp;</font><a name="_Ref487614435"></a><font style="display: inline;">shall mean any plan, program, policy, practice, </font><font style="display: inline;">Contract</font><font style="display: inline;"> or other arrangement providing for compensation, severance, termination pay, deferred compensation, retirement benefits, performance awards, stock or stock-related awards, fringe, retirement, death, disability, welfare or medical benefits or other employee benefits or remuneration of any kind, whether written, unwritten or otherwise funded or unfunded, that is or has been maintained, contributed to, or required to be contributed to, by the Company or </font><font style="display: inline;">any of the Company Subsidiaries,</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">for the benefit of any Employee, or with respect to which the Company or </font><font style="display: inline;">any of the Company Subsidiaries</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">has or may have any liability or obligation.</font><font style="display: inline;"> &nbsp; &nbsp;</font><a name="_cp_text_1_470"></a><font style="display: inline;">For clarity, the term Company Employee Plan does not include any Employee Agreements.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Company Intellectual Property</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(a)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref487608930"></a><a name="_Ref445043773"></a><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Company </font><font style="display: inline;font-weight:bold;">IP Contract</font><font style="display: inline;">&#x201D; shall mean any Contract to which the Company </font><font style="display: inline;">or any Company Subsidiary </font><font style="display: inline;">is </font><font style="display: inline;">or was </font><font style="display: inline;">a party or by which the Company </font><font style="display: inline;">or any Company Subsidiary </font><font style="display: inline;">is </font><font style="display: inline;">or was </font><font style="display: inline;">bound, that contains any assignment, authorization, immunity, covenant not to sue, access to, or some other license, right or covenant with respect to any Intellectual Property Right or Technology or that otherwise relates to Company Intellectual Property Rights or any Intellectual Property Rights developed by, with or for the Company</font><font style="display: inline;"> or any Company Subsidiary</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;"> &nbsp;&#x201C;</font><font style="display: inline;font-weight:bold;">Company Material Adverse Effect</font><font style="display: inline;">&#x201D; shall mean any change, event or effect that is or </font><font style="display: inline;">could reasonably be expected</font><font style="display: inline;"> to be materially adverse to the business, prospects, assets (whether </font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 5-</font><font style="display: inline;"></font><font style="display: inline;">3</font><font style="display: inline;"></font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">tangible or intangible), liabilities, condition (financial or otherwise), operations or capitalization of the Company and the </font><font style="display: inline;">Company Subsidiaries</font><font style="display: inline;">, taken as a whole; </font><font style="display: inline;font-style:italic;">provided, however</font><font style="display: inline;">, that any effect to the extent resulting or arising from any of the following shall not be considered when determining whether a Company Material Adverse Effect shall have occurred: (a) any change or development in general economic conditions in the industries or markets in which the Company or </font><font style="display: inline;">any of the Company Subsidiaries</font><font style="display: inline;"> operates, (b) any change in financing, banking or securities markets generally or (c) any act of war, armed hostilities or terrorism, change in political environment or any worsening thereof or actions taken in response thereto; provided, in </font><font style="display: inline;">each case</font><font style="display: inline;">, that such effects do not, individually or in the aggregate, have a materially disproportionate adverse impact on the Company and the </font><font style="display: inline;">Company Subsidiaries</font><font style="display: inline;">, taken as a whole, relative to other Persons in the industries or markets in which the Company or </font><font style="display: inline;">any of the Company Subsidiaries</font><font style="display: inline;"> operates.</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Company </font><font style="display: inline;font-weight:bold;">Net </font><font style="display: inline;font-weight:bold;">Debt </font><font style="display: inline;font-weight:bold;">Statement</font><font style="display: inline;">&#x201D; shall have the meaning as set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">3.1(b)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Company Options</font><font style="display: inline;">&#x201D; shall mean options to purchase shares of </font><font style="display: inline;">the share capital of the </font><font style="display: inline;">Company pursuant to a plan or otherwise</font><font style="display: inline;">, whether from the Company or Securityholders, including the options to purchase shares of the share capital of the Company from the Option Grantors (the &#x201C;</font><font style="display: inline;font-weight:bold;">Shareholder Options</font><font style="display: inline;">&#x201D;)</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Company Patents</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(d)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref487612720"></a><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Company Privacy Policy</font><font style="display: inline;">&#x201D; shall mean each </font><font style="display: inline;">external or </font><font style="display: inline;">internal, </font><font style="display: inline;">past or </font><font style="display: inline;">present privacy policy of the Company</font><font style="display: inline;"> or any Company Subsidiary</font><font style="display: inline;">, including any policy relating to: (a) the privacy of users of the properties, products and services</font><font style="display: inline;"> of the Company or any of the Company Subsidiaries</font><font style="display: inline;">; (b) the collection, storage, disclosure, and transfer of any User Data or Personal Information; and (c) any employee information.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Company Products</font><font style="display: inline;">&#x201D; shall mean all </font><font style="display: inline;">medical devices, </font><font style="display: inline;">products, services and Technology offerings designed, developed, distributed, sold, marketed, licensed, supplied, or otherwise provided, made available by or for the Company or </font><font style="display: inline;">any of the Company Subsidiaries</font><font style="display: inline;"> (including all versions and releases of those products, services and Technology offerings, whether already distributed, provided or made available, under development, planned or conceived, or otherwise), together with any related documentation, materials, or information.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Company Promissory Notes</font><font style="display: inline;">&#x201D; shall mean the outstanding promissory notes as of immediately prior to the Closing evidencing the portion of the Company Indebtedness payable by the Company or any of the Company Subsidiaries, including the outstanding loans payable by the Company to Securityholders (the &#x201C;</font><font style="display: inline;font-weight:bold;">Shareholder Loans</font><font style="display: inline;">&#x201D;), which are described in the Consideration Schedule, including the name of the holder of each such promissory note, the amount of principal, interest and other amounts outstanding for each of such promissory notes as of the Closing, and the daily interest rate accrual with respect to each of such promissory notes.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Company Registered Intellectual Property Rights</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(b)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 5-</font><font style="display: inline;"></font><font style="display: inline;">4</font><font style="display: inline;"></font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Company Securities</font><font style="display: inline;">&#x201D; shall mean, collectively, the Shares and the Convertible Securities. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Company Subsidiaries</font><font style="display: inline;">&#x201D; shall mean </font><font style="display: inline;">each Company Subsidiary collectively as a group.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Competing Transaction</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section 7.2</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Confidentiality Agreement</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.3</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Conflict</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.5(a)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Consideration for the Shareholder Loans</font><font style="display: inline;">&#x201D; shall have the meaning set forth in the Recitals.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Consideration Schedule</font><font style="display: inline;">&#x201D; shall have the meaning set forth in</font><font style="display: inline;"> the Recitals</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Contract</font><font style="display: inline;">&#x201D; shall mean any written, oral, express, implied or other agreement, contract, subcontract, lease, license, covenant, understanding, arrangement, instrument, note, warranty, insurance policy, benefit plan or commitment or undertaking of any nature, in each case, as amended and supplemented from time to time and including all schedules, annexes and exhibits thereto.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Convertible Securities</font><font style="display: inline;">&#x201D; shall mean one or more of any of the following securities of the Company: the Company Options;</font><font style="display: inline;"> and any other convertible securities of the Company or instruments exercisable for securities of the Company</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444772913"></a><a name="_Ref487612766"></a><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Copyrights</font><font style="display: inline;">&#x201D; shall mean</font><font style="display: inline;"> any</font><font style="display: inline;"> copyrights, license rights and all other rights with respect to Works of Authorship, and all registrations thereof and applications therefor and renewals, extensions and reversions thereof, and all other rights corresponding thereto throughout the world (including moral and economic rights, however denominated).</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">CryoLife</font><font style="display: inline;">&#x201D; &nbsp;</font><font style="display: inline;">shall have the meaning set forth in the </font><font style="display: inline;">first sentence of this Agreement</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">CryoLife</font><font style="display: inline;font-weight:bold;"> Common Stock</font><font style="display: inline;">&#x201D; means shares of </font><font style="display: inline;">CryoLife</font><font style="display: inline;">&#x2019;s common stock, $0.01 par value per share.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;"> &nbsp;&#x201C;</font><font style="display: inline;font-weight:bold;">CryoLife</font><font style="display: inline;font-weight:bold;"> Material Adverse Effect</font><font style="display: inline;">&#x201D; shall mean any change, event or effect that is or </font><font style="display: inline;">could reasonably be expected</font><font style="display: inline;"> to be materially adverse to the business, prospects, assets (whether tangible or intangible), liabilities, condition (financial or otherwise), operations or capitalization of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> taken as a whole; </font><font style="display: inline;font-style:italic;">provided, however</font><font style="display: inline;">, that any effect to the extent resulting or arising from any of the following shall not be considered when determining whether a </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Material Adverse Effect shall have occurred: (a) any change or development in general economic conditions in the industries or markets in which </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> operates, (b) any change in financing, banking or securities markets generally or (c) any act of war, armed hostilities or terrorism, change in political environment or any worsening thereof or actions taken in response thereto; provided, in each case, that such effects do not, individually or in the aggregate, have a </font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 5-</font><font style="display: inline;"></font><font style="display: inline;">5</font><font style="display: inline;"></font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">materially disproportionate adverse impact on </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, taken as a whole, relative to other Persons in the industries or markets in which </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> operates.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">CryoLife</font><font style="display: inline;font-weight:bold;"> Released Person</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.14</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">CryoLife</font><font style="display: inline;font-weight:bold;"> Subsidiaries</font><font style="display: inline;">&#x201D; shall mean CryoLife, Parent and Buyer as well as all their Affiliates, including, immediately after Closing, the Company and the Company Subsidiaries.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Current Balance Sheet</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.7(a)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Current Employee</font><font style="display: inline;">&#x201D; shall mean any Employee that, as of the date of this Agreement, is currently providing services to the Company or any Company Subsidiary. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Customers</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.28(a)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">D&amp;O Indemnified Persons</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.12</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Databases</font><font style="display: inline;">&#x201D; shall mean </font><font style="display: inline;">databases and other compilations and collections of data or information. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Deemed Share Price</font><font style="display: inline;">&#x201D; shall mean an amount equal to </font><font style="display: inline;">the </font><font style="display: inline;">volume-weighted </font><font style="display: inline;">average </font><font style="display: inline;">price </font><font style="display: inline;">of a share of </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> Common Stock reported by NYSE during the period of </font><font style="display: inline;">sixty&nbsp;&nbsp;(60) </font><font style="display: inline;">trading days ending on the date preceding the date of this Agreement.</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Discharge</font><font style="display: inline;">&#x201D; &nbsp;</font><font style="display: inline;">shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.13(b)(ii)</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Distributable Funds</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.5(f)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444773235"></a><a name="_Ref487614451"></a><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Domain Names</font><font style="display: inline;">&#x201D; &nbsp;</font><font style="display: inline;">shall mean</font><font style="display: inline;"> domain names, uniform resource locators and other names and locators associated with the </font><font style="display: inline;">i</font><font style="display: inline;">nternet.</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Downward Adjustment Amount</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">3.1(d).</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Eastern Time</font><font style="display: inline;">&#x201D; shall mean either U.S. Eastern Daylight Time (GMT &#x2013; 4) or U.S. Eastern Standard Time (GMT &#x2013; 5), as may be in effect on any applicable date. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Effective Time</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.15</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Employee</font><font style="display: inline;">&#x201D; shall mean any current or former employee (whether full time or part time), intern, consultant, independent contra</font><font style="display: inline;">ctor, director, officer or manager of the Company</font><font style="display: inline;">&nbsp;</font><a name="_cp_text_1_472"></a><font style="display: inline;">or</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">any of the Company Subsidiaries</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref487614460"></a><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Employee Agreement</font><font style="display: inline;">&#x201D; shall mean each management, employment, severance, separation, settlement, consulting, contractor, relocation, internship, change of control, retention, bonus, repatriation, expatriation, loan, visa, work permit</font><font style="display: inline;">, Company Option</font><font style="display: inline;"> or other </font><font style="display: inline;">Contract</font><font style="display: inline;"> or understanding (including any offer letter or any </font><font style="display: inline;">Contract</font><font style="display: inline;"> providing for acceleration of </font><font style="display: inline;">Company</font><font style="display: inline;"> Options that is unvested, or any other </font><font style="display: inline;">Contract</font><font style="display: inline;"> providing for compensation or benefits) between </font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 5-</font><font style="display: inline;"></font><font style="display: inline;">6</font><font style="display: inline;"></font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">the Company or </font><font style="display: inline;">any of any of the Company Subsidiaries</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">and any Employee, and pursuant to which the Company or </font><font style="display: inline;">any of the Company Subsidiaries</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">has or may have any liability or obligation.</font><font style="display: inline;"> &nbsp; &nbsp;</font><a name="_cp_text_1_481"></a><font style="display: inline;">For clarity, the term Employee Agreement does not include any Company Employee Plans</font><font style="display: inline;"> and rights and obligations pursuant to an applicable Law, such as a pension Law or occupational injury insurance Law</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Environmental Claim</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.21</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Environmental Laws</font><font style="display: inline;">&#x201D; shall mean all Laws relating to</font><font style="display: inline;">: (i)</font><font style="display: inline;"> pollution</font><font style="display: inline;">; (ii)</font><font style="display: inline;"> protection of</font><font style="display: inline;"> human health or safety or</font><font style="display: inline;"> the environment</font><font style="display: inline;">, including any natural resources; (iii) the presence, Release or threatened Release</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">of, or </font><font style="display: inline;">exposure of any </font><font style="display: inline;">Person or property</font><font style="display: inline;"> to</font><font style="display: inline;">,</font><font style="display: inline;"> Hazardous Materials</font><font style="display: inline;">;</font><font style="display: inline;"> and </font><font style="display: inline;">(iv) </font><font style="display: inline;">the </font><font style="display: inline;">generation, </font><font style="display: inline;">manufacture, processing, registration, distribution, labeling, sale, or the exposure of others to, recycling, use, treatment, storage, disposal,</font><font style="display: inline;"> or</font><font style="display: inline;"> transport, </font><font style="display: inline;">arrangement for disposal or transport </font><font style="display: inline;">or handling of Hazardous Materials or any product containing </font><font style="display: inline;">or mixed with any Hazardous Material</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">EPO</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(b)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Equity Base Amount</font><font style="display: inline;">&#x201D; shall mean </font><font style="display: inline;">the number of shares equal to (i)(a) $56,250,</font><font style="display: inline;">000 </font><font style="display: inline;">divided by the number of all Shares issued and outstanding as of immediately prior to the Closing, (b) multiplied by the number of Sold Shares, divided by (ii) the Deemed Share Price.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">ERISA</font><font style="display: inline;">&#x201D; shall mean the Employee Retirement Income Security Act of 1974. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Escrow Agent</font><font style="display: inline;">&#x201D; shall have the meaning set forth in the </font><font style="display: inline;">Recitals</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Escrow Amount</font><font style="display: inline;">&#x201D;</font><font style="display: inline;font-style:italic;">&nbsp;</font><font style="display: inline;">shall mean an amount</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">in cash equal to</font><font style="display: inline;"> $22,500,000</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Escrow </font><font style="display: inline;font-weight:bold;">Agreement</font><font style="display: inline;">&#x201D; shall have the meaning set forth in the </font><font style="display: inline;">Recitals</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Estimated Net Debt</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">3.1(a).</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Excess Withholding Amoun</font><font style="display: inline;">t&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">2.2</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Exchange Act</font><font style="display: inline;">&#x201D;</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;">shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">6.10</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Expiration Date</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.1</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Export and Import Approvals</font><font style="display: inline;">&#x201D; shall mean all export licenses, license exceptions, consents, notices, waivers, approvals, orders, authorizations, registrations, declarations and filings, from or with any Governmental Authority, that are required for compliance with </font><font style="display: inline;">applicable </font><font style="display: inline;">Export and Import Control Laws.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Export and Import Control Laws</font><font style="display: inline;">&#x201D; shall mean any regulation or law governing (i) imports, exports, reexports, or transfers of products, services, software, or technologies from or to </font><font style="display: inline;">Germany</font><font style="display: inline;"> or </font><font style="display: inline;">from or to </font><font style="display: inline;">another country</font><font style="display: inline;"> or jurisdiction</font><font style="display: inline;">; (ii) economic sanctions or embargoes; or (iii) compl</font><font style="display: inline;">iance with unsanctioned </font><font style="display: inline;">boycotts. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 5-</font><font style="display: inline;"></font><font style="display: inline;">7</font><font style="display: inline;"></font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Fee Letter</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">6.12(a)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Financials</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.7(a)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Financing</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">6.12(a)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Financing </font><font style="display: inline;font-weight:bold;">Conditions</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">6.12(b)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Financing Group</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">11.11</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Financing Sources</font><font style="display: inline;">&#x201D; &nbsp;</font><font style="display: inline;">means the Persons that have committed to provide or arrange or otherwise entered into agreements in connection with all or any part of the Financing, including the parties to any joinder agreements, indentures or credit agreements entered pursuant thereto or relating thereto.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Foreign Benefit Plan</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.23(b)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Fundamental Representations</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.1</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">GAAP</font><font style="display: inline;">&#x201D; shall mean </font><font style="display: inline;">the Swiss generally accepted accounting principles pursuant to the Swiss Code of Obligations (</font><font style="display: inline;font-style:italic;">Obligationenrecht</font><font style="display: inline;">).</font><font style="display: inline;font-size:8pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Gain Recognition Agreement</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.11(b)(xxv)</font><font style="display: inline;">. &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;"> &nbsp;&#x201C;</font><font style="display: inline;font-weight:bold;">Governmental Authority</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.6</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Hazardous Materials</font><font style="display: inline;">&#x201D; &nbsp;</font><font style="display: inline;">means any substance, whether by its nature or its use, that is regulated, or as to which Liability might arise, under or pursuant to any Environmental Law or due to a requirement of a Governmental Authority, including (i) </font><font style="display: inline;">any </font><font style="display: inline;">waste (including any infectious, biological, pathological, pharmaceutical or medical waste), </font><font style="display: inline;">pollutant or contaminant; and (ii) any chemical, product, material,&nbsp;&nbsp;or substance that has been designated under Environmental Law or by a Governmental Authority to be hazardous, toxic, radioactive, noxious, flammable, corrosive, caustic or otherwise a danger to health, reproduction or the environment (including asbestos-containing materials, mold, or sharps). </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Toc487788576"></a><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Health Care Legal Requirement</font><font style="display: inline;">&#x201D; means </font><font style="display: inline;">all applicable </font><font style="display: inline;">Laws relating to </font><font style="display: inline;">health care, including </font><font style="display: inline;">healthcare </font><font style="display: inline;">industry regulation, third-party reimbursement, and </font><font style="display: inline;">compliance</font><font style="display: inline;"> matters and p</font><font style="display: inline;">rograms.</font><font style="display: inline;"> &nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Indebtedness</font><font style="display: inline;">&#x201D; shall mean all principal, fees, penalties (including with respect to any prepayment thereof), interest, premiums and any other costs and expenses, (a) for borrowed money, or (b) evidenced by notes (including the Company Promissory Notes), bonds, debentures or similar obligations.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;"> &nbsp;&#x201C;</font><font style="display: inline;font-weight:bold;">Indemnity</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">Escrow Fund</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.3(a</font><font style="display: inline;">)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 5-</font><font style="display: inline;"></font><font style="display: inline;">8</font><font style="display: inline;"></font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Indemnity</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">Escrow Period</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.3(b)(i)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;"> &nbsp;&#x201C;</font><font style="display: inline;font-weight:bold;">In-Licensed Intellectual Property</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(i)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444772774"></a><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Intellectual Property</font><font style="display: inline;">&#x201D; shall mean Intellectual Property Rights and Technology.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444773938"></a><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Intellectual Property Rights</font><font style="display: inline;">&#x201D; shall mean </font><font style="display: inline;">any and all rights (anywhere in the world, whether statutory, </font><font style="display: inline;">common law </font><font style="display: inline;">or otherwise) relating to, arising from, or associated with Technology, including (a) Patents, (b) Copyrights, (c) other rights with respect to Software, including </font><font style="display: inline;">registrations </font><font style="display: inline;">thereof and applications therefor, (d) rights with respect to Trademarks, and all registrations thereof and </font><font style="display: inline;">applications </font><font style="display: inline;">therefor, (e) rights with respect to Domain Names, including registrations thereof and applications therefor, (f)&nbsp;rights with respect to </font><font style="display: inline;">Know-How, </font><font style="display: inline;">Trade Secrets or propriety information, including rights to limit the use or disclosure thereof by any Person, (g) rights with respect to Databases, including registrations thereof and applications therefor, (h) publicity and privacy rights, including all rights with respect to use of a Person&#x2019;s name, signature, likeness, image, photograph, voice, identity, personality, and biographical and personal</font><font style="display: inline;"> information </font><font style="display: inline;">and materials and (i) any rights equivalent or similar to any of the foregoing.&nbsp;&nbsp;Without limiting the foregoing, this includes rights to derivatives, improvements, modifications, enhancements, revisions, and releases relating to any of the foregoing, claims and causes of action arising out of or related to infringement, misappropriation, violation or unlawful use of any of the foregoing and </font><font style="display: inline;">other proprietary </font><font style="display: inline;">or intellectual property </font><font style="display: inline;">rights </font><font style="display: inline;">now known or hereafter recognized in </font><font style="display: inline;">any </font><font style="display: inline;">jurisdiction</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Interim Financials</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.7(a)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Interim Period</font><font style="display: inline;">&#x201D; shall mean the period between the signing and effectiveness of this Agreement and the Closing. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Invention Assignment Agreements</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(r)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444774503"></a><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">IT Systems</font><font style="display: inline;">&#x201D; shall mean all computer systems, servers, network equipment and other computer hardware owned, leased</font><font style="display: inline;">,</font><font style="display: inline;"> licensed </font><font style="display: inline;">or used </font><font style="display: inline;">by the Company </font><font style="display: inline;">or any of the Company Subsidiaries</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref487620040"></a><a name="_Ref444775389"></a><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">JOTEC</font><font style="display: inline;font-weight:bold;"> Brazil</font><font style="display: inline;">&#x201D; shall mean JOTEC </font><font style="display: inline;">do Brasil Importa&#xE7;&#xE3;o e Com&#xE9;rcio de Equipamentos Hospitalares Ltda</font><font style="display: inline;">., an entity formed in Brazil that is a Company Subsidiary. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">JOTEC </font><font style="display: inline;font-weight:bold;">GmbH</font><font style="display: inline;">&#x201D; shall mean JOTEC GmbH, an entity formed in Germany that is a Company Subsidiary.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">JOTEC </font><font style="display: inline;font-weight:bold;">Spain</font><font style="display: inline;">&#x201D; shall mean JOTEC </font><font style="display: inline;">Cardiovascular, S.L.</font><font style="display: inline;">, an entity formed in Spain that is a Company Subsidiary.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref451524557"></a><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Key Employee</font><font style="display: inline;">&#x201D; shall </font><font style="display: inline;">mean Thomas Bogensch&#xFC;tz</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Key Employee</font><font style="display: inline;font-weight:bold;"> Documents</font><font style="display: inline;">&#x201D;</font><font style="display: inline;"> shall have the meaning set forth in the Recitals.</font><font style="display: inline;font-weight:bold;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 5-</font><font style="display: inline;"></font><font style="display: inline;">9</font><font style="display: inline;"></font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;"> &nbsp;&#x201C;</font><font style="display: inline;font-weight:bold;">Know-How</font><font style="display: inline;">&#x201D; &nbsp;</font><font style="display: inline;">shall mean</font><font style="display: inline;"> any</font><font style="display: inline;"> and all proprietary</font><font style="display: inline;"> know-how, inventions, discoveries, trade secrets, information, data and materials</font><font style="display: inline;">,</font><font style="display: inline;"> including ideas, concepts, formulas, methods, assays, </font><font style="display: inline;">practices, </font><font style="display: inline;">processes, software,</font><font style="display: inline;"> sequences,</font><font style="display: inline;"> devices, techniques, procedures, designs, compositions, constructs, compounds, plans, applications, research</font><font style="display: inline;">, preclinical</font><font style="display: inline;"> and clinical data, regulatory information, manufacturing process, scale-up and other technical data, reports, documentation and samples</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">including</font><font style="display: inline;">: &nbsp;</font><font style="display: inline;">biological, chemical, toxicological, physical and analytical, pre-clinical, clinical, safety, manufacturing and quality control data and information, including study designs and protoco</font><font style="display: inline;">ls, in each case whether or not patentable and that is not generally known</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Know-How excludes Patent</font><font style="display: inline;">s</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Knowledge</font><font style="display: inline;font-weight:bold;"> of CryoLife, Parent</font><font style="display: inline;font-weight:bold;">, and Buyer</font><font style="display: inline;">&#x201D; shall mean, with respect to the </font><font style="display: inline;">CryoLife</font><font style="display: inline;">, Parent, and Buyer, the actual knowledge of J. Patrick Mackin, Delen Boyd, Andrew Crouse, Karen Dabbs, John Davis, Jean Holloway, Amy D. Horton, D. Ashley Lee, William R. Matthews, Dennis Maier, Joshua Wells</font><font style="display: inline;">, Jim McDermid, Sherry Saurini, John Ferros, or Scott Capps</font><font style="display: inline;"> after</font><font style="display: inline;"> reviewing the applicable representation and warranty qualified by the Knowledge of the CryoLife, Parent or Buyer with the CryoLife, Parent and Buyer Employees, if any, responsible for managing the subject matter covered in the representation and warranty</font><font style="display: inline;">. &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Knowledge</font><font style="display: inline;font-weight:bold;"> of the Company</font><font style="display: inline;">&#x201D; shall me</font><font style="display: inline;">an, with respect to the Company, the actual knowledge of</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Thomas Bogensch&#xFC;tz, Peter Barthold, Enrico Cremer, Dorota Farkas, Dr. Heike Fischer, Antonio Gonzalez, Katharina Hiller, J&#xF6;rg Horn, Rainer Lesmeister, J&#xFC;rgen Merz, Jenny Raab, Dr. Kerstin Ragnitz, Steffen Rauschenberger, Fabio Rocchi, Fernando Saraiva, Monika Schulze, Florian Tyrs, Maximiljane Tyrs, Jan Ulmer, </font><font style="display: inline;">or</font><font style="display: inline;"> Christian W&#xF6;rne</font><font style="display: inline;"> after reviewing the applicable representation and warranty qualified by Knowledge of the Company or any of the Company&#x2019;s Subsidiaries with the Company Employees responsible for managing the subject matter covered in the representation and warranty</font><font style="display: inline;">. &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Law</font><font style="display: inline;">&#x201D; shall mean any law, statute, regulation, constitution, ordinance, code, edict, rule, </font><font style="display: inline;">requirement, </font><font style="display: inline;">order, injunction, judgment, doctrine, decree, directive, ruling, writ, requirement, assessment, award </font><font style="display: inline;">(including</font><font style="display: inline;"> arbitration award</font><font style="display: inline;">) or Company Authorization, in each case,</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">which is </font><font style="display: inline;">enacted, promulgated, entered into,</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">imposed </font><font style="display: inline;">or enforced </font><font style="display: inline;">by, any Governmental Authority (including, for the sake of clarity, common law)</font><font style="display: inline;">, including any settlement or</font><font style="display: inline;"> Contract</font><font style="display: inline;"> with any Governmental Authority.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Lease Agreements</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.13(a)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Leased Real Property</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.13(a)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Letter of Intent</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.3</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Liability</font><font style="display: inline;">&#x201D; means </font><font style="display: inline;">liability, indebtedness, obligation, claim, loss, damage, cost, expense, deficiency, Taxes, guaranty or endorsement of any type, in each case whether accrued, absolute, contingent, matured, unmatured or otherwise</font><font style="display: inline;">.</font><font style="display: inline;"> &nbsp;More than one Liability is referred to in this Agreement as </font><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Liabilities</font><font style="display: inline;">&#x201D;</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 5-</font><font style="display: inline;"></font><font style="display: inline;">10</font><font style="display: inline;"></font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Lien</font><font style="display: inline;">&#x201D; shall mean any lien, pledge, charge, claim, mortgage, security interest or other encumbrance of any sort.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref366597600"></a><a name="_Ref366619736"></a><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Loss</font><font style="display: inline;">&#x201D;</font><font style="display: inline;"> and collectively </font><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Losses</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(a)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref379814908"></a><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Material Contract</font><font style="display: inline;">&#x201D; shall mean any of the following, in each case by which either the Company and/or any Company Subsidiary is bound</font><font style="display: inline;">:</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;color:#010000;">(i)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">any (A) employment, contractor or consulting Contract with </font><font style="display: inline;">a Current Employee</font><font style="display: inline;">, (B) consulting Contract with a firm or organization </font><font style="display: inline;">in excess of &#x20AC;75,000 per annum</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">or (C) consulting Contract with a health care consultant, doctor or hospital</font><font style="display: inline;"> in excess of &#x20AC;75,000 per annum</font><font style="display: inline;"> (excluding, in each of (A) and (B), (i) the Invention Assignment Agreements, and (ii) any Contract or offer letter that is terminable with a notice period of </font><font style="display: inline;">three months</font><font style="display: inline;"> &nbsp;o</font><font style="display: inline;">r shorter </font><font style="display: inline;">or does not provide severance or termination payments, continuation coverage or payments as required by applicable Law)</font><font style="display: inline;">;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:24pt;"><font style="display: inline;color:#010000;">(ii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">other than as </font><font style="display: inline;">contemplated in this Agreement</font><font style="display: inline;">, any </font><font style="display: inline;">Contract</font><font style="display: inline;">, contract or commitment to grant a severance or termination pay or benefits (in cash or otherwise) to any </font><font style="display: inline;">Employee</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">or any </font><font style="display: inline;">consulting or sales </font><font style="display: inline;">Contract</font><font style="display: inline;">, contract, or commitment with a firm or other organization</font><font style="display: inline;"> (excluding any </font><font style="display: inline;">applicable</font><font style="display: inline;"> severance or termination pay or benefits </font><font style="display: inline;">to employees </font><font style="display: inline;">pursuant to applicable Law</font><font style="display: inline;">)</font><font style="display: inline;">;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;color:#010000;">(iii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">any </font><font style="display: inline;">Contract</font><font style="display: inline;"> or plan </font><font style="display: inline;">(</font><font style="display: inline;">including any stock option plan, stock appreciation rights plan or stock purchase plan</font><font style="display: inline;">)</font><font style="display: inline;">, any of the benefits of which will be increased, or the vesting of benefits of which will be accelerated, by the occurrence of any of the transactions </font><font style="display: inline;">contemplated in this Agreement</font><font style="display: inline;"> (either alone or upon the occurrence of any additional subsequent events);</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;color:#010000;">(iv)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">any fidelity or surety bond or completion bond;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(v)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">any lease of personal property or equipment having a value in excess of </font><font style="display: inline;">&#x20AC;</font><font style="display: inline;">50,000 per annum individually or </font><font style="display: inline;">&#x20AC;</font><font style="display: inline;">100</font><font style="display: inline;">,000 </font><font style="display: inline;">per annum </font><font style="display: inline;">in the aggregate;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;color:#010000;">(vi)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">any </font><font style="display: inline;">Contract</font><font style="display: inline;"> of indemnification or guaranty, but excluding </font><font style="display: inline;">Contract</font><font style="display: inline;">s of indemnification or guaranty with respect to the infringement by the Company Products of the Intellectual Property Rights of third parties tha</font><font style="display: inline;">t are contained in the Company&#x2019;s or the Company Subsidiaries&#x2019;</font><font style="display: inline;"> written </font><font style="display: inline;">Contract</font><font style="display: inline;">s with </font><font style="display: inline;">their</font><font style="display: inline;"> customers that have been entered into in the ordinary course of business</font><font style="display: inline;"> of the Company or the Company Subsidiaries, consistent with their respective </font><font style="display: inline;">past practices, substantially </font><font style="display: inline;">on their respective </font><font style="display: inline;">standard form</font><font style="display: inline;">s</font><font style="display: inline;"> of customer </font><font style="display: inline;">Contract</font><font style="display: inline;">;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:20pt;"><font style="display: inline;color:#010000;">(vii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">any Contract relat</font><font style="display: inline;">ing to capital expenditures </font><font style="display: inline;">involvin</font><font style="display: inline;">g future payments in excess of </font><font style="display: inline;">&#x20AC;</font><font style="display: inline;">50,000 individually or </font><font style="display: inline;">&#x20AC;</font><font style="display: inline;">100</font><font style="display: inline;">,000 in the aggregate;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:18pt;"><font style="display: inline;color:#010000;">(viii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">any Contract relating to the disposition or acquisition of material assets or any interest in any business enterprise outside the ordinary course of business</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">of the Company or the Company Subsidiaries, not consistent with their respective </font><font style="display: inline;">past practices;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 5-</font><font style="display: inline;"></font><font style="display: inline;">11</font><font style="display: inline;"></font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;color:#010000;">(ix)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">any mortgages, indentures, guarantees, loans or credit </font><font style="display: inline;">Contract</font><font style="display: inline;">s, security </font><font style="display: inline;">Contract</font><font style="display: inline;">s or other </font><font style="display: inline;">Contract</font><font style="display: inline;">s or instruments relating to the borrowing of money or extension of credit</font><font style="display: inline;">, excluding any such items less than </font><font style="display: inline;">&#x20AC;</font><font style="display: inline;">10,000 individually but not more than </font><font style="display: inline;">&#x20AC;</font><font style="display: inline;">50,000 in the aggregate</font><font style="display: inline;">;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;color:#010000;">(x)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">any purchase order or Contract obligating the Company or any Company Subsidiary to purchase materials or services after the date hereof at a cost in excess of &#x20AC;50,000 individually or &#x20AC;100,000 in the aggregate</font><font style="display: inline;">, excluding Contracts entered into the ordinary course of business consistent with the Company&#x2019;s or the Company Subsidiaries&#x2019; past practices;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;color:#010000;">(xi)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">any Contract containing covenants or other obligations granting or containing any current or future commitments regarding exclusive rights, non-competition, &#x201C;most favored nations,&#x201D; or material restriction on the operation or scope of its businesses or operations, or similar terms;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:20pt;"><font style="display: inline;color:#010000;">(xii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">any Contract providing a customer with refund rights other than </font><font style="display: inline;">those </font><font style="display: inline;">offered in the ordinary course of business, consistent with past practices</font><font style="display: inline;"> of the Company or the Company Subsidiaries</font><font style="display: inline;">;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:18pt;"><font style="display: inline;color:#010000;">(xiii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">any Contract for the use, distribution or integration of the Company Products, other than by the consumer end-user, including dealer, distribution, marketing, development, sales representative, original equipment manufacturer, manufacturing, supply, value added, remarketer, reseller, vendor, business partner, service provider and joint venture </font><font style="display: inline;">Contract</font><font style="display: inline;">s; </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:17pt;"><font style="display: inline;color:#010000;">(xiv)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">any Contract pursuant to which the Company </font><font style="display: inline;">or any Company Subsidiary </font><font style="display: inline;">has received revenue or other payments </font><font style="display: inline;">or benefits (including any Tax or other Governmental Authority subsidy), </font><font style="display: inline;">in excess of </font><font style="display: inline;">&#x20AC;</font><font style="display: inline;">50,000 individually or </font><font style="display: inline;">&#x20AC;</font><font style="display: inline;">100</font><font style="display: inline;">,000 in the aggregate within the past twelve (12) months from the Balance Sheet Date; </font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref288598266"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:19pt;"><font style="display: inline;color:#010000;">(xv)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">any terms of use or terms of services, including those posted or implemented as &#x201C;browsewrap&#x201D; or &#x201C;clickwrap&#x201D; </font><font style="display: inline;">Contract</font><font style="display: inline;">s, for third-party Web sites and other publicly accessible on-line sources from which the Compan</font><font style="display: inline;">y, any Company Subsidiary, </font><font style="display: inline;">or a</font><font style="display: inline;">ny</font><font style="display: inline;"> person acting on </font><font style="display: inline;">behalf of the foregoing</font><font style="display: inline;"> has extracted or collected information through the use of any &#x201C;scrapers,&#x201D; &#x201C;spiders,&#x201D; &#x201C;bots&#x201D; or other automated software programs or processes;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:17pt;"><font style="display: inline;color:#010000;">(xvi)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">any Contracts and licenses to which the Company is a party with respect to any Technology or Intellectual Property Rights, including any in-bound licenses, out-bound licenses and cross-licenses, other than commercially available, &#x201C;off-the-shelf&#x201D; licenses used in t</font><font style="display: inline;">he ordinary course of business of the Company or the Company Subsidiaries, consistent with their respective </font><font style="display: inline;">past practices</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">and involving payments not in excess of </font><font style="display: inline;">&#x20AC;</font><font style="display: inline;">50,000 individually or </font><font style="display: inline;">&#x20AC;</font><font style="display: inline;">100</font><font style="display: inline;">,000 in the aggregate; or</font><font style="display: inline;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"><font style="display: inline;color:#010000;">(xvii)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;color:#010000;"></font><font style="display: inline;">any other </font><font style="display: inline;">Contract </font><font style="display: inline;">or commitment that involves </font><font style="display: inline;">&#x20AC;</font><font style="display: inline;">5</font><font style="display: inline;">0,000 individually or </font><font style="display: inline;">&#x20AC;</font><font style="display: inline;">100</font><font style="display: inline;">,000 in the aggregate or more and is not cancelable by the Company </font><font style="display: inline;">or the </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 5-</font><font style="display: inline;"></font><font style="display: inline;">12</font><font style="display: inline;"></font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">relevant Company Subsidiary, as applicable, </font><font style="display: inline;">without penalty within one hundred and twenty (120) days.</font></p>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Minority Shareholder</font><font style="display: inline;">&#x201D;</font><font style="display: inline;"> and &#x201C;</font><font style="display: inline;font-weight:bold;">Minority Shareholders</font><font style="display: inline;">&#x201D; shall have the </font><font style="display: inline;">respective </font><font style="display: inline;">meaning</font><font style="display: inline;">s set forth in the Recitals</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;"> &nbsp;&#x201C;</font><font style="display: inline;font-weight:bold;">Minority Shares</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.15</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Neomex</font><font style="display: inline;">&#x201D; m</font><font style="display: inline;">eans Neomex Hospitalar Ltda., an entity organized under the laws of Brazil.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;"> &nbsp;&#x201C;</font><font style="display: inline;font-weight:bold;">Net</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">Company Debt</font><font style="display: inline;">&#x201D; shall mean the amount of the Company Debt</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;text-decoration:underline;">minus</font><font style="display: inline;"> the amount of cash and cash equivalents in the accounts of the Company and Company</font><font style="display: inline;"> Subsidiaries as of the Closing, </font><font style="display: inline;">in each case, determined as of 12:0</font><font style="display: inline;">0</font><font style="display: inline;"> a.m., Eastern </font><font style="display: inline;">Time</font><font style="display: inline;"> on the Closing Date</font><font style="display: inline;"> (immediately prior to the Closing)</font><font style="display: inline;">.&nbsp; </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Non-U.S. person</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">4.7(d)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Objection Notice</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.4(d)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Officer&#x2019;s Certificate</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.4(b)(i)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Option Grantor</font><font style="display: inline;">&#x201D; and &#x201C;</font><font style="display: inline;font-weight:bold;">Option Grantors</font><font style="display: inline;">&#x201D; shall each have the meaning set forth in the Recitals.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Other Transfer</font><font style="display: inline;">&#x201D; &nbsp;</font><font style="display: inline;">shall have the meaning set forth in</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.16</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Parent</font><font style="display: inline;">&#x201D; shall have the meaning set forth in the </font><font style="display: inline;">first sentence of this Agreement</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Parent Disclosure Schedule</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">Article&nbsp;VI</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Parties</font><font style="display: inline;">&#x201D; shall have the meaning set forth in the second sentence of this Agreement.</font><a name="_Ref451526229"></a>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Patents</font><font style="display: inline;">&#x201D; &nbsp;</font><font style="display: inline;">shall mean (a)&nbsp;</font><font style="display: inline;">any </font><font style="display: inline;">national, regional and international issued </font><font style="display: inline;">patents</font><font style="display: inline;"> and pending</font><font style="display: inline;"> patent applications</font><font style="display: inline;">, including provisional patent applications, (b)&nbsp;any</font><font style="display: inline;"> patent applications </font><font style="display: inline;">filed either from the foregoing or from an application claiming priority to the foregoing, including all</font><font style="display: inline;"> provisional applications, </font><font style="display: inline;">converted provisionals, substitutions, </font><font style="display: inline;">continuations, </font><font style="display: inline;">continuations-in-part, divisional, renewals, and </font><font style="display: inline;">cont</font><font style="display: inline;">inued prosecution applications, and all patents granted thereon, (c)&nbsp;</font><font style="display: inline;">patents-of-addition, revalidations, reissues, reexaminations and extensions or restorations (including any supplementary protection certificates and the like) by existing or future extension or restoration mechanisms, including patent term adjustments, patent term extensions, supplementary protection certificates or the equivalent thereof,</font><font style="display: inline;"> (d)&nbsp;</font><font style="display: inline;">inventor&#x2019;s certificates, utility models, petty patents, innovation patents and design patents,</font><font style="display: inline;"> (e)&nbsp;</font><font style="display: inline;">other forms of government-issued rights </font><font style="display: inline;">comparable in scope</font><font style="display: inline;"> to any of the foregoing, including so-called pipeline protection or any importation, revalidation, confirmation or introduction patent or registration patent or patent of additions to any of such foregoing and</font><font style="display: inline;"> (f)&nbsp;United States </font><font style="display: inline;">and foreign counterparts of any of the foregoing</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 5-</font><font style="display: inline;"></font><font style="display: inline;">13</font><font style="display: inline;"></font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Paying Agent</font><font style="display: inline;">&#x201D; shall </font><font style="display: inline;">mean </font><font style="display: inline;">U.S. Bank, N.A</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Person</font><font style="display: inline;">&#x201D; shall mean any individual</font><font style="display: inline;"> or entity, including any</font><font style="display: inline;"> company, corporation, limited liability company, general or limited partnership, trust, proprietorship, joint venture, or other entity, unincorporated association, organization or enterprise, or any Governmental Authority.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref445044070"></a><a name="_Ref487612985"></a><a name="_Ref445043952"></a><a name="_Ref379814708"></a><a name="_Ref378953815"></a><font style="display: inline;font-weight:bold;">&#x201C;</font><font style="display: inline;font-weight:bold;">Personal Information</font><font style="display: inline;">&#x201D; shall mean, in addition to any definition provided by the Company </font><font style="display: inline;">or any Company Subsidiary </font><font style="display: inline;">for any similar term (e.g., &#x201C;personally identifiable information&#x201D; or &#x201C;PII&#x201D;) in any privacy policy of the Company or </font><font style="display: inline;">any of the Company Subsidiaries</font><font style="display: inline;"> or other public-facing statement, all information regarding or capable of being associated with an individual person or device, including (a) information that identifies, could be used to identify or is otherwise identifiable with an individual, including name, physical address, telephone number, email address, financial account number or government-issued identifier (including Social Security number and driver&#x2019;s license number), medical, health or insurance information, gender, date of birth, educational or employment information, religious or political views or affiliations, marital or other status, and any other data used or intended to be used to identify, contact or precisely locate an individual (e.g., geolocation data), (b) information that is created, maintained, or accessed by an individual (e.g., videos, audio or individual contact information), (c) any data regarding an individual&#x2019;s activities online or on a mobile device or other application (e.g., searches conducted or web pages or content visited or viewed), (d) Internet Protocol addresses, unique device identifiers or other persistent identifiers, and (e) any other data which constitutes &#x201C;personal data&#x201D; under applicable Laws, including but not limited to the European Data Protection Directive 95/46, its local law implementations and/or any EU directive (including local implementations) or regulation succeeding the European Data Protection Directive 95/46.&nbsp;&nbsp;Personal Information may relate to any individual, including a current, prospective or former customer or employee of any Person. Personal </font><font style="display: inline;">Information includes information in any form, including paper, electronic and other forms.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Privacy Obligations</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(v)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Pro Rata Portion</font><font style="display: inline;">&#x201D; shall mean with respect to each Securityholder, the quotient obtained by dividing (a) the portion of the Acquisition Consideration payable to such Securityholder with respect of such Securityholder&#x2019;s Sold Shares divided by (b) the portion of the Acquisition Consideration payable to all Securityholders with respect to the Sold Shares held by all Securityholders.&nbsp; </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">PTO</font><font style="display: inline;">&#x201D; shall have the meaning set</font><font style="display: inline;"> forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.14(b)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Qualifying Claim</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.4(a)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Quarterly Financials</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.9(b)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444775440"></a><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Registered Intellectual Property Rights</font><font style="display: inline;">&#x201D; shall mean any and all Intellectual Property Rights that have been registered, applied for, filed,</font><font style="display: inline;"> approved, granted,</font><font style="display: inline;"> certified or otherwise</font><font style="display: inline;"> requested,</font><font style="display: inline;"> perfected, issued, or recorded with or by any</font><font style="display: inline;"> Governmental Authority</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 5-</font><font style="display: inline;"></font><font style="display: inline;">14</font><font style="display: inline;"></font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Related Agreements</font><font style="display: inline;">&#x201D; shall mean the </font><font style="display: inline;">Key Employee Documents, </font><font style="display: inline;">the </font><font style="display: inline;">Securityholder </font><font style="display: inline;">Agreements, </font><font style="display: inline;">the Escrow Agreement, an</font><font style="display: inline;">d the Company Certificate.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Related Party</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.16(a)</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Released</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.21</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Released Holder Claims</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.14</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Releasing Person</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.14</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Relevant Employee</font><font style="display: inline;">&#x201D; shall mean any of </font><font style="display: inline;">Thomas Bogensch&#xFC;tz, Peter Barthold, Enrico Cremer, Dorota Farkas, Dr. Heike Fischer, Antonio Gonzalez, Katharina Hiller, </font><font style="display: inline;">J&#xF6;rg Horn, </font><font style="display: inline;">Rainer Lesmeister, J&#xFC;rgen Merz, Jenny Raab, Dr. Kerstin Ragnitz, Steffen Rauschenberger, Fabio Rocchi, Fernando Saraiva, Monika Schulze, Florian Tyrs, Maximiljane Tyrs, Jan Ulmer, </font><font style="display: inline;">and</font><font style="display: inline;"> Christian W&#xF6;rne</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Representatives</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.9(b)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;"> &nbsp;&#x201C;</font><font style="display: inline;font-weight:bold;">Required Withholding Tax</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">2.2</font><font style="display: inline;">. &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Responding Party</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section</font><font style="display: inline;font-weight:bold;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.4(d)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Restricted Period</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">4.7(b)(iv)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">SEC</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">6.10</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">SEC Documents</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">6.10</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Securities Act</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">4.10</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Securityholder</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">Agreements</font><font style="display: inline;">&#x201D; shall have the meaning set forth in the Recitals.</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Securityholder Expenses</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.4</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Securityholder Representative</font><font style="display: inline;">&#x201D; shall have the meaning set forth in the </font><font style="display: inline;">f</font><font style="display: inline;">irst sentence of this Agreement</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Securityholders</font><font style="display: inline;">&#x201D; shall have the meaning set forth in the </font><font style="display: inline;">first sentence of this Agreement, and &#x201C;</font><font style="display: inline;font-weight:bold;">Securityholder</font><font style="display: inline;">&#x201D; shall mean each of the Securityholders, individually</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Seller</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">Indemnified</font><font style="display: inline;font-weight:bold;"> Persons</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(b)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Seller</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">Indemnifying Persons</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(a)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;"> &nbsp;&#x201C;</font><font style="display: inline;font-weight:bold;">Share</font><font style="display: inline;">&#x201D; shall </font><font style="display: inline;">mean a share of the share capital of the Company and </font><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Shares</font><font style="display: inline;">&#x201D;</font><font style="display: inline;"> shall mean more than one share of the share capital of the Company, whether acquired from the Company or any of the Securityholders</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 5-</font><font style="display: inline;"></font><font style="display: inline;">15</font><font style="display: inline;"></font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Shareholder Loans</font><font style="display: inline;">&#x201D; shall have the meaning set forth in the definition of the &#x201C;Company Promissory Notes&#x201D;.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Shareholders Agreement</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">4.2</font><font style="display: inline;">. &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444775460"></a><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Social Media Account</font><font style="display: inline;">&#x201D; shall mean any and all accounts, profiles, pages, feeds, registrations and other presences </font><font style="display: inline;">on or in connection with any: (a</font><font style="display: inline;">) social media or social networki</font><font style="display: inline;">ng website or online service; (b) blog or microblog; (c) mobile application; (d</font><font style="display: inline;">) photo, video or o</font><font style="display: inline;">ther content-sharing website; (e</font><font style="display: inline;">) virtual game world or virtual social world; (</font><font style="display: inline;">f) rating and review website; (g</font><font style="display: inline;">) wiki or similar collabo</font><font style="display: inline;">rative content website; or (h</font><font style="display: inline;">) message board, bulletin board, or similar forum.</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444775488"></a><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Software</font><font style="display: inline;">&#x201D; shall mean all (a) computer programs and other software, including firmware and microcode, and including software implementations of algorithms, models, and methodologies, whether in Source Code, object code or other form, including libraries, frameworks, software development kits and tools, application programming interfaces, subroutines and </font><font style="display: inline;">other</font><font style="display: inline;"> components thereof; (b)&nbsp;computerized Databases and other computerized compilations and collections of data or information, including all data and information included in such Databases, compilations or collections; (c) screens, user interfaces, command structures, report formats, templates, menus, buttons and icons related to any of the foregoing; (d) descriptions, flow-charts, architectures, development tools, and other materials used to design, plan, organize, or develop any of the foregoing; and (e) all documentation, including development, diagnostic, support, user and training documentation related to any of the foregoing.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Sold Shares</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">2.1</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Solvent</font><font style="display: inline;">&#x201D; shall have the meaning set forth </font><font style="display: inline;">in </font><font style="display: inline;font-weight:bold;">Section</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">6.11</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Special </font><font style="display: inline;font-weight:bold;">Indemnification </font><font style="display: inline;font-weight:bold;">Matters</font><font style="display: inline;">&#x201D; has the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.2(a)(iv)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Specified Company Products</font><font style="display: inline;">&#x201D; means the following Company Products:</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:432.00pt;margin-left:41.4pt;">
			<tr>
				<td valign="top" style="width:252.00pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #BFBFBF;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;font-weight:bold;color:#000000;font-size:9pt;">Product (Registration Name)</font></p>
				</td>
				<td valign="top" style="width:47.00pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #BFBFBF;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;font-weight:bold;color:#000000;font-size:9pt;">Risk class</font></p>
				</td>
				<td valign="top" style="width:74.00pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #BFBFBF;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;font-weight:bold;color:#000000;font-size:9pt;">(Certificate) Registration No.</font></p>
				</td>
				<td valign="top" style="width:59.00pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #BFBFBF;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;font-weight:bold;color:#000000;font-size:9pt;">Valid until</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:252.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">E-wire guide Wire</font><br /><font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">(GUIAS METALICOS JOTEC)</font></p>
				</td>
				<td valign="top" style="width:47.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">IV</font></p>
				</td>
				<td valign="top" style="width:74.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">80152120001</font></p>
				</td>
				<td valign="top" style="width:59.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">10/1/2022</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:252.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:26.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">E-vita open plus Stent Graft System / E-vita thoracic 3G Stent Graft System</font><br /><font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">(PROTESE VASCULAR E-VITA JOTEC)</font></p>
				</td>
				<td valign="top" style="width:47.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:26.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">IV</font></p>
				</td>
				<td valign="top" style="width:74.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:26.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">80152120002</font></p>
				</td>
				<td valign="top" style="width:59.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:26.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">10/1/2022</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:252.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">E-njoy Peripheral Stent</font><br /><font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">(FAM&#xCD;LIA DE STENTS PERIF&#xC9;RICOS JOTEC)</font></p>
				</td>
				<td valign="top" style="width:47.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">IV</font></p>
				</td>
				<td valign="top" style="width:74.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">80152120003</font></p>
				</td>
				<td valign="top" style="width:59.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">11/12/2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:252.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">FlowLine Bipore ePTFE Vascular Graft</font><br /><font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">(FAM&#xCD;LIA DE ENXERTOS VASCULARES EPTFE JOTEC)</font></p>
				</td>
				<td valign="top" style="width:47.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">IV</font></p>
				</td>
				<td valign="top" style="width:74.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">80152120005</font></p>
				</td>
				<td valign="top" style="width:59.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">12/10/2022</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:252.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">Textile Vascular Grafts FlowNit Bioseal / FlowWeave Bioseal </font><br /><font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">(FAM&#xCD;LIA DE ENXERTOS VASCULARES INORG&#xC2;NICOS JOTEC)</font></p>
				</td>
				<td valign="top" style="width:47.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">IV</font></p>
				</td>
				<td valign="top" style="width:74.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">80152120011</font></p>
				</td>
				<td valign="top" style="width:59.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">12/8/2018</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:252.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">E-vita abdominal XT Stent Graft System</font><br /><font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">(PR&#xD3;TESE VASCULAR ABDOMINAL E-VITA JOTEC)</font></p>
				</td>
				<td valign="top" style="width:47.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">IV</font></p>
				</td>
				<td valign="top" style="width:74.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">80152120016</font></p>
				</td>
				<td valign="top" style="width:59.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">9/28/2019</font></p>
				</td>
			</tr></table>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 5-</font><font style="display: inline;"></font><font style="display: inline;">16</font><font style="display: inline;"></font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:432.00pt;margin-left:41.4pt;">
			<tr>
				<td valign="top" style="width:252.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">E-asy plus Introducer Sheath</font><br /><font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">(INTRODUTOR EASY)</font></p>
				</td>
				<td valign="top" style="width:47.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">II</font></p>
				</td>
				<td valign="top" style="width:74.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">80152120017</font></p>
				</td>
				<td valign="top" style="width:59.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">10/26/2019</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:252.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">E-xpand Stent Graft Balloon Catheter</font><br /><font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">(CATETER BAL&#xC3;O E-XPAND JOTEC)</font></p>
				</td>
				<td valign="top" style="width:47.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">IV</font></p>
				</td>
				<td valign="top" style="width:74.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">80152120019</font></p>
				</td>
				<td valign="top" style="width:59.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">2/25/2020</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:252.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">E-xl Aortic Stent</font><br /><font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">(ENDOPR&#xD3;TESE A&#xD3;RTICA E-XL)</font></p>
				</td>
				<td valign="top" style="width:47.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">IV</font></p>
				</td>
				<td valign="top" style="width:74.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">80152120021</font></p>
				</td>
				<td valign="top" style="width:59.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">5/31/2020</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:252.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">E-liac Stent Graft System</font><br /><font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">(E&#xAE;-LIAC SISTEMA STENT GRAFT )</font></p>
				</td>
				<td valign="top" style="width:47.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">III</font></p>
				</td>
				<td valign="top" style="width:74.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">80152120025</font></p>
				</td>
				<td valign="top" style="width:59.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">5/4/2020</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:252.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">E-ventus BX Peripheral Stent Graft System</font><br /><font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">(Stent Perif&#xE9;rico Recoberto E-ventus BX )</font></p>
				</td>
				<td valign="top" style="width:47.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">III</font></p>
				</td>
				<td valign="top" style="width:74.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">80152120026</font></p>
				</td>
				<td valign="top" style="width:59.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">6/6/2021</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:252.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">E-tegra Stent Graft System</font><br /><font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">(Sistema de Endopr&#xF3;tese E-Tegra)</font></p>
				</td>
				<td valign="top" style="width:47.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">III</font></p>
				</td>
				<td valign="top" style="width:74.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">80152120027</font></p>
				</td>
				<td valign="top" style="width:59.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:24.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-family:Cambria;color:#000000;font-size:9pt;">9/5/2021</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;background-color:yellow;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Specified Countries</font><font style="display: inline;">&#x201D; means Turkey, Serbia, Egypt, Israel, Morocco, Tunisia, Belarus, South Africa, Argentina, Brazil, Hong Kong, Ecuador, Honduras, Peru, Uruguay, Australia, China, and Thailand.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Squeeze-Out Merger</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.15</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Suppliers</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.28(b)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Survival Date</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.1</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;"> &nbsp;&#x201C;</font><font style="display: inline;font-weight:bold;">Tax</font><font style="display: inline;">&#x201D;</font><font style="display: inline;"> or collectively, </font><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Taxes</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.11(a)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Tax Group</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.11(b)(xiv)</font><font style="display: inline;">. &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Tax Incentive</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.11(b)(xix)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Tax</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-weight:bold;">Returns</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.11(b)(ii)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444775497"></a><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Technology</font><font style="display: inline;">&#x201D; shall mean any and all: (a) technology, formulae, algorithms, procedures, processes, methods, </font><font style="display: inline;">techniques</font><font style="display: inline;">, systems, </font><font style="display: inline;">models, compositions, K</font><font style="display: inline;">now-</font><font style="display: inline;">H</font><font style="display: inline;">ow, ideas, creations, inventions, discoveries, and improvements (whether patentable or unpatentable and whet</font><font style="display: inline;">her or not reduced to practice);</font><font style="display: inline;"> (b) technical, engineering, manufacturing, product, marketing, servicing, financial, supplier, personnel, and other infor</font><font style="display: inline;">mation, research, and materials;</font><font style="display: inline;"> (c) specifications, designs, models, devices</font><font style="display: inline;">;</font><font style="display: inline;"> prototypes, schematics</font><font style="display: inline;">, manuals and development tools;</font><font style="display: inline;"> (d) Software, content</font><font style="display: inline;">, and other Works of Authorship;</font><font style="display: inline;"> &nbsp;(</font><font style="display: inline;">e) Databases; (f)&nbsp;Trademarks; (g) Domain Names;</font><font style="display: inline;"> (h) Trade Secrets</font><font style="display: inline;">;</font><font style="display: inline;"> and (i) tangible embodiments of any of the foregoing, in any form or media whether or not specifically listed in this definition.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Termination Date</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.9</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Third Party Claim</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.4(f)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Third Party Expenses</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">7.4</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 5-</font><font style="display: inline;"></font><font style="display: inline;">17</font><font style="display: inline;"></font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Threshold Amount</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.4(a)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444776075"></a><a name="_Ref487613080"></a><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Trade Secrets</font><font style="display: inline;">&#x201D; &nbsp;</font><font style="display: inline;">shall mean any</font><font style="display: inline;"> confidential and proprietary information, whether oral or written, including ideas, designs, concepts, compilations of information, methods, techniques, procedures, processes and other know-how, whether or not patentable, of any nature in any form, including all writings, memoranda, copies, reports, papers, surveys, analyses, drawings, letters, computer printouts, computer programs, computer applications, specifications, business methods, business processes, business techniques, business plans, data (</font><font style="display: inline;">including</font><font style="display: inline;"> customer data), graphs, charts, sound recordings and/or pictorial reproductions that (a) derive independent economic value, actual or potential, from not being generally known to the public or to other Persons who can obtain economic value from its disclosure or use and (b) are the subject of efforts that are reasonable under the circumstances to maintain their secrecy.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444776080"></a><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Trademarks</font><font style="display: inline;">&#x201D; shall mean any domestic or foreign unregistered and registered trademarks and service marks, trademark and service mark applications, common law trademarks and service marks, trade dress, symbols, </font><font style="display: inline;">logos</font><font style="display: inline;">, trade names, business names, corporate names, product names and other source or business identifiers and the goodwill associated with any of the foregoing and any renewals and extensions of any of the foregoing.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Transfer Agent</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">2.4(a)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">United States</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">4.7(c)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Unsatisfied Claim</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">9.3(b)(i)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Upward Adjustment Amount</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">3.1(e)</font><font style="display: inline;">. &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">U.S. person</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">4.7(c)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">U.S. Tax P</font><font style="display: inline;font-weight:bold;">erson</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">4.8(b)</font><font style="display: inline;">. &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref445044217"></a><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">User Data</font><font style="display: inline;">&#x201D; shall mean any Personal Information or other data or information collected by or on behalf of the Company or </font><font style="display: inline;">any of the Company Subsidiaries</font><font style="display: inline;"> from users of the </font><font style="display: inline;">Company Products</font><font style="display: inline;"> and services.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">VDR</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section </font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">4.11</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref444776090"></a><a name="_Ref451526939"></a><font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Works of Authorship</font><font style="display: inline;">&#x201D; &nbsp;</font><font style="display: inline;">shall mean any</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">computer programs, source code, and executable code, whether embodied in Software, firmware or otherwise, architecture, documentation, designs, files, records, databases, data</font><font style="display: inline;">, documentation, scripts, verification </font><font style="display: inline;">components</font><font style="display: inline;">, test suites, websites, content, images, graphics, text, photographs, artwork, audiovisual works, sound recordings, graphs, drawings, reports, analyses, writings, and other works of authorship and copyrightable subject matter.</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x201C;</font><font style="display: inline;font-weight:bold;">Year-End Financials</font><font style="display: inline;">&#x201D; shall have the meaning set forth in </font><font style="display: inline;font-weight:bold;">Section&nbsp;</font><font style="display: inline;font-weight:bold;">&#x200E;</font><font style="display: inline;font-weight:bold;">5.7(a)</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="schedule6"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 5-</font><font style="display: inline;"></font><font style="display: inline;">18</font><font style="display: inline;"></font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-weight:bold;color:#010000;text-decoration:underline;">Schedule&nbsp;6</font><br /><font style="display: inline;font-weight:bold;"></font><br /><font style="display: inline;font-weight:bold;">Excluded Contracts</font><font style="display: inline;font-weight:bold;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">(excluded from releases as per sections 7.13(a)(ii) and 7.14)</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 28.35pt;text-indent: -28.35pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">(A) </font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 13.6pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;">All Contracts which are to be amended pursuant to Schedule 10; including underlying Contracts</font><font style="display: inline;">, if applicable,</font><font style="display: inline;"> and subsequent amendments thereof</font><font style="display: inline;">.</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 28.35pt;text-indent: -28.35pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">(B) </font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 13.6pt 0pt 0pt;"></font><font style="display: inline;">Further, the following Contracts:</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 57.3pt;text-indent: -21.3pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">1.</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 13.8pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;">Chief Executive Agreement, dated as of December 19, 2002, amended as of July 28, 2006 and as of November 22, 2013, by and between Thomas J. Bogensch&#xFC;tz and JOTEC GmbH.</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 57.3pt;text-indent: -21.3pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">2.</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 13.8pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;">Service Contract, by and between Thomas J. Bogensch&#xFC;tz and CryoLife, Inc. (signing pending).</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 57.3pt;text-indent: -21.3pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">3.</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 13.8pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;">Mietvertrag (Lease Agreement) for the property located at Lotzen&#xE4;cker 17, dated as of May 16, 2014, by and between NVT GmbH and JOTEC GmbH.</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 57.3pt;text-indent: -21.3pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">4.</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 13.8pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;">Mietvertrag (Lease Agreement) for the property located at Lotzen&#xE4;cker 9, dated as of November 12, 2015, by and between NVT GmbH and JOTEC GmbH.</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 57.3pt;text-indent: -21.3pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">5.</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 13.8pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;">Dienstleistungsvereinbarung (Service Agreement), dated as of March 1, 2017, by and between NVT AG and JOTEC GmbH.</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 57.3pt;text-indent: -21.3pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">6.</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 13.8pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;">Dienstleistungsvereinbarung (Service Agreement), dated as of June 23, 2015, by and between NVT GmbH and JOTEC GmbH (as amended by that certain Erg&#xE4;nzungsvereinbarung dated January 10, 2016 and that certain Erg&#xE4;nzungsvereinbarung dated January 1, 2017).</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 57.3pt;text-indent: -21.3pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">7.</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 13.8pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;">Dienstleistungsvereinbarung (Service Agreement), dated as of March 1, 2017, by and between NVT Sales GmbH and JOTEC GmbH.</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 57.3pt;text-indent: -21.3pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">8.</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 13.8pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;">Outsourcing-Vereinbarung (Outsourcing Agreement), dated as of June 24, 2014, by and between Fumedica AG and JOTEC Sales AG.</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 57.3pt;text-indent: -21.3pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">9.</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 13.8pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;">Vereinbarung Aufl&#xF6;sung Vetriebszusammenarbeit (Earn-out Agreement), dated January 21/22, 2016, by and between Fumedica Intertrade AG, Fumedica AG and JOTEC sales AG.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="schedule7"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 6-</font><font style="display: inline;">1</font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-weight:bold;color:#010000;text-decoration:underline;">Schedule&nbsp;7</font><br /><font style="display: inline;font-weight:bold;"></font><br /><font style="display: inline;font-weight:bold;">Third Party Consents and Notices</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">NONE</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="schedule8"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 7-</font><font style="display: inline;">1</font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-weight:bold;color:#010000;text-decoration:underline;">Schedule&nbsp;8</font><br /><font style="display: inline;font-weight:bold;"></font><br /><font style="display: inline;font-weight:bold;">Liens to be Released</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">NONE</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="schedule9"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 8-</font><font style="display: inline;">1</font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-weight:bold;color:#010000;text-decoration:underline;">Schedule&nbsp;9</font><br /><font style="display: inline;font-weight:bold;"></font><br /><font style="display: inline;font-weight:bold;">Contracts to be Terminated</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 36pt;text-indent: -18pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">1.</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 10.8pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;">Entwicklungs- und Liefervertrag (Development and Supply Agreement), dated as of December 22, 2011, by and between Bentley Innomed GmbH and JOTEC GmbH.</font>
		</p>
		<p style="margin:0pt 0pt 14.4pt 36pt;text-indent: -18pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">2.</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 10.8pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;">Vereinbarung &#xFC;ber die &#xDC;bernahme von Gesch&#xE4;ftsf&#xFC;hrungskosten (Agreement regarding cost allocation of CEO services), dated as of November 22, 2011, by and between JOTEC GmbH and NVT GmbH.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="schedule10"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 9-</font><font style="display: inline;">1</font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-weight:bold;color:#010000;text-decoration:underline;">Schedule&nbsp;10</font><br /><font style="display: inline;font-weight:bold;"></font><br /><font style="display: inline;font-weight:bold;">Contracts to be Amended</font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">1.</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 10.8pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;">Mietvertrag (Lease Agreement) for the property located at Lotzen&#xE4;cker&nbsp;23, dated as of June 30, 2002, by and between Lars Sunnanv&#xE4;der and Jotec GmbH. </font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">2.</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 10.8pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;">Mietvertrag (Lease Agreement) for the property located at Lotzen&#xE4;cker&nbsp;25, dated as of December 16, 2014, by and between Lars Sunnanv&#xE4;der and Jotec GmbH. </font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">3.</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 10.8pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;">Lizenzvertrag (License Agreement), dated as of December 16, 2016, by and between NVT AG and Jotec GmbH.</font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">4.</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 10.8pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;">Produktions und Liefervertrag (Production and Supply Agreement), dated as of June 2, 2017, by and between NVT GmbH and Jotec GmbH. </font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">5.</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 10.8pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;">Private Label Agreement dated 02.12.2013, as amended, by and between Bentley InnoMed GmbH and Jotec GmbH.</font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">6.</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 10.8pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;">Vereinbarung zur Nutzung der IT-Infrastruktur und Dienstleistungen der LSmedcap GmbH (IT Services Agreement), dated 01.01.2004, as amended, by and between LS medcap GmbH and Jotec GmbH.</font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">7.</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 10.8pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;">Arrangements between Joline GmbH &amp; Co. KG and Jotec GmbH &#x2013; to be supplemented with Supply Agreement (signing pending).</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="schedule11"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 1</font><font style="display: inline;">0-</font><font style="display: inline;">1</font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-weight:bold;color:#010000;text-decoration:underline;">Schedule&nbsp;11</font><br /><font style="display: inline;font-weight:bold;"></font><br /><font style="display: inline;font-weight:bold;"></font><font style="display: inline;font-weight:bold;">Special Indemnification Matters</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="border-right:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-left:1pt solid #000000 ;border-top:1pt solid #000000 ;width:121.95pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;">Special Indemnity Matter</font></p>
				</td>
				<td valign="top" style="border-right:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;width:91.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;">Accrual or Reserve</font></p>
				</td>
				<td valign="top" style="border-right:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;width:97.30pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;">Estimated Liability</font></p>
				</td>
				<td valign="top" style="border-right:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;width:82.55pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;">Limitation Amount</font></p>
				</td>
				<td valign="top" style="border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;border-top:1pt solid #000000 ;width:86.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;">Survival Period</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;width:121.95pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Liabilities arising from 2012-2014 open Tax audits</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">and </font><font style="display: inline;">Liabilities associated with the tra</font><font style="display: inline;">nsfer pricing scheme of the Company&nbsp;&nbsp;and the Company Subsidiaries</font></p>
				</td>
				<td valign="top" style="border-right:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;width:91.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#x20AC;4</font><font style="display: inline;">49</font><font style="display: inline;">,000</font></p>
				</td>
				<td valign="top" style="border-right:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;width:97.30pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#x20AC;929,000</font></p>
				</td>
				<td valign="top" style="border-right:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;width:82.55pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#x20AC;</font><font style="display: inline;">9,290,000</font></p>
				</td>
				<td valign="top" style="border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;border-right:1pt solid #000000 ;width:86.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">5 years</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;width:121.95pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Claims by Company Employees pending against the Company or any Company Subsidiary</font></p>
				</td>
				<td valign="top" style="border-right:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;width:91.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">None</font></p>
				</td>
				<td valign="top" style="border-right:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;width:97.30pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#x20AC;50,000</font></p>
				</td>
				<td valign="top" style="border-right:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;width:82.55pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#x20AC;5</font><font style="display: inline;">0</font><font style="display: inline;">0</font><font style="display: inline;">,000</font></p>
				</td>
				<td valign="top" style="border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;border-right:1pt solid #000000 ;width:86.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">3 years</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;width:121.95pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Claims by Cook Incorporated or related parties related to use of fenestrations</font></p>
				</td>
				<td valign="top" style="border-right:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;width:91.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#x20AC;1,000,000</font></p>
				</td>
				<td valign="top" style="border-right:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;width:97.30pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#x20AC;2,000,000</font></p>
				</td>
				<td valign="top" style="border-right:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;width:82.55pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#x20AC;1</font><font style="display: inline;">0</font><font style="display: inline;">,000,000</font></p>
				</td>
				<td valign="top" style="border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;border-right:1pt solid #000000 ;width:86.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">3 years</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;width:121.95pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Liabilities arising from termination of Johannes Zodl</font></p>
				</td>
				<td valign="top" style="border-right:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;width:91.00pt;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#x20AC;50,000</font></p>
				</td>
				<td valign="top" style="border-right:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;width:97.30pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#x20AC;500,000</font></p>
				</td>
				<td valign="top" style="border-right:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;width:82.55pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#x20AC;</font><font style="display: inline;">1,000</font><font style="display: inline;">,000</font></p>
				</td>
				<td valign="top" style="border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;border-right:1pt solid #000000 ;width:86.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">3 years</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;width:121.95pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Claims related to E-tegra recall and pending litigation</font></p>
				</td>
				<td valign="top" style="border-right:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;width:91.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">N</font><font style="display: inline;">one</font></p>
				</td>
				<td valign="top" style="border-right:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;width:97.30pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#x20AC;500,000</font></p>
				</td>
				<td valign="top" style="border-right:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;width:82.55pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#x20AC;5</font><font style="display: inline;">,0</font><font style="display: inline;">00,000</font></p>
				</td>
				<td valign="top" style="border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;border-right:1pt solid #000000 ;width:86.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">3 years</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;width:121.95pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Undisclosed liabilities to Securityholders or their Affiliates </font></p>
				</td>
				<td valign="top" style="border-right:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;width:91.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#x20AC;0</font></p>
				</td>
				<td valign="top" style="border-right:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;width:97.30pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Unknown</font></p>
				</td>
				<td valign="top" style="border-right:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;width:82.55pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Acquisition Consideration</font></p>
				</td>
				<td valign="top" style="border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-top:1pt solid #000000 ;border-right:1pt solid #000000 ;width:86.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">3 years</font></p>
				</td>
			</tr></table>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 1</font><font style="display: inline;">1-</font><font style="display: inline;"></font><font style="display: inline;">1</font><font style="display: inline;"></font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="border-right:1pt solid #000000 ;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;width:121.95pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Any Losses arising from the information and documents disclosed in Section 5.2(a)(i) or Section 5.2(a)(iv) of the Company Disclosure Schedule with respect to the Company and its UK subsidiary</font></p>
				</td>
				<td valign="top" style="border-right:1pt solid #000000 ;border-left:1pt solid #000000 ;border-top:1pt solid #000000 ;border-bottom:1pt solid #000000 ;width:91.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#x20AC;0</font></p>
				</td>
				<td valign="top" style="border-right:1pt solid #000000 ;border-left:1pt solid #000000 ;border-top:1pt solid #000000 ;border-bottom:1pt solid #000000 ;width:97.30pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Unknown</font></p>
				</td>
				<td valign="top" style="border-right:1pt solid #000000 ;border-left:1pt solid #000000 ;border-top:1pt solid #000000 ;border-bottom:1pt solid #000000 ;width:82.55pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Acquisition Consideration</font></p>
				</td>
				<td valign="top" style="border-left:1pt solid #000000 ;border-top:1pt solid #000000 ;border-right:1pt solid #000000 ;border-bottom:1pt solid #000000 ;width:86.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">5 years</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="schedule12"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 1</font><font style="display: inline;">1-</font><font style="display: inline;"></font><font style="display: inline;">2</font><font style="display: inline;"></font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-weight:bold;color:#010000;text-decoration:underline;">Schedule&nbsp;12</font><br /><font style="display: inline;font-weight:bold;"></font><br /><font style="display: inline;font-weight:bold;">Already Considered Purchase Price Reductions</font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;text-indent: -36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Symbol;">&#xF0B7;</font><font style="display: inline;font-family:Symbol;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 29.4pt 0pt 0pt;"></font><font style="display: inline;font-family:Symbol;"></font><font style="display: inline;">Other loans as of April 2017 in the amount of approximately &#x20AC;4,000 </font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;text-indent: -36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Symbol;">&#xF0B7;</font><font style="display: inline;font-family:Symbol;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 29.4pt 0pt 0pt;"></font><font style="display: inline;font-family:Symbol;"></font><font style="display: inline;">Contingent consideration payable regarding termination of Swiss distribution Contract in the amount of approximately &#x20AC;1,290,000</font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;text-indent: -36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Symbol;">&#xF0B7;</font><font style="display: inline;font-family:Symbol;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 29.4pt 0pt 0pt;"></font><font style="display: inline;font-family:Symbol;"></font><font style="display: inline;">Contingent consideration payable regarding the acquisition of customers lists and other assets in Brazil estimated to be in the amount of approximately &#x20AC;2,500,000</font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;text-indent: -36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Symbol;">&#xF0B7;</font><font style="display: inline;font-family:Symbol;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 29.4pt 0pt 0pt;"></font><font style="display: inline;font-family:Symbol;"></font><font style="display: inline;">Amount needed to buy</font><font style="display: inline;">out remainder of the equity in JOTEC </font><font style="display: inline;">Brazil estimated to be in the amount of approximately &#x20AC;180,000</font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;text-indent: -36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Symbol;">&#xF0B7;</font><font style="display: inline;font-family:Symbol;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 29.4pt 0pt 0pt;"></font><font style="display: inline;font-family:Symbol;"></font><font style="display: inline;">Amount needed to buyout remainder of the equity in </font><font style="display: inline;">JOTEC</font><font style="display: inline;"> Spain estimated to be in the amount of approximately &#x20AC;630,000</font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;text-indent: -36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Symbol;">&#xF0B7;</font><font style="display: inline;font-family:Symbol;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 29.4pt 0pt 0pt;"></font><font style="display: inline;font-family:Symbol;"></font><font style="display: inline;">Potential severance </font><font style="display: inline;">payments or c</font><font style="display: inline;">hange of control payments under the change of control agreements </font><font style="display: inline;">between the Company or Company Subsidiaries and</font><font style="display: inline;"> each of Enrico Cremer and </font><font style="display: inline;font-size:11pt;">Christian W&#xF6;rne </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="exhibita"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Schedule 1</font><font style="display: inline;">2-</font><font style="display: inline;">1</font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-weight:bold;color:#010000;text-decoration:underline;">Exhibit&nbsp;A</font><br /><font style="display: inline;font-weight:bold;"></font><br /><font style="display: inline;font-weight:bold;">Escrow Agreement</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="exhibitb"></a>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Exhibit A</font><font style="display: inline;">-</font><font style="display: inline;">1</font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-weight:bold;color:#010000;text-decoration:underline;">Exhibit&nbsp;B</font><br /><font style="display: inline;font-weight:bold;"></font><br /><font style="display: inline;font-weight:bold;"></font><font style="display: inline;font-weight:bold;">Securityholder Agreement</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 0pt 12pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Exhibit B-</font><font style="display: inline;">1</font>

		</p>

		<p style="margin:0pt 0pt 12pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>c199-20171010xex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--HTML document created with Certent Disclosure Management 6.10.0.3-->
<!--Created on: 10/10/2017 8:14:27 PM-->
<html>
	<head>
		<title>
			2017.10.10 8k Jolly Exh 99.1
		</title>
	</head>
	<body><div style="margin-left:72pt;margin-right:72pt;"><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt">

			<font style="display: inline;font-size:10pt;">Exhibit 99.1</font>

		</p>

</div>
		<p style="margin:0pt;line-height:115%;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<a name="_GoBack"></a><font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:5pt 0pt;line-height:150%;font-family:Times New Roman;font-size: 12pt">
			<a name="_DV_M0"></a><a name="_DV_M4"></a><font style="display: inline;font-weight:bold;font-style:italic;font-size:12pt;">FOR IMMEDIATE RELEASE</font>
		</p>
		<p style="margin:0pt;line-height:115%;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">Contacts:</font>
		</p>
		<p style="margin:0pt;line-height:115%;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:252.90pt;height:14.00pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">CryoLife</font><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">&nbsp;</font><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;;font-size: 11pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;"></font><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;;font-size: 11pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;color:#000000;font-size:11pt;"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p>
				</td>
				<td valign="top" style="width:157.50pt;height:14.00pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">The Ruth Group</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:252.90pt;height:13.95pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;color:#000000;font-size:11pt;">D. Ashley Lee</font></p>
				</td>
				<td valign="top" style="width:157.50pt;height:13.95pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;color:#000000;font-size:11pt;">Zack Kubow</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:252.90pt;height:13.95pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;color:#000000;font-size:11pt;">Executive Vice President, Chief Financial Officer and Chief Operating Officer</font></p>
				</td>
				<td valign="top" style="width:157.50pt;height:13.95pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;color:#000000;font-size:11pt;">646-536-7020</font></p>
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;color:#000000;font-size:11pt;text-decoration:underline;">zkubow@theruthgroup.com</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:252.90pt;height:13.95pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;color:#000000;font-size:11pt;">Phone: 770-419-3355</font></p>
				</td>
				<td valign="top" style="width:157.50pt;height:13.95pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;border-bottom:1pt none #D9D9D9 ;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:normal;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:normal;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><a name="_DV_M6"></a>
		</p>
		<p style="margin:0pt;line-height:100%;border-bottom:1pt none #D9D9D9 ;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 14pt">
			<font style="display: inline;font-size:14pt;">CryoLife</font><font style="display: inline;font-size:14pt;">&nbsp;</font><font style="display: inline;font-size:14pt;">Announces </font><font style="display: inline;font-size:14pt;">Definitive Agreement to Acquire </font><font style="display: inline;font-size:14pt;">JOTEC</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:left;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-weight:bold;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:normal;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:normal;font-style:italic;">Provides </font><font style="display: inline;font-weight:normal;font-style:italic;">Access</font><font style="display: inline;font-weight:normal;font-style:italic;"> into $2 Billion Global Stent Graft Market with </font><font style="display: inline;font-weight:normal;font-style:italic;">Highly Competi</font><font style="display: inline;font-weight:normal;font-style:italic;">ti</font><font style="display: inline;font-weight:normal;font-style:italic;">ve </font><font style="display: inline;font-weight:normal;font-style:italic;">Technologically</font><font style="display: inline;font-weight:normal;font-style:italic;"> Advanced </font><font style="display: inline;font-weight:normal;font-style:italic;">Product Portfolio</font>
		</p>
		<p style="margin:0pt;line-height:100%;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:normal;font-style:italic;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:normal;font-style:italic;">&nbsp;</font><font style="display: inline;font-weight:normal;font-style:italic;">Adds </font><font style="display: inline;font-weight:normal;font-style:italic;">Robust</font><font style="display: inline;font-weight:normal;font-style:italic;">&nbsp;</font><font style="display: inline;font-weight:normal;font-style:italic;">New Product Pipeline</font><font style="display: inline;font-weight:normal;font-style:italic;"> and Significantly</font><font style="display: inline;font-weight:normal;font-style:italic;"> Enhan</font><font style="display: inline;font-weight:normal;font-style:italic;">ce</font><font style="display: inline;font-weight:normal;font-style:italic;">s</font><font style="display: inline;font-weight:normal;font-style:italic;"> R&amp;D Capabilities</font>
		</p>
		<p style="margin:0pt;line-height:100%;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:normal;font-style:italic;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:normal;font-style:italic;">Accelerates European Direct Strategy and </font><font style="display: inline;font-weight:normal;font-style:italic;">Meaningfully Expands</font><font style="display: inline;font-weight:normal;font-style:italic;"> Cross-Selling Opportunities</font>
		</p>
		<p style="margin:0pt;line-height:100%;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:normal;font-style:italic;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:normal;font-style:italic;">Expected to </font><font style="display: inline;font-weight:normal;font-style:italic;">Drive</font><font style="display: inline;font-weight:normal;font-style:italic;">&nbsp;</font><font style="display: inline;font-weight:normal;font-style:italic;">High Single</font><font style="display: inline;font-weight:normal;font-style:italic;">-Digit Revenue Growth </font><font style="display: inline;font-weight:normal;font-style:italic;">with</font><font style="display: inline;font-weight:normal;font-style:italic;">&nbsp;</font><font style="display: inline;font-weight:normal;font-style:italic;">Gross</font><font style="display: inline;font-weight:normal;font-style:italic;"> Margin</font><font style="display: inline;font-weight:normal;font-style:italic;"> and Operating </font><font style="display: inline;font-weight:normal;font-style:italic;">Margin Expansion</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:left;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-weight:bold;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:normal;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:normal;font-style:italic;">Conference Call and Webcast</font><font style="display: inline;font-weight:normal;font-style:italic;"> Tomorrow, </font><font style="display: inline;font-weight:normal;font-style:italic;">October </font><font style="display: inline;font-weight:normal;font-style:italic;">11</font><font style="display: inline;font-weight:normal;font-style:italic;">, 2017 at</font><font style="display: inline;font-weight:normal;font-style:italic;"> 8:</font><font style="display: inline;font-weight:normal;font-style:italic;">3</font><font style="display: inline;font-weight:normal;font-style:italic;">0 am</font><font style="display: inline;font-weight:normal;font-style:italic;"> ET</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:left;border-top:1pt none #D9D9D9 ;font-weight:bold;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:341.5pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:normal;font-style:italic;"></font></font>
		</p>
		<p style="margin:15pt 0pt 0pt;background-color: #FFFFFF;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_DV_M7"></a><a name="_DV_M9"></a><font style="display: inline;font-weight:bold;font-size:12pt;">Atlanta, GA</font><font style="display: inline;font-weight:bold;font-size:12pt;"> &#x2013; (</font><font style="display: inline;font-weight:bold;font-size:12pt;">October </font><font style="display: inline;font-weight:bold;font-size:12pt;">10</font><font style="display: inline;font-weight:bold;font-size:12pt;">, &nbsp;</font><font style="display: inline;font-weight:bold;font-size:12pt;">201</font><font style="display: inline;font-weight:bold;font-size:12pt;">7</font><font style="display: inline;font-weight:bold;font-size:12pt;">)</font><font style="display: inline;font-weight:bold;font-size:12pt;"> &#x2013; </font><font style="display: inline;font-size:12pt;">CryoLife</font><font style="display: inline;font-size:12pt;">, Inc. (</font><font style="display: inline;font-size:12pt;">&#x201C;CryoLife&#x201D;; </font><font style="display: inline;font-size:12pt;">NYSE: </font><font style="display: inline;font-size:12pt;">CRY</font><font style="display: inline;font-size:12pt;">)</font><font style="display: inline;font-size:12pt;">, &nbsp;</font><font style="display: inline;color:#000000;font-size:12pt;">a leading medical device and tissue processing company focused on </font><font style="display: inline;color:#000000;font-size:12pt;">cardiac and vascular</font><font style="display: inline;color:#000000;font-size:12pt;"> surgery</font><font style="display: inline;font-size:12pt;">, &nbsp;</font><font style="display: inline;font-size:12pt;">announced today that it has</font><font style="display: inline;font-size:12pt;"> entered </font><font style="display: inline;font-size:12pt;">into </font><font style="display: inline;font-size:12pt;">a definit</font><font style="display: inline;font-size:12pt;">ive agreement to acquire </font><font style="display: inline;font-size:12pt;">JOTEC</font><font style="display: inline;font-size:12pt;"> AG (&#x201C;JOTEC&#x201D;). </font><font style="display: inline;font-size:12pt;">JOTEC is</font><font style="display: inline;font-size:12pt;"> &nbsp;a</font><font style="display: inline;font-size:12pt;"> German-</font><font style="display: inline;font-size:12pt;">based</font><font style="display: inline;font-size:12pt;">,</font><font style="display: inline;font-size:12pt;"> privately-held developer of </font><font style="display: inline;font-size:12pt;">technologically </font><font style="display: inline;font-size:12pt;">differentiated endovascular stent grafts, and cardiac and </font><font style="display: inline;font-size:12pt;">vascular </font><font style="display: inline;font-size:12pt;">surgical </font><font style="display: inline;font-size:12pt;">grafts</font><font style="display: inline;font-size:12pt;">,</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">focused on aortic repair</font><font style="display: inline;font-size:12pt;">.</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">The combination of </font><font style="display: inline;font-size:12pt;">CryoLife</font><font style="display: inline;font-size:12pt;"> and </font><font style="display: inline;font-size:12pt;">JOTEC</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">will </font><font style="display: inline;font-size:12pt;">create a Company with a </font><font style="display: inline;font-size:12pt;">broad and </font><font style="display: inline;font-size:12pt;">highly competitive product portfolio focused on aortic surgery, and</font><font style="display: inline;font-size:12pt;"> will </font><font style="display: inline;font-size:12pt;">position</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">CryoLife</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">to compete strongly</font><font style="display: inline;font-size:12pt;"> in the important and growing endovascular surgical market</font><font style="display: inline;font-size:12pt;">s</font><font style="display: inline;font-size:12pt;">.</font>
		</p>
		<p style="margin:15pt 0pt 0pt;background-color: #FFFFFF;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-size:12pt;">Pat</font><font style="display: inline;font-size:12pt;"> Mackin, Chairman, President, and </font><font style="display: inline;font-size:12pt;">Chief Executive Officer of </font><font style="display: inline;font-size:12pt;">CryoLife</font><font style="display: inline;font-size:12pt;">, said, &#x201C;</font><font style="display: inline;font-size:12pt;">We believe this </font><font style="display: inline;font-size:12pt;">acquisition </font><font style="display: inline;font-size:12pt;">will </font><font style="display: inline;font-size:12pt;">enable</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">CryoLife</font><font style="display: inline;font-size:12pt;"> to deliver sustained</font><font style="display: inline;font-size:12pt;">,</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">high single</font><font style="display: inline;font-size:12pt;">-</font><font style="display: inline;font-size:12pt;">digit</font><font style="display: inline;font-size:12pt;"> revenue growth, </font><font style="display: inline;font-size:12pt;">while also </font><font style="display: inline;font-size:12pt;">diversifying our revenues into a </font><font style="display: inline;font-size:12pt;">significantly </font><font style="display: inline;font-size:12pt;">larger</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">addressable </font><font style="display: inline;font-size:12pt;">market</font><font style="display: inline;font-size:12pt;">. &nbsp;</font><font style="display: inline;font-size:12pt;">JOTEC</font><font style="display: inline;font-size:12pt;"> has a </font><font style="display: inline;font-size:12pt;">technologically</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">differentiated </font><font style="display: inline;font-size:12pt;">product </font><font style="display: inline;font-size:12pt;">portfolio addressing the $2 billion global market </font><font style="display: inline;font-size:12pt;">for stent grafts used in </font><font style="display: inline;font-size:12pt;">endovascular and open repair of aortic diseases. </font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">Their</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">advanced product</font><font style="display: inline;font-size:12pt;"> portfolio has allowed them to achieve </font><font style="display: inline;font-size:12pt;">a &nbsp;</font><font style="display: inline;font-size:12pt;">17</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">percent</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">revenue CAGR over the past </font><font style="display: inline;font-size:12pt;">five</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">years</font><font style="display: inline;font-size:12pt;">, significantly outpacing the growth</font><font style="display: inline;font-size:12pt;"> in </font><font style="display: inline;font-size:12pt;">the overall</font><font style="display: inline;font-size:12pt;"> European market. W</font><font style="display: inline;font-size:12pt;">e</font><font style="display: inline;font-size:12pt;"> expect </font><font style="display: inline;font-size:12pt;">the acquired portfolio </font><font style="display: inline;font-size:12pt;">to continue to post </font><font style="display: inline;font-size:12pt;">double-digit</font><font style="display: inline;font-size:12pt;"> growth </font><font style="display: inline;font-size:12pt;">outside of the United States </font><font style="display: inline;font-size:12pt;">for at least the next </font><font style="display: inline;font-size:12pt;">five years</font><font style="display: inline;font-size:12pt;">.</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">In addition, </font><font style="display: inline;font-size:12pt;">the acquisition will</font><font style="display: inline;font-size:12pt;"> leverage our global infrastructure and accelerate our ability to go direct in Europe, </font><font style="display: inline;font-size:12pt;">and will foster </font><font style="display: inline;font-size:12pt;">considerable</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">cross-selling opportunities </font><font style="display: inline;font-size:12pt;">between the </font><font style="display: inline;font-size:12pt;">CryoLife</font><font style="display: inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:15pt 0pt 0pt;background-color: #FFFFFF;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-size:12pt;">and </font><font style="display: inline;font-size:12pt;">JOTEC</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">product portfolios</font><font style="display: inline;font-size:12pt;">.</font><font style="display: inline;font-size:12pt;"> The transaction will also drive </font><font style="display: inline;font-size:12pt;">gross </font><font style="display: inline;font-size:12pt;">margin expansion</font><font style="display: inline;font-size:12pt;"> and accelerate</font><font style="display: inline;font-size:12pt;"> our trajectory towards </font><font style="display: inline;font-size:12pt;">20 percent or higher </font><font style="display: inline;font-size:12pt;">operating margin</font><font style="display: inline;font-size:12pt;">s</font><font style="display: inline;font-size:12pt;">.</font><font style="display: inline;font-size:12pt;"> We believe this </font><font style="display: inline;font-size:12pt;">will </font><font style="display: inline;font-size:12pt;">position </font><font style="display: inline;font-size:12pt;">CryoLife</font><font style="display: inline;font-size:12pt;"> to deliver</font><font style="display: inline;font-size:12pt;"> growth in</font><font style="display: inline;font-size:12pt;"> non-GAAP EPS </font><font style="display: inline;font-size:12pt;">at a </font><font style="display: inline;font-size:12pt;">CAGR </font><font style="display: inline;font-size:12pt;">of at least 20 percent </font><font style="display: inline;font-size:12pt;">over the next five </font><font style="display: inline;font-size:12pt;">year</font><font style="display: inline;font-size:12pt;">s</font><font style="display: inline;font-size:12pt;">.</font><font style="display: inline;font-size:12pt;">&#x201D;</font>
		</p>
		<p style="margin:15pt 0pt 0pt;background-color: #FFFFFF;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-size:12pt;">Mr. Mackin added, &#x201C;</font><font style="display: inline;font-size:12pt;">We </font><font style="display: inline;font-size:12pt;">also </font><font style="display: inline;font-size:12pt;">expect the </font><font style="display: inline;font-size:12pt;">JOTEC</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">new </font><font style="display: inline;font-size:12pt;">product pipeline and R&amp;D capabilities</font><font style="display: inline;font-size:12pt;"> to </font><font style="display: inline;font-size:12pt;">drive long</font><font style="display: inline;font-size:12pt;">er</font><font style="display: inline;font-size:12pt;">-term</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">growth</font><font style="display: inline;font-size:12pt;"> beyond the five year horizon</font><font style="display: inline;font-size:12pt;">,</font><font style="display: inline;font-size:12pt;"> particularly </font><font style="display: inline;font-size:12pt;">as their</font><font style="display: inline;font-size:12pt;"> most innovative products </font><font style="display: inline;font-size:12pt;">enter the</font><font style="display: inline;font-size:12pt;"> U.S. market. </font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">We plan to </font><font style="display: inline;font-size:12pt;">utilize</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">CryoLife</font><font style="display: inline;font-size:12pt;">&#x2019;s</font><font style="display: inline;font-size:12pt;"> clinical and regulatory expertise to gain FDA approval for these products, which </font><font style="display: inline;font-size:12pt;">we believe </font><font style="display: inline;font-size:12pt;">will </font><font style="display: inline;font-size:12pt;">allow for entry in</font><font style="display: inline;font-size:12pt;">to</font><font style="display: inline;font-size:12pt;"> the U.S. market.&#x201D;</font><font style="display: inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:15pt 0pt 0pt;background-color: #FFFFFF;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-size:12pt;">Thomas </font><font style="display: inline;font-size:12pt;">Bogensch&#xFC;tz</font><font style="display: inline;font-size:12pt;">, Chief Executive Officer of </font><font style="display: inline;font-size:12pt;">JOTEC</font><font style="display: inline;font-size:12pt;">, commented, &#x201C;</font><font style="display: inline;font-size:12pt;">CryoLife</font><font style="display: inline;font-size:12pt;"> is ideally positioned to</font><font style="display: inline;font-size:12pt;"> accelerate adoption of our products through </font><font style="display: inline;font-size:12pt;">its </font><font style="display: inline;font-size:12pt;">highly complementary and global cardiac </font><font style="display: inline;font-size:12pt;">and vascular </font><font style="display: inline;font-size:12pt;">surgery business. </font><font style="display: inline;font-size:12pt;">We are </font><font style="display: inline;font-size:12pt;">looking forward </font><font style="display: inline;font-size:12pt;">to working</font><font style="display: inline;font-size:12pt;"> with </font><font style="display: inline;font-size:12pt;">CryoLife</font><font style="display: inline;font-size:12pt;">&#x2019;s </font><font style="display: inline;font-size:12pt;">team to drive </font><font style="display: inline;font-size:12pt;">growth of our existing business, </font><font style="display: inline;font-size:12pt;">expand into new geographies</font><font style="display: inline;font-size:12pt;">, and accelerate our R&amp;D initiatives in key markets such as the U.S.</font><font style="display: inline;font-size:12pt;">&#x201D;</font>
		</p>
		<p style="margin:15pt 0pt 0pt;background-color: #FFFFFF;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-size:12pt;">JOTEC</font><font style="display: inline;font-size:12pt;"> generated revenue of approximately </font><font style="display: inline;font-size:12pt;">&#x20AC;41</font><font style="display: inline;font-size:12pt;"> million in 201</font><font style="display: inline;font-size:12pt;">6</font><font style="display: inline;font-size:12pt;">, representing compound annual growth of </font><font style="display: inline;font-size:12pt;">approximately </font><font style="display: inline;font-size:12pt;">17</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">percent</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">over the preceding </font><font style="display: inline;font-size:12pt;">five </font><font style="display: inline;font-size:12pt;">years</font><font style="display: inline;font-size:12pt;">.</font><font style="display: inline;font-size:12pt;"> &nbsp; &nbsp;</font><font style="display: inline;font-size:12pt;">JOTEC</font><font style="display: inline;font-size:12pt;"> generated revenues of &#x20AC;43</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">million, or approximately $</font><font style="display: inline;font-size:12pt;">51</font><font style="display: inline;font-size:12pt;"> million</font><font style="display: inline;font-size:12pt;"> at current currency exchange rates</font><font style="display: inline;font-size:12pt;">, for the twelve months ended June 30, 2017.&nbsp; </font>
		</p>
		<p style="margin:15pt 0pt 0pt;background-color: #FFFFFF;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;font-size:12pt;">Strategic </font><font style="display: inline;font-weight:bold;font-size:12pt;">Rationale for</font><font style="display: inline;font-weight:bold;font-size:12pt;"> the Transaction</font>
		</p>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="background-color: #FFFFFF;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt;margin:15pt 0pt 0pt;">
				<font style="margin:15pt 0pt 0pt;font-family:Symbol;background-color:#FFFFFF;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-bottom:1pt none #D9D9D9;font-size:12pt;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="background-color: #FFFFFF;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt;margin:15pt 0pt 0pt;">
			<font style="display: inline;font-size:12pt;color:#000000;">Provides CryoLife with</font><font style="display: inline;font-size:12pt;color:#000000;">:</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;"><p style="width:54pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="background-color: #FFFFFF;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt;margin:15pt 0pt 0pt;">
				<font style="margin:15pt 0pt 0pt;font-family:Courier New;background-color:#FFFFFF;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9;border-bottom:1pt none #D9D9D9;font-size:12pt;;"> o</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="background-color: #FFFFFF;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt;margin:15pt 0pt 0pt;">
			<font style="display: inline;font-size:12pt;color:#000000;">T</font><font style="display: inline;font-size:12pt;color:#000000;">echnologically advanced </font><font style="display: inline;font-size:12pt;color:#000000;">and </font><font style="display: inline;font-size:12pt;color:#000000;">highly competitive product portfolio that is taking market</font><font style="display: inline;font-size:12pt;color:#000000;"> share</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;"><p style="width:54pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="background-color: #FFFFFF;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt;margin:15pt 0pt 0pt;">
				<font style="margin:15pt 0pt 0pt;font-family:Courier New;background-color:#FFFFFF;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9;border-bottom:1pt none #D9D9D9;font-size:12pt;;"> o</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="background-color: #FFFFFF;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt;margin:15pt 0pt 0pt;">
			<font style="display: inline;font-size:12pt;color:#000000;">A</font><font style="display: inline;font-size:12pt;color:#000000;"> strong new product pipeline a</font><font style="display: inline;font-size:12pt;color:#000000;">nd outstanding R&amp;D capabilities</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;"><p style="width:54pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="background-color: #FFFFFF;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt;margin:15pt 0pt 0pt;">
				<font style="margin:15pt 0pt 0pt;font-family:Courier New;background-color:#FFFFFF;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9;border-bottom:1pt none #D9D9D9;font-size:12pt;;"> o</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="background-color: #FFFFFF;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt;margin:15pt 0pt 0pt;">
			<font style="display: inline;font-size:12pt;color:#000000;">Near-term and longer-term</font><font style="display: inline;font-size:12pt;color:#000000;"> revenue growth drivers through 202</font><font style="display: inline;font-size:12pt;color:#000000;">8</font><font style="display: inline;font-size:12pt;color:#000000;">; and</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;"><p style="width:54pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="background-color: #FFFFFF;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt;margin:15pt 0pt 0pt;">
				<font style="margin:15pt 0pt 0pt;font-family:Courier New;background-color:#FFFFFF;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9;border-bottom:1pt none #D9D9D9;font-size:12pt;;"> o</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="background-color: #FFFFFF;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt;margin:15pt 0pt 0pt;">
			<font style="display: inline;font-size:12pt;color:#000000;">Access to the $1.2 billion U.S. stent graft market, which is expected to grow to approximately $1.5 billion by 2021</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="background-color: #FFFFFF;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt;margin:15pt 0pt 0pt;">
				<font style="margin:15pt 0pt 0pt;font-family:Symbol;background-color:#FFFFFF;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9;border-bottom:1pt none #D9D9D9;font-size:12pt;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="background-color: #FFFFFF;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt;margin:15pt 0pt 0pt;">
			<font style="display: inline;font-size:12pt;color:#000000;">Increases </font><font style="display: inline;font-size:12pt;color:#000000;">CryoLife&#x2019;s </font><font style="display: inline;font-size:12pt;color:#000000;">addressable</font><font style="display: inline;font-size:12pt;color:#000000;"> market opportunity via access to </font><font style="display: inline;font-size:12pt;color:#000000;">the current </font><font style="display: inline;font-size:12pt;color:#000000;">$2</font><font style="display: inline;font-size:12pt;color:#000000;">.0</font><font style="display: inline;font-size:12pt;color:#000000;"> billion</font><font style="display: inline;font-size:12pt;color:#000000;"> global stent graft market</font><font style="display: inline;font-size:12pt;color:#000000;">,</font><font style="display: inline;font-size:12pt;color:#000000;">&nbsp;</font><font style="display: inline;font-size:12pt;color:#000000;">which is expected</font><font style="display: inline;font-size:12pt;color:#000000;"> to </font><font style="display: inline;font-size:12pt;color:#000000;">grow to </font><font style="display: inline;font-size:12pt;color:#000000;">approximately $</font><font style="display: inline;font-size:12pt;color:#000000;">2.5</font><font style="display: inline;font-size:12pt;color:#000000;"> billion by 2021</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="background-color: #FFFFFF;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt;margin:15pt 0pt 0pt;">
				<font style="margin:15pt 0pt 0pt;font-family:Symbol;background-color:#FFFFFF;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9;border-bottom:1pt none #D9D9D9;font-size:12pt;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="background-color: #FFFFFF;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt;margin:15pt 0pt 0pt;">
			<font style="display: inline;font-size:12pt;color:#000000;">Accele</font><font style="display: inline;font-size:12pt;color:#000000;">rates </font><font style="display: inline;font-size:12pt;color:#000000;">CryoLife&#x2019;s </font><font style="display: inline;font-size:12pt;color:#000000;">direct sales strategy in</font><font style="display: inline;font-size:12pt;color:#000000;">&nbsp;</font><font style="display: inline;font-size:12pt;color:#000000;">key</font><font style="display: inline;font-size:12pt;color:#000000;"> European markets</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="background-color: #FFFFFF;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt;margin:15pt 0pt 0pt;">
				<font style="margin:15pt 0pt 0pt;font-family:Symbol;background-color:#FFFFFF;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9;border-bottom:1pt none #D9D9D9;font-size:12pt;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="background-color: #FFFFFF;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt;margin:15pt 0pt 0pt;">
			<font style="display: inline;font-size:12pt;color:#000000;">Creates significant cross</font><font style="display: inline;font-size:12pt;color:#000000;">-</font><font style="display: inline;font-size:12pt;color:#000000;">selling opportunities by leveraging </font><font style="display: inline;font-size:12pt;color:#000000;">CryoLife</font><font style="display: inline;font-size:12pt;color:#000000;">&#x2019;s and </font><font style="display: inline;font-size:12pt;color:#000000;">JOTEC</font><font style="display: inline;font-size:12pt;color:#000000;">&#x2019;s existing direct sales organizations</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="background-color: #FFFFFF;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt;margin:15pt 0pt 0pt;">
				<font style="margin:15pt 0pt 0pt;font-family:Symbol;background-color:#FFFFFF;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9;font-size:12pt;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="background-color: #FFFFFF;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt;margin:15pt 0pt 0pt;">
			<font style="display: inline;font-size:12pt;color:#000000;">Drives projected</font><font style="display: inline;font-size:12pt;color:#000000;">&nbsp;</font><font style="display: inline;font-size:12pt;color:#000000;">high single</font><font style="display: inline;font-size:12pt;color:#000000;">-digit revenue growth, expand</font><font style="display: inline;font-size:12pt;color:#000000;">s</font><font style="display: inline;font-size:12pt;color:#000000;"> gross margin, and </font><font style="display: inline;font-size:12pt;color:#000000;">yield</font><font style="display: inline;font-size:12pt;color:#000000;">s</font><font style="display: inline;font-size:12pt;color:#000000;">&nbsp;</font><font style="display: inline;font-size:12pt;color:#000000;">20</font><font style="display: inline;font-size:12pt;color:#000000;"> percent plus</font><font style="display: inline;font-size:12pt;color:#000000;"> operating margin</font><font style="display: inline;font-size:12pt;color:#000000;">&nbsp;</font><font style="display: inline;font-size:12pt;color:#000000;">over</font><font style="display: inline;font-size:12pt;color:#000000;"> &nbsp;a</font><font style="display: inline;font-size:12pt;color:#000000;"> five-year period</font></p></td></tr></table></div>
		<p style="margin:15pt 0pt 0pt;background-color: #FFFFFF;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:15pt 0pt 0pt;background-color: #FFFFFF;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-weight:bold;font-size:12pt;">Terms of the Agreement</font>
		</p>
		<p style="margin:15pt 0pt 0pt;background-color: #FFFFFF;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-size:12pt;">Under terms of the </font><font style="display: inline;font-size:12pt;">definitive </font><font style="display: inline;font-size:12pt;">agreement, </font><font style="display: inline;font-size:12pt;">CryoLife</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">will acquire </font><font style="display: inline;font-size:12pt;">JOTEC</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">f</font><font style="display: inline;font-size:12pt;">or</font><font style="display: inline;font-size:12pt;"> an upfront payment of</font><font style="display: inline;font-size:12pt;"> &nbsp;$</font><font style="display: inline;font-size:12pt;">225</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">million</font><font style="display: inline;font-size:12pt;">,</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">subject to certain adjustments, </font><font style="display: inline;font-size:12pt;">consisting of </font><font style="display: inline;font-size:12pt;">75 </font><font style="display: inline;font-size:12pt;">percent</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">in cash and </font><font style="display: inline;font-size:12pt;">25 </font><font style="display: inline;font-size:12pt;">percent</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">in</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">CryoLife</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">common stock</font><font style="display: inline;font-size:12pt;"> issued to </font><font style="display: inline;font-size:12pt;">JOTEC</font><font style="display: inline;font-size:12pt;">&#x2019;s shareholders</font><font style="display: inline;font-size:12pt;">. &nbsp;</font><font style="display: inline;font-size:12pt;">CryoLife</font><font style="display: inline;font-size:12pt;"> expects to finance the transaction</font><font style="display: inline;font-size:12pt;"> and related expenses, as well as </font><font style="display: inline;font-size:12pt;">refinance</font><font style="display: inline;font-size:12pt;"> its existing $</font><font style="display: inline;font-size:12pt;">69</font><font style="display: inline;font-size:12pt;"> million term loan, </font><font style="display: inline;font-size:12pt;">with</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">new </font><font style="display: inline;font-size:12pt;">$</font><font style="display: inline;font-size:12pt;">255 </font><font style="display: inline;font-size:12pt;">million </font><font style="display: inline;font-size:12pt;">senior secured credit facilit</font><font style="display: inline;font-size:12pt;">ies</font><font style="display: inline;font-size:12pt;">, consisting of a $225 million </font><font style="display: inline;font-size:12pt;">institutional term loan</font><font style="display: inline;font-size:12pt;"> &nbsp;B</font><font style="display: inline;font-size:12pt;"> and a $30 million </font><font style="display: inline;font-size:12pt;">undrawn </font><font style="display: inline;font-size:12pt;">revolving credit facility,</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">$</font><font style="display: inline;font-size:12pt;">56.25</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">million in </font><font style="display: inline;font-size:12pt;">CryoLife</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">common stock</font><font style="display: inline;font-size:12pt;">, and available cash on hand</font><font style="display: inline;font-size:12pt;">.</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">The senior secured credit facilities are </font><font style="display: inline;font-size:12pt;">fully </font><font style="display: inline;font-size:12pt;">underwritten by Deutsche Bank, Capital</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">One and Fifth Third Bank</font><font style="display: inline;font-size:12pt;">, and are expected to be syndicated to investors prior to closing of the acquisition</font><font style="display: inline;font-size:12pt;">.</font>
		</p>
		<p style="margin:15pt 0pt 0pt;background-color: #FFFFFF;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-size:12pt;">The </font><font style="display: inline;font-size:12pt;">definitive</font><font style="display: inline;font-size:12pt;"> agreement has been approved by both companies&#x2019; boards of directors. </font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">The transaction is expected to close </font><font style="display: inline;font-size:12pt;">later this year</font><font style="display: inline;font-size:12pt;">, subject to customary closing conditions.</font>
		</p>
		<p style="margin:15pt 0pt 0pt;background-color: #FFFFFF;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;font-size:12pt;">Financial </font><font style="display: inline;font-weight:bold;font-size:12pt;">Commentary</font>
		</p>
		<p style="margin:15pt 0pt 0pt;background-color: #FFFFFF;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-size:12pt;">Third quarter revenues were adversely affected </font><font style="display: inline;font-size:12pt;">due to the impact of the recent hurricanes on our business in Florida and Texas</font><font style="display: inline;font-size:12pt;">, which we estimate to be approximately $1.0 million</font><font style="display: inline;font-size:12pt;">,</font><font style="display: inline;font-size:12pt;"> and </font><font style="display: inline;font-size:12pt;">additionally due to </font><font style="display: inline;font-size:12pt;">the continued delay in obtaining the re-certification of our AAP</font><font style="display: inline;font-size:12pt;">.&nbsp;&nbsp;Including the impact of these factors, third quarter revenue was approximately $45.1 million</font><font style="display: inline;font-size:12pt;">,</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">compared to our third quarter revenue guidance of between $46.5 and $47.5 million</font><font style="display: inline;font-size:12pt;">.&nbsp;&nbsp;In addition, i</font><font style="display: inline;font-size:12pt;">n connection with the transaction, </font><font style="display: inline;font-size:12pt;">CryoLife</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">notified certain of </font><font style="display: inline;font-size:12pt;">its </font><font style="display: inline;font-size:12pt;">distributors that </font><font style="display: inline;font-size:12pt;">it</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">had</font><font style="display: inline;font-size:12pt;"> elected to terminate </font><font style="display: inline;font-size:12pt;">its</font><font style="display: inline;font-size:12pt;"> relationship with </font><font style="display: inline;font-size:12pt;">those</font><font style="display: inline;font-size:12pt;"> distributors based on </font><font style="display: inline;font-size:12pt;">a</font><font style="display: inline;font-size:12pt;"> decision to distribute product through </font><font style="display: inline;font-size:12pt;">the </font><font style="display: inline;font-size:12pt;">to be </font><font style="display: inline;font-size:12pt;">combined </font><font style="display: inline;font-size:12pt;">Company&#x2019;s</font><font style="display: inline;font-size:12pt;"> direct sales channel. </font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">As a result of this decision, </font><font style="display: inline;font-size:12pt;">at the end of the respective contract terms, </font><font style="display: inline;font-size:12pt;">CryoLife</font><font style="display: inline;font-size:12pt;"> will be buying back </font><font style="display: inline;font-size:12pt;">a portion of the </font><font style="display: inline;font-size:12pt;">inventory that was previously sold to these distributors, which will result in a </font><font style="display: inline;font-size:12pt;">$1.1 million third quarter </font><font style="display: inline;font-size:12pt;">reversal of previously recorded revenues</font><font style="display: inline;font-size:12pt;">. &nbsp;</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">Considering all of these factors, </font><font style="display: inline;font-size:12pt;">preliminary third quarter revenues </font><font style="display: inline;font-size:12pt;">were</font><font style="display: inline;font-size:12pt;"> approximately </font><font style="display: inline;font-size:12pt;">$44.0 million.</font><font style="display: inline;font-size:12pt;"> &nbsp; &nbsp;</font><font style="display: inline;font-size:12pt;">Additional revenue reversals and revisions to the third quarter estimates are possible in subsequent quarters.</font><font style="display: inline;font-size:12pt;"> &nbsp; &nbsp;</font>
		</p>
		<p style="margin:15pt 0pt 0pt;background-color: #FFFFFF;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-size:12pt;">Management expects to </font><font style="display: inline;font-size:12pt;">update its 2017 financial guidance in its third quarter financial conference call and to </font><font style="display: inline;font-size:12pt;">issue initial financial guidance for the combined Company in its year-end conference call.</font>
		</p>
		<p style="margin:15pt 0pt 0pt;background-color: #FFFFFF;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-size:12pt;">Moving forward, the Company expects pro forma compound annual revenue growth in the high single</font><font style="display: inline;font-size:12pt;">-</font><font style="display: inline;font-size:12pt;">digits on a percentage basis over the next five years. </font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">Non-GAAP earnings per share is expected to be dilutive in 2018 and </font><font style="display: inline;font-size:12pt;">accretive</font><font style="display: inline;font-size:12pt;"> in 2019.&nbsp;&nbsp;Over the next five year</font><font style="display: inline;font-size:12pt;"> period</font><font style="display: inline;font-size:12pt;">, the Company expects </font><font style="display: inline;font-size:12pt;">20 plus percent compound growth in </font><font style="display: inline;font-size:12pt;">non-GAAP earnings per </font><font style="display: inline;font-size:12pt;">share.</font>
		</p>
		<p style="margin:5pt 0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;font-size:12pt;">Advisors</font><font style="display: inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:5pt 0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-size:12pt;">In connection with the transacti</font><font style="display: inline;font-size:12pt;">on, </font><font style="display: inline;font-size:12pt;">Vinson and Elkins</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">is acting as </font><font style="display: inline;font-size:12pt;">lead </font><font style="display: inline;font-size:12pt;">legal counsel</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">to </font><font style="display: inline;font-size:12pt;">CryoLife</font><font style="display: inline;font-size:12pt;">. &nbsp;</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">Walder Wyss Ltd </font><font style="display: inline;font-size:12pt;">is acting as </font><font style="display: inline;font-size:12pt;">lead </font><font style="display: inline;font-size:12pt;">legal counsel</font><font style="display: inline;font-size:12pt;"> to </font><font style="display: inline;font-size:12pt;">JOTEC</font><font style="display: inline;font-size:12pt;">.</font><font style="display: inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:0pt;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-weight:bold;color:#000000;font-size:12pt;"></font>
		</p>
		<p style="margin:15pt 0pt 0pt;background-color: #FFFFFF;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;color:#000000;font-size:12pt;">Webcast</font><font style="display: inline;font-weight:bold;color:#000000;font-size:12pt;"> and Conference Call Information</font>
		</p>
		<p style="margin:15pt 0pt 0pt;background-color: #FFFFFF;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-size:12pt;">CryoLife</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">will hold a teleconference call and live web</font><font style="display: inline;font-size:12pt;">cast</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">tomorrow</font><font style="display: inline;font-size:12pt;"> at </font><font style="display: inline;font-size:12pt;">8:</font><font style="display: inline;font-size:12pt;">30</font><font style="display: inline;font-size:12pt;"> a.m. Eastern Time to discuss the proposed transaction, followed by a question and answer session hosted by Mr. Mackin.</font>
		</p>
		<p style="margin:15pt 0pt 0pt;background-color: #FFFFFF;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-size:12pt;">To listen to the live teleconference, please dial </font><font style="display: inline;font-size:12pt;">201-689-8261</font><font style="display: inline;font-size:12pt;"> a few minutes prior to </font><font style="display: inline;font-size:12pt;">8:</font><font style="display: inline;font-size:12pt;">30</font><font style="display: inline;font-size:12pt;"> a.m.&nbsp;&nbsp;A replay of the teleconference will be available </font><font style="display: inline;font-size:12pt;">October</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">11</font><font style="display: inline;font-size:12pt;"> through </font><font style="display: inline;font-size:12pt;">October </font><font style="display: inline;font-size:12pt;">18</font><font style="display: inline;font-size:12pt;"> and can be accessed by calling (toll free) </font><font style="display: inline;font-size:12pt;">877-660-6853</font><font style="display: inline;font-size:12pt;"> or </font><font style="display: inline;font-size:12pt;">201-612-7415</font><font style="display: inline;font-size:12pt;">.&nbsp;&nbsp;The conference number for the replay is </font><font style="display: inline;font-size:12pt;">13671595</font><font style="display: inline;font-size:12pt;">. &nbsp;</font>
		</p>
		<p style="margin:15pt 0pt 0pt;background-color: #FFFFFF;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-size:12pt;">The live </font><font style="display: inline;font-size:12pt;">webcast </font><font style="display: inline;font-size:12pt;">and replay can be accessed by going to the Investor Relations section of the </font><font style="display: inline;font-size:12pt;">CryoLife</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">website at</font><font style="display: inline;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">www.cryolife.com</font><font style="display: inline;font-size:12pt;"> and selecting the heading </font><font style="display: inline;font-size:12pt;">Webcasts</font><font style="display: inline;font-size:12pt;"> &amp; Presentations.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;color:#000000;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;color:#000000;font-size:12pt;">About </font><font style="display: inline;font-weight:bold;color:#000000;font-size:12pt;">CryoLife</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;font-size:12pt;">Headquartered in suburban Atlanta, Georgia, </font><font style="display: inline;color:#000000;font-size:12pt;">CryoLife</font><font style="display: inline;color:#000000;font-size:12pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:12pt;">is a leader in the manufacturing, processing, and distribution of</font><font style="display: inline;color:#000000;font-size:12pt;"> medical devices</font><font style="display: inline;color:#000000;font-size:12pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:12pt;">and </font><font style="display: inline;color:#000000;font-size:12pt;">implantable living tissues used in cardiac </font><font style="display: inline;color:#000000;font-size:12pt;">and vascular </font><font style="display: inline;color:#000000;font-size:12pt;">surgical procedures.&nbsp; </font><font style="display: inline;color:#000000;font-size:12pt;">CryoLife</font><font style="display: inline;color:#000000;font-size:12pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:12pt;">markets and sells products in more than 80 countries worldwide.&nbsp;&nbsp;For additional information about </font><font style="display: inline;color:#000000;font-size:12pt;">CryoLife</font><font style="display: inline;color:#000000;font-size:12pt;">, visit our website,</font><font style="display: inline;color:#000000;font-size:12pt;">&nbsp;</font><font style="display: inline;font-size:12pt;">www.cryolife.com</font><font style="display: inline;color:#000000;font-size:12pt;">.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;color:#000000;font-size:12pt;">About </font><font style="display: inline;font-weight:bold;color:#000000;font-size:12pt;">JOTEC</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;color:#000000;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;font-size:12pt;">Headquartered in</font><font style="display: inline;">&nbsp;</font><font style="display: inline;color:#000000;font-size:12pt;">Hechingen, </font><font style="display: inline;color:#000000;font-size:12pt;">Germany</font><font style="display: inline;color:#000000;font-size:12pt;">, &nbsp;</font><font style="display: inline;color:#000000;font-size:12pt;">JOTEC</font><font style="display: inline;color:#000000;font-size:12pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:12pt;">develops</font><font style="display: inline;color:#000000;font-size:12pt;">, &nbsp;</font><font style="display: inline;color:#000000;font-size:12pt;">produce</font><font style="display: inline;color:#000000;font-size:12pt;">s,</font><font style="display: inline;color:#000000;font-size:12pt;"> and market</font><font style="display: inline;color:#000000;font-size:12pt;">s</font><font style="display: inline;color:#000000;font-size:12pt;"> medical devices for aortic and peripheral vascular disease. </font><font style="display: inline;color:#000000;font-size:12pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:12pt;">JOTEC</font><font style="display: inline;color:#000000;font-size:12pt;">&#x2019;s</font><font style="display: inline;color:#000000;font-size:12pt;"> product portfolio encompasses conventional vascular grafts and interventional implants for vascular and cardiac surge</font><font style="display: inline;color:#000000;font-size:12pt;">ry and radiology and cardiology. </font><font style="display: inline;color:#000000;font-size:12pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:12pt;">JOTEC</font><font style="display: inline;color:#000000;font-size:12pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:12pt;">was founded in 2000. </font><font style="display: inline;color:#000000;font-size:12pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:12pt;">For additional information about </font><font style="display: inline;color:#000000;font-size:12pt;">JOTEC</font><font style="display: inline;color:#000000;font-size:12pt;">, visit the website, </font><font style="display: inline;font-size:12pt;">www.jotec.com/en/</font><font style="display: inline;color:#000000;font-size:12pt;">.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">Statements made in this press release that look forward in time or&nbsp;that express&nbsp;management's beliefs, expectations, or hopes are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.&nbsp; Such forward-looking statements reflect the views of management at the time such statements&nbsp;are made.&nbsp; These statements include our belief that </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> this acquisition will position</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> CryoLife</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> to deliver sustained high single-digit revenue growth, while also significantly expanding our total addressable market and diversifying our revenue</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">,</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> that </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">JOTEC</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> has a technologically differentiated portfolio addressing the $2 billion global market for stent grafts used in endovascular and open repair of aortic diseases that is taking market share, our expectation that this global market is expected to grow to approximately $2.5 billion by 2021; our expectation that&nbsp;&nbsp;the acquired portfolio will continue to post double-digit growth </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">outside of the United States </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">for at least the next five year</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">s</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">, will leverage our global infrastructure and accelerate our ability to go direct in Europe, and will foster considerable cross-selling opportunities between the </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">CryoLife</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> and </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">JOTEC</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> product portfolios; our belief that this transaction will drive </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">gross </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">margin expansion and accelerat</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">e</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> our trajectory towards 20 percent or higher operating margin</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">s</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> and will position </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">CryoLife</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> to deliver </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">growth in</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> non-GAAP EPS </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">at a </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">CAGR </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">of at least 20 percent </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">over the next five years; our expectation that the </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">JOTEC</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> new product pipeline and R&amp;D capabilities will drive long-term growth </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">beyond the five year horizon</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">, particularly as </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">JOTEC</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">&#x2019;s</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> most innovative products enter the U.S. market; our expectation that the U</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">.</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">S</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">.</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> stent market is expected to grow to approximately $1.5 billion by 2021; </font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">our belief that </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">CryoLife&#x2019;s</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> clinical and regulatory expertise to gain FDA approval for these products will allow for entry of </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">JOTEC</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> products into the U.S. market; our belief that </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">CryoLife</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> is ideally positioned to accelerate adoption of </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">JOTEC</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> products through its highly complementary and global cardiac and vascular surgery business</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">; and our estimates of revenue reversals in the third quarter 2017 or subsequent quarters associated with distributor buybacks and estimates of the revenue</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> impacts for the third quarter 2017 of the recent hurricanes in Florida and Texas</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">. &nbsp;</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">&nbsp;</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">These forward-looking statements are subject to a number of risks, uncertainties, estimates, and assumptions that may cause actual results to differ materially from current expectations. &nbsp;These risks and uncertainties include that&nbsp;the expected benefits of the acquisition may be incorrect or may not be achieved, our</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> expected assumptions regarding the growth in the global and US stent graft markets may be incorrect; the acquired portfolio may not continue to post double digit growth for the next five year</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">s</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">; we may be unable to sufficiently leverage our global infrastructure or accelerate our ability to g</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">o direct in Europe or to foster cross-selling opportunities, </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">between </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">CryoLife</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> and </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">JOTEC</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> product portfolios, we may be unable to drive margin expansion or unable to deliver non-GAAP EPS</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> at a 20 percent or higher</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> CAGR over the next five years; </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">JOTEC</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">&#x2019;s</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> new product</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> pipeline and R&amp;D capabilities may be unable to drive long term growth, even if </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">CryoLife</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> is able to successfully introduce </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">JOTEC</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> products to the U</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">.</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">S</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">.</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> market; </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">CryoLife</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> may be unable to successfully introduce </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">JOTEC</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> products to the U</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">.</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">S</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">.</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> market; C</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">ryoLife</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> may be unable to accelerate adoption of </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">JOTEC</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> products in its current or future markets. </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">&nbsp;</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">As with most acquisitions, the successful integration of </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">JOTEC</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">&#x2019;s business with ours may take longer and prove more costly than expected, and we may experience currently unforeseen difficulties related to the </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">JOTEC</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> products and our and </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">JOTEC</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">&#x2019;s combined sales forces&#x2019; ability to successfully market them.&nbsp;&nbsp;If we experience problems that slow the integration of </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">JOTEC</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">&#x2019;s business with C</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">ryoLife</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">&#x2019;s business, we may not be able to secure the anticipated financial and operational benefits of the acquisition as soon as anticipated, or at all.&nbsp;&nbsp;We may also inherit unforeseen risks and uncertainties related to </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">JOTEC</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">'s business, particularly if the information received by CryoLife during the due diligence phase of this transaction is incomplete or inaccurate.&nbsp;&nbsp;Our plans with respect to the transaction&#x2019;s financing could change based on currently unforeseen circumstances.&nbsp;&nbsp;Also, certain factors, such as those relating to transaction closing conditions, could delay or prevent the closing of the transaction.&nbsp;&nbsp;Any of these risks could cause the financial impact of the acquisition to be less beneficial than currently anticipated.</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;"> &nbsp; &nbsp;</font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">Our estimates of the revenue impacts related to distributor buybacks and recent hurricanes may be incorrect.&nbsp; </font><font style="display: inline;font-style:italic;color:#000000;font-size:12pt;">These risks and uncertainties include the risk factors detailed in our Securities and Exchange Commission filings, including our Form 10-K for the year ended December 31, 2016, and our subsequent filings with the SEC. CryoLife does not undertake to update its forward-looking statements.</font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>c199-20171010xex2_1g001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 c199-20171010xex2_1g001.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /?Z**\_
M_P"$DU;_ )^__(:?X5S8G%PP]N=/7L=.'PL\1?D:T/0**\__ .$DU;_G[_\
M(:?X4?\ "2:M_P _?_D-/\*Y?[5H]G^'^9U?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BO/\ _A)-6_Y^
M_P#R&G^%'_"2:M_S]_\ D-/\*/[5H]G^'^8?V56[K\?\CT"BL_1+F:\T>">=
M]\C;MS8 SAB.U:%>C":G%274\Z<'"3B^@5Y57JM>55Y&;_8^?Z'KY1]OY?J%
M%%%>*>R%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT*2*<$&LIT*E-7FK&L*].H[0=R*BBBLC4**** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MIS?W8_R/^-'U3">8?6\5Y'/_ /"(:A_SVMO^^F_^)H_X1#4/^>UM_P!]-_\
M$UT']IS?W8_R/^-']IS?W8_R/^-'U3">8?6\5Y'/_P#"(:A_SVMO^^F_^)H_
MX1#4/^>UM_WTW_Q-=!_:<W]V/\C_ (T?VG-_=C_(_P"-'U3">8?6\5Y'/_\
M"(:A_P ]K;_OIO\ XFC_ (1#4/\ GM;?]]-_\3711:C,\R(53#, < _XT2ZC
M,DSH%3"L0,@_XT_J>%M?47US%7MH<[_PB&H?\]K;_OIO_B:/^$0U#_GM;?\
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M=!_:<W]V/\C_ (T?VG-_=C_(_P"-'U3">8?6\5Y'/_\ "(:A_P ]K;_OIO\
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MIS?W8_R/^-'U3">8?6\5Y'/_ /"(:A_SVMO^^F_^)H_X1#4/^>UM_P!]-_\
M$UT']IS?W8_R/^-']IS?W8_R/^-'U3">8?6\5Y'/_P#"(:A_SVMO^^F_^)H_
MX1#4/^>UM_WTW_Q-=!_:<W]V/\C_ (T?VG-_=C_(_P"-'U3">8?6\5Y'/_\
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MWPW4****Y3J"BBB@ HHHH **** "BBB@ HHHH DM_P#CYB_WQ_.BX_X^9?\
M?/\ .BW_ ./F+_?'\Z+C_CYE_P!\_P ZK[!'VB.BBBI+"BBB@ HHHH ****
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MHZ[NY.XD]>@ JI4TM11J-Z'LM%?/GB#^SKY==O[;6?$NNZC"SR)=V41CM+3
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M6(;*X6>-FCP P)^8>M$UE<-/(RQY!8D?,/6JY)<NQ//'FW*=%6?L-S_SS_\
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MSGV#VD.Y6HJS]AN?^>?_ (\*/L-S_P \_P#QX4>SGV#GCW*U%6?L-S_SS_\
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MV)P:R-%M%,8; R&PJ)_#]?:JCW$S5L%>:+R9(F"IP' Q^1['ITK7I%4(@4=
M,4M)NXPHHHI %%%% !1110 4444 %%%% !1110 4444 %%%-DD6-"S'  S0
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M22GW><CI^%7:I1N3JLR87 3^Z,]N_6KM !1110 4444 %%%% !1110 4444
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M15R,\G_/J/SJG=:I%"SHIRRD#/49[CUXX]N?J*YJYU60E5E)#,Q8EVR1R#L
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M[9JCJ$DRR>423 Z$;_X@?K560KFVFIVLR.T#--L;:0BGK^-13ZLD3*HC8%N
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MW--GF%O"TA5FQT51DDUS5]K<<L2N/D^3<&Z-@\A=I''\^!]* +M]JI5"KQ[
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M'0>YJW533]OD-MV8W?P9QT'K5N@ HHHH **** "BBB@ HHHH **** "BBB@
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M110 4444 %%%% !1110 4444 <MXSB9XK*386CC=F8@$]ABG^&QYE[<2-O\
MD48R#MR??\/UKI2 1@C-"JJ#"J%'7@4[Z6%;6XM%%%(84444 %%%% !1110
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M!60[D4KG*L><]A6;:?#Y;+4D:"XT\6*7IO #IJ-=<N7\OSB3\FX]=N['&>]
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MG'7@ Z>BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M77&<,I((P0<@]ZQA+JWB;Q!J]O:ZS<:5I^ES+:C[)%$TLTIC61F8R*P"@.H
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M^&%5KZ2%X%&^)LMD;B3Z_P!VI5L;93D1X."/O'OQ574((H;92B '.WUXY/\
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M&,$84<'J.* 'T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6UC)/J&CWUG+'=V]J8Y K!C,Z(K(X)5E!<9P<C!XZ9 .BHKD?$GB>6V:ZL[
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MQ6/S'#=QC.,\&@#L:*X+Q3XVN[71-8;1K*\<V 6*74%$92*4A6QM8Y; 9<D
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ME1:;/&UN<RB/)5U.[Y>2<@AOZU5U7Q]:6FB7EY:VEX]U:7$$$UK-;2)(GFL
M&(QG!!)!'!(QUJQ=^/M"L+BXBN7NT%K)''=2?9)"ENSJK)O8#"YWJ/K0!/J_
MA^[N-8CUK1]16PU)8/L\AE@\Z*>+)8*Z;E.022"&!&X]<UGGP5<W6F^(DU'5
MUFU#7+,6<DT5J(XH4"N%VQ[B3CS&)RQSQTK6LO%.EWEMJ$YDFM5T\;KI;R!X
M6B7;N#$, <$<Y]C4$?C71VM+RXE-W;+:6K7LB7-K)$[0#JZJP!8?3D9&<9%
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M10I4]6/'OQG:Y\.)-8NM8<:A9(-28/\ :)M/$US!A5 1)"XQ'E<XQGEN><T
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M*.[NXTFA7RE;./O. S-M8A5[#G'&:L'P\D:XNYKW4+0R3Z?-8O-96 MY)Q(
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M=,=J+#P]J)UE-5UG5(;VX@M7M;<6]J8%57*EW8%VRQV+T( QTYH E\->)?\
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M>#W5@?QYKBY-#\375]9":PO!]GUQ;N1(I+:*S6$3%M\:K^\9BIW'?SG=WP"
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M>-F\Q6GWI\K$8^9#G.#D>AQ3TS2M:\/()'T&35&N]%L[-HTFB!@EB1E:-][
M;"6SE=W?CI0!V=QX@T>UU&#3I]2M8[VXV^5 T@WN&SM('<':?RIECXFT/4[]
MK&QU6TN+H GRXY020#@D>N#UQTKF_"_A?4M#OMTZ13/#X?LK".X9@5>6,R[U
MQ][;RG..1]*QM*\/>))]3\.R7EKJ$"V<4T5RTDEJD-NSP,@\B.$_<#8 SSC;
M[D ':3^+]&-MJ)L-3T^YNK*"29H3=!%^0<Y;G"@\%L''>K,WB31K6_AT^YU2
MTAO90NV!IANRWW1^/;U[5Q,NC:[<^!/^$;'AB*.XL]%GLA=22Q$22&'RU\@A
ML@.>27"X'6M"+3M6TVYUBS&@1ZDFJ7D5RES,\9A1=D:E90S;OD,9(VJV>.G-
M ':7EY;:?:27=Y<16]O$-SRRN%51[DU1MO$NB7>GW-_!JMHUK:G$\IE $7?Y
ML_=ZCK5;QA;ZE<Z 4TN!9K@3PNR[(V<(LBEFC$GR>8 ,KNXR*XM?"^OSW&L7
MCV5Y+NN=.NX(M0N83+="!V+HVP[%/0C^'[O/7 !WD?B?0I=-DU%-6LS9Q2".
M28R@+&Q( #>A)(Z^HJC9^.-"O];;3;:^AD LQ>>>)!L*Y8$?@%)/H*YW4] U
M?Q!=:GJ)TA[2.ZFTR,6<\D7F2)!<^9)(^UBH^5B -Q)"_05?\2Z9K3Z[J=QI
MFF17:WFB?9(VF,9B657D;:ZL>0P< <$9ZX% '2:7XBT?6Y)8],U*VNGB 9UB
M<$A3T./0^O2M.N"\-Z3K*>-EU2]M]4^R_P!F-;F749K<R>9YB-@)"=JKC.,>
MASCC/>T %%%% !1110 4444 5-/.8&^9&^;JBX'0>PJ:ZMTN[.:VD)"31M&Q
M'7!&*AT]]\#'S'?YNKCGH/<U;H X>P\.:[CP_::D=/2RT$%HYK:5VDNF6%HD
MRA4",;7)(#-D\=*S_ ^E:UJ7A_P7+J$=E!8Z7;)<1-%(QEF8P&-0RE0$PKG/
MS-D@=*]$CN()698YHW90"0K D ]#2"ZMRCN)XBJ %VWC"Y&1GTXH XWPYX4U
M;3)=#^V-9;-+L;JRS#*S&02/$4;!48XC;(R<<8)[3Z+X4OM-C\'K-+;,=%L)
M+:XV,QW.R(H*9'(RIZXKK3-$(?.,J"+&[>6&W'KFFM<P)")GFC6(XPY<!3GI
MS0!PL'A+Q#IEMI\NFS::;^RL[^%#,[^7YD\Z2(>%R0%4Y]\#D<U+:^%-4N?!
M^I^'+^VL;5;V!]][#?/<RS3MUDD#11YR>3@]   !T[>2:*% \LJ(I( 9F !)
MZ52TC6+;6M,BO[</''*\D:++@,2CLIZ$]U)^E '$KX O-0M]0CO+>PL'FT][
M2.2"\GNV+L58M^\P%3*+\F"3Z\5NZ7IOB";Q:FM:O%IL$<>GM:"*TG>5F<R*
MQ;+(N =IX[>ISQTKW$,:EGFC55)!)8  @9/Z<T+<0M+Y2S1F3;NV!AG'KCTH
M PIO#BW7C636+J&UGM3IR6JI(NY@XD=B<$8QAAWHU#PX;WQ#8W2^5'8P:==6
M3HO##S3%C:,8P!&W?N*Z&B@#AK/PYXC$6@VMT-,$.@*6MY8YGW7<BPM%'N78
M/+7#DM@MSTJ;PWHGB"U6[CUJTTQY=0#&^U""_D>5V*D*%0PJ%11P%W<#U.2>
MSHH \\\.>!;W2KO2DN;;3_*TR-E6Z6\GE><^68U(B;"1'!.<%O08%:>D^%+Z
MPLO!<,DML6T.(I<[&;#DP&/Y..?F.><<5V%% '*>*=#U34-=T;4].M=,NQ8Q
MW"20:A*T:MYFS!!6-^FP]N]1W.B:UJFA_8KBQT?3Y$O[6Y5;.X=T98YDD?.8
MEPV$P.#GC)%=?10!YS9_#^[M-0BA^SV,MG'J)O1=R7DYDV>:90OD#";PQP'W
M8XSMS46AZ5K6LZ=+8/'91:2GB&YNVG\QO/(CO7D"!-N.74?-N^Z>E>ET4 <<
MGA._71H+/S;;S(]?;4V.YL&(W338Z?>VD#'3/?O63XH\%:_KTFLQ^;:SK=.&
MLYKB_G1;9 J_N_(52A.X'Y\D_-G!QBO1Z* .-U+PG?WNF>,+:.6V$FM3+);E
MF;"@0Q1_/\O',;=,\$5JZ9I=]8^*M;O'%NUCJ!BE1A(?,5TC6,J5VXQ\N<[O
M;%;M% &)J^CW%_X@\/W\3Q"+3KB:68,3N8/"\8V\<G+#KCBEAT:9/%^HZL[1
M_9[JPM[5%!.\,CS,Q/&,8D7'/8UM44 <#HOA;Q#:R>&;:]_LU;/08I(!)%,[
M27 ,)C5MI0!.V1D]3SQS=TSPG?66G^#;>26V+:)"T=R59L.3 8_DXY^8YYQQ
M78T4 </X(\%WO@R.R@MY;<VLMFBZC")'/^E(H'FQ9'(8<$';PJD>E=Q110 4
M444 %%%% %2,_P#$RE&Y/N_="_-V[X_K5NJD;YU*5?,<X7[A'RCI[_TJW0 4
M444 %%%% !1110 4444 %%%% !1110 4444 ,G&8)!@G*G@=3Q1 ,01C!&%'
M!ZCBDN!FVE QRAZGVHMQBVB!QP@Z'VH DHHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *J
M:@F^!1Y;O\W1.O0^QJW5+4D+VR@%?OCJP'8^M %VN9\66MQ<ZAX::"WGF6'4
MG>4Q _(OV6=<D_P\L!D]R*Z:B@#RKP;IUU9:BMMI]C(JC3)(?M=SI3V<]J_R
M[(Y'X2<D\[E&?E)S\W+M"TU%E\+0Z=H=W8ZI8HXUBXDM'C#+Y+*ZM(0!,7E*
M,""W3/%>IT4 >)_V7>2:!I]A=Z$\<Z>';:"-I=(ENY9GVMNB4D[+<J<9+#)R
M">%%7[C1]3EMRUOIURFK7OA&&"&Y-LP<7"AMZ-)C]VY4@?,0>@[5Z[10!X]#
MH=]<6>KC0H;J%VT5[<QII!TU&<E=L?S'+2 !P& (&X_-R*Z#PW;:<?'ZWFC:
M#=:=8C1VAD>33WM4,GFH0F&498#OWQU../0:* //O%VG7US<>-3!9W$HN/#4
M<$!CB9O-D!N<HN!RWS+P.?F'K69JMG>1ZAJ7G:0TEK-K<4GVB>QFNHXE6QC4
M2>2A!D&X%,\A6Y/(KU2B@#R#2]*N8;"%M0TF[ET:W\0S3SVO]G,F^)H/W<@M
MP"2@D8-M .#R1E3CT#PZMO#H5RVFZ-/8VYFFD@MI-T1DR<[@C<Q!CG"X&,YP
M,UOT4 >0^%K&Z7Q/X6NH]*>U5$F2[2'1Y;=;;=$3LDFD):4[A][."0#U(S>M
MO#)@L;:_31W75/\ A*I)FG%N?.$)NW!;.,B,QG/I@Y[UZA10!X_8Z)J":Y"E
MU'=#5EUIKAYHM()9H_-+;S=DA?+,>%*YSCY=O%7T%VD%IHG]EZDUU!XH:[D8
M6DGE+ UV\@D\S&TC:PZ'(YR!@UZC10!YM:^$0WA#6[F+3TMM=.I7EY;W$L6V
M0LET\D/S$9V':OL0V>]4)K(ZWX?M?$MU!>12ZGJ)OD9+'[:L$7E-'")8<$LN
MS!^495GSD=:]-U/3+36-/DL;Z-I+:7&]%D9,X.<94@X]L\]#5F.-(8DBB14C
M10JJHP% Z "@#S+0M";4M3\.#5/#T265M:ZD!&;1U@^::+8QCDSY>\;F"-TY
MQTX/"GAQM+'@BXCTF2WN52Y2^E\@JX4QMM$AQG&0H ;T %>GT4 >6Z-I\MCX
MVMC;:;-,3J%R\WVS3&CFM5?S"9!=KA)4)( 4[CAAW7CU*BB@ HHHH **** "
MBBB@ HHHH **** "BBB@"I=INGMCY;MANJ]%Y'7BK=4KQ"US:D%>'YRP'<5=
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** *FGIL@8>6Z?-T?KT'L*L2_P"J?_=-5=-0
MI;,"5^^>C ]AZ5<(!!!Z&@#R#P/:6MSIG@EM&T>YM;JVMB^HW36C1J\30,,>
M80!)OD,;  G&WMBK6G>&8-*\'>"Y+G0G-K$(Y=8MDLR\K/Y+!&EC W/L=NF"
M1P<<5Z=86-MIFGV]A9Q"*UMXUBBC!)"J!@#GGI5B@#RI-,<>7>2:/=?\(L-=
M>Y73C:.66$V^T2>1C=L\_+[-N1G=BHM1TP27VFWEMH\]AX?7[7Y<,NER7@65
MV0B0VWWHPP#X^7Y<G@;J]:HH \JL=*%@GA^77M+OK_1XK.ZCCAET]I6MY'E#
M1[H4WE1Y>57KM'!QFI=,M+G2O"/@ZYETN_BAT[59Y9[<6[O-#$XN44E%!8@>
M8F< \'/2O4** /*X]'DUR\MFO=&NFL9O%4MTT5U:L 8?LC!7=6'"EL#GN<'G
MBJ.F>'[RVU:VMI;>>+4HM9,V^#1B/W0E)#?:LA?*\K"[>H'RA>*]BHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MJ1IC4I6\MQE?OG[IZ>W]:MU2C0C59GRN"G]X9[=NM7: "JQO8Q($VODR&/H.
MHQ_C5FB@"HNH1,H8*^#N[#L,GO36U*%54E9/F&1P/4CU]JNT4 5#J$0W?*_R
MJ&/ Z''O[TT:E"8R^V3 ('0=\^_M5VB@"L;V,2!-KY,ACZ#J,?XTU=0B90P5
M\'=V'89/>K=% %0:A$=ORO\ ,I8<#H,^_M0=0B&[Y7^50QX'0X]_>K=% %(:
ME"8R^V3 ('0=\^_M3O[0B\_R=K[MVW.!C.<>M6Z* *BZA$RA@KX.[L.PR>]
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M1P.O'O[T#4(CM^5_F4L.!T&??VJW10!4_M"+9NVOC;NZ#IG'K37U*%&P5DZ
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MS(WS=47 Z#V%6Z *3:E"JJ2LGS#(X'J1Z^U..H1#=\K_ "J&/ Z''O[U;HH
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M3N_Y9G![^U %FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH J7;[9[8>8ZY;HHX;D
M=>:MU6N2_G0;5E(W<[#@#IUXJS0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5-/?? Q
M\QW^;JXYZ#W-6ZK61<PMO64'=_RT.3V]JLT %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M %2-\ZE*OF.<+]PCY1T]_P"E6ZK(7^WR K+MV\$GY>W08JS0 4444 %%%% !
M1110 4444 %%%% !1110 4444 1W S;2@8Y0]3[46XQ;1 XX0=#[47!Q;2D@
M'Y#P>_%%N<VT1  ^0<#MQ0!)1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 52U)"]LH!7[
MXZL!V/K5VJ6I,%ME)16^<<'/H?2@"[1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M4KQ"US:D%>'YRP'<5=JE>,!<VH**V7X)SQR*NT %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% %+34*6S E?OGHP/8>E7:I::P:V8A%7YSP,^@]:NT %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8X3KUY'MQ2_:/F"^3+RQ7.WCZ_2@":BJZW>XX^SSC@GE*#=X"G[/.<C/"=*
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M2?:)O^>TG_?1H^T3?\]I/^^C4=%',^X<J[$GVB;_ )[2?]]&C[1-_P ]I/\
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MW_/:3_OHU'11S/N'*NQ)]HF_Y[2?]]&C[1-_SVD_[Z-1T4<S[ARKL2?:)O\
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MHHH **** "KNF?\ 'RW^X?YBJ57=,_X^6_W#_,5=+XT9U?@92HHHJ#0****
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MW$%GJ%_=13%=J74@98@-Q^4 #&=QSZUTU93=Y-FD%:*04445)84444 %%%%
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M@5@A$:3_ $6Q\W(^]&@"\=LGBF)H7VFX6>[AA78& CB'WL_WCWI!J;6J7^E
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MJOC.Z2.Y%OHMI_HMOF'RF;RP^]OXR>=W4# QC-2ZY\.)-8NM8<:A9(-28/\
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MM6NF6\$32)'J,4L^V0(5B 8,0<CU[<T@"Q\5!KR\L]8M%TR>U1)&W3B1"K'
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M=K)\-17-OX=L;:[M#:S00K$R%E;)4 ;LJ<<XS6M0 4444 %%%% $=P,VTH)
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M"_*N,@$C)P.=7PIHU[X7N+C0HH6DT",>=I\YD!:'<?F@8$[C@Y96P>#@G@9
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MD#J5?;OQR,^E5[#0-;:#QHT]I>EM4L$BM&OKB%I97$<JD-Y9VJ<E?;!'/4
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MR6!,-E&?NE?WLOZ_*I_[Z%:-%.PKE*/2[<*//WW;@YWW)W\^H'1?P JZ  ,
M8 HJL;P2+_HB_:#GJIPG_?73\LT["N6:R$\1V-QJ4FGV1>ZN(P"_E+E%STRW
M3MVSBKQMFF7_ $E]V0040D+@_P ZFBABA7;%&B+Z*,4U86I5:WNKD@S3>4G]
MR,_S-9^MZ?-_9X33PJR%CN+#)(VG^N/UK=I" 1@@$'J#0G9A8XW0K"2'5%EU
M4I+Y0;R"8P N<<_7@\_X<]D""."#]*S-3T.#4X5C>210K;AACU]\$$_0G%5H
MM.O;&,K;)%M](WVD_I_6J;3U!:&S<#-M*"0/D/)[<5'8@+9Q@,&'/(SZFLN2
MXU:.-MUJY0#G<4Z?F:U;,AK1"#D<_P (7OZ"H&3T444 %%%% !1110 4444
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M5 + #N.H)K&C6\E74;306\1W&DR:7=+<0:M!-^[EV8B6$RJ)&8DL" 6&/?%
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M/V<R2.59LC$NT#"GJP/M5A?$\D>F:EJ%_H&JZ?!86[W#?:/()D55+$+LD;G
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M1QT92,@_E4E9^@C4!X=TP:N<ZD+2+[6>/]=L&_[O'WL].*T* "BBB@ HHHH
M*K7H<PKL:4'=_P LQD]_>K-5-03? H\MW^;HG7H?8T 6Z*** "BBB@ HHHH
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M P,Y&WVJD]IKGB?PKJ&LW$#M=B6UL)84C\TR06\@^TE4R-X:3S/ES\RH!WH
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MG$8_X%W_  S3;[3UO]@DD8(O5, JWU!X/3C(-6P,*!DG QDT 0"!WYN)-_\
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M;1@GGGD^] %VBJAM)3N_TIQE0HZ\$8YZ^WZTT6<WEE?MDF20<\\=??W_ $H
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MB@"E>.5N;4 +R_.5![BKM5KD/YT&UI0-W.P9!Z=>:LT %%%% !1110 4444
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M <CI0 ^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ JIJ";X%'EN_S=$Z]#[&K=5-0&8%^
M5&^;H[8'0^XH MT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %2[3=/;'RW;#=5Z+
MR.O%6ZJ78S/;?*APW5FP1R.G/-6Z "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"IIZ;(
M&'ENGS='Z]!["K=5-/&(&^5%^;HC9'0>YJT3@$XSCM0!673K5-4EU-8L7DL*
M6[R;CRB,S*,9QP7;G&>?I53P_I4FEV4WVED>\N[B2ZN6CSMWN>@SR0JA5!/4
M**Y;3OB*TVM6UI>)IGE7$<SL+*]^T/;&-"Y60A=A. ?NG@COUJ]I_B[4I&T:
MXU'2[>WL=:!^R-'<%Y(V,;2HL@*@?,BM]TG!&.>M '0VFBZ=9:,=(@M@MB5=
M&B9BVX.26R223DL<Y/>LZX\%:%<PV\36]PBP6RVBF*\FC+P#I&Y5@77V;/4^
MIKEQXI\4:KI7A75([.PLH-4OH=L0N79FC:)VVO\ )P"5SQ[#UJ]IOB>_N9UT
MO2;-);V2YU"1VOKMRD<<-R8\YVD\L1A1PH]@,@'6VND6%E>-=VULL4S6\=J2
MA( BC+%%"] !O;H._L*S[7P=H-I&D4=B6B2*:!8Y9I)%6.8J9$"LQ&T[%XZ#
M'&,FK]M?3#1EOM2M392K$9)X/,$GED#) 8<$<<'^72N,AU_7M2U[PE=7%K'9
MZ=J(GG1(+IF8J8&9%E7:!G&&XR 0?0$@'5Z3X;TS19I)K..8RNBQ>9<7,D[*
MB]$4R,2JC/0<4W5_"^E:U=1W=U%.EW&AC6XM;F2WDV$YVEHV4E<]CQ7%6OQ!
MN+/2=$1;:VB2?3+>Y1]4OG4W+.#F-)F4J7&!DN026''>MKQ)XUN-#UQ;!;>R
MC3R4E22_N3 MRS%@8XWVE PP/O,/O#MS0!LP^$]%MQIP@M&A.G.\ELT<SJ07
MY?<0V7W'D[LY[YIH\(:(-3%^+63S!<?:A%]HD\GSO^>GE;MF_/.=N<\]>:YO
M6/B6FFZIJ444-H]OILBQS1R7#+<3':K-Y2!2#@-QDC<01QU.N/$6KWNIWRZ1
MI-O=6-A<I;3,]SY<LK%59S&"NW"AQ]YAD@CCN :H\.Z4+5+86O[E+PWZKYC<
M3F0R;\Y_ODG'3MC%2Z?H]EI<]Y-9QO&UY,9YE,KLI<]6"DD+GJ=H&>]<7>:Y
MJL.K>(TO"'L[;5-.@MU@N7C=!(\/< <'?EAGGE>E:$?C._:&+5FTR :#+?BR
M67[0?/&9?)64IMQM+XXSG!S[4 :%WX%\/WMW<7$MI,!<OYEQ!'=RQP3MW+Q*
MP1B>^1SWS2ZIX?EU;Q+H]S/':#3=+8W$6,F5IMI4+C& @R&ZY)4<#%95OXTU
M62:*YETJU32WU=]*WBY8S;A,T2R;=N-N5&1G/6NWH P[CPCHUSJ3WTMO*9))
M4GDB6YD6&21<;7:(-L9AM7DCL/04]O"NC-;ZC;O:,T&HR^=<Q-,Y4R9SN49^
M0YYRN.>>M;-% &'#X0T6&":(V\TWGS13RRSW,LLCO$P:/+LQ8A2!@9QUXY-6
M+GP[I5XFI)/:[UU+9]K'F,/,V@!>AXP .F*U** *NH:=:ZK9-9WL7FP.RLR;
MBN2K!EY!!Z@&LV^\(:)J5_)>75K(SS%&GC6XD2*<KC:9(PP1\8'W@>@]*W**
M *MKIUK97-Y<6\6R6]E$UPVXG>X14!Y/'RHHXQTJEJ?AC2=8N9+B^MWDDEM7
MLY=L\B"2%LY1@K 'J<9Y&<C%:]% &7J?A_3M7^SM<QS++;9$$UO<20R1@C!
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ME?K?)*8<B%E,952-WS#,0SR.M:VK:-'KN@R:9J$AS*B[IH!L*R*0P=,DX(8
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ME?\ ZWJ*(_&NCM:7EQ*;NV6TM6O)$N;62)V@'5U5@"P^G(R,XR* .AHKG?\
MA--,,$$D<&I2/<%S! EC+YDB+C,@7;G9\R_,>#D=Z;:>*4U+7M'@T]HY=.U"
MPN;GS&1E<-&\2@8.,??8$$9R.U '245ROC'Q'<Z'<:7;175CIT-Z\BR:E?QL
M\,!4 A2 RC<V3C+ ?*>M5;GQ9JFC^$[C5-0MK:]>.[C@@N-/RT-S&[(!(%!8
MKC<PP2>5&#R* .THKG[KQEH]G=/!,UT!#L^T2BUD,=L7 *B5P,(<$$YZ @G%
M,O?'&BV%_=6<[W6ZSE2*ZD2UD:. N%*EW P 0XYSZYH Z.BL'2/$1U3Q'K>E
M&TEB&FR(BR-&P$F4#'DC'4\#N.>]5)M5UK5M>U'3M$FL;.VTTI'<7=W TY>5
ME#[%173 "LN6)ZMC'&: .IHKG4\12Z3X=DU'Q/'%;-!<"!Y+7,B2[G"(ZJ,L
M Q8?*>1SUZU"?'VC(K-)'J4<<;*EQ))82JMLS8P)"5^4\@^P()P#0!U%%<)=
M^-;^WU;Q4RVS&QT*U++";.3?-)L#9\S. O/3:<C+9Q72C6)7\)MK,-E-+,+-
MKA;784=V"D[ #SDD8'UH UJ*X?PQXEU;6+FRE34]"U6UG!^U0V ,4UB=I(R&
MD8L,X4@JIR<XZBN@3Q1I3V5K=BX81W-TUI&"A#>:I8,I'48V.3GH%)H V**Y
M.Y\?:<-%O[^S@O96@L7OK=9;22-;F-0,,A*\KDKD]@<XQ4__  FVFQ6EJ]Q%
M>^?+:K=2Q0V<CM!&<_.X )49!QGDX.,X- '2T5B:AXKTO3WL4+3W,E_"T]JE
MI \QF1=N2-H/9U/TJ'2O&NBZU=VL%E+<,+N-I+:5[:1(YMHRP5F !(SR/8^A
MH Z&BN5G\17K?$.+0(%$5G%:?:;B22T=_,R2  ^X*@&/O$')XJWIWC'1]3NH
M8+>2X'VE6>UEEMGCCN0HR3&S !N.>.HY&1S0!OT5D>'_ !)8>)K/[9IHN3;$
M*R2S6[Q+(",Y4L!NQT..AK7H **** "BBB@"I=[?/MMVS.[C=G/4=,?UJW5*
M\<K<VH 7E^<J#W%7: "BL2]UBYL/%NEZ?*D7]GZA#*D<F#O6X3#!2<XPR;R.
M,Y0U4B\5*MQKMU=[$TG3[B.SA>.-GDFFX#@ 9W?.ZH !G(;KV .FHKGD\9Z0
M;2[FD^UP26LL<,MM+:NLV^0@1@)C+;B>,9[^AIQ\8Z4MA]J?[6CFY^R"U:UD
M$YFV[M@CQDG;\V1QCG.* -^BL;3O%&E:I=06MM+)]HF29A%)$R,GE,JR*P(^
M4@NO!ZYR.*J6_BE+_P 0Z7;61C?3[NSNYFD="'#PRQQX&3P,L^<CL* .DHKG
M]/\ &6DZE>06T'VM?M2-):RS6LD<=PJC)*,PP>.?<<C(JSX?\26'B:S^V::+
MDVQ"LDLUN\2R C.5+ ;L=#CH: ->BN<?QQHB7Z6I>Z(DNQ91SBUD,+S[MI02
M8VD@Y!YQP?0U'_PGVB--+#&+^5TN'M1Y5C*PDF1F#1H0N&8;23CMS0!T]%<?
MKOC>.W\&W>L:3%+)<13BT\J:UDS#*6"D2)PPQG/;.1@\BF:9XY02:I!JT4Z-
MI[V\/FK92(;B215P%C.2&+. %R3CG- '9T50TK5[;6()9;=9XVAD,4L4\+1/
M&X ."K =B#GIS7,Z+XU:YBUS4]5;[+IMG>&U@B-C(LA(;8.23O=FP-BJ""0.
M<T =K17.OXVT6'3[N\N9+FW%G)%'<0S6SK+&9&"IE,9()/!&1U]#3==\5C2O
M":ZY%87;[Y8HU@EMW21=\@0[EQD8R>O4X'>@#I**Y&]\;Q:9XFN[&\M[@VD6
MFP7J^1:222KN:4.7"YPH"+U .2>O;0O?&&D631#?<7/F6XNS]DMGFV0GI(VT
M'"G!QW.#CH: -ZBJ=QJUA:Z.^KRW*"P2'[09Q\R^7C.X8Z\>G6LV/Q?I;12O
M*MY;-%+!$\=S:O&^9G"1G!'(+'&1TP<XH WJ*RKOQ%IMB-6,\S*-*@%Q=X0G
M8A5F!'KPIX%99^(&B!6;9J.$C\Z3&GS?NX>TK?+PAP<'N ?0T =316!;^*+*
M:XN)S>PKI\>F0:CEXF5DCD\P[V8\8(3IC(P<]14<?CC16@GEE:\MS$B2"*>S
ME2217;:A1"N6RW& ,Y(R!0!T=%<E?^-(O[.DET^*1+N"_L[6XM[VW>-D6:9$
MS@XZJQ((R,CV(KK: "BBB@ HHHH **** *FG[?(;;LQN_@SCH/6K$T23P20R
M#,<BE&&<9!&#5737+VS$A?OGHH'8>E7&)"D@%B!P!WH Y6P\"6EE-I32:IJ-
MW%I2-%:03&(1K&T9C*D*@W?*1R3G@<\G,NG^"K6PN+%FU'4+JWTY66PM;AT,
M=ME2G!"AF(4E07+8!JM::YXAMM=T:RUF+3P=665OLELK>;9[$W_,^XK(.BD@
M*-S#&<UL>'M5EU.SN$N0BWME<R6ER$&%+KR& [!E*MCMNQ0!5;PA:#P_H^D0
MWEY FD-$UK<(R&0&-2HSE2IRI(/R]^U1?\(5:Q-'-8ZC?V-Y'-<R+<PF,OB>
M3S)$(9"I7=@C(R,#GKFM#JWB'7Y;^XT>XTRQT^UN9+6)KRW>9KEXSM<_+(@1
M=P*C[Q.,^U:]KK3)9Z2-7@%GJ&H2& 0(WFJ)0C.0&'&,(Q!/L.M %O3],M].
MTF+38]\L$:%"9FWL^>I8GJ222?K6'I_@>VL+[39_[5U.>'3%=+&VE>,QPHR%
M-O"!FP#@%B2,#GKFW/XDM6OK6"WNHUSJ36$XEB8DNL+2%5(P < '<<C (ZD5
MFQ^.[:_\0Z)8Z<DC6NH-,3//;2(LD:1E@\3' 89 YYX(]0: '/\ #^U_LB+2
MH-8U6&P%DEA- 'C99XD! SN0[6()!*;<_@,6]7\'P:JLL(U/4+2TN+9;6XM8
M71HY8QD 8=6*G!(RI!_$ U-IOB[2=5O(;>V>X'V@,UK++;ND=R%Y)C<C#<<\
M=1R,CFK5]K^G:;/<PW<QC:WLVOI,J<>2IPS ]\>G7D>M &9/X+MFN+@VFIZE
M86MVR-=6EK*JI*54+G<5+H2JJ"59<@?C4EWX/MKF_NITU"_MK>\E2:\LX'01
M3NH4 DE2ZY"J#M89 Y[TE[XNT[^Q)[RSNT#?V4VJ1220NZ+%C*LP&#_P'()P
M?2GCQEI U"\LGEF#V*;[R;[.XA@'EB3+/C:,J<CGL: &WG@^SO=0OKI[R\1;
MV:VGE@1DV>9 R,C#*DC/EJ",XQGH>:C7P39K<I_I]\=.CN_MJ::63R%FW[\_
M=WXW_-MW;<]NU7])\2Z?K%RUM MU#<"(3+%=6SPL\9.-ZA@,C./ID9QFL;4O
M%DUGXX.ENZ6NF6=B;V\N)K1V##YND@(5% 7J0V3QUH TE\)V"V$5F);GRX]3
M.I@[ESYIF,V.GW=S$8ZX[]ZWJYU/&VC-;7D\K7=L+2U:]D2YM9(G: =756 +
M#Z<C(SC(K3TO5[?5[ WMO'<I!DA3/ T18#G< P!*D<@]Z +]%9$'B72[BWTF
M>.<^7JL9EM69"-RA/,)/]WY>>:CTCQ5INM3K%:BZ3S(?M$+SVSQ+-%Q\Z,P
M(^9??D&@#;HK"TWQ=I.JWD-O;/<#[0&:UEEMW2.Y"\DQN1AN.>.HY&1S3M9\
M0V^B7\?VNXCCM5L;F\F7R69RL7EY92.  '.1@DY&.AH VZ*QM)\4:;K-[)9V
MWVE)UB$ZK<6SQ>9$3@.FX#<N?3U'K3=7\5:9HMT;:Y-S)*D/VB5;:V>;R8LD
M;WV@[1P?K@XZ&@#;HK!U+Q?I6FOM;[5<D6XNG-G;/,(X3G#L5! !P<=S@\5B
MZYX^:R?5X]/MO.%KH9U2WN'B<Q2'#E02,?+A1SGDDCM0!W%%<]8^,](NUG\R
M6:U-O:_;)#=6[PJ8>\B[@,K_ /6]15:[\=6$>C:G>6]O>?:;.R:\2VN+62)Y
M4 X8!ER5SC)'W<\XH ZJBN:_X3;38K2U>XBO?/EM5NI8H;.1V@C.?G< $J,@
MXSR<'&<&K)\6:4=8MM+A>>YN;B&.X0V]N\B"*0L%D+*,!<KU)[B@#<HKGO%'
MB-O#LVBDQ[X;V^^S2A8FD?!AD<;%7G<611T/!/U#AXPT@Z<EXK7+,]P;06RV
MSF?S@"3&8\;@0 3SQCG..: -^BN>'C/2'L8[E/M;R27+6BVJVK^?YR@LR&/&
M00H))/&.<U-)XJTN/2+?4M]PT=S*8(85MW,SR@D%!'C=N&UL\<8)Z<T ;=%8
M+>,-(&G)>![AB]P;5;9;=S.9@,F/R\;@0 3TQCGIS3?"GB%_$<.J3E D=MJ$
MEK$#$T;[55#\ZMR&RQ!X'3I0!NSX\B3.,;3G.<=/:H[/'V1-NW'/W<XZ^_-/
MN#BVE(QPAZCVJ.Q8M9QDXR<]!CN: +%%%8_B+6Y=$MK1X+,7<MU=):I&9?+^
M9@<'.#Z?K0!L45@Z;XBEGU.;3=3T\Z==QP^>H,PD1X\X)# #H:OVFM:7?1S2
M6NH6TR0#,K)("$'J?0>] %^BJ-CK.F:D)#97UO/Y7+^6X.T>I]J9;Z]I-VEP
M]OJ5K*MNI>4I(#L4=2?;WH T:*QYO$5F1;-8S6MVLMVELY%PJA-P)X_O'C[O
M4U/_ &_I'VM;3^TK7[0TAC$?FC=N!P1CUSQ0!HT5@MXJLFOM6LH2C7&G0^80
M\H19" 20#V P 2>F:M-K^GVUA9W.H7=M:&YC5U5I@1R >#W SUH U**I76L:
M;91Q27-];Q)*I>-GD #@8)(/?J/SJ>TN[:^MDN;2>.>%_NO&V0: )J*** &3
MG$$AR1A3R.HXH@.8(SDG*CD]3Q1.,P2#!.5/ ZGBB 8@C&",*.#U'% %?4]3
MM-'T^2^O93'!'@$A2Q)) 50HR222  .2362WC71H=.NKVY>YMEM)(H[B*>V=
M98S(P5,IC)!)X(R.OH:?XOT"3Q'H/V.%T2>.>*XB\QF5&:-PVUBOS '&,CD9
MR.E<Y'X(OI+2\)MM/LIKB[L9%C2[FN/W<$ZR-ND<9)/S8 4 9Y// !T*>,]'
M:QO;F5[FW^Q.D<\$]K(DP9\>6 A&YMQ( P#D\5GV7CNUEO\ 73>*]K8Z:ML%
M66VD2?S)=PV%#RQ)"[0!SGOFF:QX2O[[5M3U&VGMEE>2PN+19"V#);LS%9,#
MA6W8R,D=<<<U9_"NOZE=ZGJ=U_9MM>2SV5S9PQRO*BM;LQVR,44D-GJ!QGH<
M<@&^OB_23IVH7DC7$"Z< UW%/;NDL*GD,4(SMQDY''!]#4^H^)M*TN>:"ZG<
M20PQS.L<3.<2/L0 *#EF8$ #DXJAINAWMUJFKZGKT-HAU"UCLOL=O*TJ+"GF
M$[G*KN+&5OX1@ =:Q;3P9K]CX8O+==3CDU::> -,DSP^;:P[46+S%&Y&9%8E
ME'#.V/6@#?3QGI!M+N:3[7!):RQPRVTMJZS;Y"!& F,MN)XQGOZ&G'QCI2V'
MVI_M:.;G[(+5K603F;;NV"/&2=OS9'&.<XKF(/ VII%KV^STAX]1^RE+.>YF
MG4^46W*\K+NW$$$. 2#VXR9K+PCKUF+6^CE@,]C?M<6FGW%]+/''"T)B:/SV
M7?DY+#Y2!TZ<T =/:^*-*NTLFCED#7ET]I'')$R.LR*S,C*1E2 C=?;U%5+W
MQ2@U73;2Q,;I+JKZ?=F1""A6W>4[>1SE5YY&":JW^D^([RVTN_D.GR:I8:BU
MXMKYC+#Y9C>/RA)LR2 ^=Q7D]@*I6OA'7/M$-W<7%C%<C6YM2;R69PBO:M$J
MC*C<0S#K@$#/'2@#;T_QEI.I7D%M!]K7[4C26LLUK)''<*HR2C,,'CGW'(R*
ML^'_ !)8>)K/[9IHN3;$*R2S6[Q+(",Y4L!NQT..AKD-(\%Z[#K6B:A?FU:6
MQ65;NX?49[F2Y9XF3>H=0(QN(.P<8/7@ ]?X5TJ;0_">DZ5<M&T]G:1P2-$2
M5+*H!(R <9]J ,FP\>63Z-J6J:E#<6=M9:@UGEH');][Y:G&,DDD9 '&:G'C
MO1@3YBW\2Q[1</+92JMJ6Z"4E<(>0>>@()P"#6>_A359-+U'3F-D(Y=<CU*"
M3S6):/[2LSJR[>& 4@8)!]JH:OX!O+G5-8,%O8W-MJLPF:6ZO)T,&4574Q)\
MLHPN1EEZX/ H Z;4/&.D:9>3V]P;HK;.D=S/':N\4#-@@.X&!PRGV!&<57O_
M !E;Z9XDU#3KRWG2TL=-^WRW(A=@!EL]!C "_B<CM7/>)_!.OZXVL0B6UG2Y
M93937&H3JML@5?W?D*I0G<I^?)/S9P<8K5\4>&-5U>^U9[(V?DZEH;Z:QFE9
M6CD_>%6P%.5)?!Y!&._2@"R_Q"T.-ID*:D9(HA<&,:?-N,!S^^ V\IP>?\15
MR]\7Z19-&N^XN"]N+H_9+9YO+A/21MH.%.#CN<''0U!<^';N;6;R\62 1S:,
M-/4$G(DW.<GC[OS#W]JYR7P#J,#V\\$-E>RMI=M92I-?SVZQ21*0'4QCYU.[
M[I /'!&30!TM_P"-]%L)S"7N;AA:)>G[):R3 0-NQ)E01M^4_I2VGBJ.]\7_
M -C002/;MI\=['=+&VQPY;'.,8P!SW)([53T_P )7&GSW>Q[40R:);:;$J;E
MVO'YN3@YPG[Q<<D\'\30O#FIZ/J^ESL;26"+18-.N2)6#+)%D[D&W#*2V.2I
M&/PH U-5\5:9H]VUK/\ :99DA\^5+:V>;R8LD;WV@[1P?<X..AK,7Q1<7_CR
MTT?3V7^SC8K>//\ 97D$X?.W9(&"JN!][#9/%27^E:Y9^(-0U/1$T^<:C;10
MRI>3/'Y+Q[PKC:C;UP_*\=.O-)X=\)S:!J-FRW"2VMKHT&G!CD.SQLQ+8Z $
M$=Z +>J^)#IWBG2=&%I+(+Z*:0S+&Q";-N!D#'\7)[<>M9_A'QW:Z_INCBZ6
M6"_O[03 _9I(X)'"@R+&S<';SW/ [XK0UC2K^Y\1Z+J=F+=H[19X9TFD9#LE
M"?,N%.2-G0XSGJ*R;+P;>1:1X1L9YH/^)1;O#=F-V^;=;M%E..>6SSCC\J -
MC3?%VDZK>0V]L]P/M 9K666W=([D+R3&Y&&XYXZCD9'-;M>?>&? U[I%]I N
M;:P\K2T*K=)>3RR3G844B)L)$<$YP6]!@5Z#0 4444 %%%% !1110 54U!]D
M"GS'3YNJ#GH?<5;JIJ";X%'EN_S=$Z]#[&@"W7/^*O#H\2#1XI(K6:VM-12Z
MN(;E=RR1B.1< 8()RXX/'%=!574-2LM)M&N]0NHK: $*9)6"C)Z#W)]* ,G5
M/".FW7A74]#TZUM=-COH6C)MH%10Q'!(7&:YAO NI7>GZNDEIIMG<7.DSV$+
M)?7%SN>0#+%I!\B?*/E 8^_'/9/XFT*/3H=1?5K-;.9RD<YF&UF )*@^N%;C
MKP:/^$FT/^R%U;^U;3[ S^6)_-&TOG&W_>SQCK0!R_Q!T2YET2]U&,Q^3:>'
MM0M70$[BTBQE=HQT_=MW[BFZCX8U_P 2V5Y)J TZVG.BW&G6BPS.RN\P7=(Y
M* J/D7"@-C)Y/%;>F^-=*OM/U#49KJVM[&UO3:)<&<%)OE4@@\<G=C STK5M
M=<TJ]6U:UU"VF%V6$!CD!\PK]X#W'<=L4 <[XB\&SZ_<3*;B*&";19M.+#)9
M9&=&5L8P5&PYYS62W@74KO3]722TTVSN+G29["%DOKBYW/(!EBT@^1/E'R@,
M??CGLKOQ-H=A&7NM4M8E$K0_-(,EU^\H'4D=_2GS^(-'MM+AU.74K5;&?'DS
M^8"LF>0%(^\< ]/0T 8OB+0M7O[S3C:F.>PA@>.:R:_EM%,AV[7+1J2X ##:
M>.<U4\*^#]1T.?0WNIK1ET^TOH)/)9OF,TZ2(5!'3:ISD\''7K70S^)]"MM.
MM]0FU:S6TN3B"7S05DQUV^N,'..F#5F'5].N Y@OK>4) MRQ20,!$V=KY'\)
MVM@^QH S]>M=<>XMKG2&L[B)4>.YT^]8I'.&P0P<*Q5A@CH00QKG4\$ZD/#F
MMPQQZ;9W>HW<-W%96S,+6$QM&<;MH.6V?,P4<GH<<]+:^([:ZUJ\LU\L6MO8
M07PO/-&QTE,@],  1YSGOVQ3K7Q7X?O8+J:VU>SDCM(_.G991B./D[S_ +/!
MYZ<4 <?J/@+4+N^U1A::=-'JTBS2O/?7 %LQ15D7RT 69?EX)*'G!X%:NH^$
M;ZZTKQ?:Q2VP?69D>V+,V% ABC^?C@YC;IG@BNDL]:TS4+&:^L[Z">UA++)-
M&X95*_>Y]JQ].\?^'K[1;'4YM1M[-+T$Q1SR@-D$ CW(W+G'3- %K3-+OK'Q
M5K=XXMVL=0,4J,)#YBND:QE2NW&/ESG=[8K-U#0-5M=4U6XTNUTS4K#5PK7F
MGZA(T:^8$"%E8(X(954%2O;.><5N+XBT9M6.E+JEH;\-M-N)1OW8SMQZXYQU
MQ31XFT,ZM_90U6T-\7,?D"4;MX&2O^]CMUH Y6Q\!W=IX9NK!%TRWFN]9M]2
M:WM4*6\"QR0DHG&3\L)YP,EN@JOXH\%:_KTFLQ^;:SK=.&LYKB_G1;9 J_N_
M(52A.X'Y\D_-G!QBNBL/'>@7MK<W,E_;VT4%Y):;II0-[)NZ?4*Q ZX%6[7Q
M=X=O;FVMK76K&::Y!\F-)@2_7@#UX/'7@^E %&X\-75P/%RF:%5UJ$1P'))3
M]P(R6X]>>,\5H0V6IR^$UL9)X[#4OLODB:V;S5B<# 9=RC=V."!Z>]2W7B+1
MK+4H].NM4M(;R3;MA>4!OF.%X[9/3/7M4=SXIT"SU#[!<ZQ9178D$1A>8!@Y
M (!';(9<9ZYH YY?#NN:GK^E:AJMAHEG-I\WG27UC([SW/RLNS!1=B'.2"S=
M,>]5M$TU-0^(&LWEE<)+I=HSO$-A*)?2J$F^NT1Y(]9FKJ-,\2V&JZ[JVD6[
M@W&FNJ2?,/FRH)('H"<?4&IKKQ'HMCJ2:==:I:0WC[0(7E ;YONY';/;/7M0
M!Q=CX%UB.WOK119:9:W&FSVDD%I>32P3RNH"R"%U"P@<G"YZX[9)<^"M8ENE
MU!K/3KBZGL(K6:%M2N(DADCW!75D0&12&Y4@$$<'DUT>F^*UU7QEJ>AVR6QA
MTY )I3<'S6<XR FW&T9P26Z]JO3^*-"M=1.GSZO9QW@D$;0O* RL0"H([$[E
MQGKGB@#/LO#4UCJWAZ>-K<6VEZ9-9.J!ERS&':4!SA?W3=3D9'6JFC^$[_3X
M/"<<LML3H_G_ &C8S?-O1E&WCGEAG.*W]3\0:/HTD4>IZG:VCR@E%FD"D@=3
M]/?I537/%ND:'%,D^HV*7H@,T5O/<B+S.&*Y.#A3M/S8.,4 )<:#+<^)[R_D
M=!:7.EBQ*J3O#;W)/3&,,._6L;3_  UKK?\ "/V6HG3TLM"&8YK>5VDNF$+0
MIE"H$8VN20&;)X'%=!?>*-#TJ58=1U6SM9C&LACDE (5LX;_ '?E//3BJ5YX
MVTG3/$-QIFI75M:11VD-U'<2S@"3S&D4@#T'E@YS_%V[@%WPKI4VA^$])TJY
M:-I[.TC@D:(DJ650"1D XS[5KUF:AXCT723"-0U2TMC.N^/S)0-R_P![_=Y'
M/3FEN/$&CVNI0:=/J5M'>S[?*@:0;WW9VD#T.T_E0!I45D6GBC0]0NY+2QU6
MTN;I%9O*CE!+!>N/7!ZXSBI?#VK?V[X<TW5_)\C[;;1W'E;]VS<H.,X&<9ZX
M% &E1110!4NWVSVP\QURW11PW(Z\U;JI=INGMCY;MANJ]%Y'7BK= &-XGTFX
MU?2%2Q>*/4+:>.ZLWF)"+*C9 ; )VD94X'1C67-X9U.U\"6VCZ;>A;Y&22YE
M$S0_:6+[YAYB@LF\E_F R,UJ:AXFL--\1Z;HD[A;F_21T)8 *%QU]R3Q]#38
MO&'AR:RFO8M;L7MH2BR2K,"H+C*C/J>PH Y2#P-J:1:]OL](>/4?LI2SGN9I
MU/E%MRO*R[MQ!!#@$@]N,F:R\(Z]9BUOHY8#/8W[7%II]Q?2SQQPM"8FC\]E
MWY.2P^4@=.G-=8WB/14TI-4;5+06+ML6?S1M9LXVCU;((QUXJA>^.-#M(-+N
M([V&X@U&[^RQR1R JK $L3],8(ZY(H H2Z5XI_M;3M<QI=Q?0I<P26C3O'''
M%*T94+((R6*^4,DJ,[CTP*BT'PAJVER:1)/=VGFV=E?P221;C^\GF21&52.@
M"G()ZX'/6MR3QCX;BN7MY-<L$F0N&1IU!4H2&!]QM/'7BIAXET0Z1_:PU6T_
ML\ML^T>:-N[.-O\ O9XQUH X[2/!>NPZUHFH7YM6EL5E6[N'U&>YDN6>)DWJ
M'4",;B#L'&#UX /7^%=*FT/PGI.E7+1M/9VD<$C1$E2RJ 2,@'&?:G/XFT*/
M3H=1?5K-;.9RD<YF&UF )*@^N%;CKP:IZGXTT;3_  U_;T=W%=61F2%7AD!!
M9G"XSVQR2.O!H X-9[@76F>%[*XL9XK77Q-Y?[P7:QK.TC;XRN%5>?WFXAAC
M YKHY?"FMQ:/#:6T\3K_ &K=WES;QWDML+B*621T7S47<I&]20!@X(SBNQGO
M[.VT]K^XNH8K-4\QIY'"H%]23VK UKQWI&G>%[G6K.[M;U8I%A5%G"@RL0 K
M'!*\')XZ#.* ,FS\$ZG#X2UC2F:QCFO=32\B$<LCHB!HF*EF7<2/+89[\'C.
M!9U3POJ=U>^(-EMI5W9ZE);SK'=NXW-&J*R$!?ER$R'!)!Q\M=+'JD4.AQZG
MJ4]I;1>2LLLJS9A4$=0[!<CG@D"HK;Q+HEWI]S?P:K:-:VIQ/*90!%W^;/W>
MHZT 4?"&CZCHUI>1WTN(I9]]M:_:Y+H6R;0-HED 9LD$XQ@9P*H2^$K]M&NX
M8Y[87@UIM5M=Q8QG$WF*C\9&1P<9QG(SBMR/Q/H4NFR:BFK69LXI!'),90%C
M8D !O0DD=?45D2?$'1I+F[MK"YMKB2'3C?I(UP$B<#=\I;!VXVY)QP#WH I7
MGA36=9N+S4;[[#;75Q-IZI;Q3-(B0VUQYS9<H"S-N;'R@#@9ZFN@\6:5=:UX
M;N+&R:(7+/%+'YS%4)CD5\$@$@';C.#UJ6;Q)HUK?PZ?<ZI:0WLH7; TPW9;
M[H_'MZ]JO7EY;:?:27=Y<16]O$-SRRN%51[DT 81T.^FUO5=1E-NGV[28;,(
MKLVR53,6YVCY?WBX/4X/ KF6\ :E;?9988;*]F.E6UC,LM_/;K%+"I7>IC'S
MJ=WW2 >.",FNSA\4Z#/837T>KV9M89%BEE,H C=B H;/W221U]:=;^)M#N].
MN-0@U:S>SMCB>82C;$?]H]NHZ^M $+:(\7@L:';K9ETLA;(LT): D)MP4))V
M'TR>/6N3C\$ZW_9M]#";:QCWVDUIIYOYKJ!989A*3O=08U;:%VJ"!U]JZG0_
M%-GX@U74K2P:*:"R2%A<1R;@Y?=D8Q\I&W]>U6=1\3:'I%S]FU'5;2UFV!S'
M+*%8*20&Q_=^4\].* .;N/#&NZI9>+VO/[/M[C7+!;:WBBF=UA*QR+\[E 2,
MN#D+ZC'&3F^)[U_#>L:K]FN[".34=,BC>*]\Q2602*I@VJ1*><&/(.<'/-=Q
MJ/B+1=(:%=0U2TMFF7=&)90-R_WO]WD<]*+GQ#H]GJ$.GSZE:QWLX4Q0-( [
M[L[2!Z':>?:@#D;3P1>7N@3VUU*EN+SPW9Z;CDO%-&)"2RXQC+KWYP>E7]2L
M/&FKZ?+&\^GV)'E 06EW(//PX,G[[8&BW*-HV@D9/-:,7C31(["SFU+5-.M)
M[BVCN#$+H.H5P<,&P,IP?FP!QVIEYXVTG3/$-QIFI75M:11VD-U'<2S@"3S&
MD4@#T'E@YS_%V[@'.V_@355?4WVV-NMW=Z=<)$+N6<H+>;>X:1URQ('!]3C@
M#)]&K,U#Q'HNDF$:AJEI;&==\?F2@;E_O?[O(YZ<TMQX@T>UU*#3I]2MH[V?
M;Y4#2#>^[.T@>AVG\J -*BLBT\4:'J%W):6.JVES=(K-Y4<H)8+UQZX/7&<5
M+X>U;^W?#FFZOY/D?;;:.X\K?NV;E!QG SC/7 H TJ*** "BBB@"II[[X&/F
M._S=7'/0>YJQ+Y@B<Q!3)M.P.< GMD^E5]/39 P\MT^;H_7H/85;H XGPKHW
MB?3M5DO=;M=(N+JZR+J_BOI7E"C)5(XS" J X^7=ZDY/71\'Q-(FL:M@B+5-
M1>X@]XE1(D;Z,(]P]F%'_";:3/X@T_2=/NK:]DN9)4D:*<'R=B,V< '()4CK
MQ^E2KXQT:WTNPNM4U*PLY+NW6X""Y#J%(^\&P,IG^+ % &-<>&=7LX]0TVTT
M[1-8T6\N7NEM]3D9/(=VWL"!&X==Y+#[I&<<]:;;>#=1T?PWX?MM/:QFO=)O
MY;WR3N@@<2>=NC4@,5 $QP<'[H]:ZK4=>TG2((9]0U&VMHICB)I)  _&>/7C
MGZ57F\6^'K>U@NI=9LE@G#M"_G#$H1@K;?[V"0#B@#FX?!FK7)1]1ELE:36I
MM0F6"1R%BDM7AVJ2HRP+#DX! SQTHLO"WB!Y/#]GJ']FKI^CP26YF@F<RW"M
M"8E8*4 0X(R-QY)YXYZBY\2Z):6%M?SZK:):W0S!*91MEXS\OKQSQ1>>)M#L
M+2WNKK5K..WN5WP2&4$2+U++CJ!D<]!F@#D_#/@:]TB^T@7-M8>5I:%5NDO)
MY9)SL**1$V$B."<X+>@P*V/%_A>X\07&ERVLT47DS>7>>9G][:,RM(@P.I,:
M=>.M.O?&^FV^HWNGP36\MQ;Z;_:"L]P$B=<,0-^#@87<6P0 0>:T]0\1Z/I!
MA74]3M+229=R++*!D=S_ +O/7I0!REKX#O[?PYXKT\W-L\^I0S6>GDEML-L1
M(8D<XR,-*^< \8ZU>F\&SWFE>++"XN(HUUIP8I(\DQ@6\4?S# _B0G /0UU5
MW>VMA9R7EW<Q06T:[GFD<*JCU)-9\/BG09[":^CU>S-K#(L4LIE $;L0%#9^
MZ22.OK0!B^&?#%YI^N?VC>V-A:F.U,"^1>SW+NS,I8YDP$7Y1\N"??CF3Q#X
M1GUZ_P!5?[1'%!>Z2MBC<EDD$C.&(Q@KR._/-;%OXFT.[TZXU"#5K-[.V.)Y
MA*-L1_VCVZCKZU6T/Q39^(-5U*TL&BF@LDA87$<FX.7W9&,?*1M_7M0!@ZQX
M8\0^)HKZ341IMI<?V/<Z=;1V\[R(\DP7=([%%*J-BX4!CR>:[=(MMJL)QP@4
MX^F*S[K7K2PU"ZAOKBTMK>"&&0S27 !!D=D 92/E&5 #9Y)(XQSGZAX[T"ST
M&;5X;^"[MXIX[=O)D!(=V  /IP=WT% &+HWA7Q%;-X:MKLZ8EIH,4D"RQRO(
M]P#"8U<H4 7'&5R<Y//'+O#O@[4]/OB)4M=.L&M)(+BWL+R62*XD;&)%B=0L
M& &X4G[V.V3U$WB;0[>]ALYM6M([F8*T<;2@$AON_3/;U[4RY\5:!9WTEC<Z
MQ9Q747^LB>4!DX!Y';A@?QH Y;PSX&O=(OM(%S;6'E:6A5;I+R>62<["BD1-
MA(C@G."WH,"M/QCX6OO$,DC6DMN@;1[ZP'FLP_>3^5L/ /RC8<]^F :Z*ZU;
M3K%Y5N[VW@:*'[1)YL@79'G&XYZ#/&:K1>)M#FTV344U:S-G'(L4DQE 5'8@
M ,3]TDL.OJ* ($T:X7Q;:ZKOB^SPZ8]FR@G=O,B,"!C&,*>_IQ5*_P!*UVT\
M0W^J:&MA*=1M8H)!=RLGD/&7VN-J-O&'Y4XZ=>35R;QAHB^'M1UJVOX+NUL(
MV:;R9 2"!D+[$\8SZBBT\56%RDER]S9PV*645V9VN1E0Y<'<"!M4;.&SR<C
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MDMQ'YB98+N#$G#$'K[9]!H)P,T >;6FAZU!<IK;Z&P:+79[_ /LY9HC(T4L
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MHEM'A)(UV$RW& V]A\A[D9/ X-=_48@A6X:X$2"9U"-(%&YE&2 3UP,GCW-
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M%BAA0R2.QP%4#))]@* /-;[P]XDFTR\@ETR.6YO?"ITYFM7BCBCN%$A"8+#
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MAE##H1D<4M>8O>:>=9U1M>U6_M]6BO(%TRWMKIED:$I&5\J+.V3<Q<-P>X.
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M'(S76V+%K.,G&3GH,=S4DN$MI-OR (<;1TX[4RS;=:(=[/G/S-U/- $]%%%
M!1110 4444 %%%% !1110 4444 %%%% #)QF"08)RIX'4\40#$$8P1A1P>HX
MI+@9MI0,<H>I]J+<8MH@<<(.A]J )**** $P"02!D=#Z4M%% " !1@  >@H
M Z #)SQ2T4 )@$@X&1T-! 88(!'H:6B@ I  HP  /04M% !WS2 !1@  >@I:
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JIJ"
M;X%'EN_S=$Z]#[&K=4M20O;* 5^^.K =CZT 7:*** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@"I=INGMCY;MANJ]%Y'7BK=4KQ"US:D%>'YRP'<5=H **** "BBB@
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M)LK4S23&VA\R6,12/Y8RZ#.%)[J-S<=.3ZU)##%;P1P01I%#&H1(T4*JJ!@
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MO&5QK U2QM],N+AHOL\LLUK8W$,5T<% LB^:-K*N2"N1RPZ]*Y6;6[F*ZO\
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M *JY)W#.,$U2T#PKJRZ[HDEU;ZA:V>DQRJL=S>Q31+NC,82'8-Q4 _>E^8
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M^<L!W%7:I7C 7-J"BME^"<\<BKM !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!2TU"EL
MP)7[YZ,#V'I5VJ6FL&MF(15^<\#/H/6KM !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
M'<#-M*!CE#U/M4=BI6SC!QD9Z'/<U)<'%M*2 ?D/![\5'8D-9QD*%'/ SZF@
M"Q1110 4444 %%%% !1110 4444 %%%% !1110 R?_42<@?*>2,CI1!_J(^0
M?E'(&!THG.()#DC"GD=1Q1 <P1G).5')ZGB@!]%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !534#B!?F1?FZNN1T/L:MU4U!]D"GS'3YNJ#GH?<4 6Z*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %FJUZ7$*[%E)W?\LS@]_:HTTV%&R&DZ$<D=QCTH;386506D^48'(]2?3WH
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M'T]J +M%4GTV%VR6DZ <$=ACTJ0648D+[GR9!)U'49_QH LT5433XD\O#/\
M(VX<CKQ[>U T^(;?F?Y5*CD=#GV]Z +=%4ETV%58!I/F&#R/4'T]J'TV%VR6
MDZ <$=ACTH NT54?3XG\S+/\[;CR.O/M[T)I\2>7AG^1MPY'7CV]J +=%5!I
M\0V_,_RJ5'(Z'/M[T?V?%LV[GQMV]1TSGTH MT52?387;):3H!P1V&/2G/I\
M3^9EG^=MQY'7GV]Z +=%5$T^)/+PS_(VX<CKQ[>U T^(;?F?Y5*CD=#GV]Z
M+=%5/[/BV;=SXV[>HZ9SZ4'3XCN^9_F4*>1T&/;VH MT54?3XG\S+/\ .VX\
MCKS[>]":?$GEX9_D;<.1UX]O:@"W15)--A1LAI.A')'<8]*=_9\6S;N?&W;U
M'3.?2@"W150Z?$=WS/\ ,H4\CH,>WM0^GQ/YF6?YVW'D=>?;WH MT5433XD\
MO#/\C;AR.O'M[4U--A1LAI.A')'<8]* +M%4FTV%E4%I/E&!R/4GT]Z<=/B.
M[YG^90IY'08]O:@"W151]/B?S,L_SMN/(Z\^WO3C91F0/N?(D,G4=3C_  H
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G9:[OLR;@X/.0YR>M0/IL+MDM)T X([#'I5J&)8(EC4D@=,T ?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
